Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Physical measures,X4270.Volume level set by participant (left),GAST,Gastrin,14628,0.0552667425142154,0.0116274081585918,0.0324770225233754,0.0780564625050554,2.02186384121232e-06
Physical measures,X4270.Volume level set by participant (left),TFF1,Trefoil factor 1,16591,0.0715188527607281,0.016539611551376,0.039101214120031,0.103936491401425,1.54053651183569e-05
Physical measures,X4270.Volume level set by participant (left),DPP6,Dipeptidyl aminopeptidase-like protein 6,16576,-0.162241511124619,0.038421912232776,-0.23754845910086,-0.0869345631483781,2.42757344797653e-05
Physical measures,X4270.Volume level set by participant (left),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14629,-0.225313943503544,0.0550798913929131,-0.333270530633654,-0.117357356373435,4.32425657327119e-05
Physical measures,X4270.Volume level set by participant (left),PI3,Elafin,16403,0.0954700991091427,0.0234617209489457,0.0494851260492092,0.141455072169076,4.73988141669636e-05
Physical measures,X4270.Volume level set by participant (left),RANBP1,Ran-specific GTPase-activating protein,14288,-0.117474816432694,0.029069846024945,-0.174451714641586,-0.0604979182238019,5.34747665098664e-05
Physical measures,X4270.Volume level set by participant (left),TFF2,Trefoil factor 2,16710,0.0884722041164094,0.0219563693341346,0.0454377202215056,0.131506688011313,5.6154045872502e-05
Physical measures,X4270.Volume level set by participant (left),BCAN,Brevican core protein,16533,-0.145133931037145,0.0380972096990251,-0.219804462047234,-0.0704634000270561,0.000139713788804497
Physical measures,X4270.Volume level set by participant (left),LRRN1,Leucine-rich repeat neuronal protein 1,16350,-0.12404843419866,0.0327951361968283,-0.188326901144443,-0.0597699672528763,0.000155798869913515
Physical measures,X4270.Volume level set by participant (left),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16810,-0.179430378422123,0.0476550047180648,-0.27283418766953,-0.0860265691747161,0.000166986520708173
Physical measures,X4270.Volume level set by participant (left),SPOCK1,Testican-1,16533,-0.185896440981615,0.0496778343650496,-0.283264996337112,-0.0885278856261179,0.000183150602573401
Physical measures,X4270.Volume level set by participant (left),ANXA10,Annexin A10,16257,0.0603415723864014,0.0161514842502459,0.0286846632559193,0.0919984815168834,0.00018762787938799
Physical measures,X4270.Volume level set by participant (left),MZB1,Marginal zone B- and B1-cell-specific protein,16698,0.0905933730158849,0.0245980592923223,0.0423811768029331,0.138805569228837,0.000231280302727245
Physical measures,X4270.Volume level set by participant (left),VGF,Neurosecretory protein VGF,14629,-0.180400029691253,0.0492085971667115,-0.276848880138007,-0.083951179244498,0.000247221276567518
Physical measures,X4270.Volume level set by participant (left),CA14,Carbonic anhydrase 14,16810,-0.126869633966038,0.0354216772411275,-0.196296121358648,-0.057443146573428,0.000342337143950433
Physical measures,X4270.Volume level set by participant (left),KLK8,Kallikrein-8,16161,0.130049111816963,0.0364233850727835,0.0586592770743073,0.201438946559619,0.000357357394270223
Physical measures,X4270.Volume level set by participant (left),GHRL,Appetite-regulating hormone,16666,-0.0566497442339225,0.0159402092961763,-0.0878925544544282,-0.0254069340134169,0.000380629215461342
Physical measures,X4270.Volume level set by participant (left),CCS,Copper chaperone for superoxide dismutase,16533,-0.0964224538115704,0.0273252605307265,-0.149979964451794,-0.0428649431713465,0.000418752140723656
Physical measures,X4270.Volume level set by participant (left),SPINK6,Serine protease inhibitor Kazal-type 6,16810,0.0790817759361666,0.0230069837008214,0.0339880878825566,0.124175463989777,0.000588980339185122
Physical measures,X4270.Volume level set by participant (left),FGF21,Fibroblast growth factor 21,16794,0.0364551011055899,0.0107395427343506,0.0154055973462628,0.057504604864917,0.000689196823551681
Physical measures,X4270.Volume level set by participant (left),TEX33,Testis-expressed protein 33,14404,-0.126431947939181,0.0374515786027563,-0.199837042000583,-0.0530268538777782,0.000737752616630141
Physical measures,X4270.Volume level set by participant (left),LXN,Latexin,16433,-0.0609502274863814,0.0180587544606991,-0.0963453862293517,-0.0255550687434112,0.000739579067785885
Physical measures,X4270.Volume level set by participant (left),ATP6V1D,V-type proton ATPase subunit D,16576,-0.165444190643848,0.0493045131734819,-0.262081036463872,-0.068807344823823,0.000793828070221482
Physical measures,X4270.Volume level set by participant (left),KLK14,Kallikrein-14,16810,0.0907481373336353,0.0270611124039657,0.0377083570218626,0.143787917645408,0.000799867241176405
Physical measures,X4270.Volume level set by participant (left),TGFA,Protransforming growth factor alpha,16637,0.0948188207770348,0.0284777854293185,0.0390023613355705,0.150635280218499,0.000871689424284756
Physical measures,X4270.Volume level set by participant (left),TSNAX,Translin-associated protein X,14175,-0.12469477605453,0.0378645890953649,-0.198909370681445,-0.0504801814276145,0.000993051312615622
Physical measures,X4270.Volume level set by participant (left),GPC5,Glypican-5,16533,-0.075390562973607,0.0229918470883669,-0.120454583266806,-0.0303265426804078,0.00104386325899459
Physical measures,X4270.Volume level set by participant (left),SPINK1,Serine protease inhibitor Kazal-type 1,16671,0.0987997655148152,0.0304879220885254,0.0390434382213055,0.158556092808325,0.00119504330534091
Physical measures,X4270.Volume level set by participant (left),PSMD1,26S proteasome non-ATPase regulatory subunit 1,14629,-0.0934343036820739,0.0293056264556301,-0.150873331535109,-0.0359952758290388,0.00143427580692761
Physical measures,X4270.Volume level set by participant (left),BPIFB1,BPI fold-containing family B member 1,16640,0.063681546420497,0.0199851848906263,0.0245105840348695,0.102852508806125,0.00144302786269236
Physical measures,X4270.Volume level set by participant (left),SNAPIN,SNARE-associated protein Snapin,14629,-0.0795734151611305,0.0250295523859841,-0.128631337837659,-0.0305154924846016,0.00148001139100404
Physical measures,X4270.Volume level set by participant (left),OMG,Oligodendrocyte-myelin glycoprotein,16576,-0.0621802347176411,0.0196000688795763,-0.100596369721611,-0.0237640997136715,0.0015143470091559
Physical measures,X4270.Volume level set by participant (left),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16533,0.125644697437104,0.0396559016549549,0.0479191301933925,0.203370264680816,0.001535739012619
Physical measures,X4270.Volume level set by participant (left),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16356,-0.132455718393917,0.0418205938361876,-0.214424082312845,-0.0504873544749898,0.00154178093267283
Physical measures,X4270.Volume level set by participant (left),HDDC2,5'-deoxynucleotidase HDDC2,14588,-0.103469472589952,0.0326688209340181,-0.167500361620628,-0.039438583559277,0.00154219194613974
Physical measures,X4270.Volume level set by participant (left),COL3A1,Collagen alpha-1(III) chain,14678,-0.194863794645655,0.0619095347260351,-0.316206482708683,-0.0735211065826258,0.00164970825339481
Physical measures,X4270.Volume level set by participant (left),CLUL1,Clusterin-like protein 1,16652,-0.087051200032974,0.0279288136186507,-0.141791674725529,-0.0323107253404187,0.00183077504723022
Physical measures,X4270.Volume level set by participant (left),SLURP1,Secreted Ly-6/uPAR-related protein 1,14549,0.120377365426099,0.0386384833978138,0.044645937966384,0.196108792885814,0.00184004217136905
Physical measures,X4270.Volume level set by participant (left),COMMD9,COMM domain-containing protein 9,14572,-0.113957414698772,0.0367298808982466,-0.185947981259335,-0.0419668481382085,0.00192208545872287
Physical measures,X4270.Volume level set by participant (left),APLP1,Amyloid-like protein 1,16666,-0.0774149271690373,0.0250952578602219,-0.126601632575072,-0.0282282217630023,0.00203993418016119
Physical measures,X4270.Volume level set by participant (left),CCL20,C-C motif chemokine 20,16843,0.0450729196970393,0.0146669052155504,0.0163257854745604,0.0738200539195182,0.00212183594469358
Physical measures,X4270.Volume level set by participant (left),MMP7,Matrilysin,16339,0.0814610633271304,0.0267184317758913,0.0290929370463834,0.133829189607877,0.0023007052775283
Physical measures,X4270.Volume level set by participant (left),APOF,Apolipoprotein F,14672,-0.166637008086509,0.0548972132167179,-0.274235545991276,-0.0590384701817418,0.00240609194613179
Physical measures,X4270.Volume level set by participant (left),WFDC2,WAP four-disulfide core domain protein 2,15822,0.104251008721117,0.0344568920642584,0.0367155002751705,0.171786517167064,0.00248581331227636
Physical measures,X4270.Volume level set by participant (left),GMPR,GMP reductase 1,16843,-0.0804103519049779,0.0267230870922788,-0.132787602605844,-0.0280331012041114,0.00262478224363962
Physical measures,X4270.Volume level set by participant (left),NTRK3,NT-3 growth factor receptor,16799,-0.171416724555876,0.0577623905919067,-0.284631010116013,-0.058202438995739,0.00300540231120034
Physical measures,X4270.Volume level set by participant (left),EIF4B,Eukaryotic translation initiation factor 4B,16533,-0.0726485301177552,0.0245435143499233,-0.120753818243605,-0.0245432419919054,0.00308087043016984
Physical measures,X4270.Volume level set by participant (left),HRG,Histidine-rich glycoprotein,14620,-0.13322274205654,0.0452688982377242,-0.221949782602479,-0.0444957015106001,0.0032564389368029
Physical measures,X4270.Volume level set by participant (left),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14588,-0.136369965941349,0.0463832558431579,-0.227281147393939,-0.0454587844887597,0.00328654735755373
Physical measures,X4270.Volume level set by participant (left),TMEM106A,Transmembrane protein 106A,14572,-0.0613237961807143,0.0208612335646901,-0.102211813967507,-0.0204357783939217,0.00329146869694036
Physical measures,X4270.Volume level set by participant (left),IL19,Interleukin-19,16249,0.0542668420924251,0.0185143308317105,0.0179787536622724,0.0905549305225778,0.00338265152497497
Physical measures,X4270.Volume level set by participant (left),IL17C,Interleukin-17C,16350,0.053625473891856,0.0183856261378567,0.0175896466616569,0.0896613011220552,0.00354230060401644
Physical measures,X4270.Volume level set by participant (left),DNAJC9,DnaJ homolog subfamily C member 9,14588,-0.0572204472523908,0.0196413313758406,-0.0957174567490384,-0.0187234377557433,0.00358211763906515
Physical measures,X4270.Volume level set by participant (left),FGF7,Fibroblast growth factor 7,14144,-0.054980500258203,0.0190252073768095,-0.0922699067167497,-0.0176910937996563,0.00385979668389675
Physical measures,X4270.Volume level set by participant (left),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14629,-0.090925603703341,0.0314819255647964,-0.152630177810342,-0.02922102959634,0.00388041626484716
Physical measures,X4270.Volume level set by participant (left),NECAP2,Adaptin ear-binding coat-associated protein 2,14175,-0.0663224794457405,0.0230042750893753,-0.111410858620916,-0.021234100270565,0.00394437638581065
Physical measures,X4270.Volume level set by participant (left),IL6,Interleukin-6,16576,0.0494503713653916,0.0171998159490258,0.015738732105301,0.0831620106254822,0.00404475256347494
Physical measures,X4270.Volume level set by participant (left),TSPYL1,Testis-specific Y-encoded-like protein 1,14207,-0.107604035232757,0.0374493188269709,-0.18100470013362,-0.0342033703318936,0.00406779723226957
Physical measures,X4270.Volume level set by participant (left),ZFYVE19,Abscission/NoCut checkpoint regulator,14588,-0.0496671123327403,0.0172936214543995,-0.0835626103833633,-0.0157716142821172,0.00408483967483676
Physical measures,X4270.Volume level set by participant (left),DCTPP1,dCTP pyrophosphatase 1,16666,-0.113589275149464,0.040005277356024,-0.191999618767271,-0.035178931531657,0.00452592689444746
Physical measures,X4270.Volume level set by participant (left),NCAN,Neurocan core protein,16799,-0.0947307069612708,0.0333682079288672,-0.160132394501851,-0.0293290194206911,0.00453164711336088
Physical measures,X4270.Volume level set by participant (left),LY6D,Lymphocyte antigen 6D,16560,0.0969554863039961,0.0342597056885734,0.0298064631543923,0.1641045094536,0.00466018690559585
Physical measures,X4270.Volume level set by participant (left),GFRAL,GDNF family receptor alpha-like,14185,-0.0673205634982044,0.0237877879348346,-0.11394462785048,-0.0206964991459285,0.00466066004050939
Physical measures,X4270.Volume level set by participant (left),COL5A1,Collagen alpha-1(V) chain,14352,-0.106285229422074,0.0375888324157253,-0.179959340956896,-0.0326111178872523,0.00469670809358183
Physical measures,X4270.Volume level set by participant (left),GALNT7,N-acetylgalactosaminyltransferase 7,16576,-0.172906564954244,0.0612330814344446,-0.292923404565755,-0.0528897253427321,0.00475229027131479
Physical measures,X4270.Volume level set by participant (left),IL13RA1,Interleukin-13 receptor subunit alpha-1,16492,0.160557807669711,0.0571041594430771,0.0486336551612804,0.272481960178143,0.00493439246884584
Physical measures,X4270.Volume level set by participant (left),BMP6,Bone morphogenetic protein 6,16311,-0.0851656926205199,0.0302928151220747,-0.144539610259786,-0.0257917749812535,0.00493829354165654
Physical measures,X4270.Volume level set by participant (left),YOD1,Ubiquitin thioesterase OTU1,14175,-0.068430591395542,0.0243810839105801,-0.116217515860279,-0.020643666930805,0.00501189137294994
Physical measures,X4270.Volume level set by participant (left),CHI3L1,Chitinase-3-like protein 1,16267,0.0459606022082418,0.0165279684945339,0.0135657839589554,0.0783554204575282,0.00542913170932199
Physical measures,X4270.Volume level set by participant (left),MMP12,Macrophage metalloelastase,16679,0.0680804502419517,0.0245242736525557,0.0200128738829426,0.116148026600961,0.00550862385816508
Physical measures,X4270.Volume level set by participant (left),S100A16,Protein S100-A16,16231,-0.0584610152722881,0.0210625155344155,-0.0997435457197424,-0.0171784848248337,0.00551639173180368
Physical measures,X4270.Volume level set by participant (left),GAMT,Guanidinoacetate N-methyltransferase,14175,-0.11929885697933,0.0429965059025112,-0.203572008548252,-0.0350257054104082,0.00553391041892521
Physical measures,X4270.Volume level set by participant (left),UBE2B,Ubiquitin-conjugating enzyme E2 B,14572,-0.141116656505778,0.0511026217383055,-0.241277795112857,-0.0409555178986996,0.0057619785653427
Physical measures,X4270.Volume level set by participant (left),KIAA0319,Dyslexia-associated protein KIAA0319,14628,-0.127966425547962,0.0464638168392679,-0.219035506552927,-0.0368973445429971,0.00589248998389527
Physical measures,X4270.Volume level set by participant (left),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16576,-0.0626137598892799,0.0227654998641523,-0.107234139623018,-0.0179933801555415,0.00595909431125395
Physical measures,X4270.Volume level set by participant (left),ACAN,Aggrecan core protein,16536,-0.125657132117976,0.0457132905201141,-0.215255181537399,-0.0360590826985523,0.00598770804911807
Physical measures,X4270.Volume level set by participant (left),PRTN3,Myeloblastin,16236,0.0699992450768548,0.0255428169927059,0.0199353237711512,0.120063166382558,0.00614190871866546
Physical measures,X4270.Volume level set by participant (left),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14288,-0.19837664065332,0.072407821000571,-0.340295969814439,-0.0564573114922004,0.0061569271108753
Physical measures,X4270.Volume level set by participant (left),IL2RG,Cytokine receptor common subunit gamma,14572,-0.110831707651565,0.0405076166537322,-0.19022663629288,-0.0314367790102499,0.00622530215535404
Physical measures,X4270.Volume level set by participant (left),MEGF10,Multiple epidermal growth factor-like domains protein 10,16630,-0.0872781603467877,0.0319622994488171,-0.149924267266469,-0.0246320534271062,0.00632743723535468
Physical measures,X4270.Volume level set by participant (left),IGBP1,Immunoglobulin-binding protein 1,14629,-0.0677914903683139,0.0249274170440141,-0.116649227774582,-0.0189337529620464,0.00654469932146327
Physical measures,X4270.Volume level set by participant (left),BOLA1,BolA-like protein 1,14168,-0.0752525544359762,0.027673436693627,-0.129492490355485,-0.0210126185164672,0.00654987618570276
Physical measures,X4270.Volume level set by participant (left),CSF2RB,Cytokine receptor common subunit beta,14207,-0.0935585807915282,0.0344083233606054,-0.160998894578315,-0.0261182670047416,0.00655456947858641
Physical measures,X4270.Volume level set by participant (left),SELL,L-selectin,14697,-0.173141239899652,0.0637746602406747,-0.298139573971375,-0.0481429058279297,0.00663751162385689
Physical measures,X4270.Volume level set by participant (left),APOBR,Apolipoprotein B receptor,14288,-0.096113649825948,0.0354033571143339,-0.165504229770042,-0.0267230698818536,0.00663920479466704
Physical measures,X4270.Volume level set by participant (left),SLITRK1,SLIT and NTRK-like protein 1,14207,-0.12682377450982,0.0467156002813169,-0.218386351061202,-0.0352611979584392,0.00663948615511471
Physical measures,X4270.Volume level set by participant (left),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16639,0.106703082725685,0.0393959313671715,0.0294870572460293,0.183919108205341,0.00676614196475986
Physical measures,X4270.Volume level set by participant (left),CTSE,Cathepsin E,14352,-0.0769866932615715,0.0284522418864324,-0.132753087358979,-0.021220299164164,0.00682162059034462
Physical measures,X4270.Volume level set by participant (left),TNFSF12,Tumor necrosis factor ligand superfamily member 12,16843,-0.117897932049339,0.0441686175051995,-0.20446842235953,-0.0313274417391476,0.00760894392446344
Physical measures,X4270.Volume level set by participant (left),SMPD1,Sphingomyelin phosphodiesterase,16731,0.0679520820097972,0.0255283098523451,0.0179165946992009,0.117987569320394,0.00777909038880103
Physical measures,X4270.Volume level set by participant (left),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16630,0.083847358149749,0.0316115938586602,0.0218886341867751,0.145806082112723,0.0079991995843832
Physical measures,X4270.Volume level set by participant (left),F2,Prothrombin,14697,-0.257153108271578,0.0973847721803469,-0.448027261745058,-0.0662789547980977,0.00828497671261552
Physical measures,X4270.Volume level set by participant (left),IL1A,Interleukin-1 alpha,16350,0.0607073729057546,0.0230262155478642,0.0155759904319409,0.105838755379568,0.00838587900908461
Physical measures,X4270.Volume level set by participant (left),DKK3,Dickkopf-related protein 3,16871,-0.112212856107866,0.0425947388912207,-0.195698544334658,-0.0287271678810734,0.00843557333107278
Physical measures,X4270.Volume level set by participant (left),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14588,-0.0631855168233465,0.0239855732745175,-0.110197240441401,-0.0161737932052923,0.00843967659502686
Physical measures,X4270.Volume level set by participant (left),SLC12A2,Solute carrier family 12 member 2,14175,-0.145677670935096,0.055347887965813,-0.25415953134809,-0.0371958105221026,0.00849667668613926
Physical measures,X4270.Volume level set by participant (left),CCN1,CCN family member 1,16552,-0.0440856471391566,0.0167576094712476,-0.0769305617028019,-0.0112407325755114,0.00852672012173983
Physical measures,X4270.Volume level set by participant (left),GM2A,Ganglioside GM2 activator,14286,0.101528710209735,0.038602686580269,0.0258674445124076,0.177189975907062,0.0085452790507249
Physical measures,X4270.Volume level set by participant (left),RAPGEF2,Rap guanine nucleotide exchange factor 2,14404,-0.0736913799082797,0.02807811018365,-0.128724475868234,-0.0186582839483257,0.00868645320988068
Physical measures,X4270.Volume level set by participant (left),NCAM1,Neural cell adhesion molecule 1,16715,-0.109349888793963,0.0416667410065436,-0.191016701166789,-0.0276830764211378,0.00868826604356002
Physical measures,X4270.Volume level set by participant (left),FSTL3,Follistatin-related protein 3,16631,0.106744558486973,0.0409523553631167,0.0264779419752647,0.187011174998682,0.00915398448975912
Physical measures,X4270.Volume level set by participant (left),NID1,Nidogen-1,16643,-0.087427679337117,0.0335548165061139,-0.1531951196891,-0.0216602389851337,0.00918171756711444
Physical measures,X4270.Volume level set by participant (left),FDX1,"Adrenodoxin, mitochondrial",14175,-0.0630852176607449,0.0242325056581694,-0.110580928750757,-0.0155895065707329,0.00924192506638545
Physical measures,X4270.Volume level set by participant (left),PAGR1,PAXIP1-associated glutamate-rich protein 1,14288,-0.0894214855366477,0.0343639728382074,-0.156774872299534,-0.0220680987737611,0.00927270236781368
Physical measures,X4270.Volume level set by participant (left),NPTXR,Neuronal pentraxin receptor,16666,-0.0963991900829874,0.0371002077341173,-0.169115597241857,-0.0236827829241175,0.00937564793130687
Physical measures,X4270.Volume level set by participant (left),GHRHR,Growth hormone-releasing hormone receptor,16257,-0.0598246451723965,0.0231027405644718,-0.105106016678761,-0.0145432736660318,0.00961999969417715
Physical measures,X4270.Volume level set by participant (left),INPP1,Inositol polyphosphate 1-phosphatase,16576,-0.0617001056706526,0.0239828373162824,-0.108706466810566,-0.0146937445307392,0.0101001487196405
Physical measures,X4270.Volume level set by participant (left),RBFOX3,RNA binding protein fox-1 homolog 3,14629,-0.0995382348688939,0.038779581792795,-0.175546215182772,-0.0235302545550157,0.0102749584239971
Physical measures,X4270.Volume level set by participant (left),FGF12,Fibroblast growth factor 12,14207,-0.08360819185735,0.0325754058295623,-0.147455987283292,-0.0197603964314079,0.0102801218945423
Physical measures,X4270.Volume level set by participant (left),GCLM,Glutamate--cysteine ligase regulatory subunit,14175,-0.0850320595720407,0.0331325866108706,-0.149971929329347,-0.0200921898147343,0.0102856862084681
Physical measures,X4270.Volume level set by participant (left),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16871,0.117064005584046,0.0456723959837636,0.0275461094558694,0.206581901712223,0.0103821053865865
Physical measures,X4270.Volume level set by participant (left),PLXDC2,Plexin domain-containing protein 2,14628,-0.137369021660679,0.0536853863502521,-0.242592378907173,-0.0321456644141845,0.010514044850326
Physical measures,X4270.Volume level set by participant (left),DRAXIN,Draxin,16533,-0.0751187642549033,0.0293870925789058,-0.132717465709559,-0.017520062800248,0.0105916354522804
Physical measures,X4270.Volume level set by participant (left),TNFSF11,Tumor necrosis factor ligand superfamily member 11,16637,-0.0524531792115295,0.0205948895513416,-0.0928191627321591,-0.0120871956908999,0.0108773082287692
Physical measures,X4270.Volume level set by participant (left),CRYGD,Gamma-crystallin D,14628,-0.0394942065248051,0.0155385124107809,-0.0699496908499356,-0.00903872219967445,0.0110417840227927
Physical measures,X4270.Volume level set by participant (left),ACRBP,Acrosin-binding protein,14572,-0.0988350931100517,0.0388939467038065,-0.175067228649512,-0.022602957570591,0.0110593501500046
Physical measures,X4270.Volume level set by participant (left),ST13,Hsc70-interacting protein,14352,-0.0712959837328402,0.0281455214855229,-0.126461205844465,-0.0161307616212154,0.0113157935713843
Physical measures,X4270.Volume level set by participant (left),FABP6,Gastrotropin,16334,0.0589459065852168,0.0232771373090411,0.0133227174594962,0.104569095710937,0.0113393128845004
Physical measures,X4270.Volume level set by participant (left),DNAJB2,DnaJ homolog subfamily B member 2,14352,-0.0702817516044904,0.0279214100799755,-0.125007715361242,-0.0155557878477384,0.0118424141151509
Physical measures,X4270.Volume level set by participant (left),DCTN2,Dynactin subunit 2,16576,-0.033651026202692,0.0133730346948099,-0.0598621742045194,-0.00743987820086463,0.0118676380449826
Physical measures,X4270.Volume level set by participant (left),OMD,Osteomodulin,16733,-0.0716420512016808,0.0284748441908994,-0.127452745815844,-0.0158313565875179,0.0118795860405957
Physical measures,X4270.Volume level set by participant (left),SBSN,Suprabasin,14646,0.106874268997299,0.042526503700557,0.0235223217442069,0.19022621625039,0.0119774727833291
Physical measures,X4270.Volume level set by participant (left),HBEGF,Proheparin-binding EGF-like growth factor,16772,-0.0430080695606299,0.0171559694236262,-0.0766337696309372,-0.0093823694903226,0.0121893688964913
Physical measures,X4270.Volume level set by participant (left),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14629,-0.0790971626004313,0.03157036250254,-0.14097507310541,-0.0172192520954528,0.0122412374502226
Physical measures,X4270.Volume level set by participant (left),GDF15,Growth/differentiation factor 15,16871,0.0711943180488061,0.0284240471816951,0.0154831855726837,0.126905450524929,0.012264153247373
Physical measures,X4270.Volume level set by participant (left),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14652,-0.0606378403656663,0.0242623513920895,-0.108192049094162,-0.0130836316371708,0.012456285428454
Physical measures,X4270.Volume level set by participant (left),CDH15,Cadherin-15,16764,-0.054192477393445,0.021774613644641,-0.0968707201369413,-0.0115142346499486,0.0128274414489714
Physical measures,X4270.Volume level set by participant (left),KLK13,Kallikrein-13,16272,0.0732511201101278,0.0294380845639905,0.0155524743647064,0.130949765855549,0.0128450663353244
Physical measures,X4270.Volume level set by participant (left),AKAP12,A-kinase anchor protein 12,14352,-0.174807992972726,0.0702780330697468,-0.31255293778943,-0.0370630481560221,0.0128801600956392
Physical measures,X4270.Volume level set by participant (left),BDNF,Brain-derived neurotrophic factor,14678,-0.0432334430443422,0.0174690348642364,-0.0774727513782456,-0.00899413471043887,0.0133400055803937
Physical measures,X4270.Volume level set by participant (left),REN,Renin,16666,0.0418099569226413,0.01692104393063,0.00864471081860645,0.0749752030266761,0.0134878446697745
Physical measures,X4270.Volume level set by participant (left),DDX53,Probable ATP-dependent RNA helicase DDX53,14261,0.102684212272591,0.0415677323434119,0.021211456879504,0.184156967665679,0.0135121083266102
Physical measures,X4270.Volume level set by participant (left),DMP1,Dentin matrix acidic phosphoprotein 1,14288,-0.0584639673768672,0.0237136540352889,-0.104942729286033,-0.011985205467701,0.0136971937852898
Physical measures,X4270.Volume level set by participant (left),GAS2,Growth arrest-specific protein 2,14404,-0.0678246570306254,0.0275159883719942,-0.121755994239734,-0.0138933198215169,0.0137160516225843
Physical measures,X4270.Volume level set by participant (left),FKBPL,FK506-binding protein-like,14588,-0.0639680309987356,0.0259556916478625,-0.114841186628546,-0.0130948753689252,0.0137315719850684
Physical measures,X4270.Volume level set by participant (left),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16266,0.0255233185401821,0.0103566278924397,0.00522432787100021,0.045822309209364,0.0137329122397743
Physical measures,X4270.Volume level set by participant (left),ADGRG2,Adhesion G-protein coupled receptor G2,16666,-0.114949811379383,0.0466519300370543,-0.206387594252009,-0.0235120285067566,0.0137500890488933
Physical measures,X4270.Volume level set by participant (left),PF4,Platelet factor 4,14533,-0.0371598692925786,0.015087063160136,-0.0667305130864451,-0.00758922549871201,0.0137884093276331
Physical measures,X4270.Volume level set by participant (left),ROBO4,Roundabout homolog 4,14288,-0.204712615597995,0.0834166130331563,-0.368209177142982,-0.0412160540530091,0.0141356745228631
Physical measures,X4270.Volume level set by participant (left),COL2A1,Collagen alpha-1(II) chain,14288,-0.0463238973683443,0.0188787095703062,-0.0833261681261444,-0.00932162661054416,0.0141488393280973
Physical measures,X4270.Volume level set by participant (left),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16356,-0.116402047544466,0.0475104900480129,-0.209522608038571,-0.0232814870503605,0.0142949124277942
Physical measures,X4270.Volume level set by participant (left),NEB,Nebulin,14175,-0.093972048766537,0.0383620911666826,-0.169161747453235,-0.0187823500798392,0.0143132466190031
Physical measures,X4270.Volume level set by participant (left),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14572,-0.0660346950142618,0.0269800497946824,-0.118915592611839,-0.0131537974166842,0.0143953304240826
Physical measures,X4270.Volume level set by participant (left),CRADD,Death domain-containing protein CRADD,16498,-0.0439232158963139,0.0180646743938971,-0.0793299777083523,-0.00851645408427556,0.0150494220434619
Physical measures,X4270.Volume level set by participant (left),RTBDN,Retbindin,16576,-0.10568681058324,0.0435019268319476,-0.190950587173857,-0.0204230339926225,0.0151313010597186
Physical measures,X4270.Volume level set by participant (left),DTYMK,Thymidylate kinase,14652,-0.0541189604083076,0.0223186690414571,-0.0978635517295635,-0.0103743690870516,0.0153276137197813
Physical measures,X4270.Volume level set by participant (left),RGS10,Regulator of G-protein signaling 10,14629,-0.06140097780346,0.0253222098203726,-0.11103250905139,-0.0117694465555296,0.0153293925996249
Physical measures,X4270.Volume level set by participant (left),STAB2,Stabilin-2,14678,0.125433751714877,0.0517798657828698,0.0239452147804524,0.226922288649302,0.0154286012698269
Physical measures,X4270.Volume level set by participant (left),MRPL52,"39S ribosomal protein L52, mitochondrial",14100,-0.140245834166241,0.0579970223125095,-0.25391999789876,-0.0265716704337224,0.0156120010220655
Physical measures,X4270.Volume level set by participant (left),MANSC1,MANSC domain-containing protein 1,16719,0.110850785941777,0.0458747814066359,0.0209362143847712,0.200765357498784,0.0156864550094202
Physical measures,X4270.Volume level set by participant (left),HSP90B1,Endoplasmin,16163,-0.0464843299819989,0.0192941255594428,-0.0843008160785068,-0.00866784388549097,0.0159965594651785
Physical measures,X4270.Volume level set by participant (left),GMPR2,GMP reductase 2,14352,-0.0563202013094492,0.0234968349056676,-0.102373997724558,-0.0102664048943407,0.016545934923417
Physical measures,X4270.Volume level set by participant (left),TBCA,Tubulin-specific chaperone A,14352,-0.0438290970047155,0.0182863119384464,-0.0796702684040705,-0.00798792560536041,0.0165505275181743
Physical measures,X4270.Volume level set by participant (left),CSNK2A1,Casein kinase II subunit alpha,14629,-0.0787158882611784,0.0331254237558331,-0.143641718822611,-0.0137900576997455,0.0175001290693715
Physical measures,X4270.Volume level set by participant (left),GSR,"Glutathione reductase, mitochondrial",14577,-0.156395833183643,0.0658755064337529,-0.285511825793799,-0.0272798405734875,0.0176041022438938
Physical measures,X4270.Volume level set by participant (left),CD27,CD27 antigen,16719,0.07383170330356,0.0311389439855447,0.0127993730918925,0.134864033515228,0.0177493580645794
Physical measures,X4270.Volume level set by participant (left),YY1,Transcriptional repressor protein YY1,14207,-0.127029356434006,0.0537016555777419,-0.23228460136638,-0.0217741115016317,0.0180208411120812
Physical measures,X4270.Volume level set by participant (left),PCDH17,Protocadherin-17,16666,-0.0840575550123683,0.0355657355679477,-0.153766396725546,-0.0143487132991909,0.018117480033715
Physical measures,X4270.Volume level set by participant (left),MELTF,Melanotransferrin,14652,-0.115940060241959,0.0494355425941022,-0.212833723726399,-0.0190463967575188,0.0190262111814068
Physical measures,X4270.Volume level set by participant (left),SEPTIN9,Septin-9,16576,-0.107547909260067,0.0458615335022707,-0.197436514924517,-0.0176593035956162,0.0190359142669163
Physical measures,X4270.Volume level set by participant (left),SUSD2,Sushi domain-containing protein 2,16671,-0.103721579530626,0.0442762334640179,-0.190502997120102,-0.0169401619411513,0.0191615240458371
Physical measures,X4270.Volume level set by participant (left),IMPA1,Inositol monophosphatase 1,16533,-0.0500881115977597,0.0214368870683216,-0.0921044102516701,-0.00807181294384923,0.0194750872332937
Physical measures,X4270.Volume level set by participant (left),CAPN3,Calpain-3,14572,-0.0899757969525688,0.0385415448907104,-0.165517224938361,-0.0144343689667764,0.0195823233579272
Physical measures,X4270.Volume level set by participant (left),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14352,-0.0613260661704475,0.0263167849813667,-0.112906964733926,-0.00974516760696878,0.0198039798504326
Physical measures,X4270.Volume level set by participant (left),GGT1,Glutathione hydrolase 1 proenzyme,16640,0.0597906878364225,0.0256898379354806,0.00943860548288057,0.110142770189964,0.0199556007879942
Physical measures,X4270.Volume level set by participant (left),TERF1,Telomeric repeat-binding factor 1,14207,-0.118109205617276,0.050854383057179,-0.217783796409347,-0.0184346148252053,0.020220205977827
Physical measures,X4270.Volume level set by participant (left),STAMBP,STAM-binding protein,16498,-0.049239404171236,0.0212821230402577,-0.0909523653301411,-0.00752644301233085,0.0206991178091777
Physical measures,X4270.Volume level set by participant (left),TREML1,Trem-like transcript 1 protein,14672,-0.064327292130553,0.0278184375519444,-0.118851429732364,-0.00980315452874191,0.0207695613572212
Physical measures,X4270.Volume level set by participant (left),SERPINE2,Glia-derived nexin,14652,-0.0529566243335649,0.0229236271088151,-0.0978869334668426,-0.00802631520028723,0.0208946409142711
Physical measures,X4270.Volume level set by participant (left),ADGRF5,Adhesion G protein-coupled receptor F5,14652,-0.120190314850099,0.0520518737046345,-0.222211987311183,-0.0181686423890159,0.0209547338243973
Physical measures,X4270.Volume level set by participant (left),PDGFRA,Platelet-derived growth factor receptor alpha,16666,-0.102454609354939,0.0443718792028125,-0.189423492592451,-0.0154857261174263,0.0209558386526184
Physical measures,X4270.Volume level set by participant (left),UBXN1,UBX domain-containing protein 1,14352,-0.0518647957590206,0.0224802703514229,-0.0959261256478094,-0.00780346587023172,0.0210620274879236
Physical measures,X4270.Volume level set by participant (left),GORASP2,Golgi reassembly-stacking protein 2,14588,-0.0732410851604555,0.031779725539157,-0.135529347217203,-0.0109528231037078,0.0212002775772183
Physical measures,X4270.Volume level set by participant (left),GZMB,Granzyme B,16637,-0.0455354929493402,0.0197952605119069,-0.0843342035526777,-0.0067367823460026,0.0214422531489972
Physical measures,X4270.Volume level set by participant (left),LYZL2,Lysozyme-like protein 2,14144,-0.0951056262755394,0.0413490024009875,-0.176149670981475,-0.014061581569604,0.0214587232405702
Physical measures,X4270.Volume level set by participant (left),CD164,Sialomucin core protein 24,16671,-0.104779008232194,0.045575496349688,-0.194106981077583,-0.0154510353868059,0.0215160838045153
Physical measures,X4270.Volume level set by participant (left),AHNAK,Neuroblast differentiation-associated protein AHNAK,14288,-0.110763853260122,0.0482478682700275,-0.205329675069376,-0.0161980314508686,0.0217060203229351
Physical measures,X4270.Volume level set by participant (left),COL1A1,Collagen alpha-1(I) chain,16871,-0.113704269374214,0.0495300474088101,-0.210783162295482,-0.0166253764529462,0.0217074081221157
Physical measures,X4270.Volume level set by participant (left),BST2,Bone marrow stromal antigen 2,16799,0.0555010137489247,0.0241822548284853,0.00810379428509358,0.102898233212756,0.0217389126875214
Physical measures,X4270.Volume level set by participant (left),NAP1L4,Nucleosome assembly protein 1-like 4,14544,-0.089175542740966,0.0389210346386157,-0.165460770632653,-0.0128903148492792,0.021966589054526
Physical measures,X4270.Volume level set by participant (left),ARID3A,AT-rich interactive domain-containing protein 3A,14168,-0.08702528770774,0.0380116011137472,-0.161528025890684,-0.0125225495247956,0.0220684431268094
Physical measures,X4270.Volume level set by participant (left),SV2A,Synaptic vesicle glycoprotein 2A,14261,-0.0546263622913078,0.0238788261308804,-0.101428861507833,-0.00782386307478225,0.0221725833873645
Physical measures,X4270.Volume level set by participant (left),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14628,-0.0806995749193497,0.0352809265944775,-0.149850191044526,-0.0115489587941739,0.0221900460865136
Physical measures,X4270.Volume level set by participant (left),AFM,Afamin,14697,-0.170693417873468,0.0746504795813827,-0.317008357852978,-0.0243784778939581,0.0222352068783195
Physical measures,X4270.Volume level set by participant (left),GPA33,Cell surface A33 antigen,16576,-0.0214745153241138,0.00939500126151768,-0.0398887177966885,-0.00306031285153913,0.0222821414018937
Physical measures,X4270.Volume level set by participant (left),HIP1,Huntingtin-interacting protein 1,14175,-0.0998389740426198,0.0437172782776616,-0.185524839466837,-0.0141531086184031,0.0224014528604682
Physical measures,X4270.Volume level set by participant (left),PRCP,Lysosomal Pro-X carboxypeptidase,16755,0.0906522354704176,0.0397320586925357,0.0127774004330476,0.168527070507788,0.0225261038473187
Physical measures,X4270.Volume level set by participant (left),LHB,Lutropin subunit beta,16266,0.0337926998430656,0.0148140368609661,0.00475718759557211,0.0628282120905591,0.0225538121956424
Physical measures,X4270.Volume level set by participant (left),NECTIN4,Nectin-4,16719,0.0924379778406399,0.0406323909566329,0.0127984915656394,0.17207746411564,0.0229195970814279
Physical measures,X4270.Volume level set by participant (left),BOLA2_BOLA2B,BolA-like protein 2,14288,-0.0647685399140986,0.0285447059542724,-0.120716163584473,-0.00882091624372472,0.0232819058634854
Physical measures,X4270.Volume level set by participant (left),MMP10,Stromelysin-2,16619,0.0487565181417584,0.0215115106773553,0.00659395721414201,0.0909190790693748,0.0234316666624754
Physical measures,X4270.Volume level set by participant (left),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,14175,-0.0932610381132299,0.0412516001341443,-0.174114174376153,-0.012407901850307,0.0237876305457365
Physical measures,X4270.Volume level set by participant (left),CCND2,G1/S-specific cyclin-D2,14404,-0.093323171080212,0.0413095070073687,-0.174289804814655,-0.0123565373457693,0.0238907665153756
Physical measures,X4270.Volume level set by participant (left),THTPA,Thiamine-triphosphatase,14538,-0.0392980042431992,0.017405103448288,-0.0734120070018437,-0.00518400148455465,0.0239701863273579
Physical measures,X4270.Volume level set by participant (left),UROD,Uroporphyrinogen decarboxylase,14352,-0.0510021424941801,0.0226138616597123,-0.0953253113472162,-0.00667897364114404,0.0241264693213296
Physical measures,X4270.Volume level set by participant (left),LEP,Leptin,16666,0.0425156492982984,0.0188711840026522,0.0055281286531001,0.0795031699434967,0.0242758814956281
Physical measures,X4270.Volume level set by participant (left),EFNB2,Ephrin-B2,14261,-0.0584074317905839,0.0259325493303409,-0.109235228478052,-0.00757963510311583,0.0243195757866892
Physical measures,X4270.Volume level set by participant (left),PRDX1,Peroxiredoxin-1,16148,-0.0316048751484946,0.0140330920411891,-0.0591097355492251,-0.00410001474776405,0.0243250728841137
Physical measures,X4270.Volume level set by participant (left),NRN1,Neuritin,14629,-0.0923958267000833,0.041044216448945,-0.172842490940016,-0.0119491624601511,0.0243921652680524
Physical measures,X4270.Volume level set by participant (left),PSRC1,Proline/serine-rich coiled-coil protein 1,16266,-0.0488591242976126,0.0217255768956012,-0.091441255012991,-0.00627699358223424,0.0245308080363879
Physical measures,X4270.Volume level set by participant (left),LEFTY2,Left-right determination factor 2,16794,-0.0535321433737557,0.0238240467114868,-0.10022727492827,-0.00683701181924158,0.0246542858969637
Physical measures,X4270.Volume level set by participant (left),BEX3,Protein BEX3,14144,-0.0727948103788345,0.0324071207653666,-0.136312767078953,-0.00927685367871593,0.0247027619785886
Physical measures,X4270.Volume level set by participant (left),CNTN4,Contactin-4,16671,-0.116892660255286,0.052104414130722,-0.219017311951502,-0.0147680085590714,0.0248821218027869
Physical measures,X4270.Volume level set by participant (left),HDGFL2,Hepatoma-derived growth factor-related protein 2,14628,-0.054172794579384,0.0241756766181703,-0.101557120750998,-0.00678846840777018,0.0250541599196915
Physical measures,X4270.Volume level set by participant (left),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14288,-0.0613840724620286,0.0274428288819463,-0.115172017070643,-0.00759612785341386,0.0253149096202767
Physical measures,X4270.Volume level set by participant (left),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14288,-0.104227940811497,0.0467103096736722,-0.195780147771895,-0.0126757338510999,0.0256721609006408
Physical measures,X4270.Volume level set by participant (left),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14288,-0.0832554016169399,0.0373259258009083,-0.15641421618672,-0.0100965870471596,0.0257298860176843
Physical measures,X4270.Volume level set by participant (left),C7,Complement component C7,14299,-0.101997452318734,0.0458004990329677,-0.191766430423351,-0.0122284742141172,0.0259631796812839
Physical measures,X4270.Volume level set by participant (left),SLA2,Src-like-adapter 2,14629,-0.03202155663335,0.0143907814688471,-0.0602274883122902,-0.00381562495440969,0.0260867994577235
Physical measures,X4270.Volume level set by participant (left),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14288,-0.127937302373225,0.0575220520597003,-0.240680524410238,-0.0151940803362128,0.0261543715936564
Physical measures,X4270.Volume level set by participant (left),REG4,Regenerating islet-derived protein 4,16675,0.0576552253366366,0.0259485773266522,0.00679601377639833,0.108514436896875,0.0263032351562675
Physical measures,X4270.Volume level set by participant (left),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14628,-0.0385041622494085,0.0173755483429101,-0.0725602370015124,-0.00444808749730465,0.0267070604402079
Physical measures,X4270.Volume level set by participant (left),VTCN1,V-set domain-containing T-cell activation inhibitor 1,16266,0.0872052623906487,0.0394318304705716,0.00991887466832832,0.164491650112969,0.0270119929787825
Physical measures,X4270.Volume level set by participant (left),DKKL1,Dickkopf-like protein 1,16576,-0.0327093147706954,0.0148090458682049,-0.0617350446723769,-0.0036835848690139,0.0272064549283905
Physical measures,X4270.Volume level set by participant (left),CD226,CD226 antigen,14207,-0.0799557179161311,0.0362008694892691,-0.150909422115099,-0.00900201371716362,0.0272136338606306
Physical measures,X4270.Volume level set by participant (left),IMPACT,Protein IMPACT,14628,-0.0611556523148521,0.0277346576065181,-0.115515581223628,-0.00679572340607648,0.0274677621531368
Physical measures,X4270.Volume level set by participant (left),DNAJC6,Putative tyrosine-protein phosphatase auxilin,14288,-0.040809839807339,0.018549190532326,-0.077166253250698,-0.00445342636398004,0.0278166652852056
Physical measures,X4270.Volume level set by participant (left),DGKA,Diacylglycerol kinase alpha,14207,-0.0625053048226072,0.0284187367355131,-0.118206028824213,-0.00680458082100149,0.0278627247486555
Physical measures,X4270.Volume level set by participant (left),GOT1,"Aspartate aminotransferase, cytoplasmic",14678,-0.0784096675786976,0.0357182395723582,-0.14841741714052,-0.00840191801687559,0.0281628893715626
Physical measures,X4270.Volume level set by participant (left),B2M,Beta-2-microglobulin,14697,-0.101654648414863,0.0463957273650865,-0.192590274050433,-0.0107190227792937,0.028464944389768
Physical measures,X4270.Volume level set by participant (left),ACYP1,Acylphosphatase-1,14281,-0.0505802275568833,0.023123139113534,-0.0959015802194099,-0.00525887489435668,0.0287273895162245
Physical measures,X4270.Volume level set by participant (left),CASP8,Caspase-8,16772,-0.0463989033326113,0.0212169752988008,-0.0879841749182609,-0.00481363174696162,0.0287653241461831
Physical measures,X4270.Volume level set by participant (left),SRPX,Sushi repeat-containing protein SRPX,14652,-0.0899517380659028,0.0411615901814194,-0.170628454821485,-0.00927502131032074,0.0288803149164144
Physical measures,X4270.Volume level set by participant (left),RAB6A,Ras-related protein Rab-6A,16637,-0.0567778311050625,0.0260238259112434,-0.1077845298911,-0.00577113231902546,0.0291409580435479
Physical measures,X4270.Volume level set by participant (left),JPT2,Jupiter microtubule associated homolog 2,14588,-0.0391541223327471,0.0179750645864247,-0.0743852489221396,-0.00392299574335469,0.02940366323321
Physical measures,X4270.Volume level set by participant (left),SORBS1,Sorbin and SH3 domain-containing protein 1,14629,-0.0805644404802351,0.0370386128358726,-0.153160121638545,-0.00796875932192487,0.0296350555880051
Physical measures,X4270.Volume level set by participant (left),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14629,-0.0476156170965384,0.0219025034067926,-0.0905445237738519,-0.004686710419225,0.0297225906602023
Physical measures,X4270.Volume level set by participant (left),FGF9,Fibroblast growth factor 9,14117,-0.081685363541103,0.0376473698320405,-0.155474208411902,-0.00789651867030369,0.0300424694482541
Physical measures,X4270.Volume level set by participant (left),LEG1,Protein LEG1 homolog,13902,0.0479408314815726,0.022124795031512,0.00457623321980903,0.0913054297433363,0.030264210290166
Physical measures,X4270.Volume level set by participant (left),MEGF11,Multiple epidermal growth factor-like domains protein 11,14175,-0.100186395767459,0.046263432314634,-0.190862723104141,-0.00951006843077611,0.0303612081943946
Physical measures,X4270.Volume level set by participant (left),PQBP1,Polyglutamine-binding protein 1,16266,0.0512200740198368,0.0236576105216028,0.00485115739749536,0.0975889906421783,0.030397832041195
Physical measures,X4270.Volume level set by participant (left),WFDC12,WAP four-disulfide core domain protein 12,16807,0.0423469424121656,0.0196066701531097,0.00391786891207054,0.0807760159122606,0.0308004628347703
Physical measures,X4270.Volume level set by participant (left),ENOPH1,Enolase-phosphatase E1,14572,-0.0559373969313349,0.0259394236951334,-0.106778667373796,-0.00509612648887347,0.0310638884433746
Physical measures,X4270.Volume level set by participant (left),OFD1,Oral-facial-digital syndrome 1 protein,14404,0.048534102103636,0.0225075702829698,0.00441926434901527,0.0926489398582568,0.0310732016876104
Physical measures,X4270.Volume level set by participant (left),SEZ6L,Seizure 6-like protein,16719,-0.099058051582467,0.0461529595821047,-0.189517852363392,-0.00859825080154183,0.0318634922958792
Physical measures,X4270.Volume level set by participant (left),SELENOP,Selenoprotein P,14697,-0.137087517035713,0.0639646306288179,-0.262458193068196,-0.0117168410032299,0.032115285497812
Physical measures,X4270.Volume level set by participant (left),EFCAB14,EF-hand calcium-binding domain-containing protein 14,14588,-0.112988754578869,0.052738823909969,-0.216356849442409,-0.00962065971533016,0.0321761545018724
Physical measures,X4270.Volume level set by participant (left),CCL28,C-C motif chemokine 28,16596,-0.0469422389811384,0.0219220288283484,-0.0899094154847012,-0.00397506247757558,0.0322621866199179
Physical measures,X4270.Volume level set by participant (left),TNR,Tenascin-R,16533,-0.0642018886906286,0.0299852313244853,-0.12297294208662,-0.00543083529463746,0.0322791961092677
Physical measures,X4270.Volume level set by participant (left),PRR5,Proline-rich protein 5,14207,-0.0683765507676943,0.0319760121521139,-0.131049534585837,-0.00570356694955118,0.0325037377820586
Physical measures,X4270.Volume level set by participant (left),KITLG,Kit ligand,16666,-0.0739300085940685,0.0345811799975704,-0.141709121389307,-0.00615089579883041,0.0325419519424998
Physical measures,X4270.Volume level set by participant (left),KLKB1,Plasma kallikrein,14350,-0.123809930312347,0.0580196783220601,-0.237528499823585,-0.0100913608011092,0.0328654383298792
Physical measures,X4270.Volume level set by participant (left),CDSN,Corneodesmosin,16810,0.0619300354694736,0.0290388635536584,0.00501386290430317,0.118846208034644,0.0329670529816149
Physical measures,X4270.Volume level set by participant (left),GGACT,Gamma-glutamylaminecyclotransferase,14652,-0.045621427136556,0.0213941458885663,-0.087553953078146,-0.00368890119496594,0.032988461650354
Physical measures,X4270.Volume level set by participant (left),TXN,Thioredoxin,14428,-0.0756445428718037,0.0354789892847839,-0.14518336186998,-0.00610572387362733,0.0330159740451693
Physical measures,X4270.Volume level set by participant (left),PRSS8,Prostasin,16583,0.0667135761520777,0.0313357114919993,0.00529558162775906,0.128131570676396,0.0332693736520472
Physical measures,X4270.Volume level set by participant (left),IL1RN,Interleukin-1 receptor antagonist protein,16616,0.0497572716993964,0.0233866740558333,0.00391939054996313,0.0955951528488296,0.0333857254924494
Physical measures,X4270.Volume level set by participant (left),VPS28,Vacuolar protein sorting-associated protein 28 homolog,14404,-0.0488825773950158,0.0230081241451729,-0.0939785007195547,-0.0037866540704769,0.0336387594275928
Physical measures,X4270.Volume level set by participant (left),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16733,-0.0624524758408198,0.0294998956765514,-0.120272271366861,-0.00463268031477903,0.0342711350724852
Physical measures,X4270.Volume level set by participant (left),ASGR1,Asialoglycoprotein receptor 1,16533,0.0926501315644403,0.0437650001991064,0.00687073117419187,0.178429531954689,0.0342754817752235
Physical measures,X4270.Volume level set by participant (left),SMAD2,Mothers against decapentaplegic homolog 2,14572,-0.0457972101368505,0.0216392252423877,-0.0882100916119304,-0.00338432866177055,0.0343279099182993
Physical measures,X4270.Volume level set by participant (left),DDHD2,Phospholipase DDHD2,14629,-0.0489593920219892,0.0231347648238746,-0.0943035310767835,-0.00361525296719501,0.0343387745815483
Physical measures,X4270.Volume level set by participant (left),IL17A,Interleukin-17A,16327,0.0634076101235112,0.0300557879850316,0.00449826567284925,0.122316954574173,0.0349025117676212
Physical measures,X4270.Volume level set by participant (left),GSTT2B,Glutathione S-transferase theta-2B,14628,-0.0128758889333833,0.00610911857404307,-0.0248497613385077,-0.000902016528258845,0.0350781916523438
Physical measures,X4270.Volume level set by participant (left),OTUD6B,Deubiquitinase OTUD6B,14588,-0.0551647483585068,0.0261863273262026,-0.106489949917864,-0.00383954679914975,0.0351672269590561
Physical measures,X4270.Volume level set by participant (left),L1CAM,Neural cell adhesion molecule L1,16719,0.0914282494468674,0.0434409308360695,0.00628402500817117,0.176572473885564,0.035336096291023
Physical measures,X4270.Volume level set by participant (left),PTH,Parathyroid hormone,14261,-0.037954595791772,0.0180553042542433,-0.073342992130089,-0.00256619945345508,0.0355594039992362
Physical measures,X4270.Volume level set by participant (left),SERPINB9,Serpin B9,16533,-0.0878744024319813,0.0418157336714211,-0.169833240427967,-0.00591556443599599,0.0356150635803036
Physical measures,X4270.Volume level set by participant (left),CLGN,Calmegin,14261,0.0716068114773777,0.0340773704609692,0.00481516537387806,0.138398457580877,0.0356320771972339
Physical measures,X4270.Volume level set by participant (left),GNPDA1,Glucosamine-6-phosphate isomerase 1,14288,-0.0951029987469967,0.0452989479616259,-0.183888936751784,-0.00631706074220988,0.0357945294437676
Physical measures,X4270.Volume level set by participant (left),MDM1,Nuclear protein MDM1,14261,-0.0976655191537635,0.0465773185402034,-0.188957063492562,-0.00637397481496485,0.0360246936653761
Physical measures,X4270.Volume level set by participant (left),ATP6V1G1,V-type proton ATPase subunit G 1,14288,-0.0442767480538361,0.0211258954968922,-0.0856835032277448,-0.00286999287992745,0.0361129011775557
Physical measures,X4270.Volume level set by participant (left),BLMH,Bleomycin hydrolase,16871,-0.084300843698492,0.0402394485694354,-0.163170162894585,-0.00543152450239855,0.0361876500301579
Physical measures,X4270.Volume level set by participant (left),SNX18,Sorting nexin-18,14588,-0.0691002091938555,0.0329857951433718,-0.133752367674864,-0.00444805071284669,0.0362017771244115
Physical measures,X4270.Volume level set by participant (left),DDC,Aromatic-L-amino-acid decarboxylase,16639,-0.0549148001536536,0.0262389151454005,-0.106343073838639,-0.00348652646866867,0.0363753326072589
Physical measures,X4270.Volume level set by participant (left),SOX2,Transcription factor SOX-2,14586,0.129186387101632,0.0617787291526763,0.00810007796238638,0.250272696240878,0.0365350934058816
Physical measures,X4270.Volume level set by participant (left),SF3B4,Splicing factor 3B subunit 4,16576,-0.0366327536369159,0.017544411696168,-0.0710198005614053,-0.00224570671242656,0.0368129631473582
Physical measures,X4270.Volume level set by participant (left),DARS1,"Aspartate--tRNA ligase, cytoplasmic",16498,-0.0398294204954074,0.0190928172029548,-0.0772513422131988,-0.00240749877761599,0.0369854040066378
Physical measures,X4270.Volume level set by participant (left),SPINK8,Serine protease inhibitor Kazal-type 8,14175,-0.0882437834555983,0.0423927267845305,-0.171333527953278,-0.00515403895791863,0.0373989193687962
Physical measures,X4270.Volume level set by participant (left),PCBP2,Poly(rC)-binding protein 2,14629,-0.0443542294344516,0.021322965466234,-0.0861472417482703,-0.00256121712063295,0.0375323320985387
Physical measures,X4270.Volume level set by participant (left),APOA1,Apolipoprotein A-I,14697,-0.111554302641033,0.0536428536885497,-0.216694295870591,-0.00641430941147571,0.0375819039813609
Physical measures,X4270.Volume level set by participant (left),AHSG,Alpha-2-HS-glycoprotein,14672,-0.110486412512053,0.0531549031855179,-0.214670022755668,-0.00630280226843762,0.03767385674721
Physical measures,X4270.Volume level set by participant (left),DPP4,Dipeptidyl peptidase 4,16297,-0.0900090858704306,0.0434080764066028,-0.175088915627372,-0.00492925611348913,0.0381362341886656
Physical measures,X4270.Volume level set by participant (left),PPME1,Protein phosphatase methylesterase 1,16576,-0.0455422109759696,0.0219667746000751,-0.0885970891921168,-0.00248733275982243,0.0381661591549098
Physical measures,X4270.Volume level set by participant (left),DTX3,Probable E3 ubiquitin-protein ligase DTX3,16576,-0.111011956357655,0.0535932188722596,-0.216054665347284,-0.00596924736802655,0.0383386882409314
Physical measures,X4270.Volume level set by participant (left),CCL14,C-C motif chemokine 14,16578,0.0651574390582357,0.0314790464906969,0.00345850793646978,0.126856370180002,0.0384802695114924
Physical measures,X4270.Volume level set by participant (left),FAM171B,Protein FAM171B,14572,-0.111302442029714,0.053855691371541,-0.216859597117934,-0.0057452869414935,0.0387820277896548
Physical measures,X4270.Volume level set by participant (left),AGRN,Agrin,16733,0.0766308957445751,0.0370830986110754,0.00394802246686737,0.149313769022283,0.0388000348086403
Physical measures,X4270.Volume level set by participant (left),RABEPK,Rab9 effector protein with kelch motifs,16266,-0.0451269190640107,0.0218682595722733,-0.0879887078256664,-0.00226513030235501,0.0390733296336698
Physical measures,X4270.Volume level set by participant (left),CBLN4,Cerebellin-4,16810,-0.0811617296614226,0.0393432186652884,-0.158274438245388,-0.00404902107745739,0.0391360098650224
Physical measures,X4270.Volume level set by participant (left),PAXX,Protein PAXX,14352,-0.0681804910734868,0.0330787407323005,-0.133014822908796,-0.0033461592381778,0.0393060201604588
Physical measures,X4270.Volume level set by participant (left),SELE,E-selectin,16871,0.0512548539717028,0.0248973657859154,0.00245601703130861,0.100053690912097,0.0395435299179779
Physical measures,X4270.Volume level set by participant (left),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14404,-0.0378696671483334,0.0184330695981142,-0.0739984835606373,-0.00174085073602955,0.0399509822212646
Physical measures,X4270.Volume level set by participant (left),ELN,Elastin,14652,-0.0856976354284284,0.0417229720342189,-0.167474660615497,-0.00392061024135931,0.0399965458277592
Physical measures,X4270.Volume level set by participant (left),EPN1,Epsin-1,14404,-0.0717655617158322,0.0349646699407849,-0.140296314799771,-0.00323480863189385,0.0401375442009627
Physical measures,X4270.Volume level set by participant (left),ACP5,Tartrate-resistant acid phosphatase type 5,16718,0.0785212766175662,0.0382826484334322,0.00348728568803905,0.153555267547093,0.0402734461756884
Physical measures,X4270.Volume level set by participant (left),DDX1,ATP-dependent RNA helicase DDX1,14588,-0.0592845589807637,0.0289210735891403,-0.115969863215479,-0.00259925474604868,0.0403945795733872
Physical measures,X4270.Volume level set by participant (left),SCRN1,Secernin-1,16637,-0.0465833461075417,0.0227402409739027,-0.091154218416391,-0.00201247379869229,0.0405268674008426
Physical measures,X4270.Volume level set by participant (left),PLIN1,Perilipin-1,16257,0.075641386910795,0.0369671140670921,0.00318584333929459,0.148096930482295,0.0407546870891573
Physical measures,X4270.Volume level set by participant (left),CHL1,Neural cell adhesion molecule L1-like protein,16685,-0.0839554996545481,0.0410449885733388,-0.164403677258292,-0.0035073220508041,0.0408261124971819
Physical measures,X4270.Volume level set by participant (left),CST6,Cystatin-M,16229,0.0542786957816073,0.0265507924244952,0.00223914262959671,0.106318248933618,0.0409366521931366
Physical measures,X4270.Volume level set by participant (left),DHODH,Dihydroorotate dehydrogenase,14175,-0.0650986415159733,0.0318520097852385,-0.127528580695041,-0.00266870233690579,0.0409933146689612
Physical measures,X4270.Volume level set by participant (left),APP,Amyloid-beta precursor protein,16642,-0.0393397719018901,0.0192555926675429,-0.0770807335302742,-0.00159881027350606,0.0410651087491906
Physical measures,X4270.Volume level set by participant (left),TRIM58,E3 ubiquitin-protein ligase TRIM58,14572,-0.0357271762487012,0.017504913747294,-0.0700368071933975,-0.00141754530400492,0.0412708308894226
Physical measures,X4270.Volume level set by participant (left),SMOC1,SPARC-related modular calcium-binding protein 1,16810,-0.0782816207976336,0.0383690555313073,-0.153484969638996,-0.00307827195627136,0.0413432346401278
Physical measures,X4270.Volume level set by participant (left),ENO2,Gamma-enolase,16799,-0.0411856999468693,0.0201995522733664,-0.0807768224026673,-0.0015945774910712,0.0414715297285065
Physical measures,X4270.Volume level set by participant (left),WDR46,WD repeat-containing protein 46,14572,-0.0878850072341342,0.0431125614731378,-0.172385627721484,-0.003384386746784,0.0415178722037213
Physical measures,X4270.Volume level set by participant (left),PCDH1,Protocadherin-1,16779,-0.119804161899804,0.0587731225169048,-0.234999482032937,-0.00460884176667019,0.0415238580876467
Physical measures,X4270.Volume level set by participant (left),ACTA2,"Actin, aortic smooth muscle",16356,-0.0583109428169667,0.0286460735215413,-0.114457246919188,-0.00216463871474581,0.0418101630357814
Physical measures,X4270.Volume level set by participant (left),ACP1,Low molecular weight phosphotyrosine protein phosphatase,14207,-0.0669982179550629,0.0329171743142369,-0.131515879610967,-0.00248055629915848,0.0418334560977287
Physical measures,X4270.Volume level set by participant (left),CHGA,Chromogranin-A,14678,0.0341759710994111,0.016803510046405,0.0012410914084573,0.0671108507903649,0.041983775258846
Physical measures,X4270.Volume level set by participant (left),KCTD5,BTB/POZ domain-containing protein KCTD5,14316,-0.0709374621936452,0.0349371264539944,-0.139414230043474,-0.00246069434381609,0.0423311083208873
Physical measures,X4270.Volume level set by participant (left),USP25,Ubiquitin carboxyl-terminal hydrolase 25,14572,-0.0442591960288284,0.021810026255033,-0.087006847488693,-0.0015115445689638,0.042445390811634
Physical measures,X4270.Volume level set by participant (left),RAD51,DNA repair protein RAD51 homolog 1,14404,-0.0566346602128961,0.0279381610967368,-0.1113934559625,-0.00187586446329194,0.0426661459002296
Physical measures,X4270.Volume level set by participant (left),STX7,Syntaxin-7,14207,-0.0602267053538446,0.0297219291042004,-0.118481686398077,-0.00197172430961189,0.0427487208126649
Physical measures,X4270.Volume level set by participant (left),NMI,N-myc-interactor,14508,-0.0422805765808193,0.0208656311789007,-0.0831772136914646,-0.00138393947017402,0.0427496412558972
Physical measures,X4270.Volume level set by participant (left),CENPF,Centromere protein F,14404,-0.053594251661657,0.0264874369061339,-0.105509627997679,-0.00167887532563445,0.0430520418488008
Physical measures,X4270.Volume level set by participant (left),RICTOR,Rapamycin-insensitive companion of mTOR,14207,-0.0599752885869701,0.029707622266557,-0.118202228229422,-0.00174834894451824,0.0435213892250256
Physical measures,X4270.Volume level set by participant (left),LGALS4,Galectin-4,16630,0.0472182720311131,0.0234078673722541,0.00133885198149516,0.0930976920807311,0.0436910459777332
Physical measures,X4270.Volume level set by participant (left),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16689,0.0520705490746175,0.0258463644145886,0.00141167482202378,0.102729423327211,0.0439607229387413
Physical measures,X4270.Volume level set by participant (left),SERPINA4,Kallistatin,14403,-0.126616175465428,0.062860554430068,-0.249822862148361,-0.00340948878249457,0.044003031813797
Physical measures,X4270.Volume level set by participant (left),RTN4R,Reticulon-4 receptor,16810,0.076257923888382,0.0380024069580578,0.00177320625058866,0.150742641526175,0.0448018394079281
Physical measures,X4270.Volume level set by participant (left),CARHSP1,Calcium-regulated heat-stable protein 1,16257,-0.0493834437596916,0.0246375658570104,-0.097673072839432,-0.00109381467995132,0.0450442064300176
Physical measures,X4270.Volume level set by participant (left),ADM,Pro-adrenomedullin,16810,0.0935079607912168,0.0466619135279356,0.00205061027646299,0.184965311305971,0.0450918632491856
Physical measures,X4270.Volume level set by participant (left),BCAM,Basal cell adhesion molecule,16671,-0.103329921129996,0.0515921240095064,-0.204450484188628,-0.00220935807136315,0.0452124087958709
Physical measures,X4270.Volume level set by participant (left),ART3,Ecto-ADP-ribosyltransferase 3,16715,-0.0746089295310284,0.0373619273785167,-0.147838307192921,-0.0013795518691356,0.0458496414970033
Physical measures,X4270.Volume level set by participant (left),EDAR,Tumor necrosis factor receptor superfamily member EDAR,16637,-0.027608734709274,0.0138644232822708,-0.0547830043425248,-0.00043446507602312,0.0464602259395333
Physical measures,X4270.Volume level set by participant (left),ITGB1BP1,Integrin beta-1-binding protein 1,16266,0.0627659880505067,0.0315399751214259,0.000947636812511907,0.124584339288501,0.0466026438772434
Physical measures,X4270.Volume level set by participant (left),ATXN2L,Ataxin-2-like protein,14629,-0.0601709135269334,0.0302438896487999,-0.119448937238581,-0.000892889815285604,0.0466621175960259
Physical measures,X4270.Volume level set by participant (left),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14288,-0.086509259994064,0.0435448833829955,-0.171857231424735,-0.00116128856339288,0.0469782063361981
Physical measures,X4270.Volume level set by participant (left),SPARCL1,SPARC-like protein 1,16653,-0.0892901290794366,0.0449581323424536,-0.177408068470646,-0.00117218968822745,0.0470416120914244
Physical measures,X4270.Volume level set by participant (left),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16533,-0.0723936018284762,0.0364776855266674,-0.143889865460744,-0.00089733819620802,0.0472055513524504
Physical measures,X4270.Volume level set by participant (left),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16533,-0.0864434838563803,0.0435789102505228,-0.171858147947405,-0.00102881976535571,0.0473160648208366
Physical measures,X4270.Volume level set by participant (left),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16533,0.0645900343197051,0.0326073394118814,0.000679649072417451,0.128500419566993,0.0476253953440162
Physical measures,X4270.Volume level set by participant (left),MCAM,Cell surface glycoprotein MUC18,16715,-0.0746984331305363,0.0377772732393101,-0.148741888679584,-0.000654977581488567,0.0480198708799394
Physical measures,X4270.Volume level set by participant (left),AREG,Amphiregulin,16576,0.0548405887168279,0.0277501320777049,0.000450329844526337,0.10923084758913,0.0481455267273036
Physical measures,X4270.Volume level set by participant (left),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16639,0.0222716013911102,0.0112779391552934,0.000166840646735233,0.0443763621354852,0.0483081049187732
Physical measures,X4270.Volume level set by participant (left),OPLAH,5-oxoprolinase,14288,-0.0438022485054052,0.0221814101302474,-0.08727781236069,-0.000326684650120299,0.0483182851188473
Physical measures,X4270.Volume level set by participant (left),TPMT,Thiopurine S-methyltransferase,16266,-0.0352499654403034,0.0178828025333393,-0.0703002584056484,-0.000199672474958335,0.0487218778951906
Physical measures,X4270.Volume level set by participant (left),PSMD9,26S proteasome non-ATPase regulatory subunit 9,16576,-0.043954187908019,0.0223069634886688,-0.0876758363458099,-0.000232539470228103,0.0488063704407294
Physical measures,X4270.Volume level set by participant (left),CD300LF,CMRF35-like molecule 1,16810,0.0411024466026915,0.0208629251193493,0.000211113368766828,0.0819937798366162,0.0488411306878827
Physical measures,X4270.Volume level set by participant (left),CLSTN3,Calsyntenin-3,14628,-0.0946860460152918,0.0480757591331491,-0.188914533916264,-0.000457558114319703,0.0489125640248948
Physical measures,X4270.Volume level set by participant (left),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,14139,0.107327263938536,0.0545809854615612,0.000348532433875975,0.214305995443196,0.0492736404372451
Physical measures,X4270.Volume level set by participant (left),CSF1,Macrophage colony-stimulating factor 1,16733,0.0920164533406578,0.0469546241503787,-1.46099940844108e-05,0.1840475166754,0.0500487612490152
Physical measures,X4270.Volume level set by participant (left),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,14207,-0.0639179812849227,0.0326252540563796,-0.127863479235427,2.75166655812897e-05,0.0501140040860691
Physical measures,X4270.Volume level set by participant (left),RBM19,Probable RNA-binding protein 19,14175,-0.0651601360831128,0.0332921572271042,-0.130412764248237,9.24920820114389e-05,0.0503410167518091
Physical measures,X4270.Volume level set by participant (left),CFHR5,Complement factor H-related protein 5,14466,0.0695078095576057,0.0355316098907836,-0.000134145828330129,0.139149764943542,0.0504579387202859
Physical measures,X4270.Volume level set by participant (left),ADD1,Alpha-adducin,14352,-0.0442628710323907,0.0226476723569521,-0.0886523088520167,0.000126566787235334,0.0506719860274935
Physical measures,X4270.Volume level set by participant (left),NOS3,"Nitric oxide synthase, endothelial",16257,0.0481572546012312,0.024655743894453,-0.000168003431896747,0.0964825126343591,0.0508147043568115
Physical measures,X4270.Volume level set by participant (left),GLYR1,Putative oxidoreductase GLYR1,14572,-0.0482796761601631,0.0247908002810467,-0.0968696447110146,0.000310292390688333,0.051495990553029
Physical measures,X4270.Volume level set by participant (left),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16642,-0.0406134000994629,0.0208565296733976,-0.0814921982593221,0.000265398060396355,0.051518580648246
Physical measures,X4270.Volume level set by participant (left),CAT,Catalase,14444,-0.0514896373185821,0.0265058498955592,-0.103441103113878,0.00046182847671393,0.0520867976339287
Physical measures,X4270.Volume level set by participant (left),GCG,Pro-glucagon,16266,-0.0204241325094934,0.0105357014395461,-0.0410741073310037,0.000225842312016829,0.0525717344493512
Physical measures,X4270.Volume level set by participant (left),LGALS3,Galectin-3,16691,0.0818671031059532,0.0422449885874957,-0.000933074525538452,0.164667280737445,0.0526507259488464
Physical measures,X4270.Volume level set by participant (left),CRYZL1,Quinone oxidoreductase-like protein 1,14288,-0.0337333678720367,0.0174194127888232,-0.0678754169381302,0.000408681194056827,0.0528214678730217
Physical measures,X4270.Volume level set by participant (left),NT5C3A,Cytosolic 5'-nucleotidase 3A,16612,-0.030143677294345,0.0155724890764056,-0.0606657558841,0.000378401295409978,0.0529213382034277
Physical measures,X4270.Volume level set by participant (left),IGFBP4,Insulin-like growth factor-binding protein 4,16461,0.0593916916943001,0.0307001793321528,-0.000780659796719298,0.11956404318532,0.0530600326640566
Physical measures,X4270.Volume level set by participant (left),PCARE,Photoreceptor cilium actin regulator,14168,0.0341035825358959,0.0176335329663333,-0.00045814207811741,0.0686653071499092,0.0531307424410011
Physical measures,X4270.Volume level set by participant (left),GSN,Gelsolin,14621,-0.150422367469988,0.0780144735914806,-0.30333073570929,0.00248600076931427,0.0538578115123398
Physical measures,X4270.Volume level set by participant (left),PPBP,Platelet basic protein,14546,-0.0333328365824159,0.0173146529428231,-0.0672695563503491,0.000603883185517309,0.0542334710590283
Physical measures,X4270.Volume level set by participant (left),ADGRE2,Adhesion G protein-coupled receptor E2,16733,-0.0856997767096696,0.0445425349073385,-0.173003145128053,0.00160359170871378,0.0543717122864702
Physical measures,X4270.Volume level set by participant (left),PDGFRB,Platelet-derived growth factor receptor beta,16871,-0.0691720246475941,0.0361024865465196,-0.139932898278773,0.00158884898358425,0.0553831910351411
Physical measures,X4270.Volume level set by participant (left),VPS4B,Vacuolar protein sorting-associated protein 4B,14572,-0.0309366239752283,0.0161759204636395,-0.0626414280839618,0.000768180133505207,0.0558303038661967
Physical measures,X4270.Volume level set by participant (left),DSG3,Desmoglein-3,16745,0.0706148166363815,0.0369656705045031,-0.00183789755244462,0.143067530825208,0.05611412839387
Physical measures,X4270.Volume level set by participant (left),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,14175,-0.100275668759638,0.0524973482711025,-0.203170471370999,0.00261913385172315,0.0561393359988889
Physical measures,X4270.Volume level set by participant (left),SETMAR,Histone-lysine N-methyltransferase SETMAR,16481,-0.0825651994278973,0.0434006803591372,-0.167630532931806,0.00250013407601166,0.0571370796079981
Physical measures,X4270.Volume level set by participant (left),LIPF,Gastric triacylglycerol lipase,14288,-0.0474026402538978,0.024941914549996,-0.0962887927718901,0.00148351226409444,0.0573848712624666
Physical measures,X4270.Volume level set by participant (left),NHLRC3,NHL repeat-containing protein 3,13987,0.0888953629888724,0.0468145967774415,-0.00286124669491304,0.180651972672658,0.0576006659898277
Physical measures,X4270.Volume level set by participant (left),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16617,0.0360637856561236,0.0190171805262507,-0.00120988817532777,0.073337459487575,0.0579272655085944
Physical measures,X4270.Volume level set by participant (left),PSMG4,Proteasome assembly chaperone 4,14207,-0.0482750188537933,0.0254790706625653,-0.0982139973524212,0.00166395964483457,0.0581533853894462
Physical measures,X4270.Volume level set by participant (left),FASLG,Tumor necrosis factor ligand superfamily member 6,16843,-0.0638967137794264,0.0337625913337651,-0.130071392793606,0.00227796523475306,0.0584375613790848
Physical measures,X4270.Volume level set by participant (left),CETN3,Centrin-3,14588,-0.0367476407008695,0.0194186867407499,-0.0748082667127394,0.00131298531100037,0.0584594438911251
Physical measures,X4270.Volume level set by participant (left),TP53BP1,TP53-binding protein 1,14207,-0.0328869868140496,0.0173928406025735,-0.0669769543950937,0.00120298076699447,0.0586667638937842
Physical measures,X4270.Volume level set by participant (left),FETUB,Fetuin-B,16685,0.0719883989080048,0.0380778694056462,-0.00264422512706174,0.146621022943071,0.058700776726479
Physical measures,X4270.Volume level set by participant (left),CTSF,Cathepsin F,16719,0.0593992866607298,0.031440218012351,-0.00222354064347818,0.121022113964938,0.0588720024360417
Physical measures,X4270.Volume level set by participant (left),FGFR2,Fibroblast growth factor receptor 2,16719,0.108338119473487,0.0574123642163807,-0.00419011439061935,0.220866353337593,0.0591753371720606
Physical measures,X4270.Volume level set by participant (left),CDC26,Anaphase-promoting complex subunit CDC26,14544,-0.0395238722203303,0.0209994844292778,-0.0806828617017147,0.00163511726105407,0.0598376111616206
Physical measures,X4270.Volume level set by participant (left),SEPTIN8,Septin-8,14587,-0.0836763210781309,0.0444630950851216,-0.170823987444969,0.00347134528870738,0.0598657761104969
Physical measures,X4270.Volume level set by participant (left),TLR3,Toll-like receptor 3,16843,0.0385903943276839,0.0205147811616405,-0.00161857674913148,0.0787993654044992,0.0599753076159221
Physical measures,X4270.Volume level set by participant (left),PRR4,Proline-rich protein 4,14247,0.0409541122553686,0.0217906726581443,-0.00175560615459433,0.0836638306653315,0.0602057928073004
Physical measures,X4270.Volume level set by participant (left),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,14175,-0.0600184910261571,0.0320192999077633,-0.122776318845373,0.002739336793059,0.0608893699670544
Physical measures,X4270.Volume level set by participant (left),UHRF2,E3 ubiquitin-protein ligase UHRF2,14175,-0.0777460673069462,0.0415120489705063,-0.159109683289139,0.00361754867524608,0.0611089386266685
Physical measures,X4270.Volume level set by participant (left),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,14168,-0.0456361576262831,0.0243755668731245,-0.0934122686976072,0.00213995344504097,0.061198290996524
Physical measures,X4270.Volume level set by participant (left),FLT4,Vascular endothelial growth factor receptor 3,16719,0.0699914934504668,0.0374537832600031,-0.00341792173913917,0.143400908640073,0.0616760758796933
Physical measures,X4270.Volume level set by participant (left),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14404,-0.0742156530142773,0.0397190935110324,-0.152065076295901,0.00363377026734632,0.0617108705501556
Physical measures,X4270.Volume level set by participant (left),CUZD1,CUB and zona pellucida-like domain-containing protein 1,14261,0.0740660815245947,0.0396517742409395,-0.00365139598764669,0.151783559036836,0.0617946563467505
Physical measures,X4270.Volume level set by participant (left),OSM,Oncostatin-M,16550,0.0334725415251125,0.0179534988779591,-0.0017163162756873,0.0686613993259124,0.0622829617971754
Physical measures,X4270.Volume level set by participant (left),FAM172A,Cotranscriptional regulator FAM172A,14288,-0.0465702403884026,0.0250096675952117,-0.0955891888750175,0.00244870809821234,0.0626110081495636
Physical measures,X4270.Volume level set by participant (left),FABP4,"Fatty acid-binding protein, adipocyte",16871,0.0471614112449606,0.0253846110202609,-0.00259242635475072,0.096915248844672,0.0632043217701171
Physical measures,X4270.Volume level set by participant (left),LY96,Lymphocyte antigen 96,16533,0.0653295186654998,0.0351858979963738,-0.0036348414073928,0.134293878738392,0.0633721991610046
Physical measures,X4270.Volume level set by participant (left),ABHD14B,Protein ABHD14B,16478,-0.0422539013750262,0.0227735368685442,-0.086890033637373,0.00238223088732047,0.0635577360084193
Physical measures,X4270.Volume level set by participant (left),TMED8,Protein TMED8,14588,-0.0277084650336477,0.0149540731436821,-0.0570184483952647,0.00160151832796928,0.0639162946596899
Physical measures,X4270.Volume level set by participant (left),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14629,-0.0350358867498303,0.0189232050457349,-0.0721253686394707,0.00205359513981008,0.0641210626264745
Physical measures,X4270.Volume level set by participant (left),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14572,-0.0757685596516982,0.0409883626905853,-0.156105750525245,0.00456863122184899,0.064544772944777
Physical measures,X4270.Volume level set by participant (left),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14404,-0.0574173546128446,0.0310890096004455,-0.118351813429718,0.00351710420402855,0.0647865262413199
Physical measures,X4270.Volume level set by participant (left),REG3A,Regenerating islet-derived protein 3-alpha,16871,0.0374078092465632,0.0202763619429127,-0.00233386016154578,0.0771494786546722,0.0650699856322347
Physical measures,X4270.Volume level set by participant (left),LPP,Lipoma-preferred partner,14175,-0.0429282940043005,0.0232744071561892,-0.0885461320304312,0.00268954402183029,0.065139628625105
Physical measures,X4270.Volume level set by participant (left),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14588,-0.123188472566149,0.0668482052105138,-0.254210954778756,0.00783400964645803,0.0653772064244619
Physical measures,X4270.Volume level set by participant (left),CCL23,C-C motif chemokine 23,16733,0.0555815868012572,0.0301787737785019,-0.00356880980460651,0.114731983407121,0.0655302544689225
Physical measures,X4270.Volume level set by participant (left),HLA_A,,14629,-0.0828544771623009,0.0450183873830912,-0.17109051643316,0.00538156210855775,0.0657212059133378
Physical measures,X4270.Volume level set by participant (left),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",14207,-0.0780961297119627,0.0424802899161452,-0.161357497947607,0.005165238523682,0.0660231086122198
Physical measures,X4270.Volume level set by participant (left),OXT,Oxytocin-neurophysin 1,16799,0.0166740774016618,0.00907507281097587,-0.0011130653078509,0.0344612201111745,0.0661760370731542
Physical measures,X4270.Volume level set by participant (left),NOTCH3,Neurogenic locus notch homolog protein 3,16871,-0.0673022662138315,0.0366715094353741,-0.139178424707165,0.00457389227950179,0.0664827189304666
Physical measures,X4270.Volume level set by participant (left),YJU2,Splicing factor YJU2,14572,-0.0846820470381799,0.0461711329679255,-0.175177467655314,0.0058133735789541,0.0666609306552484
Physical measures,X4270.Volume level set by participant (left),LTA4H,Leukotriene A-4 hydrolase,16810,-0.0424538032984432,0.0231583039869828,-0.0878440791129294,0.002936472516043,0.0667905226162032
Physical measures,X4270.Volume level set by participant (left),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16533,-0.0575244862310486,0.0313797135869861,-0.119028724861541,0.00397975239944422,0.066794634661172
Physical measures,X4270.Volume level set by participant (left),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14697,-0.139338891757785,0.0760145987791047,-0.28832750536483,0.00964972184926002,0.0668147266333941
Physical measures,X4270.Volume level set by participant (left),NAA10,N-alpha-acetyltransferase 10,14175,-0.0550694031762258,0.0300822324792954,-0.114030578835645,0.00389177248319325,0.0671769649305673
Physical measures,X4270.Volume level set by participant (left),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14404,0.0526719938366914,0.0287779181603499,-0.00373272575759447,0.109076713430977,0.0672269614979562
Physical measures,X4270.Volume level set by participant (left),EPPK1,Epiplakin,14288,0.0365667873830958,0.0199803750423919,-0.00259474769999227,0.0757283224661839,0.0672505730719879
Physical measures,X4270.Volume level set by participant (left),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,14144,-0.0461607517052069,0.0252760804124237,-0.0957018693135574,0.00338036590314351,0.067831861978365
Physical measures,X4270.Volume level set by participant (left),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16715,-0.0602948987061726,0.0330164702706854,-0.125007180436716,0.00441738302437074,0.0678369819829023
Physical measures,X4270.Volume level set by participant (left),SLC13A1,Solute carrier family 13 member 1,14572,-0.0438414858370458,0.0240211900230085,-0.0909230182821425,0.00324004660805077,0.0680038375072323
Physical measures,X4270.Volume level set by participant (left),MDH1,"Malate dehydrogenase, cytoplasmic",14578,-0.0677116231558508,0.037118997693896,-0.140464858635887,0.00504161232418535,0.0681457967670833
Physical measures,X4270.Volume level set by participant (left),NELL2,Protein kinase C-binding protein NELL2,16733,-0.0796345931357282,0.043680644505105,-0.165248656365734,0.00597947009427757,0.068304676652048
Physical measures,X4270.Volume level set by participant (left),SIGLEC8,Sialic acid-binding Ig-like lectin 8,14288,-0.0596632244877513,0.0327431128271451,-0.123839725628956,0.00451327665345306,0.0684514732575022
Physical measures,X4270.Volume level set by participant (left),GGCT,Gamma-glutamylcyclotransferase,14623,-0.0575005369425688,0.0315601240498044,-0.119358380080185,0.00435730619504787,0.0684850864416758
Physical measures,X4270.Volume level set by participant (left),NUDT5,ADP-sugar pyrophosphatase,16671,-0.0472703580047699,0.0259628104194783,-0.0981574664269474,0.00361675041740759,0.0686711760885605
Physical measures,X4270.Volume level set by participant (left),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16712,0.0352508708423057,0.0193675672948105,-0.00270956105552278,0.0732113027401342,0.0687619768615732
Physical measures,X4270.Volume level set by participant (left),PTN,Pleiotrophin,16356,-0.0473258267737001,0.0260024893772384,-0.0982907059530873,0.0036390524056872,0.068769702197099
Physical measures,X4270.Volume level set by participant (left),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,14185,-0.0777723115175118,0.042737951317401,-0.161538696099618,0.00599407306459411,0.0688184467337411
Physical measures,X4270.Volume level set by participant (left),SCP2,Non-specific lipid-transfer protein,16266,-0.0305106926359777,0.0167752056023281,-0.0633900956165408,0.00236871034458543,0.0689608141128673
Physical measures,X4270.Volume level set by participant (left),CXCL8,Interleukin-8,16547,0.0348995931879713,0.0191905310168183,-0.00271384760499246,0.0725130339809351,0.0689930041821551
Physical measures,X4270.Volume level set by participant (left),DIPK2B,Divergent protein kinase domain 2B,14352,-0.0959726807784718,0.0528231459276454,-0.199506046796657,0.00756068523971315,0.0692582079440903
Physical measures,X4270.Volume level set by participant (left),KRT19,"Keratin, type I cytoskeletal 19",16617,0.0344578800728267,0.01901018456177,-0.00280208166824261,0.0717178418138959,0.0699114359158449
Physical measures,X4270.Volume level set by participant (left),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16257,-0.0219338412947411,0.0121071517264239,-0.045663858678532,0.00179617608904974,0.0700597815605249
Physical measures,X4270.Volume level set by participant (left),MIF,Macrophage migration inhibitory factor,16627,-0.0365131648828602,0.0201648542004186,-0.0760362791156806,0.00300994934996024,0.0702002675936343
Physical measures,X4270.Volume level set by participant (left),CSPG4,Chondroitin sulfate proteoglycan 4,14678,-0.0795605007543705,0.0439984662773587,-0.165797494657994,0.00667649314925269,0.0705871121567334
Physical measures,X4270.Volume level set by participant (left),PLPBP,Pyridoxal phosphate homeostasis protein,16666,-0.0357711215359169,0.0197848890449226,-0.0745495040639651,0.00300726099213134,0.0706242067260395
Physical measures,X4270.Volume level set by participant (left),MTSS1,Protein MTSS 1,14588,-0.0244082575921547,0.0135175699487689,-0.0509026946917417,0.00208617950743223,0.070990680555972
Physical measures,X4270.Volume level set by participant (left),OGFR,Opioid growth factor receptor,16576,-0.0713707738480445,0.0395284769661165,-0.148846588701633,0.00610504100554379,0.071006289404478
Physical measures,X4270.Volume level set by participant (left),PHLDB2,Pleckstrin homology-like domain family B member 2,14144,0.0288922621685412,0.0160023926533523,-0.00247242743202931,0.0602569517691117,0.0710183193522936
Physical measures,X4270.Volume level set by participant (left),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14257,-0.036295690355307,0.0201139448438568,-0.0757190222492663,0.00312764153865221,0.0711734795140632
Physical measures,X4270.Volume level set by participant (left),MAPKAPK2,MAP kinase-activated protein kinase 2,14404,-0.0375561980028895,0.0208158144699178,-0.0783551943639284,0.00324279835814945,0.0712185648702496
Physical measures,X4270.Volume level set by participant (left),DXO,Decapping and exoribonuclease protein,14628,-0.0606368627552708,0.0336352727628679,-0.126561997370492,0.00528827185995032,0.0714439966241783
Physical measures,X4270.Volume level set by participant (left),ENSA,Alpha-endosulfine,14572,-0.0525739742417544,0.0292108612264917,-0.109827262245678,0.0046793137621693,0.0719114851626301
Physical measures,X4270.Volume level set by participant (left),ADGRE5,Adhesion G protein-coupled receptor E5,16773,-0.0759634163423567,0.0422111509225069,-0.15869727215047,0.00677043946575671,0.0719409462789373
Physical measures,X4270.Volume level set by participant (left),FGFBP3,Fibroblast growth factor-binding protein 3,14628,-0.0713062957595459,0.0396623928930819,-0.149044585829986,0.00643199431089465,0.0722243655000034
Physical measures,X4270.Volume level set by participant (left),XCL1,Lymphotactin,16810,0.0413993525888625,0.023060670225472,-0.00379956105306253,0.0865982662307875,0.0726340312027134
Physical measures,X4270.Volume level set by participant (left),NEK7,Serine/threonine-protein kinase Nek7,14404,-0.0367210821614923,0.0204582348740437,-0.0768192225146178,0.00337705819163332,0.0726859710945783
Physical measures,X4270.Volume level set by participant (left),CD101,Immunoglobulin superfamily member 2,14588,-0.0620694251610038,0.0345877985468213,-0.129861510312774,0.00572265999076602,0.0727466472772023
Physical measures,X4270.Volume level set by participant (left),VSIG4,V-set and immunoglobulin domain-containing protein 4,16647,0.0561579549010728,0.0313067245702802,-0.00520322525667626,0.117519135058822,0.0728635002041706
Physical measures,X4270.Volume level set by participant (left),SNX15,Sorting nexin-15,14352,-0.0494836168035645,0.0276335518724279,-0.103645378473523,0.00467814486639406,0.0733612905295907
Physical measures,X4270.Volume level set by participant (left),STOML2,"Stomatin-like protein 2, mitochondrial",14144,-0.029043478919952,0.0162285095980787,-0.0608513577321862,0.00276439989228222,0.0735303508679866
Physical measures,X4270.Volume level set by participant (left),AZU1,Azurocidin,16164,0.0288461938986018,0.016126086690123,-0.00276093601403929,0.060453323811243,0.0736672685656641
Physical measures,X4270.Volume level set by participant (left),PENK,Proenkephalin-A,14352,0.0869686977723048,0.0487124319149698,-0.00850766878103593,0.182445064325646,0.074225840312873
Physical measures,X4270.Volume level set by participant (left),KLK3,Prostate-specific antigen,14678,0.0291759280949182,0.0163439308355082,-0.00285817634267777,0.0612100325325142,0.0742620227410561
Physical measures,X4270.Volume level set by participant (left),SORT1,Sortilin,16639,-0.0610603201371491,0.0342253620168251,-0.128142029690126,0.00602138941582819,0.0744311040299675
Physical measures,X4270.Volume level set by participant (left),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14652,-0.043553984418608,0.0244432314728595,-0.0914627181054127,0.00435474926819667,0.0747956767748123
Physical measures,X4270.Volume level set by participant (left),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14588,-0.0195168290908579,0.0109532871934755,-0.0409852719900698,0.00195161380835409,0.0747987708561687
Physical measures,X4270.Volume level set by participant (left),ACVRL1,Serine/threonine-protein kinase receptor R3,16500,0.0935986756312641,0.0525580223580386,-0.00941504819049159,0.19661239945302,0.0749531269233712
Physical measures,X4270.Volume level set by participant (left),FHIP2A,FHF complex subunit HOOK interacting protein 2A,14175,-0.0555012218139918,0.0311916554128069,-0.116636866423093,0.00563442279510962,0.075202007895592
Physical measures,X4270.Volume level set by participant (left),IL10RB,Interleukin-10 receptor subunit beta,16733,0.0779755847195508,0.043869500901918,-0.00800863704820837,0.16395980648731,0.0755133808956971
Physical measures,X4270.Volume level set by participant (left),ELAC1,Zinc phosphodiesterase ELAC protein 1,14629,-0.0322807555062203,0.018189730380769,-0.0679326270525276,0.00337111604008707,0.0759733279166775
Physical measures,X4270.Volume level set by participant (left),FLT1,Vascular endothelial growth factor receptor 1,16535,0.0986196288679872,0.0556000407381709,-0.0103564509788278,0.207595708714802,0.0761257394694788
Physical measures,X4270.Volume level set by participant (left),PSME2,Proteasome activator complex subunit 2,16447,-0.0635734495095564,0.0358511452085619,-0.133841694118338,0.00669479509922492,0.0762039347069716
Physical measures,X4270.Volume level set by participant (left),EPCAM,Epithelial cell adhesion molecule,16644,-0.0232073484854003,0.0131000483970237,-0.0488834433435668,0.00246874637276616,0.0764881346845235
Physical measures,X4270.Volume level set by participant (left),NTRK2,BDNF/NT-3 growth factors receptor,16666,-0.0883691633867294,0.0500250083342943,-0.186418179721946,0.00967985294848733,0.0773303688075311
Physical measures,X4270.Volume level set by participant (left),TREM2,Triggering receptor expressed on myeloid cells 2,16630,0.0431125622242319,0.0244234794843506,-0.00475745756509523,0.090982582013559,0.0775469022629446
Physical measures,X4270.Volume level set by participant (left),BOC,Brother of CDO,16356,-0.0961451841821216,0.054500783522049,-0.202966719885338,0.0106763515210944,0.0777327411102521
Physical measures,X4270.Volume level set by participant (left),THBS4,Thrombospondin-4,16643,-0.0490745877080881,0.02785590408143,-0.103672159707691,0.00552298429151474,0.0781332672789928
Physical measures,X4270.Volume level set by participant (left),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16576,-0.112810627192649,0.0640666458790005,-0.23838125311549,0.0127599987301922,0.0782852264377703
Physical measures,X4270.Volume level set by participant (left),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14629,-0.0689364746341765,0.0391908926878054,-0.145750624302275,0.00787767503392219,0.0785997608472737
Physical measures,X4270.Volume level set by participant (left),SIGLEC1,Sialoadhesin,16733,0.052392739768178,0.0298006650090128,-0.00601656364948705,0.110802043185843,0.0787477066694616
Physical measures,X4270.Volume level set by participant (left),GPI,Glucose-6-phosphate isomerase,14672,-0.0557974159150358,0.0317445987678161,-0.118016829499955,0.0064219976698839,0.0788197935768689
Physical measures,X4270.Volume level set by participant (left),CPM,Carboxypeptidase M,16707,0.0640831158251183,0.0366032881182157,-0.00765932888658435,0.135825560536821,0.0800077816382344
Physical measures,X4270.Volume level set by participant (left),LPO,Lactoperoxidase,16156,0.0383500242401375,0.0219071227385243,-0.00458793632737001,0.0812879848076451,0.0800384365631067
Physical measures,X4270.Volume level set by participant (left),MYO6,Unconventional myosin-VI,14629,-0.0695281221011144,0.0397445076614457,-0.147427357117548,0.00837111291531918,0.0802468907029375
Physical measures,X4270.Volume level set by participant (left),SAT2,Thialysine N-epsilon-acetyltransferase,14404,-0.0387129529563432,0.0221624382824529,-0.0821513319899509,0.00472542607726448,0.0806964620466425
Physical measures,X4270.Volume level set by participant (left),TFF3,Trefoil factor 3,16654,0.0493627912583245,0.0282705030130621,-0.00604739464727717,0.104772977163926,0.080814086566077
Physical measures,X4270.Volume level set by participant (left),MSMB,Beta-microseminoprotein,16624,0.0321221977901718,0.0184010739501195,-0.00394390715206246,0.0681883027324061,0.0808868504782963
Physical measures,X4270.Volume level set by participant (left),IL4R,Interleukin-4 receptor subunit alpha,16637,0.0585144446974374,0.0335218424953523,-0.00718836659345314,0.124217255988328,0.0809056193835418
Physical measures,X4270.Volume level set by participant (left),IGF1R,Insulin-like growth factor 1 receptor,16576,-0.102875174201299,0.0589802421795974,-0.21847644887331,0.0127261004707123,0.0811373503514177
Physical measures,X4270.Volume level set by participant (left),CLEC12A,C-type lectin domain family 12 member A,14207,-0.129198639397855,0.0741292390469482,-0.274491947929873,0.0160946691341637,0.0813755999753339
Physical measures,X4270.Volume level set by participant (left),AGBL2,Cytosolic carboxypeptidase 2,14168,-0.0297901163682131,0.0171118848758484,-0.0633294107248759,0.0037491779884497,0.0817224738145179
Physical measures,X4270.Volume level set by participant (left),ADAMTSL4,ADAMTS-like protein 4,14288,-0.110898758283807,0.0637421238876547,-0.23583332110361,0.0140358045359963,0.0819151188406348
Physical measures,X4270.Volume level set by participant (left),ATP1B4,Protein ATP1B4,14144,-0.0622460139322347,0.0357838198315881,-0.132382300802147,0.00789027293767795,0.081968340726354
Physical measures,X4270.Volume level set by participant (left),HAVCR2,Hepatitis A virus cellular receptor 2,16671,0.0647560944363857,0.0372401064222028,-0.00823451415113179,0.137746703023903,0.0820742655450336
Physical measures,X4270.Volume level set by participant (left),TWF2,Twinfilin-2,14678,-0.0310092116859327,0.0178358669507768,-0.0659675109094553,0.00394908753758993,0.0821283751697927
Physical measures,X4270.Volume level set by participant (left),CDNF,Cerebral dopamine neurotrophic factor,16576,-0.0689062542445218,0.0396696468607052,-0.146658762091504,0.00884625360246036,0.0824054203641321
Physical measures,X4270.Volume level set by participant (left),S100P,Protein S100-P,16356,0.0391046360941377,0.0225698840340471,-0.00513233661259451,0.0833416088008699,0.0831852253760772
Physical measures,X4270.Volume level set by participant (left),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14572,-0.0517645660334371,0.0298833440233936,-0.110335920319288,0.00680678825241431,0.0832553469055794
Physical measures,X4270.Volume level set by participant (left),DYNLT1,Dynein light chain Tctex-type 1,14261,0.0331154950733421,0.0191234296764535,-0.00436642709250676,0.0705974172391909,0.0833537472931686
Physical measures,X4270.Volume level set by participant (left),TIMP2,Metalloproteinase inhibitor 2,14652,-0.0999309325173686,0.0577715795498547,-0.213163228435084,0.0133013634003466,0.0836943557757434
Physical measures,X4270.Volume level set by participant (left),TBCB,Tubulin-folding cofactor B,16533,-0.0234713992409241,0.0135703367382654,-0.0500692592479243,0.00312646076607609,0.0837185415797711
Physical measures,X4270.Volume level set by participant (left),IL15,Interleukin-15,16637,0.0663013712119518,0.0383449393037047,-0.00885470982330934,0.141457452247213,0.0838137975631559
Physical measures,X4270.Volume level set by participant (left),C1QL2,Complement C1q-like protein 2,14207,-0.060714399898719,0.0351280982177957,-0.129565472405599,0.00813667260816053,0.0839434153344206
Physical measures,X4270.Volume level set by participant (left),ITGAM,Integrin alpha-M,16671,-0.0694363671978226,0.0401856582983812,-0.14820025746265,0.00932752306700466,0.0840266187236805
Physical measures,X4270.Volume level set by participant (left),GUCY2C,Heat-stable enterotoxin receptor,14404,-0.030426559490203,0.0176210231176398,-0.0649637648007771,0.00411064582037106,0.0842395659407604
Physical measures,X4270.Volume level set by participant (left),PDLIM5,PDZ and LIM domain protein 5,14629,-0.0225098027445266,0.0130541210715151,-0.0480958800446962,0.00307627455564302,0.0846668075313353
Physical measures,X4270.Volume level set by participant (left),MAX,Protein max,16257,-0.0218072935558824,0.0126560726198484,-0.0466131958907853,0.00299860877902052,0.0848949814372967
Physical measures,X4270.Volume level set by participant (left),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14588,-0.0186199210621588,0.0108447993113471,-0.039875727712399,0.00263588558808143,0.0860105216711025
Physical measures,X4270.Volume level set by participant (left),YWHAQ,14-3-3 protein theta,14352,-0.0359269913802635,0.0209316207399034,-0.0769529680304742,0.00509898526994711,0.0861108318060501
Physical measures,X4270.Volume level set by participant (left),REPS1,RalBP1-associated Eps domain-containing protein 1,14207,-0.065668757328326,0.0382695334952338,-0.140677042978984,0.00933952832233217,0.0861922979317694
Physical measures,X4270.Volume level set by participant (left),FAM20A,Pseudokinase FAM20A,14652,0.0897146572801377,0.0523160909421528,-0.0128248809664817,0.192254195526757,0.086392468896471
Physical measures,X4270.Volume level set by participant (left),CRHBP,Corticotropin-releasing factor-binding protein,16630,0.0781596377343801,0.0455784617933936,-0.0111741473806714,0.167493422849432,0.086393744952956
Physical measures,X4270.Volume level set by participant (left),AMPD3,AMP deaminase 3,14628,-0.0344622004650835,0.0201053535024225,-0.0738686933298316,0.00494429239966464,0.0865350960125319
Physical measures,X4270.Volume level set by participant (left),FHIT,Bis(5'-adenosyl)-triphosphatase,16257,-0.0322087466841862,0.0188228663567018,-0.0691015647433217,0.00468407137494926,0.087072532644199
Physical measures,X4270.Volume level set by participant (left),MST1,Hepatocyte growth factor-like protein,14407,-0.0393150555129753,0.0230072086174919,-0.0844091844032593,0.00577907337730876,0.0875068489254117
Physical measures,X4270.Volume level set by participant (left),CRELD1,Protein disulfide isomerase CRELD1,14352,0.0684718549432699,0.0400741119369591,-0.0100734044531699,0.14701711433971,0.0875410395411186
Physical measures,X4270.Volume level set by participant (left),TLR1,Toll-like receptor 1,14207,-0.0969215520052604,0.0567306628636761,-0.208113651218066,0.0142705472075447,0.0875745793207689
Physical measures,X4270.Volume level set by participant (left),TST,Thiosulfate sulfurtransferase,16214,-0.0298003264409438,0.0174451373592279,-0.0639927956650305,0.00439214278314289,0.0876126280804551
Physical measures,X4270.Volume level set by participant (left),UMOD,Uromodulin,16815,-0.0403391344475855,0.0236153452187114,-0.0866252110762599,0.00594694218108889,0.0876224132239171
Physical measures,X4270.Volume level set by participant (left),PTPRH,Receptor-type tyrosine-protein phosphatase H,14588,-0.0514587813522904,0.0301279985452452,-0.110509658500971,0.00759209579639014,0.0876566583053239
Physical measures,X4270.Volume level set by participant (left),CD5,T-cell surface glycoprotein CD5,16788,0.0646839174761266,0.0379102157740052,-0.00962010544092352,0.138987940393177,0.0879819629441392
Physical measures,X4270.Volume level set by participant (left),GET3,ATPase GET3,14652,-0.0457968704886421,0.0268725490183578,-0.0984670665646234,0.00687332558733911,0.0883602828502457
Physical measures,X4270.Volume level set by participant (left),RARRES2,Retinoic acid receptor responder protein 2,16762,0.0450107713366692,0.0264332540240609,-0.00679840655049012,0.0968199492238286,0.0886224581543922
Physical measures,X4270.Volume level set by participant (left),C1RL,Complement C1r subcomponent-like protein,14664,0.126519461167778,0.074318551351873,-0.0191448994818928,0.27218382181745,0.0887027397631258
Physical measures,X4270.Volume level set by participant (left),SPON2,Spondin-2,16600,0.0631867603284937,0.0371171799063402,-0.00956291228793311,0.135936432944921,0.0887068577555533
Physical measures,X4270.Volume level set by participant (left),TXNDC15,Thioredoxin domain-containing protein 15,16719,0.078201204030586,0.0459529210077434,-0.0118665211445911,0.168268929205763,0.0888175047442516
Physical measures,X4270.Volume level set by participant (left),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14652,-0.0344641217977037,0.0202623837481353,-0.0741783939440489,0.00525015034864158,0.0889845559916412
Physical measures,X4270.Volume level set by participant (left),ICOSLG,ICOS ligand,16576,-0.112421130163407,0.0661171564755458,-0.242010756855477,0.0171684965286627,0.0890872350374767
Physical measures,X4270.Volume level set by participant (left),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14404,-0.0227531072844562,0.0133937683060561,-0.0490048931643261,0.00349867859541377,0.0893816795063057
Physical measures,X4270.Volume level set by participant (left),NXPH3,Neurexophilin-3,14207,-0.0842522563592226,0.0496580026548706,-0.181581941562769,0.0130774288443238,0.0897847595663534
Physical measures,X4270.Volume level set by participant (left),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14499,-0.0821949840811553,0.0484697754220846,-0.177195743908441,0.0128057757461305,0.0899454954109598
Physical measures,X4270.Volume level set by participant (left),AARSD1,Alanyl-tRNA editing protein Aarsd1,16576,-0.0389762322000328,0.0230099248309694,-0.0840756848687328,0.00612322046866731,0.0903054017547295
Physical measures,X4270.Volume level set by participant (left),TMPRSS11D,Transmembrane protease serine 11D,14587,0.065248242364871,0.038522152639966,-0.0102551768094622,0.140751661539204,0.0903275292883051
Physical measures,X4270.Volume level set by participant (left),SLC51B,Organic solute transporter subunit beta,14175,-0.0339185559201618,0.0200293240795969,-0.0731760311161717,0.00533891927584808,0.0903928199542756
Physical measures,X4270.Volume level set by participant (left),DPEP2,Dipeptidase 2,16576,-0.0736248094768051,0.0434996405105359,-0.158884104877455,0.0116344859238452,0.0905621879032293
Physical measures,X4270.Volume level set by participant (left),CETN2,Centrin-2,16257,-0.0325012460485798,0.0192053975068413,-0.0701438251619888,0.00514133306482922,0.0906084483798566
Physical measures,X4270.Volume level set by participant (left),UBAC1,Ubiquitin-associated domain-containing protein 1,16576,-0.0636624689672201,0.0377565319589521,-0.137665271606766,0.010340333672326,0.0917893581569888
Physical measures,X4270.Volume level set by participant (left),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16266,-0.0430382952153461,0.0255552236678105,-0.0931265336042547,0.00704994317356246,0.0921759326962176
Physical measures,X4270.Volume level set by participant (left),ARHGAP30,Rho GTPase-activating protein 30,14404,-0.061938701394762,0.0368118702809961,-0.134089967145514,0.0102125643559903,0.0924792583782824
Physical measures,X4270.Volume level set by participant (left),DKK4,Dickkopf-related protein 4,16501,-0.0470196410388077,0.0279889668880802,-0.101878016139445,0.00783873406182951,0.0929889404667096
Physical measures,X4270.Volume level set by participant (left),RALB,Ras-related protein Ral-B,14207,-0.0836908913652458,0.0498226253017669,-0.181343236956709,0.0139614542262173,0.0930227590038094
Physical measures,X4270.Volume level set by participant (left),USP8,Ubiquitin carboxyl-terminal hydrolase 8,16356,-0.0233136908746422,0.0138850946415794,-0.0505284763721378,0.00390109462285333,0.0931625050996897
Physical measures,X4270.Volume level set by participant (left),RBM17,Splicing factor 45,14629,-0.0329338447097772,0.0196161486500691,-0.0713814960639125,0.00551380664435816,0.0931900069460681
Physical measures,X4270.Volume level set by participant (left),TG,Thyroglobulin,14572,-0.0219540756235544,0.0130904277593197,-0.047611314031821,0.00370316278471218,0.0935426209599742
Physical measures,X4270.Volume level set by participant (left),PKN3,Serine/threonine-protein kinase N3,14404,-0.0321582106347029,0.0191941613759186,-0.0697787669315035,0.00546234566209763,0.093874313705188
Physical measures,X4270.Volume level set by participant (left),MYDGF,Myeloid-derived growth factor,14652,-0.0249775472844248,0.0149193108467474,-0.0542193965440498,0.00426430197520014,0.0941174469077014
Physical measures,X4270.Volume level set by participant (left),PCDH7,Protocadherin-7,14588,-0.069216214224,0.0413440016839206,-0.150250457524484,0.0118180290764844,0.0941218542003212
Physical measures,X4270.Volume level set by participant (left),RRAS,Ras-related protein R-Ras,14261,-0.0195247661065199,0.0116656605130397,-0.0423894607120776,0.0033399284990379,0.0942123713668555
Physical measures,X4270.Volume level set by participant (left),PIGR,Polymeric immunoglobulin receptor,16431,0.0591307410882789,0.0353408121980685,-0.0101372508199355,0.128398732996493,0.0943153720056032
Physical measures,X4270.Volume level set by participant (left),APOC1,Apolipoprotein C-I,14672,-0.0652776737985365,0.0390273620656048,-0.141771303447122,0.0112159558500489,0.0944248480404438
Physical measures,X4270.Volume level set by participant (left),GFRA2,GDNF family receptor alpha-2,16576,-0.102143459717314,0.0611534715665879,-0.222004263987826,0.0177173445531986,0.0948827508627547
Physical measures,X4270.Volume level set by participant (left),SIGLEC5,Sialic acid-binding Ig-like lectin 5,16671,0.0175036692839596,0.0104987639913513,-0.00307390813908897,0.0380812467070081,0.095490984672663
Physical measures,X4270.Volume level set by participant (left),AP3S2,AP-3 complex subunit sigma-2,14628,-0.0503568507558135,0.0302448245874897,-0.109636706947293,0.00892300543566627,0.0959393558298131
Physical measures,X4270.Volume level set by participant (left),CTSD,Cathepsin D,15561,0.058305196546631,0.0350396111259394,-0.0103724412602102,0.126982834353472,0.0961366720937834
Physical measures,X4270.Volume level set by participant (left),SLIT2,Slit homolog 2 protein,16257,-0.0411150958420358,0.0247116847381091,-0.0895499979287297,0.00731980624465804,0.0961733579826011
Physical measures,X4270.Volume level set by participant (left),NOMO1,Nodal modulator 1,16671,0.0899118924135315,0.0540638360032138,-0.0160532261527675,0.19587701097983,0.0963174308657956
Physical measures,X4270.Volume level set by participant (left),NME1,Nucleoside diphosphate kinase A,14207,-0.113371155982845,0.0681806743836293,-0.247005277774758,0.0202629658090688,0.0963735906762347
Physical measures,X4270.Volume level set by participant (left),NRP1,Neuropilin-1,16762,-0.0759571966497285,0.0457108240578945,-0.165550411803202,0.0136360185037448,0.0965937652382899
Physical measures,X4270.Volume level set by participant (left),RYR1,Ryanodine receptor 1,14175,-0.0719222473538072,0.0433071535514469,-0.156804268314643,0.0129597736070288,0.0967863104704308
Physical measures,X4270.Volume level set by participant (left),PSMC3,26S proteasome regulatory subunit 6A,14144,-0.079472903822297,0.0478544192577137,-0.173267565567416,0.0143217579228219,0.0967914132557867
Physical measures,X4270.Volume level set by participant (left),NPHS1,Nephrin,14207,-0.0721178082011311,0.0434582349944768,-0.157295948790306,0.0130603323880434,0.0970424267545428
Physical measures,X4270.Volume level set by participant (left),STXBP3,Syntaxin-binding protein 3,16266,-0.0478680168524612,0.028849925247062,-0.104413870336703,0.00867783663178041,0.0970932540141903
Physical measures,X4270.Volume level set by participant (left),BECN1,Beclin-1,14288,-0.0417450251659221,0.0251614425157897,-0.09106145249687,0.00757140216502574,0.0971202125095763
Physical measures,X4270.Volume level set by participant (left),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13996,0.049548721661684,0.0298665485863614,-0.00898971356758445,0.108087156890952,0.0971374324348116
Physical measures,X4270.Volume level set by participant (left),TNFSF13,Tumor necrosis factor ligand superfamily member 13,16733,-0.0775600295692667,0.0467584652729291,-0.169206621504208,0.0140865623656743,0.097187418243094
Physical measures,X4270.Volume level set by participant (left),GMFG,Glia maturation factor gamma,14652,-0.0351177179053025,0.0211752767782409,-0.0766212603906546,0.00638582458004953,0.0972521007171173
Physical measures,X4270.Volume level set by participant (left),CEBPB,CCAAT/enhancer-binding protein beta,16356,0.0533183895949397,0.0321502444830219,-0.00969608959178329,0.116332868781663,0.097253290574392
Physical measures,X4270.Volume level set by participant (left),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14652,-0.0337216354855652,0.0203643687233569,-0.0736357981833447,0.00619252721221421,0.0977607524133718
Physical measures,X4270.Volume level set by participant (left),CDH23,Cadherin-23,14628,-0.0925856972576549,0.0559942665601416,-0.202334459715532,0.0171630652002227,0.0982536159340427
Physical measures,X4270.Volume level set by participant (left),CORO6,Coronin-6,14168,-0.0655750972168445,0.0396614404711962,-0.143311520540389,0.0121613261067,0.0982774512686062
Physical measures,X4270.Volume level set by participant (left),SUGP1,SURP and G-patch domain-containing protein 1,14588,-0.0602312468022127,0.036447872056712,-0.131669076033368,0.0112065824289429,0.098447849439409
Physical measures,X4270.Volume level set by participant (left),RAB11FIP3,Rab11 family-interacting protein 3,14652,-0.0230206409794422,0.0139317190555214,-0.0503268103282642,0.0042855283693798,0.0984764110920744
Physical measures,X4270.Volume level set by participant (left),CCL21,C-C motif chemokine 21,16733,0.0505285162466022,0.0305863341797355,-0.00942069874567936,0.110477731238884,0.0985540514934479
Physical measures,X4270.Volume level set by participant (left),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16732,-0.0190098979695028,0.0115165822995566,-0.0415823992766337,0.00356260333762813,0.0988279383251972
Physical measures,X4270.Volume level set by participant (left),PSME1,Proteasome activator complex subunit 1,16509,-0.0585971994956338,0.0355045145163106,-0.128186047947603,0.0109916489563349,0.0988770340906243
Physical measures,X4270.Volume level set by participant (left),UNG,Uracil-DNA glycosylase,14572,-0.0724532222152403,0.0439501219586107,-0.158595461254117,0.0136890168236367,0.099264946626625
Physical measures,X4270.Volume level set by participant (left),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16671,-0.0467991168473048,0.028391497663072,-0.102446452266926,0.00884821857231619,0.0992997929161145
Physical measures,X4270.Volume level set by participant (left),KLK12,Kallikrein-12,16266,0.0154785424543155,0.00940267181768128,-0.00295069430833979,0.0339077792169708,0.0997449032025091
Physical measures,X4270.Volume level set by participant (left),LTBP2,Latent-transforming growth factor beta-binding protein 2,16871,-0.0644196436843998,0.0391480507478468,-0.141149823150179,0.0123105357813798,0.0998773569826757
Physical measures,X4270.Volume level set by participant (left),DOCK9,Dedicator of cytokinesis protein 9,14168,0.0213746012403635,0.0129902766754671,-0.00408634104355199,0.0468355435242791,0.0999032129692737
Physical measures,X4270.Volume level set by participant (left),IL2RA,Interleukin-2 receptor subunit alpha,16536,0.0522314480980563,0.0317496721021897,-0.00999790922223539,0.114460805418348,0.0999678109356337
Physical measures,X4270.Volume level set by participant (left),MYBPC1,"Myosin-binding protein C, slow-type",14652,-0.0338082812274269,0.0205515383804277,-0.0740892964530653,0.00647273399821145,0.0999812470009875
Physical measures,X4270.Volume level set by participant (left),EGF,Pro-epidermal growth factor,16630,-0.0205870042289939,0.0125314459191329,-0.0451486382304944,0.00397462977250658,0.100437549494819
Physical measures,X4270.Volume level set by participant (left),IST1,IST1 homolog,14457,-0.0263938431781542,0.0160727722247802,-0.0578964767387234,0.00510879038241509,0.100581466873033
Physical measures,X4270.Volume level set by participant (left),PNMA2,Paraneoplastic antigen Ma2,14168,0.0568162577454223,0.03465811732607,-0.0111136522136748,0.124746167704519,0.101165781508896
Physical measures,X4270.Volume level set by participant (left),F11,Coagulation factor XI,14469,-0.0772957779638812,0.0471791339535086,-0.169766880512758,0.0151753245849958,0.101371161777708
Physical measures,X4270.Volume level set by participant (left),TPK1,Thiamin pyrophosphokinase 1,14652,-0.0882257444857269,0.053971528278432,-0.194009939911454,0.0175584509399997,0.102139338638435
Physical measures,X4270.Volume level set by participant (left),RGMA,Repulsive guidance molecule A,16799,-0.0655838329232916,0.0401715489662516,-0.144320068897145,0.0131524030505616,0.102573158538792
Physical measures,X4270.Volume level set by participant (left),OGA,Protein O-GlcNAcase,14588,-0.0356046484358362,0.0218088247196643,-0.0783499448863783,0.0071406480147059,0.102578993386358
Physical measures,X4270.Volume level set by participant (left),EXTL1,Exostosin-like 1,14175,-0.0516523974201325,0.0316570570499199,-0.113700229237976,0.0103954343977105,0.102781070589168
Physical measures,X4270.Volume level set by participant (left),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14652,-0.0461788931990693,0.0283087910532107,-0.101664123663362,0.0093063372652237,0.102857771052131
Physical measures,X4270.Volume level set by participant (left),GOLM2,Protein GOLM2,16799,0.088981287874475,0.0545720772511498,-0.0179799835377786,0.195942559286728,0.103008764995317
Physical measures,X4270.Volume level set by participant (left),TMED4,Transmembrane emp24 domain-containing protein 4,14175,0.0429988785303374,0.0263790664949081,-0.00870409179968237,0.0947018488603572,0.10311572918712
Physical measures,X4270.Volume level set by participant (left),KIF20B,Kinesin-like protein KIF20B,14168,0.032133193561017,0.0197207903054272,-0.00651955543762028,0.0707859425596543,0.103249148031102
Physical measures,X4270.Volume level set by participant (left),DNAJB14,DnaJ homolog subfamily B member 14,14588,-0.0386132746088301,0.0236997392118575,-0.0850647634640707,0.00783821424641058,0.103277486242357
Physical measures,X4270.Volume level set by participant (left),ARID4B,AT-rich interactive domain-containing protein 4B,16257,-0.0511406842659481,0.0314313370403956,-0.112746104865124,0.0104647363332273,0.103743667716063
Physical measures,X4270.Volume level set by participant (left),PNMA1,Paraneoplastic antigen Ma1,14288,-0.0433746286992169,0.0266611891109698,-0.0956305593567177,0.00888130195828393,0.10378407947954
Physical measures,X4270.Volume level set by participant (left),AMBP,Protein AMBP,16788,0.102891190965556,0.0632604667243929,-0.0210993238142543,0.226881705745366,0.103868700469934
Physical measures,X4270.Volume level set by participant (left),ITPA,Inosine triphosphate pyrophosphatase,14175,-0.0355712675005938,0.0218805534409351,-0.0784571522448266,0.00731461724363901,0.104035243333913
Physical measures,X4270.Volume level set by participant (left),PRTG,Protogenin,16810,-0.0817340240246418,0.050313060996567,-0.180347623577913,0.0168795755286294,0.104285972980262
Physical measures,X4270.Volume level set by participant (left),RRM2,Ribonucleoside-diphosphate reductase subunit M2,16266,0.0416955808831645,0.0256889450224985,-0.00865475136093254,0.0920459131272615,0.104588641181311
Physical measures,X4270.Volume level set by participant (left),MAPK13,Mitogen-activated protein kinase 13,14144,0.0584153044778001,0.0360137545057595,-0.0121716543534885,0.129002263309089,0.104819749662871
Physical measures,X4270.Volume level set by participant (left),NFX1,Transcriptional repressor NF-X1,14175,-0.0369413338569109,0.0227755171072234,-0.0815813473870687,0.00769867967324687,0.104830831262625
Physical measures,X4270.Volume level set by participant (left),APOM,Apolipoprotein M,16685,-0.0735970260112465,0.0455895877159592,-0.162952617934526,0.0157585659120336,0.106472955199492
Physical measures,X4270.Volume level set by participant (left),NGFR,Tumor necrosis factor receptor superfamily member 16,14652,-0.0800465258503404,0.0497425490888227,-0.177541922064433,0.0174488703637521,0.107590599828484
Physical measures,X4270.Volume level set by participant (left),C5,Complement C5,14697,-0.152639386466126,0.0948610446992823,-0.338567034076719,0.0332882611444671,0.10761948447662
Physical measures,X4270.Volume level set by participant (left),ARHGAP25,Rho GTPase-activating protein 25,16266,-0.0354396197586705,0.0220376516461429,-0.0786334169851106,0.00775417746776953,0.107824041487495
Physical measures,X4270.Volume level set by participant (left),CD36,Platelet glycoprotein 4,14207,-0.0532343442255139,0.0331051720246533,-0.118120481393834,0.0116517929428065,0.10784930489519
Physical measures,X4270.Volume level set by participant (left),PEPD,Xaa-Pro dipeptidase,14672,-0.088812341271824,0.0553604458421644,-0.197318815122466,0.0196941325788182,0.108679128748888
Physical measures,X4270.Volume level set by participant (left),ANGPTL4,Angiopoietin-related protein 4,16710,0.0441539097910599,0.027528917520742,-0.00980276854959445,0.0981105881317142,0.108752780935882
Physical measures,X4270.Volume level set by participant (left),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14404,-0.0226430550999342,0.0141335151573411,-0.0503447448083227,0.00505863460845431,0.109159355381358
Physical measures,X4270.Volume level set by participant (left),LRP2BP,LRP2-binding protein,14261,-0.0297627022542798,0.0185881696935635,-0.0661955148536641,0.00667011034510459,0.109362845909251
Physical measures,X4270.Volume level set by participant (left),PDGFB,Platelet-derived growth factor subunit B,16733,-0.0235765225182525,0.014726781200533,-0.0524410136712973,0.00528796863479222,0.109411671414933
Physical measures,X4270.Volume level set by participant (left),CD86,T-lymphocyte activation antigen CD86,14588,-0.0793144312412848,0.0495576895875673,-0.176447502832917,0.0178186403503472,0.109521243999184
Physical measures,X4270.Volume level set by participant (left),CFHR4,Complement factor H-related protein 4,14668,0.0321147344487185,0.0200757615790885,-0.00723375824629506,0.071463227143732,0.109691814602855
Physical measures,X4270.Volume level set by participant (left),ITGAL,Integrin alpha-L,14207,-0.0543446339392047,0.0340069009727423,-0.12099815984578,0.0123088919673703,0.110054731456605
Physical measures,X4270.Volume level set by participant (left),MYL4,Myosin light chain 4,14288,-0.0431936492264594,0.0270599592191648,-0.0962311692960225,0.00984387084310364,0.110461816460467
Physical measures,X4270.Volume level set by participant (left),RABEP1,Rab GTPase-binding effector protein 1,14352,-0.0323199081433781,0.0202582255560765,-0.072026030233288,0.00738621394653179,0.110645576347266
Physical measures,X4270.Volume level set by participant (left),DTNB,Dystrobrevin beta,14528,-0.0521849196656198,0.0327246382603337,-0.116325210655874,0.0119553713246343,0.11080836973012
Physical measures,X4270.Volume level set by participant (left),ERP44,Endoplasmic reticulum resident protein 44,16552,-0.0796362346548381,0.0499504396970733,-0.177539096461102,0.0182666271514256,0.110886856009112
Physical measures,X4270.Volume level set by participant (left),APRT,Adenine phosphoribosyltransferase,16509,-0.0466031827962199,0.0292416723134411,-0.103916860530564,0.0107104949381246,0.111016816325041
Physical measures,X4270.Volume level set by participant (left),CD48,CD48 antigen,16710,0.0684002251612412,0.0429467560785231,-0.0157754167526642,0.152575867075147,0.111252050322979
Physical measures,X4270.Volume level set by participant (left),EGFR,Epidermal growth factor receptor,16871,-0.120403438853672,0.0756305924599818,-0.268639400075236,0.0278325223678926,0.111404837845794
Physical measures,X4270.Volume level set by participant (left),SEPTIN3,Neuronal-specific septin-3,14629,0.0305375175044985,0.0191844202991189,-0.00706394628177453,0.0681389812907716,0.111454125492506
Physical measures,X4270.Volume level set by participant (left),CAPG,Macrophage-capping protein,16558,-0.0348486615325467,0.0219041177000666,-0.0777807322246772,0.00808340915958385,0.111636799785386
Physical measures,X4270.Volume level set by participant (left),CCL16,C-C motif chemokine 16,16871,0.0373214728269169,0.0234654076240306,-0.00867072611618319,0.0833136717700169,0.111743377518304
Physical measures,X4270.Volume level set by participant (left),TTN,Titin,14175,-0.0338609380301752,0.0212933737906161,-0.0755959506597827,0.00787407459943226,0.111809782321495
Physical measures,X4270.Volume level set by participant (left),THSD1,Thrombospondin type-1 domain-containing protein 1,14115,-0.0704920108334188,0.0443354555261542,-0.157389503664681,0.0164054819978434,0.111864159876593
Physical measures,X4270.Volume level set by participant (left),LSM1,U6 snRNA-associated Sm-like protein LSm1,16266,-0.0369066522761288,0.0232309649428357,-0.0824393435640868,0.00862603901182918,0.112151306440614
Physical measures,X4270.Volume level set by participant (left),PARK7,Parkinson disease protein 7,16671,-0.0403384952336362,0.0254098777296323,-0.0901418555837156,0.00946486511644314,0.112415631458365
Physical measures,X4270.Volume level set by participant (left),BPIFB2,BPI fold-containing family B member 2,14624,0.0359011763425811,0.022634529879322,-0.00846250222089012,0.0802648549060522,0.112732776764155
Physical measures,X4270.Volume level set by participant (left),TNXB,Tenascin-X,16671,-0.0771704432300688,0.0486570145807858,-0.172538191808409,0.0181973053482714,0.112756345889994
Physical measures,X4270.Volume level set by participant (left),DEFA1_DEFA1B,Neutrophil defensin 1,16305,0.0375210146725191,0.023700295973195,-0.00893156543494313,0.0839735947799813,0.113407741631509
Physical measures,X4270.Volume level set by participant (left),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14588,-0.0266199813361684,0.0168244679592779,-0.0595959385363532,0.00635597586401636,0.113621444570831
Physical measures,X4270.Volume level set by participant (left),CD40LG,CD40 ligand,16843,-0.0256217200572379,0.0162028211869379,-0.0573792495836363,0.00613580946916047,0.113825449824187
Physical measures,X4270.Volume level set by participant (left),IL6R,Interleukin-6 receptor subunit alpha,16505,-0.0591289842829233,0.0374106389411729,-0.132453836607622,0.0141958680417756,0.114002600929966
Physical measures,X4270.Volume level set by participant (left),PDIA2,Protein disulfide-isomerase A2,14144,-0.059926352507085,0.0379605659227463,-0.134329061715668,0.0144763567014978,0.114439322342158
Physical measures,X4270.Volume level set by participant (left),LAMP3,Lysosome-associated membrane glycoprotein 3,16811,0.0387307556001347,0.0245369194293875,-0.00936160648146486,0.0868231176817343,0.114476842024369
Physical measures,X4270.Volume level set by participant (left),ADGRD1,Adhesion G-protein coupled receptor D1,14352,0.0613816303043811,0.0389318240643054,-0.0149247448616574,0.13768800547042,0.114899508134271
Physical measures,X4270.Volume level set by participant (left),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16630,0.0681369669956672,0.0432217970491412,-0.0165777552206495,0.152851689211984,0.114941360080872
Physical measures,X4270.Volume level set by participant (left),ECM1,Extracellular matrix protein 1,14281,-0.0629213703637052,0.0399224512010648,-0.141169374717792,0.0153266339903818,0.11502727305159
Physical measures,X4270.Volume level set by participant (left),LATS1,Serine/threonine-protein kinase LATS1,14207,-0.0284392658893242,0.0180609552543166,-0.0638387381877847,0.00696020640913634,0.115364884502829
Physical measures,X4270.Volume level set by participant (left),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16715,0.0459644269925036,0.0292598658730841,-0.0113849101187412,0.103313764103748,0.116224002514741
Physical measures,X4270.Volume level set by participant (left),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,14175,-0.0905593841748395,0.0577766090284531,-0.203801537870608,0.0226827695209286,0.117042249488439
Physical measures,X4270.Volume level set by participant (left),DCN,Decorin,16356,-0.0898925842019532,0.0574273576326713,-0.202450205161989,0.0226650367580826,0.117525659171166
Physical measures,X4270.Volume level set by participant (left),TRIM26,Tripartite motif-containing protein 26,14144,-0.0429298318414875,0.0274298835524867,-0.0966924036043614,0.0108327399213864,0.117587664660538
Physical measures,X4270.Volume level set by participant (left),IL4,Interleukin-4,16350,-0.0227742794677846,0.014573764156249,-0.0513388572140326,0.00579029827846339,0.118144837751984
Physical measures,X4270.Volume level set by participant (left),CXCL14,C-X-C motif chemokine 14,16350,0.0325655043534486,0.0208440804877319,-0.00828889340250597,0.0734199021094031,0.118227698417376
Physical measures,X4270.Volume level set by participant (left),SNX5,Sorting nexin-5,14288,-0.0776332703128787,0.0497189779583773,-0.175082467111298,0.0198159264855408,0.11844181496299
Physical measures,X4270.Volume level set by participant (left),OGN,Mimecan,16671,0.0485187808859014,0.0310762772755919,-0.0123907225742586,0.109428284346061,0.118476620151369
Physical measures,X4270.Volume level set by participant (left),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14245,-0.0612179467264944,0.0392134550457674,-0.138076318616199,0.0156404251632097,0.118511437765919
Physical measures,X4270.Volume level set by participant (left),ASRGL1,Isoaspartyl peptidase/L-asparaginase,14288,-0.0239877270877261,0.0153663514163727,-0.0541057758638166,0.00613032168836429,0.118532834934141
Physical measures,X4270.Volume level set by participant (left),MEP1B,Meprin A subunit beta,16666,-0.016860883127365,0.0108073004179826,-0.0380431919466109,0.00432142569188095,0.118746213142015
Physical measures,X4270.Volume level set by participant (left),STIP1,Stress-induced-phosphoprotein 1,16627,-0.0317405901542917,0.0203701789793593,-0.0716661409538359,0.00818496064525254,0.119207488067774
Physical measures,X4270.Volume level set by participant (left),CRTAC1,Cartilage acidic protein 1,16871,-0.0657178764625755,0.0421803316960979,-0.148391326586927,0.0169555736617764,0.119246855714996
Physical measures,X4270.Volume level set by participant (left),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16266,0.0431601118253763,0.0277071002276081,-0.0111458046207355,0.0974660282714881,0.119317335107204
Physical measures,X4270.Volume level set by participant (left),NCAM2,Neural cell adhesion molecule 2,16671,-0.0725927151821563,0.0466193226991954,-0.163966587672579,0.0187811573082666,0.119456745337766
Physical measures,X4270.Volume level set by participant (left),IL18,Interleukin-18,16604,0.0416361399914606,0.026750071170842,-0.0107939995033897,0.0940662794863109,0.119611392616674
Physical measures,X4270.Volume level set by participant (left),AIF1,Allograft inflammatory factor 1,16266,0.0394090727048323,0.025337121414798,-0.0102516852681717,0.0890698306778364,0.119872995684579
Physical measures,X4270.Volume level set by participant (left),IGFL4,Insulin growth factor-like family member 4,14207,-0.0314153363349615,0.0202302707404343,-0.0710666669862127,0.00823599431628975,0.120472293905156
Physical measures,X4270.Volume level set by participant (left),CYB5R2,NADH-cytochrome b5 reductase 2,14424,-0.0411336475707835,0.0264936886898449,-0.0930612774028795,0.0107939822613126,0.120544782970631
Physical measures,X4270.Volume level set by participant (left),PILRA,Paired immunoglobulin-like type 2 receptor alpha,16671,0.0472385161585605,0.0304406384559331,-0.0124251352150685,0.106902167532189,0.120723321251305
Physical measures,X4270.Volume level set by participant (left),DEFB104A_DEFB104B,Beta-defensin 104,14168,-0.0421359023746201,0.0271940858793682,-0.0954363106981817,0.0111645059489415,0.121295714898456
Physical measures,X4270.Volume level set by participant (left),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14288,-0.0335529190798913,0.0216619970776271,-0.0760104333520404,0.00890459519225768,0.121420701042011
Physical measures,X4270.Volume level set by participant (left),NFE2,Transcription factor NF-E2 45 kDa subunit,14288,-0.0315263224281608,0.0203602214913123,-0.0714323565511329,0.00837971169481141,0.121541631155609
Physical measures,X4270.Volume level set by participant (left),CXCL3,C-X-C motif chemokine 3,16645,-0.0203966841042328,0.0131954116847386,-0.0462596910063204,0.0054663227978548,0.12218624861093
Physical measures,X4270.Volume level set by participant (left),CHMP1A,Charged multivesicular body protein 1a,16533,-0.0265758936806173,0.0171960758433045,-0.0602802023334942,0.00712841497225948,0.12225354562865
Physical measures,X4270.Volume level set by participant (left),RP2,Protein XRP2,16576,-0.0475334009626682,0.0307846351758411,-0.107871285907317,0.0128044839819803,0.122592300035415
Physical measures,X4270.Volume level set by participant (left),PRDX6,Peroxiredoxin-6,16810,-0.0299772054122789,0.0194249391759222,-0.0680500861970864,0.0080956753725285,0.122793117827197
Physical measures,X4270.Volume level set by participant (left),IDO1,"Indoleamine 2,3-dioxygenase 1",14288,-0.0349737955615323,0.0226694261717573,-0.0794058708581766,0.00945827973511208,0.122907853862833
Physical measures,X4270.Volume level set by participant (left),NINJ1,Ninjurin-1,16266,-0.0357030327314465,0.0231436169392716,-0.0810645219324187,0.00965845646952579,0.12292961209728
Physical measures,X4270.Volume level set by participant (left),PNLIPRP2,Pancreatic lipase-related protein 2,16630,0.00666262882278784,0.00432064586658058,-0.00180583707571009,0.0151310947212858,0.12308179150173
Physical measures,X4270.Volume level set by participant (left),EBI3_IL27,Interleukin-27,16794,0.0627975596723797,0.0408669294421639,-0.0173016220342615,0.142896741379021,0.124401541302861
Physical measures,X4270.Volume level set by participant (left),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14288,-0.0510866824012392,0.0332692183344573,-0.116294350336776,0.0141209855342971,0.124669963914913
Physical measures,X4270.Volume level set by participant (left),FBLN2,Fibulin-2,14678,-0.0715699022962075,0.0466229086418777,-0.162950803234288,0.0198109986418728,0.12478571643239
Physical measures,X4270.Volume level set by participant (left),TP53I3,Quinone oxidoreductase PIG3,14014,-0.0451285191429674,0.0294127419773661,-0.102777493418605,0.0125204551326701,0.12497387666981
Physical measures,X4270.Volume level set by participant (left),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16266,0.0319197849901849,0.02081928834085,-0.00888602015788121,0.0727255901382509,0.125250168895118
Physical measures,X4270.Volume level set by participant (left),PPCDC,Phosphopantothenoylcysteine decarboxylase,16799,-0.0417027678460919,0.0272079013978946,-0.0950302545859653,0.0116247188937816,0.125357610116458
Physical measures,X4270.Volume level set by participant (left),RBKS,Ribokinase,16264,-0.037444538375699,0.0244325221390198,-0.0853322817681778,0.0104432050167798,0.12540143039734
Physical measures,X4270.Volume level set by participant (left),CHAD,Chondroadherin,14352,-0.0440213960987068,0.028747277847826,-0.100366060680446,0.0123232684830321,0.125711406868657
Physical measures,X4270.Volume level set by participant (left),CASP7,Caspase-7,14628,-0.0275180390925772,0.0180336241165741,-0.0628639423610625,0.00782786417590802,0.127049066939378
Physical measures,X4270.Volume level set by participant (left),C9orf40,Uncharacterized protein C9orf40,14588,-0.0269747726336306,0.0176787023578126,-0.0616250292549432,0.00767548398768203,0.127072809330225
Physical measures,X4270.Volume level set by participant (left),PZP,Pregnancy zone protein,14697,0.0419283535687553,0.027494616334875,-0.0119610944475997,0.0958178015851104,0.127289134198141
Physical measures,X4270.Volume level set by participant (left),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14261,-0.0219007535501699,0.0143624837066411,-0.0500512216151864,0.00624971451484661,0.127316627679772
Physical measures,X4270.Volume level set by participant (left),HS1BP3,HCLS1-binding protein 3,14288,-0.0261381490271235,0.017162929380506,-0.0597774906129153,0.00750119255866825,0.127795329844934
Physical measures,X4270.Volume level set by participant (left),LYN,Tyrosine-protein kinase Lyn,16576,-0.023864220630126,0.0157059259421454,-0.054647835476731,0.00691939421647898,0.128670735669249
Physical measures,X4270.Volume level set by participant (left),CTSC,Dipeptidyl peptidase 1,16614,-0.0437060271458793,0.0287821625351597,-0.100119065714792,0.0127070114230337,0.128904704586687
Physical measures,X4270.Volume level set by participant (left),IL1R2,Interleukin-1 receptor type 2,16612,0.097201760177955,0.064036476418533,-0.0283097336023696,0.22271325395828,0.129055538205127
Physical measures,X4270.Volume level set by participant (left),SEZ6L2,Seizure 6-like protein 2,16576,-0.0802698324978373,0.0529460648234798,-0.184044119551858,0.0235044545561831,0.129521257139463
Physical measures,X4270.Volume level set by participant (left),CDC37,Hsp90 co-chaperone Cdc37,16719,-0.0238484443449824,0.0157531918522187,-0.054724700375331,0.0070278116853663,0.130075163238679
Physical measures,X4270.Volume level set by participant (left),NIT1,Deaminated glutathione amidase,14288,-0.0544387173490005,0.0359630424771865,-0.124926280604286,0.0160488459062851,0.130113789595254
Physical measures,X4270.Volume level set by participant (left),LRRC37A2,Leucine-rich repeat-containing protein 37A2,14588,-0.052106624653984,0.0344628689704248,-0.119653847836017,0.0154405985280487,0.130564652812967
Physical measures,X4270.Volume level set by participant (left),FLT3LG,Fms-related tyrosine kinase 3 ligand,16843,-0.0563206376028892,0.0372531384068299,-0.129336788880276,0.0166955136744974,0.130594356132366
Physical measures,X4270.Volume level set by participant (left),BMPER,BMP-binding endothelial regulator protein,14352,0.0986682404462647,0.0653623362396264,-0.0294419385834031,0.226778419475932,0.131178273779075
Physical measures,X4270.Volume level set by participant (left),TCL1A,T-cell leukemia/lymphoma protein 1A,16513,-0.0196457459400992,0.0130212341722998,-0.0451673649178069,0.00587587303760836,0.131382641434763
Physical measures,X4270.Volume level set by participant (left),PTGES2,Prostaglandin E synthase 2,14129,-0.0425361124023198,0.0282017518285839,-0.0978115459863443,0.0127393211817046,0.131505500198949
Physical measures,X4270.Volume level set by participant (left),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16163,0.0229701324651678,0.015250500567368,-0.00692084864687359,0.0528611135772091,0.132038288044066
Physical measures,X4270.Volume level set by participant (left),TACC3,Transforming acidic coiled-coil-containing protein 3,16576,-0.0169642997532,0.0112708117186434,-0.039055090721741,0.00512649121534095,0.132303734801056
Physical measures,X4270.Volume level set by participant (left),KIF22,Kinesin-like protein KIF22,14175,-0.0188981046655273,0.0125624054511136,-0.04352041934971,0.00572421001865534,0.132516649858961
Physical measures,X4270.Volume level set by participant (left),PRELP,Prolargin,16630,-0.0819982286052334,0.0545535877827587,-0.18892326065944,0.0249268034489736,0.13283826542167
Physical measures,X4270.Volume level set by participant (left),COL9A1,Collagen alpha-1(IX) chain,16637,-0.0406000594639599,0.0270464286015862,-0.0936110595230689,0.0124109405951491,0.133342332581237
Physical measures,X4270.Volume level set by participant (left),CD99L2,CD99 antigen-like protein 2,16671,0.0792926553268852,0.0528263178799912,-0.0242469277178975,0.182832238371668,0.133372795024844
Physical measures,X4270.Volume level set by participant (left),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16498,-0.0181257844185573,0.01208845428072,-0.0418191548087685,0.00556758597165389,0.133781411044219
Physical measures,X4270.Volume level set by participant (left),DNAJB6,DnaJ homolog subfamily B member 6,14185,-0.0275892476914952,0.0184040142291245,-0.0636611155805793,0.00848262019758887,0.133872932316651
Physical measures,X4270.Volume level set by participant (left),GPR158,Probable G-protein coupled receptor 158,14629,-0.0604534049839461,0.040345961898317,-0.139531490304647,0.0186246803367552,0.134057293391319
Physical measures,X4270.Volume level set by participant (left),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16579,0.0288572538697924,0.0192817020626073,-0.00893488217291795,0.0666493899125027,0.134512934287469
Physical measures,X4270.Volume level set by participant (left),VCPKMT,Protein-lysine methyltransferase METTL21D,14144,-0.0259365844362879,0.017333508018811,-0.0599102601531574,0.00803709128058153,0.134590976280487
Physical measures,X4270.Volume level set by participant (left),IL36G,Interleukin-36 gamma,14136,0.0333022119723864,0.0222750098472537,-0.0103568073282308,0.0769612312730037,0.134924228885634
Physical measures,X4270.Volume level set by participant (left),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16799,-0.0277560418240382,0.0185811548885042,-0.0641751054055064,0.00866302175743002,0.135253559457683
Physical measures,X4270.Volume level set by participant (left),DFFA,DNA fragmentation factor subunit alpha,16843,-0.0293945342985374,0.0196804125600348,-0.0679681429162057,0.00917907431913089,0.135300676605725
Physical measures,X4270.Volume level set by participant (left),NAGK,N-acetyl-D-glucosamine kinase,14257,-0.0404667680525359,0.0271272093558797,-0.09363609839006,0.0127025622849883,0.135789231008436
Physical measures,X4270.Volume level set by participant (left),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16350,-0.0521528423268894,0.0349722031212603,-0.12069836044456,0.0163926757907808,0.135911097570822
Physical measures,X4270.Volume level set by participant (left),CNPY4,Protein canopy homolog 4,16576,-0.025859283607069,0.0173559173460231,-0.0598768816052744,0.00815831439113629,0.136258935924949
Physical measures,X4270.Volume level set by participant (left),ITGA11,Integrin alpha-11,16637,-0.0548392769289156,0.0368148388917422,-0.12699636115673,0.0173178072988991,0.136349182739385
Physical measures,X4270.Volume level set by participant (left),VIPR1,Vasoactive intestinal polypeptide receptor 1,14288,-0.0892278970526198,0.059935201353713,-0.206700891705897,0.0282450976006577,0.136578096304658
Physical measures,X4270.Volume level set by participant (left),BCL2L1,Bcl-2-like protein 1,14628,-0.0230896801803853,0.0155130388945527,-0.0534952364137086,0.00731587605293795,0.136665776554758
Physical measures,X4270.Volume level set by participant (left),SPON1,Spondin-1,16675,0.057840166361596,0.0388651568747453,-0.0183355411129048,0.134015873836097,0.136710032572347
Physical measures,X4270.Volume level set by participant (left),CEP43,Centrosomal protein 43,16243,-0.0285897168368622,0.0192167511608888,-0.0662545491122043,0.00907511543847985,0.136836333018288
Physical measures,X4270.Volume level set by participant (left),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14652,-0.029246342945422,0.019670971900673,-0.067801447870741,0.00930876197989706,0.137095336317909
Physical measures,X4270.Volume level set by participant (left),PON3,Serum paraoxonase/lactonase 3,16733,-0.0642677566971466,0.0432320852820579,-0.14900264384998,0.020467130455687,0.137145835605028
Physical measures,X4270.Volume level set by participant (left),HSPA2,Heat shock-related 70 kDa protein 2,14572,-0.0630420127228143,0.0424432184558202,-0.146230720896222,0.0201466954505933,0.137479164791586
Physical measures,X4270.Volume level set by participant (left),CD209,CD209 antigen,16705,0.0481257586651048,0.0324599153691526,-0.0154956754584342,0.111747192788644,0.138193964635954
Physical measures,X4270.Volume level set by participant (left),PPT1,Palmitoyl-protein thioesterase 1,14261,-0.028249211102677,0.0190537125411254,-0.0655944876832827,0.00909606547792867,0.138200372275865
Physical measures,X4270.Volume level set by participant (left),AKT2,RAC-beta serine/threonine-protein kinase,14629,-0.0177376522258302,0.0119854832150746,-0.0412291993273764,0.00575389487571603,0.138914020840219
Physical measures,X4270.Volume level set by participant (left),CST5,Cystatin-D,16357,-0.0342660847192291,0.0231607238482217,-0.0796611034617436,0.0111289340232853,0.139028387264385
Physical measures,X4270.Volume level set by participant (left),LARP1,La-related protein 1,14572,-0.034918518057727,0.0236031803408347,-0.0811807515257629,0.0113437154103089,0.139055386959235
Physical measures,X4270.Volume level set by participant (left),MRC1,Macrophage mannose receptor 1,14672,0.0744934759184401,0.0503545924528424,-0.0242015252891311,0.173188477126011,0.139060812725132
Physical measures,X4270.Volume level set by participant (left),NAPRT,Nicotinate phosphoribosyltransferase,14628,-0.0639848452545127,0.0432944388950851,-0.148841945488879,0.020872254979854,0.13945613832629
Physical measures,X4270.Volume level set by participant (left),ATRAID,All-trans retinoic acid-induced differentiation factor,14588,-0.0784421240560188,0.0531304713015924,-0.18257784780714,0.0256935996951023,0.139856656848528
Physical measures,X4270.Volume level set by participant (left),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14404,-0.0338219505835378,0.0229123853042889,-0.078730225779944,0.0110863246128683,0.139927470387475
Physical measures,X4270.Volume level set by participant (left),C4BPB,C4b-binding protein beta chain,16719,0.0467112859654955,0.0316473361624049,-0.0153174929128181,0.108740064843809,0.139964289668295
Physical measures,X4270.Volume level set by participant (left),VCAM1,Vascular cell adhesion protein 1,16685,-0.0687819645840293,0.0466380004019762,-0.160192445371903,0.022628516203844,0.140283815466828
Physical measures,X4270.Volume level set by participant (left),GSTA1,Glutathione S-transferase A1,16642,0.0227551362080569,0.0154299750021543,-0.00748761479616556,0.0529978872122794,0.140302528858211
Physical measures,X4270.Volume level set by participant (left),TBL1X,F-box-like/WD repeat-containing protein TBL1X,16266,-0.0233391725961997,0.0158360579890009,-0.0543778462546416,0.00769950106224213,0.140554984497591
Physical measures,X4270.Volume level set by participant (left),MAMDC4,Apical endosomal glycoprotein,14572,-0.0395244252903933,0.0268832795959318,-0.0922156532984197,0.0131668027176331,0.141522889352874
Physical measures,X4270.Volume level set by participant (left),LAT,Linker for activation of T-cells family member 1,16843,-0.0247035907574134,0.0168076139609824,-0.0576465141209389,0.00823933260611206,0.141638498732162
Physical measures,X4270.Volume level set by participant (left),TIA1,Nucleolysin TIA-1 isoform p40,16252,-0.016187886476975,0.011014260302574,-0.03777583667002,0.00540006371606992,0.14165678879459
Physical measures,X4270.Volume level set by participant (left),ERVV_1,,14175,-0.047780010822712,0.0325346980812672,-0.111548019061996,0.0159879974165717,0.141967258477293
Physical measures,X4270.Volume level set by participant (left),SARG,Specifically androgen-regulated gene protein,14591,-0.0205259128488395,0.013977778791182,-0.0479223592795561,0.00687053358187719,0.141998880188241
Physical measures,X4270.Volume level set by participant (left),ITGB6,Integrin beta-6,16350,-0.0626944354833654,0.0427420534971178,-0.146468860337716,0.0210799893709855,0.14244723112489
Physical measures,X4270.Volume level set by participant (left),GRN,Progranulin,16586,0.0768947053305547,0.0524965637620261,-0.0259985596430165,0.179787970304126,0.143006221074939
Physical measures,X4270.Volume level set by participant (left),ATXN3,Ataxin-3,14628,-0.0355178847042311,0.0242495553353384,-0.0830470131614944,0.0120112437530322,0.143029241914826
Physical measures,X4270.Volume level set by participant (left),MFAP3L,Microfibrillar-associated protein 3-like,14261,-0.0344623612704101,0.0235563754868942,-0.0806328572247227,0.0117081346839026,0.14349659958411
Physical measures,X4270.Volume level set by participant (left),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14261,0.0398552667590548,0.0272453741962606,-0.013545666665616,0.0932562001837256,0.143536809333184
Physical measures,X4270.Volume level set by participant (left),SIRT2,NAD-dependent protein deacetylase sirtuin-2,16576,-0.0226724170106664,0.0155086378045422,-0.0530693471075692,0.0077245130862364,0.143781593678687
Physical measures,X4270.Volume level set by participant (left),AFAP1,Actin filament-associated protein 1,14352,-0.0250885792848707,0.0171658945655637,-0.0587337326333755,0.00855657406363407,0.143890220523966
Physical measures,X4270.Volume level set by participant (left),PCDH9,Protocadherin-9,14588,-0.0634929822887232,0.0434872985744791,-0.148728087494702,0.0217421229172558,0.144301987055452
Physical measures,X4270.Volume level set by participant (left),CEP350,Centrosome-associated protein 350,14144,-0.0599918789046399,0.0410911948658659,-0.140530620841737,0.0205468630324573,0.144320775570342
Physical measures,X4270.Volume level set by participant (left),CMIP,C-Maf-inducing protein,14572,-0.0266161732074266,0.0182445507049583,-0.0623754925891449,0.00914314617429177,0.144626310345505
Physical measures,X4270.Volume level set by participant (left),NELL1,Protein kinase C-binding protein NELL1,16719,-0.0442336699025234,0.0303399869310301,-0.103700044287342,0.0152327044822957,0.144877798076268
Physical measures,X4270.Volume level set by participant (left),TANK,TRAF family member-associated NF-kappa-B activator,16350,-0.0273462834241356,0.0187726026336965,-0.0641405845861807,0.00944801773790941,0.14521500304296
Physical measures,X4270.Volume level set by participant (left),TFAP2A,Transcription factor AP-2-alpha,14168,0.0371660234562302,0.0255360782609259,-0.0128846899351845,0.0872167368476449,0.145571907159507
Physical measures,X4270.Volume level set by participant (left),CXCL10,C-X-C motif chemokine 10,16733,-0.0282337373361178,0.0193998646278857,-0.0662574720067738,0.00978999733453821,0.145589110837039
Physical measures,X4270.Volume level set by participant (left),REEP4,Receptor expression-enhancing protein 4,14629,-0.0319778113514545,0.0220048937026997,-0.075107403008746,0.0111517803058369,0.146185925163226
Physical measures,X4270.Volume level set by participant (left),SERPINA9,Serpin A9,16478,-0.0261422343397361,0.0179989692079672,-0.0614202139873517,0.00913574530787954,0.146401271290014
Physical measures,X4270.Volume level set by participant (left),PDZD2,PDZ domain-containing protein 2,14175,-0.0348575211158501,0.0240010881302681,-0.0818996538511755,0.0121846116194754,0.146431789155578
Physical measures,X4270.Volume level set by participant (left),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14629,-0.0275467278995518,0.018973614085446,-0.0647350115070258,0.0096415557079223,0.146566454400466
Physical measures,X4270.Volume level set by participant (left),GNPDA2,Glucosamine-6-phosphate isomerase 2,14352,-0.059273073872726,0.0408591243977703,-0.139356957692356,0.0208108099469037,0.146893872317663
Physical measures,X4270.Volume level set by participant (left),PMVK,Phosphomevalonate kinase,16223,-0.0179912377992441,0.0124031114377016,-0.0423013362171393,0.00631886061865105,0.146926705944869
Physical measures,X4270.Volume level set by participant (left),XIAP,E3 ubiquitin-protein ligase XIAP,14207,-0.0375899863631117,0.0259252042407923,-0.0884033866750646,0.0132234139488411,0.147097398696227
Physical measures,X4270.Volume level set by participant (left),GIMAP7,GTPase IMAP family member 7,14352,-0.0683045921527126,0.0471351296070879,-0.160689446182605,0.0240802618771798,0.14732515937193
Physical measures,X4270.Volume level set by participant (left),ACE2,Angiotensin-converting enzyme 2,16356,0.0373139800474886,0.0257551614616925,-0.0131661364174287,0.087794096512406,0.147413695840303
Physical measures,X4270.Volume level set by participant (left),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16266,-0.0255317470152699,0.0176237193288024,-0.0600742368997227,0.00901074286918292,0.147436478745386
Physical measures,X4270.Volume level set by participant (left),GTPBP2,GTP-binding protein 2,14261,-0.0275432885545389,0.0190123333745028,-0.0648074619685644,0.00972088485948665,0.147441612076969
Physical measures,X4270.Volume level set by participant (left),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16681,-0.0303197730807726,0.0209314415712974,-0.0713453985605156,0.0107058523989704,0.147488337956243
Physical measures,X4270.Volume level set by participant (left),LZTFL1,Leucine zipper transcription factor-like protein 1,14352,-0.0312888131357473,0.0216192582558601,-0.073662559317233,0.0110849330457384,0.147844360488336
Physical measures,X4270.Volume level set by participant (left),TPBGL,Trophoblast glycoprotein-like,14261,0.0517086363686631,0.0357549240073217,-0.0183710146856874,0.121788287423014,0.148144173006577
Physical measures,X4270.Volume level set by participant (left),GLI2,Zinc finger protein GLI2,14207,-0.063920073943855,0.044220591733491,-0.150592433741497,0.0227522858537873,0.148344599961897
Physical measures,X4270.Volume level set by participant (left),CRISP3,Cysteine-rich secretory protein 3,14539,-0.0784458398330651,0.0542771777256473,-0.184829108175334,0.0279374285092035,0.1484002082913
Physical measures,X4270.Volume level set by participant (left),SH3GL3,Endophilin-A3,14305,-0.0257233899488111,0.0178326723419867,-0.060675427739105,0.00922864784148275,0.149187084034132
Physical measures,X4270.Volume level set by participant (left),REXO2,"Oligoribonuclease, mitochondrial",14175,-0.0436910531763944,0.0302963767415903,-0.103071951589911,0.0156898452371227,0.149290249282474
Physical measures,X4270.Volume level set by participant (left),VIM,Vimentin,16356,0.0160787061585177,0.0111521787135421,-0.00577956412002474,0.0379369764370602,0.14939075007345
Physical measures,X4270.Volume level set by participant (left),NID2,Nidogen-2,16671,-0.0248821651709,0.0172654674530231,-0.0587224813788254,0.00895815103702531,0.149560510389593
Physical measures,X4270.Volume level set by participant (left),C2CD2L,Phospholipid transfer protein C2CD2L,16222,-0.0439651453159274,0.0305301231140666,-0.103804186619498,0.0158738959876432,0.149870333601399
Physical measures,X4270.Volume level set by participant (left),CCL8,C-C motif chemokine 8,16788,-0.0299962174328254,0.0208358999703029,-0.0708345813746191,0.0108421465089683,0.14998763693518
Physical measures,X4270.Volume level set by participant (left),CASP4,Caspase-4,14404,0.012678283103623,0.00880660468310361,-0.00458266207526005,0.0299392282825061,0.149992874550878
Physical measures,X4270.Volume level set by participant (left),PTPRR,Receptor-type tyrosine-protein phosphatase R,14628,-0.0579251726404491,0.0402547921541786,-0.136824565262639,0.0209742199817411,0.150182313435364
Physical measures,X4270.Volume level set by participant (left),SIGLEC6,Sialic acid-binding Ig-like lectin 6,16810,0.054962780057991,0.0382067200659958,-0.0199223912713607,0.129847951387343,0.150292965915683
Physical measures,X4270.Volume level set by participant (left),UPK3A,Uroplakin-3a,14168,0.0435998668596538,0.0303137646849474,-0.0158151119228431,0.103014845642151,0.150375004144425
Physical measures,X4270.Volume level set by participant (left),KDR,Vascular endothelial growth factor receptor 2,16719,0.0708336327827098,0.0492884925848432,-0.025771812683583,0.167439078249003,0.150701742326937
Physical measures,X4270.Volume level set by participant (left),SCT,Secretin,14261,-0.0471866536097833,0.0328339676016321,-0.111541230108982,0.0171679228894156,0.150703250537
Physical measures,X4270.Volume level set by participant (left),HTR1A,5-hydroxytryptamine receptor 1A,14168,-0.0279552929237165,0.0194786375988931,-0.0661334226175468,0.010222836770114,0.151258763169365
Physical measures,X4270.Volume level set by participant (left),IL34,Interleukin-34,16231,0.0513605711589916,0.0358140086015816,-0.0188348857001082,0.121556028018092,0.151565391376118
Physical measures,X4270.Volume level set by participant (left),SFTPA1,Pulmonary surfactant-associated protein A1,16266,-0.0320366289667267,0.0223664611244676,-0.0758748927706833,0.0118016348372298,0.15206255378784
Physical measures,X4270.Volume level set by participant (left),SNCA,Alpha-synuclein,14352,-0.019387993512706,0.0135374962490541,-0.0459214861608521,0.00714549913544012,0.152117031702402
Physical measures,X4270.Volume level set by participant (left),GP5,Platelet glycoprotein V,14352,-0.0587333690638596,0.0410236813143319,-0.13913978443995,0.0216730463122309,0.152253141646416
Physical measures,X4270.Volume level set by participant (left),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14288,-0.0336626909528932,0.0235236104395412,-0.079768967414394,0.0124435855086075,0.152447184556079
Physical measures,X4270.Volume level set by participant (left),KIRREL2,Kin of IRRE-like protein 2,16257,-0.045852590827967,0.0320464909591617,-0.108663713107924,0.01695853145199,0.152502565575288
Physical measures,X4270.Volume level set by participant (left),MCTS1,Malignant T-cell-amplified sequence 1,14588,-0.0791798890650391,0.0553892989852909,-0.187742915076209,0.0293831369461311,0.152877418886927
Physical measures,X4270.Volume level set by participant (left),TALDO1,Transaldolase,14616,-0.0483789186619359,0.0338686005319303,-0.114761375704519,0.0180035383806474,0.153189576699366
Physical measures,X4270.Volume level set by participant (left),FOXO3,Forkhead box protein O3,16266,-0.0196865338275062,0.0137939695595519,-0.0467227141642279,0.00734964650921543,0.153546056152758
Physical measures,X4270.Volume level set by participant (left),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16576,-0.0418552069506223,0.0293480623967162,-0.0993774092481862,0.0156669953469415,0.153839300806636
Physical measures,X4270.Volume level set by participant (left),SAFB2,Scaffold attachment factor B2,14629,-0.075675589267393,0.0531544718584473,-0.17985835410995,0.0285071755751636,0.154557041295207
Physical measures,X4270.Volume level set by participant (left),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16533,-0.0202914146643675,0.014254203213633,-0.0482296529630881,0.00764682363435307,0.154598845157122
Physical measures,X4270.Volume level set by participant (left),PLA2G15,Phospholipase A2 group XV,16719,0.0680471661605686,0.0478624268662797,-0.0257631904973397,0.161857522818477,0.155125030741159
Physical measures,X4270.Volume level set by participant (left),DDT,D-dopachrome decarboxylase,14678,-0.0492797727613309,0.0346659368600124,-0.117225009006955,0.0186654634842934,0.15517476199488
Physical measures,X4270.Volume level set by participant (left),CLNS1A,Methylosome subunit pICln,14261,-0.0587401197550592,0.0413474868224133,-0.139781193926989,0.022300954416871,0.155441742256704
Physical measures,X4270.Volume level set by participant (left),PLAT,Tissue-type plasminogen activator,16805,0.0361193723782506,0.0254459003138019,-0.013754592236801,0.0859933369933022,0.155784265123756
Physical measures,X4270.Volume level set by participant (left),NUP50,Nuclear pore complex protein Nup50,14175,-0.0656483843994399,0.0462529979209915,-0.156304260324583,0.0250074915257034,0.155824108961868
Physical measures,X4270.Volume level set by participant (left),IFNAR1,Interferon alpha/beta receptor 1,14588,-0.0810423976495867,0.0572009740390905,-0.193156306766204,0.0310715114670306,0.156562494089204
Physical measures,X4270.Volume level set by participant (left),ICAM4,Intercellular adhesion molecule 4,16637,-0.0338536557762489,0.0238979830617382,-0.0806937025772556,0.0129863910247579,0.156621430050596
Physical measures,X4270.Volume level set by participant (left),TNNI3,"Troponin I, cardiac muscle",16356,0.0217083428467974,0.0153606870843066,-0.00839860383844363,0.0518152895320383,0.157604114881377
Physical measures,X4270.Volume level set by participant (left),SUOX,"Sulfite oxidase, mitochondrial",14629,-0.0328642806477947,0.0232602242261243,-0.0784543201309983,0.0127257588354089,0.157707568500167
Physical measures,X4270.Volume level set by participant (left),TXNDC9,Thioredoxin domain-containing protein 9,14628,-0.0391681086301546,0.0277249000985891,-0.0935089128233891,0.01517269556308,0.157753133034323
Physical measures,X4270.Volume level set by participant (left),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14629,0.0865822251168096,0.0613280422916643,-0.0336207377748525,0.206785188008472,0.158033538101232
Physical measures,X4270.Volume level set by participant (left),IL17D,Interleukin-17D,16350,-0.0543941317076974,0.0385354175791001,-0.129923550162733,0.0211352867473388,0.158105658143223
Physical measures,X4270.Volume level set by participant (left),HARS1,"Histidine--tRNA ligase, cytoplasmic",16671,-0.0243789408254019,0.0172756444581016,-0.058239203963281,0.00948132231247718,0.158211985685722
Physical measures,X4270.Volume level set by participant (left),FMR1,Synaptic functional regulator FMR1,16266,-0.0513077004035992,0.0363659393994854,-0.122584941626591,0.0199695408193921,0.158301384426553
Physical measures,X4270.Volume level set by participant (left),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14352,-0.05055261482597,0.0358371756215354,-0.120793479044179,0.0196882493922393,0.158378570262773
Physical measures,X4270.Volume level set by participant (left),NRGN,Neurogranin,14672,-0.0233669853970567,0.016569421501477,-0.0558430515399517,0.00910908074583831,0.158487835464349
Physical measures,X4270.Volume level set by participant (left),BIRC2,Baculoviral IAP repeat-containing protein 2,16266,-0.0297238840456735,0.0210992577656554,-0.071078429266358,0.0116306611750111,0.158923967947117
Physical measures,X4270.Volume level set by participant (left),FADD,FAS-associated death domain protein,16666,-0.0243615657338643,0.0173362342088594,-0.0583405847832287,0.0096174533155002,0.159968650955151
Physical measures,X4270.Volume level set by participant (left),GABARAP,Gamma-aminobutyric acid receptor-associated protein,14572,-0.0418152241126725,0.0297763052102466,-0.100176782324756,0.0165463340994108,0.160247286494051
Physical measures,X4270.Volume level set by participant (left),TLR2,Toll-like receptor 2,14404,0.0894610946916824,0.0638066354656239,-0.0355999108209405,0.214522100204305,0.160917204731233
Physical measures,X4270.Volume level set by participant (left),CD79B,B-cell antigen receptor complex-associated protein beta chain,16843,0.0402190599418311,0.0287293116476911,-0.0160903908876435,0.0965285107713056,0.16155235701084
Physical measures,X4270.Volume level set by participant (left),TGOLN2,Trans-Golgi network integral membrane protein 2,14672,0.0782649749381304,0.0559070688479702,-0.0313128800038912,0.187842829880152,0.161560849254129
Physical measures,X4270.Volume level set by participant (left),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,14175,-0.0527719259743105,0.0377126156751995,-0.126688652697702,0.0211448007490806,0.161739679246715
Physical measures,X4270.Volume level set by participant (left),HNMT,Histamine N-methyltransferase,16465,0.0388955080236503,0.0278001294169698,-0.0155927456336104,0.0933837616809111,0.161798112677916
Physical measures,X4270.Volume level set by participant (left),BCHE,Cholinesterase,14371,-0.0732782138865915,0.052390275128472,-0.175963153138397,0.0294067253652135,0.161924935799294
Physical measures,X4270.Volume level set by participant (left),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14629,-0.01714238518513,0.0122703396643987,-0.0411922509273515,0.00690748055709153,0.162417124799038
Physical measures,X4270.Volume level set by participant (left),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16266,-0.0273129226550427,0.0195744471215821,-0.0656788390133436,0.0110529937032582,0.162933734332968
Physical measures,X4270.Volume level set by participant (left),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14288,-0.042418991774751,0.030415681815728,-0.102033728133578,0.0171957445840759,0.163145486570976
Physical measures,X4270.Volume level set by participant (left),SMS,Spermine synthase,14168,-0.0328286636699071,0.0235396015206466,-0.0789662826503745,0.0133089553105603,0.163154087810162
Physical measures,X4270.Volume level set by participant (left),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,14168,-0.0665536029189671,0.0477498817425171,-0.160143371134301,0.0270361652963664,0.163401047822371
Physical measures,X4270.Volume level set by participant (left),ACTN2,Alpha-actinin-2,14175,-0.0343500826943818,0.0246480954823459,-0.0826603498397798,0.0139601844510161,0.163454213190906
Physical measures,X4270.Volume level set by participant (left),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14404,-0.032016720883096,0.0229794552668103,-0.0770564532060443,0.0130230114398522,0.163557904579548
Physical measures,X4270.Volume level set by participant (left),DAB2,Disabled homolog 2,16810,-0.0163624595269079,0.0117510919084586,-0.0393945996674868,0.00666968061367102,0.163813581663079
Physical measures,X4270.Volume level set by participant (left),RPL14,60S ribosomal protein L14,14288,-0.052118756787142,0.0374439320531554,-0.125508863611326,0.0212713500370425,0.163969942979408
Physical measures,X4270.Volume level set by participant (left),BABAM1,BRISC and BRCA1-A complex member 1,14207,-0.0717554777732644,0.0515622858997681,-0.17281755813681,0.0293066025902811,0.164057141919791
Physical measures,X4270.Volume level set by participant (left),CLSPN,Claspin,16222,-0.0490701910836629,0.0352743242887443,-0.118207866689602,0.020067484522276,0.164213528139062
Physical measures,X4270.Volume level set by participant (left),FGF16,Fibroblast growth factor 16,14207,0.044801561964901,0.0322389034394826,-0.0183866887764848,0.107989812706287,0.164649732429846
Physical measures,X4270.Volume level set by participant (left),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16773,0.050480143365477,0.036332390432195,-0.0207313418816252,0.121691628612579,0.164730280463974
Physical measures,X4270.Volume level set by participant (left),TFPI,Tissue factor pathway inhibitor,16578,-0.0545740917880168,0.0392914279053713,-0.131585290482545,0.022437106906511,0.164864596118114
Physical measures,X4270.Volume level set by participant (left),ITGB2,Integrin beta-2,16560,-0.0624667040774688,0.0450114639463508,-0.150689173412316,0.0257557652573789,0.165218037156862
Physical measures,X4270.Volume level set by participant (left),APOA4,Apolipoprotein A-IV,14697,-0.0568958076067311,0.0410563610423173,-0.137366275249673,0.0235746600362107,0.165829759142669
Physical measures,X4270.Volume level set by participant (left),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14352,-0.0211750156031863,0.0153005895679234,-0.0511641711563161,0.00881413994994356,0.166400021407267
Physical measures,X4270.Volume level set by participant (left),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14572,-0.0450826857191705,0.0325926732921519,-0.108964325371788,0.0187989539334472,0.166620063285669
Physical measures,X4270.Volume level set by participant (left),BRD2,Bromodomain-containing protein 2,14168,-0.0596630638611174,0.0431545983799055,-0.144246076685732,0.0249199489634974,0.166827025615777
Physical measures,X4270.Volume level set by participant (left),BCL2L15,Bcl-2-like protein 15,14207,0.0347841461427562,0.025179387914967,-0.0145674541705791,0.0841357464560915,0.167161407230934
Physical measures,X4270.Volume level set by participant (left),QDPR,Dihydropteridine reductase,16595,-0.0420580270775738,0.0304464959642653,-0.101733159167534,0.0176171050123862,0.167182318873238
Physical measures,X4270.Volume level set by participant (left),RILPL2,RILP-like protein 2,14652,-0.0213624416645914,0.015475785945014,-0.0516949821168189,0.00897009878763618,0.167491229662916
Physical measures,X4270.Volume level set by participant (left),MCFD2,Multiple coagulation factor deficiency protein 2,16600,-0.0400507937645085,0.0290163140291869,-0.0969227692617149,0.0168211817326979,0.167517403243327
Physical measures,X4270.Volume level set by participant (left),F3,Tissue factor,16730,-0.0633860890447934,0.0459229324527447,-0.153395036652173,0.0266228585625863,0.167521700550618
Physical measures,X4270.Volume level set by participant (left),CCN2,CCN family member 2,16654,-0.0307058724489203,0.0222492283480721,-0.0743143600111417,0.012902615113301,0.167578380948838
Physical measures,X4270.Volume level set by participant (left),DNPEP,Aspartyl aminopeptidase,14628,-0.0357420211721715,0.0259480708978018,-0.086600240131863,0.01511619778752,0.168396037650035
Physical measures,X4270.Volume level set by participant (left),FAP,Prolyl endopeptidase FAP,16871,-0.0633518703982526,0.0460098709901595,-0.153531217538965,0.02682747674246,0.168555547932255
Physical measures,X4270.Volume level set by participant (left),HCLS1,Hematopoietic lineage cell-specific protein,16843,-0.0331683479288967,0.024093612722469,-0.080391828864936,0.0140551330071425,0.168640393784533
Physical measures,X4270.Volume level set by participant (left),CASQ2,Calsequestrin-2,14175,0.0417417319294795,0.030377633027119,-0.0177984288036736,0.101281892662633,0.169434165602943
Physical measures,X4270.Volume level set by participant (left),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14628,-0.0361798327784471,0.0263505024059355,-0.0878268174940806,0.0154671519371863,0.169766421809921
Physical measures,X4270.Volume level set by participant (left),JAM3,Junctional adhesion molecule C,14352,-0.0401044616688369,0.0292329472804106,-0.0974010383384417,0.0171921150007678,0.170118368758733
Physical measures,X4270.Volume level set by participant (left),SYT1,Synaptotagmin-1,14628,-0.0524989793622459,0.0382814238695966,-0.127530570146655,0.0225326114221634,0.170272703295971
Physical measures,X4270.Volume level set by participant (left),RASSF2,Ras association domain-containing protein 2,16266,0.0326176534695739,0.0237867455414692,-0.0140043677917058,0.0792396747308535,0.170314942523798
Physical measures,X4270.Volume level set by participant (left),MRI1,Methylthioribose-1-phosphate isomerase,14261,-0.0297035567808724,0.0216888007941263,-0.07221360633736,0.0128064927756151,0.170853908552356
Physical measures,X4270.Volume level set by participant (left),PHACTR2,Phosphatase and actin regulator 2,14629,-0.0180666515511762,0.0132033368004405,-0.0439451916800395,0.00781188857768718,0.171226769471625
Physical measures,X4270.Volume level set by participant (left),SWAP70,Switch-associated protein 70,14588,-0.0589653879153094,0.043127774673501,-0.143495826275371,0.0255650504447525,0.171575764376909
Physical measures,X4270.Volume level set by participant (left),TMEM25,Transmembrane protein 25,14629,-0.0443907542251568,0.0325075898315674,-0.108105630295029,0.0193241218447153,0.172101125091274
Physical measures,X4270.Volume level set by participant (left),CD5L,CD5 antigen-like,14620,-0.0423280609617548,0.0310703532958005,-0.103225953421524,0.0185698314980142,0.173114911645063
Physical measures,X4270.Volume level set by participant (left),TPM3,Tropomyosin alpha-3 chain,14175,-0.0460607075249228,0.0338200542266474,-0.112348013809152,0.0202265987593061,0.173240142984757
Physical measures,X4270.Volume level set by participant (left),MYL3,Myosin light chain 3,14288,-0.0277503632494732,0.0203847911560735,-0.0677045539153772,0.0122038274164308,0.173431918771381
Physical measures,X4270.Volume level set by participant (left),TAP1,Antigen peptide transporter 1,14404,-0.0332262248890151,0.024435790485155,-0.0811203742399189,0.0146679244618887,0.173934778649326
Physical measures,X4270.Volume level set by participant (left),PSAP,Prosaposin,14511,-0.0694750953313007,0.0511050577042013,-0.169641008431535,0.0306908177689338,0.174023173763962
Physical measures,X4270.Volume level set by participant (left),TBCC,Tubulin-specific chaperone C,16533,-0.0225220098922208,0.0165694990551582,-0.0549982280403308,0.00995420825588919,0.174087502739438
Physical measures,X4270.Volume level set by participant (left),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16100,0.02769133168437,0.020372823164802,-0.012239401718642,0.067622065087382,0.174093098499184
Physical measures,X4270.Volume level set by participant (left),NT5E,5'-nucleotidase,16719,0.0302554108027263,0.0222656707737011,-0.0133853039137279,0.0738961255191804,0.174216687582803
Physical measures,X4270.Volume level set by participant (left),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16533,-0.0190111991300825,0.0139991914875488,-0.0464496144456781,0.00842721618551312,0.174475501455337
Physical measures,X4270.Volume level set by participant (left),ATRN,"Attractin, Isoform 2",14697,-0.119888233253597,0.0883241981688796,-0.293003661664601,0.0532271951574074,0.174685921574316
Physical measures,X4270.Volume level set by participant (left),RNF43,E3 ubiquitin-protein ligase RNF43,14404,-0.0341537642912815,0.0251727554542547,-0.0834923649816206,0.0151848363990577,0.174874013308044
Physical measures,X4270.Volume level set by participant (left),MTIF3,"Translation initiation factor IF-3, mitochondrial",14588,-0.0234631130470303,0.0172994320745078,-0.0573699999130656,0.0104437738190051,0.175026711943307
Physical measures,X4270.Volume level set by participant (left),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16466,-0.0535445577720463,0.0395125944863933,-0.130989242965377,0.0239001274212846,0.17539591477236
Physical measures,X4270.Volume level set by participant (left),ROBO2,Roundabout homolog 2,16799,-0.0725649415920804,0.0536088555472021,-0.177638298464597,0.0325084152804356,0.175882288269131
Physical measures,X4270.Volume level set by participant (left),PILRB,Paired immunoglobulin-like type 2 receptor beta,16666,0.0301024860059361,0.0222388370585636,-0.0134856346288485,0.0736906066407206,0.175882457544896
Physical measures,X4270.Volume level set by participant (left),PDAP1,28 kDa heat- and acid-stable phosphoprotein,14652,-0.0212289662041952,0.0156964133917967,-0.0519939364521167,0.0095360040437263,0.176245132081739
Physical measures,X4270.Volume level set by participant (left),ATP2B4,Plasma membrane calcium-transporting ATPase 4,14175,-0.0312105919067547,0.0230783353764496,-0.076444129244596,0.0140229454310866,0.176276592927687
Physical measures,X4270.Volume level set by participant (left),DUSP3,Dual specificity protein phosphatase 3,16257,-0.0205492851388737,0.0152104788773837,-0.0503618237385457,0.00926325346079835,0.176715766812028
Physical measures,X4270.Volume level set by participant (left),PREB,Prolactin regulatory element-binding protein,16350,0.0592370344130663,0.043869839043082,-0.0267478501113745,0.145221918937507,0.176941473246447
Physical measures,X4270.Volume level set by participant (left),GYS1,"Glycogen [starch] synthase, muscle",16356,-0.0192927332063442,0.0142914731921851,-0.047304020663027,0.0087185542503386,0.177051643354774
Physical measures,X4270.Volume level set by participant (left),PVALB,Parvalbumin alpha,16758,-0.0152373755393185,0.0112930423213296,-0.0373717384891245,0.00689698741048744,0.177268154776331
Physical measures,X4270.Volume level set by participant (left),NFKBIE,NF-kappa-B inhibitor epsilon,16266,-0.0360815633457173,0.0268045893690697,-0.0886185585090939,0.0164554318176593,0.178290183182861
Physical measures,X4270.Volume level set by participant (left),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14288,-0.0469629416569251,0.0348891377292058,-0.115345651606168,0.0214197682923183,0.178303911581421
Physical measures,X4270.Volume level set by participant (left),ERP29,Endoplasmic reticulum resident protein 29,14352,-0.0175745400177275,0.0130607498475643,-0.0431736097189534,0.00802452968349848,0.178452957023535
Physical measures,X4270.Volume level set by participant (left),LACTB2,Endoribonuclease LACTB2,16666,-0.0269657050493308,0.0200541561641398,-0.0662718511310449,0.0123404410323832,0.17875847613084
Physical measures,X4270.Volume level set by participant (left),AK2,"Adenylate kinase 2, mitochondrial",14628,-0.0190402990566654,0.0141722476943467,-0.046817904537585,0.00873730642425424,0.179133632901475
Physical measures,X4270.Volume level set by participant (left),SIT1,Signaling threshold-regulating transmembrane adapter 1,16350,0.0318967691168703,0.0237734697186447,-0.0146992315316734,0.0784927697654139,0.179713238885807
Physical measures,X4270.Volume level set by participant (left),PLXNB3,Plexin-B3,16635,-0.035916284501276,0.026789422229929,-0.0884235520719368,0.0165909830693848,0.18003976400127
Physical measures,X4270.Volume level set by participant (left),CRIP2,Cysteine-rich protein 2,16533,-0.046476965076746,0.0347112655731073,-0.114511045600036,0.0215571154465444,0.180602414341911
Physical measures,X4270.Volume level set by participant (left),KLK10,Kallikrein-10,16681,0.0421445369181527,0.0314934558289289,-0.0195826365065481,0.103871710342853,0.180849566858906
Physical measures,X4270.Volume level set by participant (left),SEMA4C,Semaphorin-4C,16576,-0.061376454491873,0.0458834928118121,-0.151308100403025,0.0285551914192788,0.181026082830373
Physical measures,X4270.Volume level set by participant (left),AHSP,Alpha-hemoglobin-stabilizing protein,16633,-0.0193567879929433,0.014472149893297,-0.0477222017838055,0.00900862579791879,0.181071309107557
Physical measures,X4270.Volume level set by participant (left),ANGPT1,Angiopoietin-1,16615,-0.0200250547950882,0.0149919349868643,-0.0494092473693422,0.0093591377791659,0.181658527106924
Physical measures,X4270.Volume level set by participant (left),CLTA,Clathrin light chain A,16356,-0.0365606253874888,0.0273863190519043,-0.0902378107292212,0.0171165599542436,0.181896267693968
Physical measures,X4270.Volume level set by participant (left),COL24A1,Collagen alpha-1(XXIV) chain,14588,-0.0343145321410159,0.0257453373957306,-0.0847753934366478,0.016146329154616,0.182603668886107
Physical measures,X4270.Volume level set by participant (left),MITD1,MIT domain-containing protein 1,16533,-0.0184161529371884,0.0138193686401335,-0.04550211547185,0.00866980959747317,0.182670506160965
Physical measures,X4270.Volume level set by participant (left),ATF4,Cyclic AMP-dependent transcription factor ATF-4,14144,-0.0595686364874321,0.0447158171895163,-0.147211638178884,0.0280743652040199,0.182829008169293
Physical measures,X4270.Volume level set by participant (left),DNM3,Dynamin-3,14629,-0.0354147405917153,0.0266364227049381,-0.0876221290933941,0.0167926479099634,0.183683812364584
Physical measures,X4270.Volume level set by participant (left),AK1,Adenylate kinase isoenzyme 1,16666,-0.0265005785654021,0.0199583434363987,-0.0656189317007434,0.0126177745699393,0.184264209593163
Physical measures,X4270.Volume level set by participant (left),SERPINI1,Neuroserpin,14314,-0.0633282862946082,0.0477156251389921,-0.156850911567033,0.0301943389778163,0.184462973345482
Physical measures,X4270.Volume level set by participant (left),IGFBP3,Insulin-like growth factor-binding protein 3,16715,-0.0564065587613712,0.0425440012187438,-0.139792801150109,0.0269796836273666,0.184910680000223
Physical measures,X4270.Volume level set by participant (left),PLAUR,Urokinase plasminogen activator surface receptor,16508,0.0613648623091742,0.0463028393425202,-0.0293887028021654,0.152118427420514,0.185092110739556
Physical measures,X4270.Volume level set by participant (left),NCK2,Cytoplasmic protein NCK2,16733,-0.0164194817182512,0.012393133117572,-0.0407100226286924,0.00787105919218997,0.185227258604261
Physical measures,X4270.Volume level set by participant (left),COL15A1,Collagen alpha-1(XV) chain,14678,-0.0743730349561922,0.05617832176776,-0.184482545621002,0.0357364757086174,0.185565444060316
Physical measures,X4270.Volume level set by participant (left),MATN3,Matrilin-3,16500,-0.052913284794306,0.0400031688870211,-0.131319495812867,0.0254929262242554,0.185944422081037
Physical measures,X4270.Volume level set by participant (left),PARP1,Poly [ADP-ribose] polymerase 1,16637,-0.029663358555409,0.0224286171151265,-0.0736234481010569,0.014296730990239,0.185997469006891
Physical measures,X4270.Volume level set by participant (left),TARBP2,RISC-loading complex subunit TARBP2,16257,-0.0221992506551436,0.0167865742330014,-0.0551009361518264,0.0107024348415392,0.186040033647586
Physical measures,X4270.Volume level set by participant (left),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14288,-0.0261242125784755,0.0197545820608985,-0.0648431934178366,0.0125947682608855,0.186043491274166
Physical measures,X4270.Volume level set by participant (left),MAG,Myelin-associated glycoprotein,14261,0.0417330034519267,0.0315730518545971,-0.0201501781830836,0.103616185086937,0.186258691661517
Physical measures,X4270.Volume level set by participant (left),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,14207,-0.0255084646513075,0.01929848436158,-0.0633334940000043,0.0123165646973894,0.186260760760854
Physical measures,X4270.Volume level set by participant (left),MRPS16,"28S ribosomal protein S16, mitochondrial",14207,-0.0664343909078402,0.0503081945734832,-0.165038452271867,0.0321696704561868,0.186673384480747
Physical measures,X4270.Volume level set by participant (left),UGDH,UDP-glucose 6-dehydrogenase,14175,-0.0194379514042624,0.0147271144967779,-0.0483030958179471,0.00942719300942232,0.186898069508111
Physical measures,X4270.Volume level set by participant (left),BTLA,B- and T-lymphocyte attenuator,14144,0.0221151050340237,0.0167557958316516,-0.0107262547960135,0.0549564648640609,0.186907130360892
Physical measures,X4270.Volume level set by participant (left),RWDD1,RWD domain-containing protein 1,16799,-0.0279121568616489,0.0211670806318521,-0.069399634900079,0.0135753211767812,0.187301205515181
Physical measures,X4270.Volume level set by participant (left),CCL3,C-C motif chemokine 3,16637,0.0255018283890725,0.0193477632363972,-0.012419787554266,0.063423444332411,0.187496269464948
Physical measures,X4270.Volume level set by participant (left),LGALS9,Galectin-9,16645,0.0530303793290606,0.0402379448945974,-0.0258359926643503,0.131896751322472,0.187548693904133
Physical measures,X4270.Volume level set by participant (left),ATP5PO,"ATP synthase subunit O, mitochondrial",16257,-0.0392967496315288,0.0298678437594765,-0.0978377234001027,0.0192442241370451,0.188297513586574
Physical measures,X4270.Volume level set by participant (left),RHOC,Rho-related GTP-binding protein RhoC,16434,-0.0150251852110178,0.0114330454722845,-0.0374339543366953,0.00738358391465975,0.18880089368219
Physical measures,X4270.Volume level set by participant (left),CD163,Scavenger receptor cysteine-rich type 1 protein M130,16715,0.0387423418347346,0.0295438263096744,-0.0191635577322272,0.0966482414016964,0.189757057558745
Physical measures,X4270.Volume level set by participant (left),VAV3,Guanine nucleotide exchange factor VAV3,14168,-0.0206285231201847,0.015739174702925,-0.0514773055379177,0.0102202592975483,0.189997871431594
Physical measures,X4270.Volume level set by participant (left),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14628,-0.0397251030009629,0.0303316174438276,-0.099175073190865,0.0197248671889391,0.190320350120275
Physical measures,X4270.Volume level set by participant (left),BAP18,Chromatin complexes subunit BAP18,14628,0.029894713718166,0.0228432827501911,-0.0148781204722085,0.0746675479085405,0.190660883702985
Physical measures,X4270.Volume level set by participant (left),BAG6,Large proline-rich protein BAG6,16356,-0.0459157904276989,0.0351220053634723,-0.114754920940105,0.0229233400847068,0.191121577203069
Physical measures,X4270.Volume level set by participant (left),KIRREL1,Kin of IRRE-like protein 1,14168,0.0335713972932326,0.0256844579080808,-0.0167701402066059,0.083912934793071,0.191210006722337
Physical measures,X4270.Volume level set by participant (left),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16356,-0.0549082970210319,0.0420337016210025,-0.137294352198197,0.0274777581561329,0.191471593168313
Physical measures,X4270.Volume level set by participant (left),HPSE,Heparanase,14430,-0.0208186255890468,0.0159479382692746,-0.0520765845968249,0.0104393334187313,0.191773525953498
Physical measures,X4270.Volume level set by participant (left),SMAD3,Mothers against decapentaplegic homolog 3,14572,-0.0377365906814119,0.0289136405571291,-0.094407326173385,0.0189341448105612,0.191862964754405
Physical measures,X4270.Volume level set by participant (left),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16498,-0.0175395889813289,0.0134585184690885,-0.0439182851807425,0.00883910721808458,0.192513342241827
Physical measures,X4270.Volume level set by participant (left),COCH,Cochlin,14652,-0.0409588764398454,0.0314382631228744,-0.102577872160679,0.0206601192809884,0.192651522754874
Physical measures,X4270.Volume level set by participant (left),GSAP,Gamma-secretase-activating protein,16266,0.019376890908787,0.0148784857643918,-0.009784941189421,0.048538723006995,0.192817637407076
Physical measures,X4270.Volume level set by participant (left),RAB2B,Ras-related protein Rab-2B,14572,-0.032395946918959,0.0248979099829849,-0.0811958504856094,0.0164039566476914,0.19322728167595
Physical measures,X4270.Volume level set by participant (left),ANKRA2,Ankyrin repeat family A protein 2,14144,-0.0353559656038657,0.0271828262390032,-0.088634305032312,0.0179223738245805,0.193391656170157
Physical measures,X4270.Volume level set by participant (left),CA7,Carbonic anhydrase 7,14404,-0.0565861007391284,0.0435108014619461,-0.141867271604543,0.028695070126286,0.193448098847121
Physical measures,X4270.Volume level set by participant (left),GLOD4,Glyoxalase domain-containing protein 4,16624,-0.0494763376427336,0.0380559620506772,-0.124066023262061,0.0251133479765938,0.193586709675646
Physical measures,X4270.Volume level set by participant (left),PRDX5,"Peroxiredoxin-5, mitochondrial",16843,-0.0260750897481451,0.0200782927766047,-0.0654285435902904,0.0132783640940001,0.194074774331751
Physical measures,X4270.Volume level set by participant (left),HBQ1,Hemoglobin subunit theta-1,16810,-0.0254310754178529,0.019595452664154,-0.0638381626395948,0.012976011803889,0.194372194689034
Physical measures,X4270.Volume level set by participant (left),PRC1,Protein regulator of cytokinesis 1,14572,-0.0421732507366173,0.0325026449774611,-0.105878434892441,0.0215319334192065,0.194468461482166
Physical measures,X4270.Volume level set by participant (left),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14288,-0.0756729502989351,0.0583833667851259,-0.190104349197782,0.0387584485999117,0.194948610285027
Physical measures,X4270.Volume level set by participant (left),PROS1,Vitamin K-dependent protein S,14697,-0.0739056358167113,0.0570345286468871,-0.18569331196461,0.0378820403311874,0.195062997482671
Physical measures,X4270.Volume level set by participant (left),TNFSF10,Tumor necrosis factor ligand superfamily member 10,16843,-0.0626066504922149,0.0483621485671128,-0.157396461683756,0.0321831606993262,0.195497335851124
Physical measures,X4270.Volume level set by participant (left),FABP9,Fatty acid-binding protein 9,16637,0.0293933762678605,0.0227076231045851,-0.0151135650171264,0.0739003175528473,0.195535713254313
Physical measures,X4270.Volume level set by participant (left),ATG16L1,Autophagy-related protein 16-1,14588,-0.0232190039413029,0.0179393349943899,-0.0583801005303071,0.0119420926477012,0.195579967761707
Physical measures,X4270.Volume level set by participant (left),ERCC1,DNA excision repair protein ERCC-1,14144,-0.0596538765490396,0.0460956565974061,-0.150001363479956,0.0306936103818764,0.19564089300423
Physical measures,X4270.Volume level set by participant (left),EIF4E,Eukaryotic translation initiation factor 4E,14207,-0.0230439111969089,0.017825382084464,-0.0579816600824583,0.0118938376886405,0.196115704400356
Physical measures,X4270.Volume level set by participant (left),RANBP2,E3 SUMO-protein ligase RanBP2,14168,-0.0583771113937948,0.0451671232816149,-0.14690467302576,0.0301504502381705,0.196215842024372
Physical measures,X4270.Volume level set by participant (left),CIRBP,Cold-inducible RNA-binding protein,14588,-0.0207189244641108,0.016032621126223,-0.0521428618715078,0.0107050129432862,0.196274452608284
Physical measures,X4270.Volume level set by participant (left),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16668,0.0524597253261391,0.0406174771677851,-0.0271505299227198,0.132069980574998,0.1965290569162
Physical measures,X4270.Volume level set by participant (left),PCDHB15,Protocadherin beta-15,14572,-0.0479018200822454,0.0371111207025766,-0.120639616659296,0.0248359764948046,0.196804891156636
Physical measures,X4270.Volume level set by participant (left),AGRP,Agouti-related protein,16843,-0.0304617392014342,0.0236157960365175,-0.0767486994330085,0.01582522103014,0.197107168555242
Physical measures,X4270.Volume level set by participant (left),ABCA2,ATP-binding cassette sub-family A member 2,14175,-0.0541028224439687,0.0419846286041145,-0.136392694508033,0.0281870496200957,0.19754639278679
Physical measures,X4270.Volume level set by participant (left),TMEM132A,Transmembrane protein 132A,14288,-0.0295667003374322,0.0229450030632765,-0.0745389063414541,0.0154055056665897,0.197561568688658
Physical measures,X4270.Volume level set by participant (left),LAMP1,Lysosome-associated membrane glycoprotein 1,14276,0.0673083502737987,0.0522413824069768,-0.0350847592438759,0.169701459791473,0.197623979860224
Physical measures,X4270.Volume level set by participant (left),CELA2A,Chymotrypsin-like elastase family member 2A,14678,0.030607857113432,0.0237638274677273,-0.0159692447233135,0.0771849589501775,0.197765598006518
Physical measures,X4270.Volume level set by participant (left),SERPINH1,Serpin H1,14404,-0.0151050965246385,0.0117480334215624,-0.0381312420309009,0.00792104898162386,0.198549160322322
Physical measures,X4270.Volume level set by participant (left),NEO1,Neogenin,14629,-0.0851317685768148,0.0662395155535492,-0.214961219061771,0.0446976819081417,0.198738854211863
Physical measures,X4270.Volume level set by participant (left),LAMA4,Laminin subunit alpha-4,16733,-0.0496769174008857,0.0386589982594738,-0.125448553989454,0.0260947191876829,0.198809142788382
Physical measures,X4270.Volume level set by participant (left),DKK1,Dickkopf-related protein 1,16799,-0.0272394380978517,0.0211980903495494,-0.0687876951829686,0.0143088189872652,0.198811798931051
Physical measures,X4270.Volume level set by participant (left),IDS,Iduronate 2-sulfatase,16843,-0.178096670001161,0.138971057573045,-0.450479942844329,0.0942866028420076,0.200022474678096
Physical measures,X4270.Volume level set by participant (left),ANXA2,Annexin A2,14036,-0.0269058256755841,0.0209997795885157,-0.0680653936690749,0.0142537423179067,0.200129434668532
Physical measures,X4270.Volume level set by participant (left),LCN2,Neutrophil gelatinase-associated lipocalin,16188,0.0426667335716864,0.033350756322659,-0.0227007488207252,0.108034215964098,0.200798062325525
Physical measures,X4270.Volume level set by participant (left),STEAP4,Metalloreductase STEAP4,14168,0.0258642189787687,0.0202494245366621,-0.013824653113089,0.0655530910706264,0.201523774942456
Physical measures,X4270.Volume level set by participant (left),DOK1,Docking protein 1,14628,-0.0147884175639382,0.0115887186924332,-0.0375023062011071,0.00792547107323082,0.201938820144133
Physical measures,X4270.Volume level set by participant (left),TMED1,Transmembrane emp24 domain-containing protein 1,14404,0.0350259833622905,0.0274495405767823,-0.0187751161682027,0.0888270828927838,0.20197135903288
Physical measures,X4270.Volume level set by participant (left),MAPRE3,Microtubule-associated protein RP/EB family member 3,14144,-0.0129767781500033,0.0101702796837447,-0.032910526330143,0.00695697003013639,0.20199383225578
Physical measures,X4270.Volume level set by participant (left),PLEKHO1,Pleckstrin homology domain-containing family O member 1,14628,-0.0268582297711918,0.0210650925340296,-0.0681458111378899,0.0144293515955063,0.202325537233302
Physical measures,X4270.Volume level set by participant (left),GART,Trifunctional purine biosynthetic protein adenosine-3,14629,-0.0694274257042397,0.0544927428144966,-0.176233201620653,0.0373783502121736,0.202659803401184
Physical measures,X4270.Volume level set by participant (left),MORN4,MORN repeat-containing protein 4,14144,0.0241422591922934,0.0189571966778581,-0.0130138462963085,0.0612983646808953,0.202856589718879
Physical measures,X4270.Volume level set by participant (left),PLA2G7,Platelet-activating factor acetylhydrolase,16671,-0.0502758387961145,0.039515965712647,-0.127727131592903,0.0271754540006736,0.203287227668201
Physical measures,X4270.Volume level set by participant (left),IL10,Interleukin-10,16350,0.0202901121703332,0.0159665988758248,-0.0110044216262834,0.0515846459669497,0.203823294488878
Physical measures,X4270.Volume level set by participant (left),TTF2,Transcription termination factor 2,14261,-0.0380610401937879,0.0299561376140004,-0.0967750699172286,0.0206529895296528,0.203906332857434
Physical measures,X4270.Volume level set by participant (left),FST,Follistatin,16710,0.0315547694193562,0.0248623103946172,-0.0171753589540935,0.080284897792806,0.204394247688567
Physical measures,X4270.Volume level set by participant (left),MASP1,Mannan-binding lectin serine protease 1,16498,-0.0686106109523565,0.0540838299416558,-0.174614917638002,0.0373936957332889,0.204602577370771
Physical measures,X4270.Volume level set by participant (left),DNAJB8,DnaJ homolog subfamily B member 8,16356,-0.0291932781964683,0.0230137585292014,-0.074300244913703,0.0159136885207664,0.204632475627146
Physical measures,X4270.Volume level set by participant (left),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16576,-0.0467433202249302,0.0368514535466629,-0.11897216917639,0.0254855287265292,0.204663902393268
Physical measures,X4270.Volume level set by participant (left),CTSS,Cathepsin S,12906,0.0815100735113885,0.0643665727075076,-0.0446484089953264,0.207668556018103,0.205413667908005
Physical measures,X4270.Volume level set by participant (left),PALM,Paralemmin-1,14494,-0.0626488278131054,0.0495416243056125,-0.159750411452106,0.034452755825895,0.206046044058836
Physical measures,X4270.Volume level set by participant (left),SERPINC1,Antithrombin-III,14672,-0.124280035189532,0.0982805198427438,-0.31690985408131,0.0683497837022459,0.206054971746566
Physical measures,X4270.Volume level set by participant (left),KLF4,Krueppel-like factor 4,14168,-0.0472050691499024,0.0373656794303103,-0.120441800833311,0.0260316625335057,0.206492524502426
Physical measures,X4270.Volume level set by participant (left),LBR,Delta(14)-sterol reductase LBR,16799,0.0240737858168845,0.0190614984758242,-0.0132867511957309,0.0614343228294998,0.206623445828376
Physical measures,X4270.Volume level set by participant (left),CXCL17,C-X-C motif chemokine 17,16843,0.0364745841823856,0.0288850122927318,-0.0201400399113688,0.09308920827614,0.206696103637557
Physical measures,X4270.Volume level set by participant (left),HEG1,Protein HEG homolog 1,14352,0.0703550909125825,0.0557420638343553,-0.0388993542027538,0.179609536027919,0.206913768825584
Physical measures,X4270.Volume level set by participant (left),HYOU1,Hypoxia up-regulated protein 1,16871,0.0718958530998312,0.0569827353507686,-0.0397903081876752,0.183582014387338,0.207069569186407
Physical measures,X4270.Volume level set by participant (left),DNAJA4,DnaJ homolog subfamily A member 4,14628,-0.0252763547116558,0.0200348678163199,-0.0645446956316427,0.0139919862083312,0.207106329491222
Physical measures,X4270.Volume level set by participant (left),CD248,Endosialin,14678,-0.0459963550621088,0.0364970690381387,-0.117530610376861,0.0255379002526432,0.207590121138037
Physical measures,X4270.Volume level set by participant (left),AMIGO2,Amphoterin-induced protein 2,16576,-0.0696295555813868,0.0552535271849363,-0.177926468863862,0.0386673577010885,0.207621112853009
Physical measures,X4270.Volume level set by participant (left),CLEC4D,C-type lectin domain family 4 member D,16637,0.0255535517798423,0.0202821043120771,-0.0141993726718288,0.0653064762315133,0.207720842668964
Physical measures,X4270.Volume level set by participant (left),CDC25A,M-phase inducer phosphatase 1,14144,0.0467162132517015,0.0370795021618898,-0.0259596109856025,0.119392037489006,0.207728698541857
Physical measures,X4270.Volume level set by participant (left),PLAU,Urokinase-type plasminogen activator,16671,-0.05549088595882,0.0441115774807316,-0.141949577821054,0.0309678059034138,0.208421515377937
Physical measures,X4270.Volume level set by participant (left),IL25,Interleukin-25,14097,-0.0556681141899012,0.0442786027622815,-0.142454175603973,0.0311179472241706,0.208693453060126
Physical measures,X4270.Volume level set by participant (left),LYAR,Cell growth-regulating nucleolar protein,16266,0.0320476807305018,0.0255090194631571,-0.0179499974172862,0.0820453588782898,0.20901534426447
Physical measures,X4270.Volume level set by participant (left),SUGT1,Protein SGT1 homolog,16266,-0.0216005378753705,0.017195945650275,-0.0553045913499095,0.0121035155991684,0.20908279706033
Physical measures,X4270.Volume level set by participant (left),GRK5,G protein-coupled receptor kinase 5,16356,-0.0317276777380848,0.0252624585830919,-0.081242096560945,0.0177867410847754,0.209162206391952
Physical measures,X4270.Volume level set by participant (left),RABGAP1L,Rab GTPase-activating protein 1-like,16350,-0.0274664986522646,0.0219062697281157,-0.0704027873193714,0.0154697900148422,0.209925722991747
Physical measures,X4270.Volume level set by participant (left),NCF2,Neutrophil cytosol factor 2,16602,0.0190635469223078,0.0152066706715131,-0.010741527593858,0.0488686214384735,0.209993992706148
Physical measures,X4270.Volume level set by participant (left),RAP1A,Ras-related protein Rap-1A,14207,-0.0270433971274336,0.0215764871292533,-0.06933331190077,0.0152465176459029,0.210090462781497
Physical measures,X4270.Volume level set by participant (left),QPCT,Glutaminyl-peptide cyclotransferase,16678,0.0578023021809228,0.0461412381983414,-0.0326345246878264,0.148239129049672,0.210323232332297
Physical measures,X4270.Volume level set by participant (left),INSL3,Insulin-like 3,14628,-0.0244165410053805,0.0195236416982262,-0.062682878733904,0.0138497967231429,0.2110953416618
Physical measures,X4270.Volume level set by participant (left),SLC34A3,Sodium-dependent phosphate transport protein 2C,14144,-0.0380040245863798,0.0304006184078958,-0.0975892366658556,0.021581187493096,0.211281186036168
Physical measures,X4270.Volume level set by participant (left),TSC22D1,TSC22 domain family protein 1,14629,-0.0275454256111562,0.0220453131641876,-0.0707542394129639,0.0156633881906515,0.211505470407795
Physical measures,X4270.Volume level set by participant (left),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14588,-0.0180017621096629,0.0144210436220204,-0.0462670076088229,0.0102634833894971,0.211941947947508
Physical measures,X4270.Volume level set by participant (left),CD300E,CMRF35-like molecule 2,16750,0.0393680985575161,0.0315461410593407,-0.0224623379187916,0.101198535033824,0.212065765058244
Physical measures,X4270.Volume level set by participant (left),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16533,0.0228301997598325,0.0182954347404755,-0.0130288523314995,0.0586892518511644,0.21209885017134
Physical measures,X4270.Volume level set by participant (left),GSTP1,Glutathione S-transferase P,16172,-0.0232169959042948,0.018622690736988,-0.0597174697487914,0.0132834779402017,0.212523873602425
Physical measures,X4270.Volume level set by participant (left),BCL7B,B-cell CLL/lymphoma 7 protein family member B,14572,-0.039578885967723,0.0317627002186811,-0.101833778396338,0.0226760064608919,0.212754845682112
Physical measures,X4270.Volume level set by participant (left),NTF4,Neurotrophin-4,16266,0.0401948991241502,0.0323608191499145,-0.0232323064096823,0.103622104657983,0.214223002629366
Physical measures,X4270.Volume level set by participant (left),FIS1,Mitochondrial fission 1 protein,16647,-0.0207646085952782,0.0167538349990664,-0.0536021251934482,0.0120729080028919,0.215216979628877
Physical measures,X4270.Volume level set by participant (left),ATP6AP2,Renin receptor,16266,-0.0383546322655715,0.0309475864992939,-0.0990119018041876,0.0223026372730446,0.215236908114862
Physical measures,X4270.Volume level set by participant (left),CD14,Monocyte differentiation antigen CD14,16280,0.0389446213555241,0.0314753954005537,-0.0227471536295612,0.100636396340609,0.215992240907581
Physical measures,X4270.Volume level set by participant (left),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16799,0.0351318787008685,0.028426712254657,-0.0205844773182591,0.0908482347199962,0.216522124340039
Physical measures,X4270.Volume level set by participant (left),NFAT5,Nuclear factor of activated T-cells 5,14207,-0.0207355564671133,0.0167838145762063,-0.0536318330364776,0.012160720102251,0.216683688178454
Physical measures,X4270.Volume level set by participant (left),PKD2,Polycystin-2,14175,-0.0310549740729435,0.0251882187147114,-0.0804238827537779,0.0183139346078909,0.217627336132711
Physical measures,X4270.Volume level set by participant (left),SERPINF2,Alpha-2-antiplasmin,14379,-0.131979490497859,0.107072787929156,-0.341842154839005,0.077883173843287,0.217739733118955
Physical measures,X4270.Volume level set by participant (left),NXPH1,Neurexophilin-1,16257,-0.0424277023869265,0.0344494003316402,-0.109948527036941,0.0250931222630883,0.218118316921343
Physical measures,X4270.Volume level set by participant (left),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14617,-0.023663672899483,0.0192368740224888,-0.0613679459835611,0.0140406001845951,0.218671808334274
Physical measures,X4270.Volume level set by participant (left),MINK1,Misshapen-like kinase 1,14628,-0.0200451433474917,0.0163118402974491,-0.052016350330492,0.0119260636355086,0.219140062739149
Physical measures,X4270.Volume level set by participant (left),ATG4A,Cysteine protease ATG4A,16266,-0.0268376209327153,0.0218512962773738,-0.069666161636368,0.0159909197709375,0.219392112533002
Physical measures,X4270.Volume level set by participant (left),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16356,0.0282703717668349,0.023025705594978,-0.016860011199322,0.0734007547329918,0.219549357205651
Physical measures,X4270.Volume level set by participant (left),PLXDC1,Plexin domain-containing protein 1,16266,-0.0463108172341189,0.0377338200194216,-0.120269104472185,0.0276474700039474,0.219726641152308
Physical measures,X4270.Volume level set by participant (left),SEC31A,Protein transport protein Sec31A,14288,-0.0246968917636217,0.0201322109723487,-0.0641560252694251,0.0147622417421818,0.219942373106192
Physical measures,X4270.Volume level set by participant (left),KLHL41,Kelch-like protein 41,14629,-0.0347207818657948,0.0283562002042716,-0.0902989342661673,0.0208573705345776,0.220801825095582
Physical measures,X4270.Volume level set by participant (left),APOD,Apolipoprotein D,14079,-0.0443969700497536,0.0362813583475989,-0.115508432411047,0.0267144923115403,0.221091416723157
Physical measures,X4270.Volume level set by participant (left),BRSK2,Serine/threonine-protein kinase BRSK2,14629,-0.0445977637739109,0.0364821756803393,-0.116102828107376,0.0269073005595541,0.221555891457155
Physical measures,X4270.Volume level set by participant (left),FLI1,Friend leukemia integration 1 transcription factor,16266,-0.0148018823212397,0.0121160762125052,-0.0385493916977499,0.00894562705527046,0.221849060533122
Physical measures,X4270.Volume level set by participant (left),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14629,-0.0167003230365662,0.0136787515910911,-0.0435106761551047,0.0101100300819724,0.222145377817658
Physical measures,X4270.Volume level set by participant (left),NGRN,Neugrin,14628,-0.0814619695571571,0.0668193453903338,-0.212427886522211,0.0495039474078972,0.22281169089024
Physical measures,X4270.Volume level set by participant (left),CIAPIN1,Anamorsin,16719,-0.0260578668908697,0.0214112454857259,-0.0680239080428924,0.015908174261153,0.223614639234135
Physical measures,X4270.Volume level set by participant (left),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16772,-0.021122904207888,0.0173656056927538,-0.0551594913656855,0.0129136829499094,0.223863281585292
Physical measures,X4270.Volume level set by participant (left),CD3D,T-cell surface glycoprotein CD3 delta chain,14168,-0.0539934522198658,0.0444001229301021,-0.141017693162866,0.0330307887231343,0.223980303058019
Physical measures,X4270.Volume level set by participant (left),IL6ST,Interleukin-6 receptor subunit beta,16666,-0.0878139308885019,0.072259442173243,-0.229442437548058,0.0538145757710543,0.224284591541044
Physical measures,X4270.Volume level set by participant (left),DTD1,D-aminoacyl-tRNA deacylase 1,14352,-0.0213309363641255,0.0175735039485098,-0.0557750041032048,0.0131131313749538,0.224839381610476
Physical measures,X4270.Volume level set by participant (left),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16675,0.0457272025720562,0.0376997241297216,-0.0281642567221981,0.11961866186631,0.225173011909658
Physical measures,X4270.Volume level set by participant (left),PLA2G4A,Cytosolic phospholipase A2,16733,-0.0180699402733121,0.0149020669603712,-0.0472779915156397,0.0111381109690155,0.225307783404873
Physical measures,X4270.Volume level set by participant (left),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14352,-0.0217654739771594,0.0179500562561328,-0.0569475842391798,0.0134166362848609,0.225319057900573
Physical measures,X4270.Volume level set by participant (left),INSR,Insulin receptor,14207,-0.108661634150471,0.0896766619779025,-0.28442789162716,0.0671046233262176,0.225645610274939
Physical measures,X4270.Volume level set by participant (left),CSDE1,Cold shock domain-containing protein E1,14175,-0.0150489554731771,0.0124299115813209,-0.0394115821725661,0.0093136712262119,0.226028715046882
Physical measures,X4270.Volume level set by participant (left),EPHA1,Ephrin type-A receptor 1,16712,0.046263924338358,0.0382654452478158,-0.028736348347361,0.121264197024077,0.226669917051471
Physical measures,X4270.Volume level set by participant (left),FCRL1,Fc receptor-like protein 1,16666,-0.0341897812638019,0.0282846984840744,-0.0896277902925878,0.0212482277649839,0.226767214516961
Physical measures,X4270.Volume level set by participant (left),ENTR1,Endosome-associated-trafficking regulator 1,14288,-0.0310914667161587,0.0257301553751479,-0.0815225712514486,0.0193396378191311,0.226926208422235
Physical measures,X4270.Volume level set by participant (left),ARFIP1,Arfaptin-1,14629,-0.0259862007654147,0.0215065233015947,-0.0681389864365403,0.016166584905711,0.226953790703478
Physical measures,X4270.Volume level set by participant (left),KIAA1549,UPF0606 protein KIAA1549,14404,-0.0262612247599511,0.0217427043699878,-0.0688769253251273,0.016354475805225,0.227137217877157
Physical measures,X4270.Volume level set by participant (left),PALLD,Palladin,14207,-0.0455868228026858,0.0377513286200743,-0.119579426898031,0.0284057812926597,0.227238428814103
Physical measures,X4270.Volume level set by participant (left),RPE,Ribulose-phosphate 3-epimerase,14404,-0.0257582001423498,0.0213472839049912,-0.0675988765961325,0.0160824763114328,0.227595826029814
Physical measures,X4270.Volume level set by participant (left),FGF6,Fibroblast growth factor 6,14207,0.043155199482035,0.0357696346254073,-0.0269532843837632,0.113263683347833,0.227654188030821
Physical measures,X4270.Volume level set by participant (left),SFTPD,Pulmonary surfactant-associated protein D,16666,-0.0228538350722961,0.0189461267244101,-0.05998824345214,0.0142805733075477,0.2277368324632
Physical measures,X4270.Volume level set by participant (left),LCP1,Plastin-2,14678,0.0368803833058806,0.0305764579700092,-0.0230494743153374,0.0968102409270986,0.227771702451654
Physical measures,X4270.Volume level set by participant (left),S100A3,Protein S100-A3,14572,-0.040822436441809,0.0338846339187515,-0.107236318922562,0.0255914460389439,0.228320285194854
Physical measures,X4270.Volume level set by participant (left),THPO,Thrombopoietin,16356,-0.0403234878109062,0.0334720355370983,-0.105928677463619,0.0252817018418064,0.228339739584622
Physical measures,X4270.Volume level set by participant (left),LTBP3,Latent-transforming growth factor beta-binding protein 3,16266,0.0285987561810263,0.023806597307395,-0.0180621745414679,0.0752596869035205,0.229654137959234
Physical measures,X4270.Volume level set by participant (left),SPTLC1,Serine palmitoyltransferase 1,14628,-0.0471946313811167,0.0393454438477524,-0.124311701322711,0.0299224385604779,0.230355292458268
Physical measures,X4270.Volume level set by participant (left),ACOT13,Acyl-coenzyme A thioesterase 13,14588,-0.0160293259323033,0.0133795793299677,-0.0422533014190399,0.0101946495544333,0.230919339913307
Physical measures,X4270.Volume level set by participant (left),NPC2,NPC intracellular cholesterol transporter 2,14398,0.0566374981525096,0.0473126403179428,-0.0360952768706583,0.149370273175678,0.231291130898903
Physical measures,X4270.Volume level set by participant (left),GFRA3,GDNF family receptor alpha-3,16494,-0.0548817082233859,0.0458760343896302,-0.144798735627061,0.0350353191802893,0.231594951547764
Physical measures,X4270.Volume level set by participant (left),AP3B1,AP-3 complex subunit beta-1,14588,-0.0235469789622283,0.0196844101805819,-0.0621284229161689,0.0150344649917123,0.231628323257403
Physical measures,X4270.Volume level set by participant (left),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16666,-0.0480712518770811,0.0402329920031177,-0.126927916203192,0.0307854124490295,0.232173720621753
Physical measures,X4270.Volume level set by participant (left),NRCAM,Neuronal cell adhesion molecule,16666,-0.053011720764671,0.044400272203342,-0.140036254283221,0.0340128127538794,0.232514399230394
Physical measures,X4270.Volume level set by participant (left),SERPINI2,Serpin I2,14588,0.0304459117052405,0.0255272806269112,-0.0195875583235054,0.0804793817339864,0.233013610908761
Physical measures,X4270.Volume level set by participant (left),PRND,Prion-like protein doppel,14628,-0.0340617120586783,0.0286151320054374,-0.0901473707893357,0.0220239466719791,0.233932456532023
Physical measures,X4270.Volume level set by participant (left),NAA80,N-alpha-acetyltransferase 80,14261,-0.0151603748276802,0.0127382328475335,-0.0401273112088458,0.00980656155348541,0.234008294437793
Physical measures,X4270.Volume level set by participant (left),CCN3,CCN family member 3,16832,-0.0445375189910497,0.0374781837336131,-0.117994759108931,0.028919721126832,0.234708974311974
Physical measures,X4270.Volume level set by participant (left),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14629,-0.0412881047246231,0.0347481122442292,-0.109394404723312,0.026818195274066,0.234769427018316
Physical measures,X4270.Volume level set by participant (left),TPT1,Translationally-controlled tumor protein,16350,-0.0237017160984539,0.0199571871840274,-0.0628178029791476,0.0154143707822399,0.234997236634468
Physical measures,X4270.Volume level set by participant (left),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14629,-0.0540877882113099,0.0456136570979821,-0.143490556123355,0.0353149797007351,0.235728249415335
Physical measures,X4270.Volume level set by participant (left),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16666,-0.0185344646403812,0.0156400713723009,-0.0491890045300909,0.0121200752493284,0.236009586778028
Physical measures,X4270.Volume level set by participant (left),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14652,0.0236971179544928,0.0200090962565329,-0.0155207107083117,0.0629149466172972,0.236306734403537
Physical measures,X4270.Volume level set by participant (left),PRAP1,Proline-rich acidic protein 1,14678,0.042503200977599,0.0359159738644377,-0.027892107796699,0.112898509751897,0.236667225851034
Physical measures,X4270.Volume level set by participant (left),TXLNA,Alpha-taxilin,16533,-0.0181351602597685,0.0153310385292517,-0.0481839957771018,0.0119136752575648,0.236863875677556
Physical measures,X4270.Volume level set by participant (left),PDCD5,Programmed cell death protein 5,16799,-0.0263118962102245,0.022251732663011,-0.069925292229726,0.017301499809277,0.237037977523361
Physical measures,X4270.Volume level set by participant (left),B4GAT1,"Beta-1,4-glucuronyltransferase 1",16671,-0.0613796678572697,0.0519217353180399,-0.163146269080628,0.0403869333660886,0.237160098096408
Physical measures,X4270.Volume level set by participant (left),CTHRC1,Collagen triple helix repeat-containing protein 1,14678,-0.0614026568713148,0.0519547246835875,-0.163233917251146,0.0404286035085166,0.23728465650599
Physical measures,X4270.Volume level set by participant (left),NSFL1C,NSFL1 cofactor p47,16799,-0.0237742057724881,0.0201263265618645,-0.0632218058337425,0.0156733942887663,0.237520508150191
Physical measures,X4270.Volume level set by participant (left),EVPL,Envoplakin,14404,-0.0513801220148855,0.0435041154153306,-0.136648188228933,0.0338879441991624,0.237606160131464
Physical measures,X4270.Volume level set by participant (left),TRIM21,E3 ubiquitin-protein ligase TRIM21,16637,-0.0197087382503313,0.0166907626103063,-0.0524226329665317,0.0130051564658691,0.237692279112494
Physical measures,X4270.Volume level set by participant (left),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16356,-0.0707562322521907,0.0599819083222534,-0.188320772563807,0.046808308059426,0.238166081871795
Physical measures,X4270.Volume level set by participant (left),TP53INP1,Tumor protein p53-inducible nuclear protein 1,16356,-0.0462841953210258,0.0392653182826932,-0.123244219155104,0.0306758285130528,0.238512861811218
Physical measures,X4270.Volume level set by participant (left),CRKL,Crk-like protein,16689,-0.0150187529542881,0.0127611051595728,-0.0400305190670508,0.00999301315847452,0.239245708728876
Physical measures,X4270.Volume level set by participant (left),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,14144,-0.0413750192716172,0.0351683377107828,-0.110304961184751,0.0275549226415171,0.239420975062475
Physical measures,X4270.Volume level set by participant (left),CHMP6,Charged multivesicular body protein 6,14652,-0.0311356061489481,0.0264656281408127,-0.083008237304941,0.0207370250070448,0.239432456883563
Physical measures,X4270.Volume level set by participant (left),SYAP1,Synapse-associated protein 1,14352,-0.0308838556323267,0.026260211152687,-0.0823538694915933,0.0205861582269399,0.239586296821171
Physical measures,X4270.Volume level set by participant (left),RBP5,Retinol-binding protein 5,16576,0.0273733106708098,0.0232769970213056,-0.0182496034909493,0.0729962248325688,0.239619298862481
Physical measures,X4270.Volume level set by participant (left),IL36A,Interleukin-36 alpha,14207,-0.0304665433653036,0.0259128299608457,-0.0812556900885612,0.020322603357954,0.239721713063659
Physical measures,X4270.Volume level set by participant (left),ERBB4,Receptor tyrosine-protein kinase erbB-4,16719,-0.0615699982693015,0.0523732244146661,-0.164221518122047,0.041081521583444,0.239771240867568
Physical measures,X4270.Volume level set by participant (left),TGFB1,Transforming growth factor beta-1 proprotein,16811,-0.0380860488589798,0.0324306372596853,-0.101650097887963,0.0254780001700034,0.240257565583212
Physical measures,X4270.Volume level set by participant (left),ARF6,ADP-ribosylation factor 6,14588,-0.0168673102522468,0.0143658756674826,-0.0450244265605128,0.0112898060560191,0.240364806081729
Physical measures,X4270.Volume level set by participant (left),IL1RAP,Interleukin-1 receptor accessory protein,16671,-0.0342364038645512,0.029185742949377,-0.0914404600453302,0.0229676523162278,0.240791597200171
Physical measures,X4270.Volume level set by participant (left),CNTN2,Contactin-2,16810,-0.0326072789616249,0.027801256031525,-0.0870977407834138,0.0218831828601641,0.240864292416651
Physical measures,X4270.Volume level set by participant (left),OTUD7B,OTU domain-containing protein 7B,14629,-0.0272840914084043,0.0232744522758799,-0.0729020178691289,0.0183338350523203,0.241105210552252
Physical measures,X4270.Volume level set by participant (left),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16266,-0.0257090544275279,0.0219310147571692,-0.0686938433515795,0.0172757344965236,0.24110615587389
Physical measures,X4270.Volume level set by participant (left),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14572,-0.0508922513627588,0.0434364272975598,-0.136027648865976,0.0342431461404583,0.24135714138498
Physical measures,X4270.Volume level set by participant (left),NARS1,"Asparagine--tRNA ligase, cytoplasmic",14629,-0.038965704167568,0.0332592946129193,-0.10415392160889,0.0262225132737538,0.24138748423107
Physical measures,X4270.Volume level set by participant (left),PPM1F,Protein phosphatase 1F,14652,-0.0334057059781321,0.0285212894515283,-0.0893074333031275,0.0224960213468633,0.241515318768345
Physical measures,X4270.Volume level set by participant (left),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14207,-0.0522840213384075,0.0446503369257267,-0.139798681712832,0.0352306390360169,0.24163215281484
Physical measures,X4270.Volume level set by participant (left),PRKD2,Serine/threonine-protein kinase D2,14175,-0.0377963237707163,0.0323602532284449,-0.101222420098468,0.0256297725570357,0.242832067078645
Physical measures,X4270.Volume level set by participant (left),CXCL16,C-X-C motif chemokine 16,16823,0.0636533787493835,0.0545227063841352,-0.0432111257635216,0.170517883262289,0.243038995623402
Physical measures,X4270.Volume level set by participant (left),RNF41,E3 ubiquitin-protein ligase NRDP1,16266,-0.0233996942927249,0.0200683241853681,-0.0627336096960463,0.0159342211105965,0.24363098947942
Physical measures,X4270.Volume level set by participant (left),EDF1,Endothelial differentiation-related factor 1,14629,-0.0253982594899865,0.0217903396504825,-0.0681073252049322,0.0173108062249592,0.243805636727532
Physical measures,X4270.Volume level set by participant (left),ASPSCR1,Tether containing UBX domain for GLUT4,14629,-0.0262144412896281,0.0224910073402191,-0.0702968156764575,0.0178679330972013,0.24381460124983
Physical measures,X4270.Volume level set by participant (left),CD2,T-cell surface antigen CD2,14175,0.0448060779135606,0.0384697611567011,-0.0305946539535736,0.120206809780695,0.24415641982249
Physical measures,X4270.Volume level set by participant (left),FCAR,Immunoglobulin alpha Fc receptor,16637,0.0309817790953248,0.0266180854636508,-0.0211896684134308,0.0831532266040804,0.244466182854493
Physical measures,X4270.Volume level set by participant (left),C1QA,Complement C1q subcomponent subunit A,16785,-0.0644111922578875,0.0553707414511641,-0.172937845502169,0.0441154609863943,0.244736015221464
Physical measures,X4270.Volume level set by participant (left),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14678,0.0432563635458195,0.0372011049832895,-0.0296578022214278,0.116170529313067,0.244941379279866
Physical measures,X4270.Volume level set by participant (left),FGFBP2,Fibroblast growth factor-binding protein 2,14678,-0.0337621293216725,0.0290437914252907,-0.0906879605152423,0.0231637018718973,0.245069213230797
Physical measures,X4270.Volume level set by participant (left),FSTL1,Follistatin-related protein 1,14288,-0.0760012356743788,0.0653860916481466,-0.204157975304746,0.0521555039559885,0.245114549889708
Physical measures,X4270.Volume level set by participant (left),MPI,Mannose-6-phosphate isomerase,16576,-0.0178594251484242,0.0153784738942248,-0.0480012339811047,0.0122823836842563,0.245525995414686
Physical measures,X4270.Volume level set by participant (left),ITGB5,Integrin beta-5,16719,0.0388081410418442,0.0334535704695177,-0.0267608570784105,0.104377139162099,0.246041056895399
Physical measures,X4270.Volume level set by participant (left),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",14207,-0.0366695041634605,0.0316491396941579,-0.09870181796401,0.025362809637089,0.24662831850948
Physical measures,X4270.Volume level set by participant (left),BRD1,Bromodomain-containing protein 1,14404,-0.0555897237449885,0.0479903402430754,-0.149650790621416,0.0384713431314393,0.246739500703951
Physical measures,X4270.Volume level set by participant (left),CD200,OX-2 membrane glycoprotein,16637,-0.0555513072814267,0.047993621202472,-0.149618804838272,0.0385161902754184,0.247095912613437
Physical measures,X4270.Volume level set by participant (left),PCYT2,Ethanolamine-phosphate cytidylyltransferase,14588,-0.0233871675507128,0.0202106291351164,-0.063000000655541,0.0162256655541154,0.247221197307105
Physical measures,X4270.Volume level set by participant (left),SCN4B,Sodium channel subunit beta-4,14288,-0.0405118711244689,0.035035871211388,-0.109182178698789,0.0281584364498517,0.247579070433503
Physical measures,X4270.Volume level set by participant (left),MYOM3,Myomesin-3,14352,-0.0182584187165806,0.0157984892721617,-0.0492234576900176,0.0127066202568564,0.24782043920011
Physical measures,X4270.Volume level set by participant (left),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14628,-0.0681646251998861,0.0589952445552424,-0.183795304528161,0.047466054128389,0.247935012847013
Physical measures,X4270.Volume level set by participant (left),IGFBP2,Insulin-like growth factor-binding protein 2,16839,-0.0235304706574157,0.0203713794025163,-0.0634583742863478,0.0163974329715163,0.248076129889681
Physical measures,X4270.Volume level set by participant (left),LAP3,Cytosol aminopeptidase,16350,0.0304816216288502,0.0264086126705004,-0.0212792592053307,0.0822425024630311,0.248422640468503
Physical measures,X4270.Volume level set by participant (left),CD28,T-cell-specific surface glycoprotein CD28,16266,0.0422059421026854,0.0365719454759398,-0.0294750710301566,0.113886955235527,0.248495652611424
Physical measures,X4270.Volume level set by participant (left),BGLAP,Osteocalcin,14678,0.0185707968898729,0.0161003620925395,-0.0129859128115045,0.0501275065912504,0.248748756272324
Physical measures,X4270.Volume level set by participant (left),TCOF1,Treacle protein,14652,-0.0553523872852882,0.0479950291491389,-0.1494226444176,0.038717869847024,0.248808497498633
Physical measures,X4270.Volume level set by participant (left),SERPIND1,Heparin cofactor 2,14672,0.0594581073013085,0.0515678805175865,-0.041614938513161,0.160531153115778,0.24892647536855
Physical measures,X4270.Volume level set by participant (left),VASP,Vasodilator-stimulated phosphoprotein,14672,-0.0237973214600598,0.0206405984840473,-0.0642528944887925,0.016658251568673,0.248954814572721
Physical measures,X4270.Volume level set by participant (left),CDKN1A,Cyclin-dependent kinase inhibitor 1,16576,-0.0142197693362568,0.0123396828875361,-0.0384055477958275,0.00996600912331401,0.249189394953435
Physical measures,X4270.Volume level set by participant (left),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16799,0.0533663016451671,0.0463264388055435,-0.0374335184136982,0.144166121704032,0.249353058534476
Physical measures,X4270.Volume level set by participant (left),CCL7,C-C motif chemokine 7,16637,0.0247948972512179,0.0215322934279206,-0.0174083978675064,0.0669981923699422,0.249534350267496
Physical measures,X4270.Volume level set by participant (left),EFCAB2,Dynein regulatory complex protein 8,14404,-0.0496226030293071,0.0430958263714331,-0.134090422717316,0.0348452166587017,0.249567111634918
Physical measures,X4270.Volume level set by participant (left),SSNA1,Sjoegren syndrome nuclear autoantigen 1,14588,-0.0337007436925034,0.0292745569037541,-0.0910788752238614,0.0236773878388546,0.249670628323241
Physical measures,X4270.Volume level set by participant (left),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,14168,-0.0295406742092929,0.0256613766743464,-0.0798369724910117,0.020755624072426,0.249680677173051
Physical measures,X4270.Volume level set by participant (left),AOC3,Membrane primary amine oxidase,16715,-0.0480101789291603,0.0417142232915999,-0.129770056580696,0.0337496987223754,0.24977723983249
Physical measures,X4270.Volume level set by participant (left),GPR15L,Protein GPR15L,14588,0.0274206225515794,0.0238294971060826,-0.0192851917763424,0.0741264368795012,0.249874210302707
Physical measures,X4270.Volume level set by participant (left),TPD52L2,Tumor protein D54,14352,-0.0164934792651939,0.0143384453503281,-0.044596832151837,0.0116098736214492,0.250040507797213
Physical measures,X4270.Volume level set by participant (left),ALPI,Intestinal-type alkaline phosphatase,14207,-0.0140893380957096,0.0122520834206783,-0.038103421600239,0.00992474540881985,0.250182004257057
Physical measures,X4270.Volume level set by participant (left),LGALS7_LGALS7B,Galectin-7,16667,0.0357767547060355,0.0311481077398893,-0.0252735364641476,0.0968270458762186,0.250736952447425
Physical measures,X4270.Volume level set by participant (left),MTSS2,Protein MTSS 2,14572,-0.0176113923522321,0.0153362140590235,-0.0476703719079182,0.012447587203454,0.250841607651421
Physical measures,X4270.Volume level set by participant (left),NAGA,Alpha-N-acetylgalactosaminidase,14184,-0.029056011609928,0.0253159432672216,-0.0786752604136824,0.0205632371938263,0.25109707366381
Physical measures,X4270.Volume level set by participant (left),NMRK2,Nicotinamide riboside kinase 2,14144,-0.0425374125635267,0.0370703826615047,-0.115195362580076,0.0301205374530226,0.251203953567444
Physical measures,X4270.Volume level set by participant (left),NEXN,Nexilin,14672,-0.0236587567419601,0.0206358987305969,-0.0641051182539301,0.0167876047700099,0.251613080828891
Physical measures,X4270.Volume level set by participant (left),SNCG,Gamma-synuclein,16533,0.0222844682633349,0.0194406356526017,-0.0158191776157644,0.0603881141424342,0.251694722018684
Physical measures,X4270.Volume level set by participant (left),CRLF1,Cytokine receptor-like factor 1,16733,0.0560302179504131,0.0488835822316493,-0.0397816032236196,0.151842039124446,0.251730033884633
Physical measures,X4270.Volume level set by participant (left),PPM1B,Protein phosphatase 1B,14207,-0.0271916663746256,0.023752436889298,-0.0737464426776498,0.0193631099283986,0.252313476099512
Physical measures,X4270.Volume level set by participant (left),PDIA4,Protein disulfide-isomerase A4,14678,-0.0276736725424427,0.0241839656397324,-0.0750742451963183,0.0197269001114328,0.252518599265826
Physical measures,X4270.Volume level set by participant (left),SSB,Lupus La protein,16257,-0.0247611476414853,0.0216388256727792,-0.0671732459601326,0.017650950677162,0.252519184917423
Physical measures,X4270.Volume level set by participant (left),ASS1,Argininosuccinate synthase,14175,0.0218676872785608,0.0191144738576439,-0.0155966814824213,0.0593320560395429,0.252627158249372
Physical measures,X4270.Volume level set by participant (left),SLC39A5,Zinc transporter ZIP5,16637,-0.0267466113471867,0.0233873442150002,-0.0725858060085871,0.0190925833142138,0.252791051722703
Physical measures,X4270.Volume level set by participant (left),LECT2,Leukocyte cell-derived chemotaxin-2,14652,-0.0244913777256547,0.0214208693960054,-0.0664762817418254,0.0174935262905159,0.252915362668425
Physical measures,X4270.Volume level set by participant (left),STXBP1,Syntaxin-binding protein 1,14629,-0.0223080946255688,0.0195153818217438,-0.0605582429961867,0.0159420537450491,0.253014490596432
Physical measures,X4270.Volume level set by participant (left),CFP,Properdin,14697,-0.0748013226099422,0.0654924761801443,-0.203166575923025,0.0535639307031406,0.253416072064169
Physical measures,X4270.Volume level set by participant (left),EPO,Erythropoietin,16637,0.019058692672079,0.0166871696727642,-0.0136481598865388,0.0517655452306968,0.253422030301815
Physical measures,X4270.Volume level set by participant (left),BLNK,B-cell linker protein,14207,-0.0442730937893576,0.0388086334811323,-0.120338015412377,0.0317918278336617,0.253970217934089
Physical measures,X4270.Volume level set by participant (left),PPL,Periplakin,14207,-0.0527734594510741,0.0463504035467589,-0.143620250402721,0.0380733315005732,0.254899243509988
Physical measures,X4270.Volume level set by participant (left),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",14168,-0.0370672198929965,0.0326062564810745,-0.100975482595903,0.0268410428099096,0.255635670636417
Physical measures,X4270.Volume level set by participant (left),ITGB1,Integrin beta-1,16639,-0.0662144807729686,0.0582606954693445,-0.180405443892884,0.0479764823469467,0.255755132294301
Physical measures,X4270.Volume level set by participant (left),LACRT,Extracellular glycoprotein lacritin,14541,-0.0346502355002929,0.0305020537156982,-0.0944342607830614,0.0251337897824756,0.255976646499811
Physical measures,X4270.Volume level set by participant (left),OCLN,Occludin,14629,0.0380664822139916,0.0336444957324963,-0.0278767294217011,0.104009693849684,0.257891588506279
Physical measures,X4270.Volume level set by participant (left),FCRL3,Fc receptor-like protein 3,16350,-0.0267638506823899,0.0236745522480728,-0.0731659730886126,0.0196382717238328,0.258286301278758
Physical measures,X4270.Volume level set by participant (left),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14572,-0.0201355506856104,0.0178133208979777,-0.0550496596456466,0.0147785582744258,0.258341171635568
Physical measures,X4270.Volume level set by participant (left),ROBO1,Roundabout homolog 1,16675,-0.0600142832562889,0.0531141448992956,-0.164118007258908,0.0440894407463305,0.258529786011028
Physical measures,X4270.Volume level set by participant (left),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16637,-0.0123273498836186,0.010913071587477,-0.0337169701950736,0.00906227042783643,0.258663268437901
Physical measures,X4270.Volume level set by participant (left),STAT5B,Signal transducer and activator of transcription 5B,16576,-0.0110672907733408,0.00982084673009301,-0.0303161503643231,0.00818156881764155,0.259793403750167
Physical measures,X4270.Volume level set by participant (left),TNFSF14,Tumor necrosis factor ligand superfamily member 14,16533,-0.0251450859059618,0.0223144637707823,-0.0688814348966952,0.0185912630847716,0.259821663769329
Physical measures,X4270.Volume level set by participant (left),CANT1,Soluble calcium-activated nucleotidase 1,16614,-0.0715780174109618,0.0635291809917615,-0.196095212154814,0.0529391773328907,0.259887701380653
Physical measures,X4270.Volume level set by participant (left),DIABLO,"Diablo homolog, mitochondrial",16600,-0.0134520848624294,0.0119537379286046,-0.0368814112024944,0.00997724147763554,0.260458954284917
Physical measures,X4270.Volume level set by participant (left),MSLN,Mesothelin,16551,0.0257330382924994,0.0228673523831917,-0.0190869723785563,0.0705530489635552,0.260470731423836
Physical measures,X4270.Volume level set by participant (left),DBNL,Drebrin-like protein,16733,-0.0161094968017427,0.0143217461674935,-0.0441801192900299,0.0119611256865445,0.260678204973642
Physical measures,X4270.Volume level set by participant (left),MORC3,MORC family CW-type zinc finger protein 3,14628,-0.0600133001689795,0.0533544860493047,-0.164588092825617,0.0445614924876576,0.260690887550379
Physical measures,X4270.Volume level set by participant (left),PTS,6-pyruvoyl tetrahydrobiopterin synthase,16203,0.0266243010259309,0.0236728942970751,-0.0197745717963362,0.0730231738481981,0.260743660674788
Physical measures,X4270.Volume level set by participant (left),CKB,Creatine kinase B-type,14678,-0.0281071203638714,0.0249997307214728,-0.0771065925779582,0.0208923518502154,0.260905489987747
Physical measures,X4270.Volume level set by participant (left),MICALL2,MICAL-like protein 2,14261,-0.0223471275571713,0.0198850892636941,-0.0613219025140117,0.0166276473996691,0.261111182150928
Physical measures,X4270.Volume level set by participant (left),LUZP2,Leucine zipper protein 2,14572,-0.0366074420134447,0.0326689787518131,-0.100638640366998,0.027423756340109,0.26249510663047
Physical measures,X4270.Volume level set by participant (left),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16266,-0.022602136041143,0.0201826748474859,-0.0621601787422154,0.0169559066599294,0.262782254316299
Physical measures,X4270.Volume level set by participant (left),QSOX1,Sulfhydryl oxidase 1,14369,-0.0397714671445449,0.0355267749557922,-0.109403946057898,0.0298610117688077,0.262954715855123
Physical measures,X4270.Volume level set by participant (left),AFP,Alpha-fetoprotein,16481,-0.0211260971441415,0.0188754453441387,-0.0581219700186534,0.0158697757303704,0.263055365605049
Physical measures,X4270.Volume level set by participant (left),BTNL10,Butyrophilin-like protein 10,14144,0.041104937463492,0.0367534289875049,-0.0309317833520176,0.113141658279002,0.263416344236985
Physical measures,X4270.Volume level set by participant (left),MAMDC2,MAM domain-containing protein 2,14652,-0.0466853378822031,0.0417805404154125,-0.128575197096412,0.0352045213320055,0.26384411240895
Physical measures,X4270.Volume level set by participant (left),NPTN,Neuroplastin,16266,-0.017621573001172,0.0157907384640191,-0.0485714203906494,0.0133282743883055,0.264462794038174
Physical measures,X4270.Volume level set by participant (left),CA3,Carbonic anhydrase 3,16866,-0.0222505533340786,0.019957708671631,-0.0613676623304753,0.0168665556623182,0.264915536235189
Physical measures,X4270.Volume level set by participant (left),METAP2,Methionine aminopeptidase 2,16794,-0.0264625087453525,0.0237603214728046,-0.0730327388320495,0.0201077213413445,0.265412328857098
Physical measures,X4270.Volume level set by participant (left),CNTNAP4,Contactin-associated protein-like 4,14261,-0.0157775608941925,0.0141667065827846,-0.0435443057964504,0.0119891840080654,0.265423679609823
Physical measures,X4270.Volume level set by participant (left),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16576,-0.0313840901187918,0.0281828130514592,-0.0866224036996518,0.0238542234620682,0.265471414359339
Physical measures,X4270.Volume level set by participant (left),HMOX1,Heme oxygenase 1,16460,-0.0294853735362313,0.026496136809113,-0.0814178016820928,0.0224470546096302,0.265802943207009
Physical measures,X4270.Volume level set by participant (left),LSP1,Lymphocyte-specific protein 1,16637,-0.0353609219386138,0.0317779075429811,-0.0976456207228567,0.0269237768456291,0.265831161137502
Physical measures,X4270.Volume level set by participant (left),F13B,Coagulation factor XIII B chain,14620,0.0662900942029302,0.0595739884794134,-0.0504749232167201,0.18305511162258,0.265840344044512
Physical measures,X4270.Volume level set by participant (left),CERT,Ceramide transfer protein,16257,-0.024497972595259,0.022017176139722,-0.0676516378291141,0.0186556926385962,0.265864288782127
Physical measures,X4270.Volume level set by participant (left),CX3CL1,Fractalkine,16533,0.042072250220718,0.03783612426568,-0.0320865533400148,0.116231053781451,0.266171608633607
Physical measures,X4270.Volume level set by participant (left),NPPC,C-type natriuretic peptide,16637,0.0299661825753646,0.0269504759359898,-0.0228567502591754,0.0827891154099045,0.266198055698802
Physical measures,X4270.Volume level set by participant (left),ACTN4,Alpha-actinin-4,16350,0.0437066812315636,0.0393115269791798,-0.0333439116476287,0.120757274110756,0.266239143343818
Physical measures,X4270.Volume level set by participant (left),DBI,Acyl-CoA-binding protein,16588,-0.018548637590568,0.0166907438622091,-0.0512624955604978,0.0141652203793618,0.266449847634319
Physical measures,X4270.Volume level set by participant (left),CSNK1D,Casein kinase I isoform delta,14207,-0.0261647421065629,0.0235704022736557,-0.072362730562928,0.0200332463498022,0.266988667565268
Physical measures,X4270.Volume level set by participant (left),AAMDC,Mth938 domain-containing protein,14288,-0.0316715113427781,0.0285517164812258,-0.0876328756459807,0.0242898529604245,0.267333188257272
Physical measures,X4270.Volume level set by participant (left),GZMH,Granzyme H,16356,-0.0182991353947271,0.0165276725724653,-0.0506933736367591,0.0140951028473048,0.268231709287823
Physical measures,X4270.Volume level set by participant (left),CSF3,Granulocyte colony-stimulating factor,16350,0.0292128604471856,0.0264289265434977,-0.0225878355780699,0.081013556472441,0.26903003549584
Physical measures,X4270.Volume level set by participant (left),MMP9,Matrix metalloproteinase-9,16639,0.0233024156103648,0.0210874085774028,-0.0180289052013448,0.0646337364220743,0.269158547020812
Physical measures,X4270.Volume level set by participant (left),SNX2,Sorting nexin-2,14572,-0.0196828277153105,0.017833323374395,-0.0546361415291248,0.0152704860985037,0.26973695076661
Physical measures,X4270.Volume level set by participant (left),RGS8,Regulator of G-protein signaling 8,16350,0.0223661124203567,0.0202845810244173,-0.0173916663875012,0.0621238912282146,0.270210016196927
Physical measures,X4270.Volume level set by participant (left),BAG4,BAG family molecular chaperone regulator 4,14207,-0.0336749769080446,0.0306270307048103,-0.0937039570894729,0.0263540032733836,0.271560764149699
Physical measures,X4270.Volume level set by participant (left),ZNF75D,Zinc finger protein 75D,14404,-0.0260325122824345,0.0237175386606624,-0.0725188880573329,0.0204538634924639,0.272394949758858
Physical measures,X4270.Volume level set by participant (left),LTO1,Protein LTO1 homolog,16350,-0.0336990795741334,0.0307476594040283,-0.0939644920060289,0.0265663328577622,0.273099988785078
Physical measures,X4270.Volume level set by participant (left),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14629,-0.0214065052469154,0.0195539297254011,-0.0597322075087015,0.0169191970148708,0.27364779220041
Physical measures,X4270.Volume level set by participant (left),COL18A1,Collagen alpha-1(XVIII) chain,16736,0.0599086685918739,0.0547432927829476,-0.0473881852627035,0.167205522446451,0.273814497752533
Physical measures,X4270.Volume level set by participant (left),PEBP1,Phosphatidylethanolamine-binding protein 1,16671,-0.024725569819396,0.022607980392063,-0.0690372113878394,0.0195860717490475,0.27411749713888
Physical measures,X4270.Volume level set by participant (left),HAO1,Hydroxyacid oxidase 1,16810,0.0108895605009241,0.00995803299323299,-0.00862818416581256,0.0304073051676608,0.274170122488033
Physical measures,X4270.Volume level set by participant (left),ANGPTL3,Angiopoietin-related protein 3,16643,-0.0389428262556214,0.0356126010849135,-0.108743524382052,0.0308578718708092,0.274184664459334
Physical measures,X4270.Volume level set by participant (left),PON2,Serum paraoxonase/arylesterase 2,16356,0.0403685374828147,0.0369283352593425,-0.0320109996254965,0.112748074591126,0.274340165899931
Physical measures,X4270.Volume level set by participant (left),SCG3,Secretogranin-3,16675,-0.041324001909424,0.0378034049862755,-0.115418675682524,0.0327706718636761,0.27435293039949
Physical measures,X4270.Volume level set by participant (left),DDX25,ATP-dependent RNA helicase DDX25,14261,-0.0416454310858364,0.0381139841771751,-0.1163488400731,0.0330579779014269,0.274563833417788
Physical measures,X4270.Volume level set by participant (left),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14628,-0.0170977206757428,0.0156523881073351,-0.0477764013661195,0.0135809600146339,0.274701946654207
Physical measures,X4270.Volume level set by participant (left),MYBPC2,"Myosin-binding protein C, fast-type",14288,-0.0192052915332196,0.0175984007438835,-0.0536981569912312,0.015287573924792,0.275155402581635
Physical measures,X4270.Volume level set by participant (left),SPART,Spartin,14352,-0.0217058025383478,0.0198982833414892,-0.0607064378876666,0.017294832810971,0.275362530669873
Physical measures,X4270.Volume level set by participant (left),PLIN3,Perilipin-3,16666,-0.0327934690025828,0.0300910330928963,-0.0917718938646597,0.026184955859494,0.275813203490685
Physical measures,X4270.Volume level set by participant (left),PLSCR3,Phospholipid scramblase 3,14591,-0.0268169733687668,0.0246072782220271,-0.0750472386839399,0.0214132919464063,0.275819960861761
Physical measures,X4270.Volume level set by participant (left),CFHR2,Complement factor H-related protein 2,14601,0.0285129852532837,0.0261673459112755,-0.0227750127328163,0.0798009832393838,0.275889785705502
Physical measures,X4270.Volume level set by participant (left),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16811,0.0367266125311907,0.0337211226466271,-0.0293667878561984,0.10282001291858,0.276113154946504
Physical measures,X4270.Volume level set by participant (left),MGMT,Methylated-DNA--protein-cysteine methyltransferase,16637,-0.0118358124713456,0.0108888388772427,-0.0331779366707414,0.00950631172805019,0.277066997561607
Physical measures,X4270.Volume level set by participant (left),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",14207,0.0264550573815635,0.0243384389026882,-0.0212482828677054,0.0741583976308324,0.277070266268709
Physical measures,X4270.Volume level set by participant (left),ITGAX,Integrin alpha-X,14404,0.0300030181292105,0.0276087801410653,-0.0241101909472776,0.0841162272056986,0.277178705580406
Physical measures,X4270.Volume level set by participant (left),STK11,Serine/threonine-protein kinase STK11,16356,-0.0202102451686581,0.0186044140015401,-0.0566748966116767,0.0162544062743605,0.277355888735797
Physical measures,X4270.Volume level set by participant (left),SERPINB6,Serpin B6,16733,-0.0235482789964711,0.0216813810557837,-0.0660437858658072,0.018947227872865,0.277447740712513
Physical measures,X4270.Volume level set by participant (left),HPGDS,Hematopoietic prostaglandin D synthase,16266,0.0374067513304411,0.0344486777842925,-0.0301126571267721,0.104926159787654,0.277553062095908
Physical measures,X4270.Volume level set by participant (left),ATOX1,Copper transport protein ATOX1,16719,-0.0199925789416643,0.0184132822933984,-0.0560826122367251,0.0160974543533965,0.277596686895155
Physical measures,X4270.Volume level set by participant (left),PCSK7,Proprotein convertase subtilisin/kexin type 7,14572,-0.0354471060274814,0.0326641048941336,-0.0994687516199832,0.0285745395650203,0.277850794854118
Physical measures,X4270.Volume level set by participant (left),FXN,"Frataxin, mitochondrial",16810,-0.0196551805277754,0.0181206841734094,-0.0551717215076579,0.0158613604521071,0.278078080245224
Physical measures,X4270.Volume level set by participant (left),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14629,-0.0191118652744883,0.0176331150718566,-0.0536727708153272,0.0154490402663506,0.278443825930713
Physical measures,X4270.Volume level set by participant (left),LCAT,Phosphatidylcholine-sterol acyltransferase,14672,-0.0705940615130504,0.0651570050327978,-0.198301791377334,0.0571136683512333,0.278628570120539
Physical measures,X4270.Volume level set by participant (left),IL33,Interleukin-33,16350,-0.0355342714546081,0.0328036932057149,-0.0998295101378093,0.0287609672285931,0.278717916091023
Physical measures,X4270.Volume level set by participant (left),PDGFA,Platelet-derived growth factor subunit A,16871,-0.0188122001631173,0.0173991220019184,-0.0529144792868775,0.0152900789606428,0.279616740919932
Physical measures,X4270.Volume level set by participant (left),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14652,-0.0479360601616338,0.0443827421643194,-0.1349262348037,0.0390541144804322,0.280132903373834
Physical measures,X4270.Volume level set by participant (left),KYAT1,Kynurenine--oxoglutarate transaminase 1,16618,-0.0247732836291752,0.0229490687650516,-0.0697534584086764,0.020206891150326,0.280385160836583
Physical measures,X4270.Volume level set by participant (left),CLEC14A,C-type lectin domain family 14 member A,16671,0.043836387467427,0.0406602662654736,-0.0358577344129012,0.123530509347755,0.280998662507872
Physical measures,X4270.Volume level set by participant (left),IL22,Interleukin-22,14572,0.0238806999483806,0.0221858008033478,-0.019603469626181,0.0673648695229423,0.281768178397898
Physical measures,X4270.Volume level set by participant (left),MSTN,Growth/differentiation factor 8,16356,-0.0263819506961702,0.0245398839511322,-0.0744801232403893,0.0217162218480489,0.282361861340325
Physical measures,X4270.Volume level set by participant (left),APOB,Apolipoprotein B-100,14672,-0.0686930215099589,0.063940120090462,-0.194015656887264,0.0566296138673466,0.28269086414892
Physical measures,X4270.Volume level set by participant (left),SLK,STE20-like serine/threonine-protein kinase,14404,0.0201258760967474,0.0187497180655883,-0.0166235713118057,0.0568753235053004,0.283111392514254
Physical measures,X4270.Volume level set by participant (left),TOR1AIP1,Torsin-1A-interacting protein 1,14288,-0.0309316495978885,0.0288174644493087,-0.0874138799185335,0.0255505807227565,0.283125657233323
Physical measures,X4270.Volume level set by participant (left),PCNA,Proliferating cell nuclear antigen,14144,-0.0245870027333578,0.0229085727534087,-0.069487805330039,0.0203137998633233,0.283169912593216
Physical measures,X4270.Volume level set by participant (left),MESD,LRP chaperone MESD,16671,-0.01153804304485,0.0107551476849326,-0.0326181325073179,0.00954204641761794,0.28337971801756
Physical measures,X4270.Volume level set by participant (left),ADIPOQ,Adiponectin,14697,-0.022608340765385,0.0210876568825659,-0.0639401482552141,0.0187234667244442,0.283687124648602
Physical measures,X4270.Volume level set by participant (left),KIAA1549L,UPF0606 protein KIAA1549L,14404,-0.0567749154330803,0.0529659950209819,-0.160588265674205,0.0470384348080443,0.283777287497603
Physical measures,X4270.Volume level set by participant (left),NUMB,Protein numb homolog,14207,-0.020138667114172,0.0188105797491116,-0.0570074034224308,0.0167300691940869,0.284366087610857
Physical measures,X4270.Volume level set by participant (left),FES,Tyrosine-protein kinase Fes/Fps,16266,0.0297714040961072,0.0278662356020759,-0.0248464176839616,0.0843892258761759,0.285370260175604
Physical measures,X4270.Volume level set by participant (left),CEP170,Centrosomal protein of 170 kDa,14288,-0.020285908209047,0.0189925548977673,-0.057511315808671,0.016939499390577,0.285494415003184
Physical measures,X4270.Volume level set by participant (left),MYH9,Myosin-9,14678,-0.0138870055142731,0.01300840498792,-0.0393834792905963,0.0116094682620501,0.285745192926807
Physical measures,X4270.Volume level set by participant (left),PROCR,Endothelial protein C receptor,14175,-0.0463734272285294,0.0434580000569471,-0.131551107340146,0.0388042528830869,0.285951158953285
Physical measures,X4270.Volume level set by participant (left),CINP,Cyclin-dependent kinase 2-interacting protein,14404,-0.0356482531363884,0.0334071870972324,-0.101126339846964,0.029829833574187,0.285952104915226
Physical measures,X4270.Volume level set by participant (left),COL28A1,Collagen alpha-1(XXVIII) chain,14261,-0.0208573201707764,0.0195491802029334,-0.0591737133685257,0.017459073026973,0.286028151393166
Physical measures,X4270.Volume level set by participant (left),ECI2,Enoyl-CoA delta isomerase 2,14175,-0.0260720237548379,0.024439423586435,-0.0739732939842505,0.0218292464745747,0.286079486640642
Physical measures,X4270.Volume level set by participant (left),KAZN,Kazrin,14588,-0.0158410642192422,0.014869989551012,-0.0449862437392257,0.0133041153007413,0.286755887099445
Physical measures,X4270.Volume level set by participant (left),AHCY,Adenosylhomocysteinase,16666,-0.020516669266177,0.0192741710520922,-0.0582940445282777,0.0172607059959237,0.287133802827304
Physical measures,X4270.Volume level set by participant (left),FABP1,"Fatty acid-binding protein, liver",16630,0.0144618893537875,0.0135900183704513,-0.012174546652297,0.041098325359872,0.287273843671126
Physical measures,X4270.Volume level set by participant (left),SART1,U4/U6.U5 tri-snRNP-associated protein 1,14175,-0.0440285472936933,0.0414655091162755,-0.125300945161593,0.0372438505742067,0.288339457705313
Physical measures,X4270.Volume level set by participant (left),CA4,Carbonic anhydrase 4,16871,-0.0564059413383677,0.0531411397075143,-0.160562575165096,0.0477506924883603,0.288506820161369
Physical measures,X4270.Volume level set by participant (left),EHBP1,EH domain-binding protein 1,14652,-0.0206060273049754,0.0194176318438405,-0.0586645857189027,0.017452531108952,0.288615679663694
Physical measures,X4270.Volume level set by participant (left),BPIFA2,BPI fold-containing family A member 2,13827,-0.0149548648884764,0.0140972739911764,-0.0425855219111822,0.0126757921342293,0.28878398566559
Physical measures,X4270.Volume level set by participant (left),NGF,Beta-nerve growth factor,16533,0.110349675727402,0.10409740554211,-0.0936812391351338,0.314380590589938,0.289132019061191
Physical measures,X4270.Volume level set by participant (left),CA6,Carbonic anhydrase 6,16631,-0.021267640228968,0.0200781577899275,-0.0606208294972259,0.0180855490392899,0.289504704124612
Physical measures,X4270.Volume level set by participant (left),SCG2,Secretogranin-2,16746,-0.0412364529010908,0.03894168977108,-0.117562164852408,0.035089259050226,0.289647775886018
Physical measures,X4270.Volume level set by participant (left),ATP5IF1,"ATPase inhibitor, mitochondrial",16733,-0.0125670251364908,0.0118725065545571,-0.0358371379834228,0.0107030877104411,0.289843730741096
Physical measures,X4270.Volume level set by participant (left),NEFL,Neurofilament light polypeptide,16220,-0.0315562762798391,0.0298194785469281,-0.0900024542318182,0.02688990167214,0.289960114089734
Physical measures,X4270.Volume level set by participant (left),ATXN10,Ataxin-10,16257,-0.0196610373903121,0.0185999524927097,-0.0561169442760231,0.016794869495399,0.29050553218808
Physical measures,X4270.Volume level set by participant (left),SPINK5,Serine protease inhibitor Kazal-type 5,16671,0.0400237492599205,0.0378811889380306,-0.0342233810586195,0.11427087957846,0.290727766592312
Physical measures,X4270.Volume level set by participant (left),PTTG1,Securin,14404,0.0377237793780009,0.0357050139574378,-0.0322580479785771,0.107705606734579,0.290739266283296
Physical measures,X4270.Volume level set by participant (left),LSM8,U6 snRNA-associated Sm-like protein LSm8,14404,-0.0179717229482662,0.017026404788003,-0.0513434763327522,0.0154000304362198,0.291204965115289
Physical measures,X4270.Volume level set by participant (left),CDCP1,CUB domain-containing protein 1,16533,0.025997561362176,0.0246390546299923,-0.0222949857126089,0.0742901084369609,0.291378418728652
Physical measures,X4270.Volume level set by participant (left),MYOM2,Myomesin-2,14175,-0.0307076777385585,0.0291224783931356,-0.0877877353891042,0.0263723799119872,0.291703099271844
Physical measures,X4270.Volume level set by participant (left),MGLL,Monoglyceride lipase,16710,-0.0159482117678673,0.0151325677671647,-0.0456080445915101,0.0137116210557755,0.291943999177982
Physical measures,X4270.Volume level set by participant (left),SLC4A1,Band 3 anion transport protein,14678,-0.0301001585095586,0.0285814643203281,-0.0861198285774018,0.0259195115582845,0.292296189972377
Physical measures,X4270.Volume level set by participant (left),EFNA4,Ephrin-A4,16500,0.0462427966899009,0.0439283903275497,-0.0398568483520965,0.132342441731898,0.292500408786092
Physical measures,X4270.Volume level set by participant (left),RAD23B,UV excision repair protein RAD23 homolog B,16266,-0.0304360218360238,0.0289270428879186,-0.0871330258963442,0.0262609822242967,0.292739504583918
Physical measures,X4270.Volume level set by participant (left),USP47,Ubiquitin carboxyl-terminal hydrolase 47,14175,0.0180236702877036,0.0171530116403596,-0.0155962325274013,0.0516435731028084,0.293387521623407
Physical measures,X4270.Volume level set by participant (left),PAEP,Glycodelin,16533,-0.00995789474794904,0.00947776711029715,-0.0285343182841315,0.00861852878823337,0.293430923792542
Physical measures,X4270.Volume level set by participant (left),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14588,-0.0134358068537941,0.0127922988367036,-0.0385087125737332,0.011637098866145,0.293595634198773
Physical measures,X4270.Volume level set by participant (left),CD164L2,CD164 sialomucin-like 2 protein,14261,-0.0432103531352812,0.041149714300729,-0.12386379316471,0.0374430868941476,0.293700699678007
Physical measures,X4270.Volume level set by participant (left),CLC,Galectin-10,16642,-0.0186936524089787,0.0178105644816882,-0.0536023587930876,0.0162150539751303,0.29392547666711
Physical measures,X4270.Volume level set by participant (left),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16533,-0.0187301811869037,0.0178515164354578,-0.053719153400401,0.0162587910265936,0.294091890421163
Physical measures,X4270.Volume level set by participant (left),ARSB,Arylsulfatase B,16576,-0.0244134721755627,0.0233014246144956,-0.070084264419974,0.0212573200688486,0.294780873654401
Physical measures,X4270.Volume level set by participant (left),ENG,Endoglin,16871,-0.0763082522230235,0.0728567537562844,-0.219107489585341,0.0664909851392939,0.29494224807225
Physical measures,X4270.Volume level set by participant (left),HSPA1A,Heat shock 70 kDa protein 1A,16712,-0.0192891913404593,0.0184254000406154,-0.0554029754200655,0.0168245927391469,0.29516986917633
Physical measures,X4270.Volume level set by participant (left),MPO,Myeloperoxidase,16671,0.0280383571596093,0.0268161790133395,-0.0245213537065361,0.0805980680257548,0.295771941590417
Physical measures,X4270.Volume level set by participant (left),FCRLB,Fc receptor-like B,16266,0.0221059408946027,0.0211540062532172,-0.019355911361703,0.0635677931509084,0.29603841958172
Physical measures,X4270.Volume level set by participant (left),SAP18,Histone deacetylase complex subunit SAP18,14404,-0.022036542310665,0.0210957754272354,-0.0633842621480463,0.0193111775267164,0.296227725125972
Physical measures,X4270.Volume level set by participant (left),CFD,Complement factor D,14697,-0.0776548843355911,0.0743400941481619,-0.223361468865988,0.0680517001948063,0.296229918953164
Physical measures,X4270.Volume level set by participant (left),CRIM1,Cysteine-rich motor neuron 1 protein,16733,-0.0633702585791361,0.0607573290127596,-0.182454623444145,0.0557141062858727,0.296960598398958
Physical measures,X4270.Volume level set by participant (left),KIAA2013,Uncharacterized protein KIAA2013,14572,-0.0258708944596303,0.0248147976414426,-0.0745078978368578,0.0227661089175973,0.297169830616331
Physical measures,X4270.Volume level set by participant (left),HNF1A,Hepatocyte nuclear factor 1-alpha,14261,-0.0217380165138503,0.02086154085923,-0.0626266365979411,0.0191506035702405,0.297422898286827
Physical measures,X4270.Volume level set by participant (left),LEO1,RNA polymerase-associated protein LEO1,14629,-0.0495739694754823,0.0475766741312285,-0.14282425077269,0.0436763118217256,0.297437931935231
Physical measures,X4270.Volume level set by participant (left),CD300LG,CMRF35-like molecule 9,16671,-0.0358093620705765,0.0343832751397478,-0.103200581344482,0.0315818572033293,0.297669720893915
Physical measures,X4270.Volume level set by participant (left),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16533,-0.0169236091613068,0.0162570573767809,-0.0487874416197974,0.0149402232971837,0.297890431475646
Physical measures,X4270.Volume level set by participant (left),WASL,Neural Wiskott-Aldrich syndrome protein,14207,-0.0253040143427691,0.0243141991456292,-0.0729598446682024,0.0223518159826642,0.298028194508281
Physical measures,X4270.Volume level set by participant (left),LY9,T-lymphocyte surface antigen Ly-9,16452,0.0455583197984962,0.0438214449255959,-0.0403317122556717,0.131448351852664,0.298524677442126
Physical measures,X4270.Volume level set by participant (left),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,14207,-0.0264830165191833,0.0254848907921374,-0.0764334024717727,0.023467369433406,0.298745529004746
Physical measures,X4270.Volume level set by participant (left),NT5C1A,Cytosolic 5'-nucleotidase 1A,14628,-0.0477438322208588,0.0459472068292501,-0.137800357606189,0.0423126931644713,0.298774518884018
Physical measures,X4270.Volume level set by participant (left),COPE,Coatomer subunit epsilon,16257,0.0287342809847639,0.0277542379497414,-0.0256640253967292,0.083132587366257,0.300538889180038
Physical measures,X4270.Volume level set by participant (left),VNN1,Pantetheinase,14672,0.0207187604032726,0.0200320218757382,-0.0185440024731742,0.0599815232797194,0.301021398373677
Physical measures,X4270.Volume level set by participant (left),RELT,Tumor necrosis factor receptor superfamily member 19L,16671,0.0478635961946147,0.0462808813633402,-0.0428469312775321,0.138574123666762,0.301058613369842
Physical measures,X4270.Volume level set by participant (left),MKI67,Proliferation marker protein Ki-67,14207,-0.0393683810121551,0.0380711459587289,-0.113987827091264,0.0352510650669536,0.301119207008679
Physical measures,X4270.Volume level set by participant (left),MUC13,Mucin-13,16257,0.0259500735074001,0.0251115189276725,-0.0232685035908381,0.0751686506056383,0.301435304439828
Physical measures,X4270.Volume level set by participant (left),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14629,-0.0218877469541611,0.021181636129053,-0.0634037537671049,0.0196282598587828,0.301463791833235
Physical measures,X4270.Volume level set by participant (left),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14672,-0.0352171845024565,0.0340830393003226,-0.102019941531089,0.0315855725261759,0.301491833742368
Physical measures,X4270.Volume level set by participant (left),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14588,-0.0186160678707058,0.0180194830356389,-0.053934254620558,0.0167021188791464,0.301570615571887
Physical measures,X4270.Volume level set by participant (left),CD59,CD59 glycoprotein,16070,0.060527806110732,0.0586079281860775,-0.0543437331339799,0.175399345355444,0.301732726289093
Physical measures,X4270.Volume level set by participant (left),GSTA3,Glutathione S-transferase A3,16266,0.0174973868792184,0.0169601435507232,-0.0157444944801991,0.0507392682386359,0.302238897319357
Physical measures,X4270.Volume level set by participant (left),YTHDF3,YTH domain-containing family protein 3,16350,-0.016159656176889,0.0156650176526072,-0.0468630907759991,0.0145437784222211,0.302286065123335
Physical measures,X4270.Volume level set by participant (left),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14588,-0.0329402437103399,0.0319336610588998,-0.0955302193857834,0.0296497319651036,0.302313661190672
Physical measures,X4270.Volume level set by participant (left),ITGB1BP2,Integrin beta-1-binding protein 2,16356,-0.0123506409183556,0.0119830916536563,-0.0358375005595219,0.0111362187228107,0.302709763803602
Physical measures,X4270.Volume level set by participant (left),CALB2,Calretinin,16257,-0.0447371172416873,0.0434342233435835,-0.129868194995111,0.0403939605117364,0.303026780284664
Physical measures,X4270.Volume level set by participant (left),IL3RA,Interleukin-3 receptor subunit alpha,16350,-0.04090783863625,0.0397329749205219,-0.118784469480473,0.0369687922079729,0.303227627002552
Physical measures,X4270.Volume level set by participant (left),BCL7A,B-cell CLL/lymphoma 7 protein family member A,14144,-0.0238930698918647,0.0232197419566369,-0.069403764126873,0.0216176243431436,0.303498194222038
Physical measures,X4270.Volume level set by participant (left),NFASC,Neurofascin,16843,-0.0455879370564254,0.0443066695202576,-0.13242900931613,0.0412531352032795,0.303532922278023
Physical measures,X4270.Volume level set by participant (left),SERPINB5,Serpin B5,16356,0.0272881398148276,0.026526952077218,-0.0247046862565197,0.0792809658861748,0.303638303867418
Physical measures,X4270.Volume level set by participant (left),TRIM24,Transcription intermediary factor 1-alpha,14374,-0.0237139046918795,0.023078322386304,-0.0689474165690353,0.0215196071852763,0.304183463224637
Physical measures,X4270.Volume level set by participant (left),RAB37,Ras-related protein Rab-37,16350,-0.0161649509030206,0.0157332083618734,-0.0470020392922925,0.0146721374862513,0.304227842712864
Physical measures,X4270.Volume level set by participant (left),A1BG,Alpha-1B-glycoprotein,14697,-0.0858695951256231,0.0836928675738085,-0.249907615570288,0.0781684253190416,0.304904474123666
Physical measures,X4270.Volume level set by participant (left),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16576,-0.0146370298783487,0.0142662639310084,-0.0425989071831251,0.0133248474264277,0.304911755684494
Physical measures,X4270.Volume level set by participant (left),CES1,Liver carboxylesterase 1,16729,0.0161968444165909,0.0157907641838246,-0.0147530533837053,0.0471467422168872,0.305040168809116
Physical measures,X4270.Volume level set by participant (left),PEAR1,Platelet endothelial aggregation receptor 1,16871,-0.056124114813111,0.0547578304816292,-0.163449462557104,0.0512012329308822,0.305400831905401
Physical measures,X4270.Volume level set by participant (left),SMAD1,Mothers against decapentaplegic homolog 1,16266,-0.0163836630164331,0.0159893745518287,-0.0477228371380174,0.0149555111051511,0.305539177576299
Physical measures,X4270.Volume level set by participant (left),IL7R,Interleukin-7 receptor subunit alpha,16671,-0.0252321771019814,0.0246623159228359,-0.0735703163107397,0.0231059621067768,0.306272328401693
Physical measures,X4270.Volume level set by participant (left),MARS1,"Methionine--tRNA ligase, cytoplasmic",14314,-0.0185782840949061,0.0181802453739793,-0.0542115650279055,0.0170549968380934,0.306848352034621
Physical measures,X4270.Volume level set by participant (left),GCC1,GRIP and coiled-coil domain-containing protein 1,14628,-0.0143274277159009,0.0140358197766807,-0.0418376344781952,0.0131827790463933,0.307377487091351
Physical measures,X4270.Volume level set by participant (left),SUMF1,Formylglycine-generating enzyme,14207,-0.0224934379553506,0.0220530977946503,-0.0657175096328651,0.0207306337221639,0.307761372490619
Physical measures,X4270.Volume level set by participant (left),KRT6C,"Keratin, type II cytoskeletal 6C",14175,0.0380493413776611,0.0373474255900722,-0.0351516127788804,0.111250295534203,0.308318078193699
Physical measures,X4270.Volume level set by participant (left),IGSF3,Immunoglobulin superfamily member 3,16576,-0.0368657562445046,0.0362647231402133,-0.107944613599323,0.0342131011103135,0.309371222243342
Physical measures,X4270.Volume level set by participant (left),C19orf12,Protein C19orf12,16257,0.0203128140425845,0.0200110108939036,-0.0189087673094666,0.0595343953946356,0.310081933057416
Physical measures,X4270.Volume level set by participant (left),MYOC,Myocilin,16671,-0.0280896157895565,0.0276863589715728,-0.0823548793738392,0.0261756477947262,0.310327883326374
Physical measures,X4270.Volume level set by participant (left),CD84,SLAM family member 5,16637,-0.0412918590416664,0.040751224479946,-0.12116425902236,0.0385805409390277,0.310947535942471
Physical measures,X4270.Volume level set by participant (left),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16843,0.0335122728621352,0.033125018399874,-0.0314127632016177,0.0984373089258882,0.311700513965856
Physical measures,X4270.Volume level set by participant (left),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,14175,-0.0381357063168084,0.0377109668681131,-0.11204920137831,0.0357777887446933,0.311907841222804
Physical measures,X4270.Volume level set by participant (left),RILP,Rab-interacting lysosomal protein,16772,-0.0223474779395099,0.022123287170666,-0.0657091207940152,0.0210141649149953,0.312445825188234
Physical measures,X4270.Volume level set by participant (left),NOS1,"Nitric oxide synthase, brain",16257,-0.0242066081185964,0.0239821868184543,-0.0712116942827668,0.0227984780455741,0.312818091628045
Physical measures,X4270.Volume level set by participant (left),PHLDB1,Pleckstrin homology-like domain family B member 1,14588,-0.0268149782038559,0.0266062557703228,-0.0789632395136887,0.0253332831059769,0.313545680429315
Physical measures,X4270.Volume level set by participant (left),GP1BB,Platelet glycoprotein Ib beta chain,14175,-0.0223804788023104,0.0222298454594866,-0.0659509759029041,0.0211900182982833,0.314059551713168
Physical measures,X4270.Volume level set by participant (left),VWC2L,von Willebrand factor C domain-containing protein 2-like,14629,-0.0327968784884798,0.0326135942560293,-0.0967195232302971,0.0311257662533376,0.31461511310905
Physical measures,X4270.Volume level set by participant (left),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16637,-0.0138051060951522,0.0137438099076898,-0.0407429735142242,0.0131327613239198,0.315171607974569
Physical measures,X4270.Volume level set by participant (left),PXN,Paxillin,16257,0.0252028935535465,0.0251017542374303,-0.0239965447518169,0.07440233185891,0.31537951148864
Physical measures,X4270.Volume level set by participant (left),HAVCR1,Hepatitis A virus cellular receptor 1,16788,0.0202179680471451,0.0201578226329431,-0.0192913643134234,0.0597273004077136,0.315883184169026
Physical measures,X4270.Volume level set by participant (left),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16871,-0.017894334013843,0.0178463998955444,-0.0528732778091099,0.017084609781424,0.316026817494711
Physical measures,X4270.Volume level set by participant (left),SRC,Proto-oncogene tyrosine-protein kinase Src,16679,-0.0108425216976952,0.0108165625252584,-0.0320429842472016,0.0103579408518112,0.316165024818337
Physical measures,X4270.Volume level set by participant (left),PRDX2,Peroxiredoxin-2,14382,-0.0233461154960266,0.0233304159412462,-0.0690737307408691,0.022381499748816,0.317001817991089
Physical measures,X4270.Volume level set by participant (left),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14678,-0.0560021422752793,0.056006287238054,-0.165774465261865,0.0537701807113066,0.317362828032196
Physical measures,X4270.Volume level set by participant (left),RGCC,Regulator of cell cycle RGCC,14629,-0.0196174993914249,0.019627950621677,-0.0580882826099118,0.0188532838270621,0.31758480980051
Physical measures,X4270.Volume level set by participant (left),COL4A1,Collagen alpha-1(IV) chain,16666,-0.0315770073846276,0.0316276648430385,-0.093567230476983,0.0304132157077279,0.318100759006296
Physical measures,X4270.Volume level set by participant (left),BRME1,Break repair meiotic recombinase recruitment factor 1,14168,-0.0354467374861418,0.0355180318427302,-0.105062079897893,0.0341686049256093,0.318299949533504
Physical measures,X4270.Volume level set by participant (left),MCEMP1,Mast cell-expressed membrane protein 1,14207,-0.0167122759887418,0.0167502810121608,-0.049542826772577,0.0161182747950934,0.318426790426507
Physical measures,X4270.Volume level set by participant (left),NPDC1,Neural proliferation differentiation and control protein 1,16666,0.0406757025792807,0.0407711840779425,-0.0392358182134866,0.120587223372048,0.318459670391559
Physical measures,X4270.Volume level set by participant (left),S100A4,Protein S100-A4,16719,-0.0238862053995212,0.0239718090363905,-0.0708709511108466,0.0230985403118041,0.319056190094508
Physical measures,X4270.Volume level set by participant (left),TYMP,Thymidine phosphorylase,16558,-0.0194277910195004,0.0195024253704193,-0.0576525447455222,0.0187969627065215,0.319180632255167
Physical measures,X4270.Volume level set by participant (left),FMNL1,Formin-like protein 1,16257,0.0211463636595899,0.0212525396251616,-0.0205086140057269,0.0628013413249068,0.319749104319141
Physical measures,X4270.Volume level set by participant (left),MSR1,Macrophage scavenger receptor types I and II,16799,0.0272780377495163,0.0274169224502665,-0.0264591302530061,0.0810152057520386,0.31978254300664
Physical measures,X4270.Volume level set by participant (left),ANXA4,Annexin A4,16591,-0.0180966647513281,0.0182013139853962,-0.0537712401627047,0.0175779106600485,0.320115463804159
Physical measures,X4270.Volume level set by participant (left),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16871,-0.0540733981989491,0.0545617916637839,-0.161014509859966,0.0528677134620673,0.321675979142889
Physical measures,X4270.Volume level set by participant (left),APPL2,DCC-interacting protein 13-beta,14352,-0.0135196330390093,0.0136640720303068,-0.0403012142184107,0.0132619481403921,0.322469851660125
Physical measures,X4270.Volume level set by participant (left),ARAF,Serine/threonine-protein kinase A-Raf,14404,-0.0221863576057762,0.0224287967858475,-0.0661467993060374,0.021774084094485,0.322586474354098
Physical measures,X4270.Volume level set by participant (left),SHH,Sonic hedgehog protein,14207,-0.0337753163602802,0.0341712546884273,-0.100750975549598,0.0332003428290373,0.322967219240291
Physical measures,X4270.Volume level set by participant (left),RBM25,RNA-binding protein 25,14144,-0.0326418895675169,0.0331254489668424,-0.0975677695425279,0.0322839904074941,0.324443436251202
Physical measures,X4270.Volume level set by participant (left),AGR3,Anterior gradient protein 3,16252,0.0214691372566028,0.0217906072582857,-0.0212404529696371,0.0641787274828428,0.324517288029048
Physical measures,X4270.Volume level set by participant (left),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13827,-0.0147451079677703,0.0149707730401964,-0.0440878231265553,0.0145976071910147,0.324677533054627
Physical measures,X4270.Volume level set by participant (left),MME,Neprilysin,16576,0.0156914793313116,0.0159343247757726,-0.0155397972292026,0.0469227558918258,0.324756556293722
Physical measures,X4270.Volume level set by participant (left),SELPLG,P-selectin glycoprotein ligand 1,16637,-0.044028150446127,0.044718360394122,-0.131676136818606,0.0436198359263521,0.324851923940911
Physical measures,X4270.Volume level set by participant (left),CCL27,C-C motif chemokine 27,16666,0.0204175986406159,0.0207496355027059,-0.0202516869446877,0.0610868842259196,0.32513082362927
Physical measures,X4270.Volume level set by participant (left),GOLGA3,Golgin subfamily A member 3,14629,-0.0192094629278633,0.019528093014222,-0.0574845252357385,0.0190655993800118,0.32528744107946
Physical measures,X4270.Volume level set by participant (left),EPHB4,Ephrin type-B receptor 4,16871,0.0499780098373935,0.0508255251099401,-0.0496400193780891,0.149596039052876,0.32546162155933
Physical measures,X4270.Volume level set by participant (left),SEMA6C,Semaphorin-6C,14207,-0.0562561062735977,0.0572165652789,-0.168400574220242,0.0558883616730463,0.325519076140038
Physical measures,X4270.Volume level set by participant (left),ORM1,Alpha-1-acid glycoprotein 1,14651,0.0712055872832035,0.0724416149039246,-0.0707799779284887,0.213191152494896,0.325654399654393
Physical measures,X4270.Volume level set by participant (left),DPY30,Protein dpy-30 homolog,16766,0.0209973930116834,0.0213766883497823,-0.0209009161538899,0.0628957021772567,0.325987642633401
Physical measures,X4270.Volume level set by participant (left),ICAM2,Intercellular adhesion molecule 2,16871,0.0389095542831081,0.0396274621060417,-0.0387602714447337,0.11657938001095,0.326171301187219
Physical measures,X4270.Volume level set by participant (left),PPIB,Peptidyl-prolyl cis-trans isomerase B,16636,-0.0134410215087418,0.0136951278511297,-0.0402834720969561,0.0134014290794724,0.326387388227379
Physical measures,X4270.Volume level set by participant (left),VSIG2,V-set and immunoglobulin domain-containing protein 2,14572,0.0247189003418208,0.0251921705841511,-0.0246577540031155,0.074095554686757,0.326503728983945
Physical measures,X4270.Volume level set by participant (left),GUSB,Beta-glucuronidase,16718,0.020753967413983,0.0211612490045732,-0.0207220806349804,0.0622300154629464,0.326728558367885
Physical measures,X4270.Volume level set by participant (left),FAM3C,Protein FAM3C,16639,-0.0425072421567354,0.0433425221719226,-0.127458585613704,0.0424441013002329,0.3267409718051
Physical measures,X4270.Volume level set by participant (left),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",14175,-0.0336042981197464,0.0342944337642616,-0.100821388297699,0.0336127920582063,0.327163994521569
Physical measures,X4270.Volume level set by participant (left),FAM3B,Protein FAM3B,16576,-0.0343513705490077,0.035068258803144,-0.10308515780317,0.0343824167051545,0.327318978822256
Physical measures,X4270.Volume level set by participant (left),CA12,Carbonic anhydrase 12,16576,-0.0386970614560431,0.0395122980790267,-0.116141165690936,0.0387470427788492,0.327412726492082
Physical measures,X4270.Volume level set by participant (left),S100A14,Protein S100-A14,14629,-0.0275420637134196,0.0281302223049105,-0.0826772994310441,0.027593172004205,0.327550942865484
Physical measures,X4270.Volume level set by participant (left),MMP15,Matrix metalloproteinase-15,14652,0.0286662892883483,0.0293241077251418,-0.0288089618529295,0.0861415404296262,0.3283045274074
Physical measures,X4270.Volume level set by participant (left),CSF1R,Macrophage colony-stimulating factor 1 receptor,14672,-0.036554724484567,0.0373985218120501,-0.109855827236185,0.0367463782670513,0.328368649483403
Physical measures,X4270.Volume level set by participant (left),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,14175,-0.0220017209832213,0.022515277975763,-0.0661316658157167,0.0221282238492742,0.328491431391958
Physical measures,X4270.Volume level set by participant (left),HEPH,Hephaestin,14652,-0.0557866963805199,0.057109040766789,-0.167720416283426,0.0561470235223865,0.328661906371851
Physical measures,X4270.Volume level set by participant (left),RAB33A,Ras-related protein Rab-33A,14175,-0.022372919258888,0.0229230421880154,-0.0673020819473982,0.0225562434296222,0.329080489520238
Physical measures,X4270.Volume level set by participant (left),MANSC4,MANSC domain-containing protein 4,14175,-0.0218062315872035,0.0223487848915803,-0.0656098499747009,0.021997386800294,0.32921824128088
Physical measures,X4270.Volume level set by participant (left),CDHR2,Cadherin-related family member 2,16576,0.0171220620779445,0.0175567052260584,-0.0172890801651301,0.051533204321019,0.329453751768524
Physical measures,X4270.Volume level set by participant (left),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16671,0.0432089426573238,0.0443325291074233,-0.0436828143932259,0.130100699707873,0.329745337347658
Physical measures,X4270.Volume level set by participant (left),CABP2,Calcium-binding protein 2,14261,-0.0225915031146609,0.0231908028033356,-0.0680454766091986,0.0228624703798768,0.329994701150179
Physical measures,X4270.Volume level set by participant (left),GUK1,Guanylate kinase,14175,-0.0358489544083981,0.0369019474041164,-0.108176771320466,0.0364788625036701,0.331333315107754
Physical measures,X4270.Volume level set by participant (left),AZI2,5-azacytidine-induced protein 2,14629,-0.0251212253160519,0.0259035747652471,-0.0758922318559363,0.0256497812238324,0.33216342841575
Physical measures,X4270.Volume level set by participant (left),MET,Hepatocyte growth factor receptor,16728,-0.0616539482900437,0.0635945980200736,-0.186299360409388,0.0629914638293006,0.332317766916582
Physical measures,X4270.Volume level set by participant (left),MBL2,Mannose-binding protein C,14488,0.0131520066058293,0.0135787180999272,-0.013462280870028,0.0397662940816865,0.332773479474952
Physical measures,X4270.Volume level set by participant (left),CALB1,Calbindin,16576,-0.028922192980484,0.0298822702435806,-0.087491442657902,0.0296470566969341,0.33312276446999
Physical measures,X4270.Volume level set by participant (left),ACSL1,Long-chain-fatty-acid--CoA ligase 1,14175,-0.0399836409106017,0.0413206724035776,-0.120972158821614,0.0410048770004104,0.333239446763224
Physical measures,X4270.Volume level set by participant (left),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16576,-0.0382261673954639,0.0395085781305372,-0.115662980531317,0.039210645740389,0.33328780892675
Physical measures,X4270.Volume level set by participant (left),GZMA,Granzyme A,16843,-0.0354061695543997,0.0366229454946628,-0.107187142723939,0.0363748036151395,0.333670127361205
Physical measures,X4270.Volume level set by participant (left),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14629,-0.0477677057398751,0.049414857076517,-0.144620825609848,0.0490854141300982,0.333726587501555
Physical measures,X4270.Volume level set by participant (left),SHD,SH2 domain-containing adapter protein D,14152,-0.0170580934671191,0.017650420444848,-0.0516529175390212,0.0175367306047829,0.333839992370915
Physical measures,X4270.Volume level set by participant (left),TRAF2,TNF receptor-associated factor 2,16637,-0.0180295350954326,0.0186738704602217,-0.0546303211974672,0.0185712510066019,0.334310812120893
Physical measures,X4270.Volume level set by participant (left),CDH4,Cadherin-4,14168,0.031193432268707,0.0323141015107294,-0.0321422066923227,0.0945290712297367,0.334401304501506
Physical measures,X4270.Volume level set by participant (left),TEK,Angiopoietin-1 receptor,16719,0.0555874196216984,0.0576077707703968,-0.0573238110882793,0.168498650331676,0.334594250215983
Physical measures,X4270.Volume level set by participant (left),CMC1,COX assembly mitochondrial protein homolog,14652,-0.0158380834271414,0.0164288411477181,-0.048038612076669,0.0163624452223861,0.335041086480521
Physical measures,X4270.Volume level set by participant (left),PSPN,Persephin,16637,-0.0129452141108542,0.0134281304438198,-0.0392643497807411,0.0133739215590326,0.335041420134653
Physical measures,X4270.Volume level set by participant (left),P4HB,Protein disulfide-isomerase,16593,-0.0320001628153039,0.0332145622357935,-0.0971007047974592,0.0331003791668513,0.335341948394717
Physical measures,X4270.Volume level set by participant (left),EP300,Histone acetyltransferase p300,14207,-0.0478399378406876,0.0497162902996772,-0.145283866828055,0.0496039911466796,0.335936015963215
Physical measures,X4270.Volume level set by participant (left),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16533,0.0203542612950333,0.0211542626345578,-0.0211080934687,0.0618166160587665,0.335972024937699
Physical measures,X4270.Volume level set by participant (left),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,14175,-0.0470386051908131,0.0489034668010516,-0.142889400120874,0.0488121897392481,0.336133108138387
Physical measures,X4270.Volume level set by participant (left),SLC39A14,Zinc transporter ZIP14,16257,-0.0382152243397706,0.0397733754186479,-0.116171040160321,0.0397405914807793,0.336654839017919
Physical measures,X4270.Volume level set by participant (left),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14588,-0.0142097592853812,0.014789128864591,-0.0431964518599796,0.0147769332892172,0.336656295146061
Physical measures,X4270.Volume level set by participant (left),IL20RA,Interleukin-20 receptor subunit alpha,16350,0.0275329684992145,0.028697093978912,-0.0287133356994531,0.0837792726978821,0.33735434119136
Physical measures,X4270.Volume level set by participant (left),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",14144,-0.0285187497970087,0.0297354412212759,-0.0868002145907095,0.0297627149966921,0.337533455370905
Physical measures,X4270.Volume level set by participant (left),RSPO3,R-spondin-3,16810,-0.0438845108744033,0.0457801208081354,-0.133613547658349,0.0458445259095422,0.337777537978121
Physical measures,X4270.Volume level set by participant (left),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14376,-0.023166469729322,0.0241686636349485,-0.070537050453821,0.0242041109951771,0.337810029806464
Physical measures,X4270.Volume level set by participant (left),CDK1,Cyclin-dependent kinase 1,14144,-0.0395976540128971,0.041313422057274,-0.120571961245154,0.0413766532193599,0.337842478617531
Physical measures,X4270.Volume level set by participant (left),LCN15,Lipocalin-15,14629,0.0227434060481964,0.0237334112994781,-0.0237740800987807,0.0692608921951735,0.337934198412349
Physical measures,X4270.Volume level set by participant (left),PRSS2,Trypsin-2,16715,0.0227158118090313,0.0237308507202617,-0.0237966556026816,0.0692282792207442,0.338466534109714
Physical measures,X4270.Volume level set by participant (left),HDAC9,Histone deacetylase 9,14168,-0.0222898026519741,0.023321657033484,-0.0680002504376026,0.0234206451336545,0.339212087497436
Physical measures,X4270.Volume level set by participant (left),PMM2,Phosphomannomutase 2,14175,-0.0239960501519738,0.0251274844355828,-0.073245919645716,0.0252538193417685,0.339608039007168
Physical measures,X4270.Volume level set by participant (left),SCLY,Selenocysteine lyase,16772,0.0254669163103077,0.0266731750454986,-0.0268125067788696,0.077746339399485,0.3397045918853
Physical measures,X4270.Volume level set by participant (left),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16637,-0.0125968725257234,0.0131968103448488,-0.0384626208016271,0.0132688757501803,0.339824669527409
Physical measures,X4270.Volume level set by participant (left),CCDC50,Coiled-coil domain-containing protein 50,14629,-0.018298282922434,0.019197957017202,-0.0559262786761499,0.0193297128312819,0.340536434065425
Physical measures,X4270.Volume level set by participant (left),BAX,Apoptosis regulator BAX,16231,-0.0140335303536694,0.0147242466531667,-0.0428930537938762,0.0148259930865374,0.340558745277158
Physical measures,X4270.Volume level set by participant (left),HSPB1,Heat shock protein beta-1,16374,-0.0186583282981167,0.0195778100634562,-0.0570308360224908,0.0197141794262573,0.340586677002339
Physical measures,X4270.Volume level set by participant (left),SCARB1,Scavenger receptor class B member 1,16257,-0.0217324523780028,0.0228077357303127,-0.0664356144094157,0.0229707096534101,0.340678005476825
Physical measures,X4270.Volume level set by participant (left),ABO,Histo-blood group ABO system transferase,14672,0.0096654340013487,0.0101531864750644,-0.0102348114897775,0.0295656794924749,0.341132638329817
Physical measures,X4270.Volume level set by participant (left),ABRAXAS2,BRISC complex subunit Abraxas 2,14175,-0.0223317610633769,0.0234603064706022,-0.0683139617457572,0.0236504396190033,0.341166212212849
Physical measures,X4270.Volume level set by participant (left),CDAN1,Codanin-1,14628,-0.0591849919932809,0.0622427461038631,-0.181180774356853,0.0628107903702908,0.341684208499122
Physical measures,X4270.Volume level set by participant (left),TRPV3,Transient receptor potential cation channel subfamily V member 3,14175,-0.0288932497849497,0.0304299731232624,-0.0885359971065441,0.0307494975366446,0.342382741044876
Physical measures,X4270.Volume level set by participant (left),STAM,Signal transducing adapter molecule 1,14572,-0.0361155321138611,0.038053021208829,-0.110699453683166,0.0384683894554438,0.342593401419691
Physical measures,X4270.Volume level set by participant (left),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14588,-0.0474630053510297,0.0501042430695548,-0.145667321767357,0.0507413110652976,0.343509205640057
Physical measures,X4270.Volume level set by participant (left),ADA2,Adenosine deaminase 2,16496,-0.0287130769336726,0.0303112212309103,-0.0881230705462569,0.0306969166789116,0.343512307303134
Physical measures,X4270.Volume level set by participant (left),SLITRK2,SLIT and NTRK-like protein 2,16810,0.0302044417813179,0.0318997500149884,-0.0323190682480595,0.0927279518106952,0.343726231644924
Physical measures,X4270.Volume level set by participant (left),MEGF9,Multiple epidermal growth factor-like domains protein 9,16805,0.0572906882741634,0.0605617430234137,-0.0614103280517274,0.175991704600054,0.344168270471879
Physical measures,X4270.Volume level set by participant (left),CXCL5,C-X-C motif chemokine 5,16616,-0.0105533152797174,0.0111589619605726,-0.0324248807224397,0.011318250163005,0.3443023605808
Physical measures,X4270.Volume level set by participant (left),DNAJB1,DnaJ homolog subfamily B member 1,16576,-0.0147036147651237,0.0156130515968619,-0.045305195894973,0.0158979663647255,0.346333619656035
Physical measures,X4270.Volume level set by participant (left),PACS2,Phosphofurin acidic cluster sorting protein 2,14175,-0.0235751648388407,0.025050047148398,-0.0726732572497008,0.0255229275720195,0.346658105662594
Physical measures,X4270.Volume level set by participant (left),IGFBP7,Insulin-like growth factor-binding protein 7,16871,0.0393748158635608,0.0418639792748636,-0.0426785835151718,0.121428215242293,0.346953279165363
Physical measures,X4270.Volume level set by participant (left),LAMTOR5,Ragulator complex protein LAMTOR5,14572,-0.0336554668427775,0.0358323290740226,-0.103886831827862,0.0365758981423067,0.347618680448007
Physical measures,X4270.Volume level set by participant (left),PDCL2,Phosducin-like protein 2,14144,0.0262199155221109,0.0279308050985283,-0.0285244624710046,0.0809642935152263,0.347877514003006
Physical measures,X4270.Volume level set by participant (left),ANKRD54,Ankyrin repeat domain-containing protein 54,16266,-0.0210243700632376,0.022396964150282,-0.0649224197977902,0.0228736796713151,0.347890954367641
Physical measures,X4270.Volume level set by participant (left),NFYA,Nuclear transcription factor Y subunit alpha,14175,-0.0386800088536295,0.0412600620952622,-0.119549730560343,0.0421897128530845,0.348533606679902
Physical measures,X4270.Volume level set by participant (left),KHDC3L,KH domain-containing protein 3,14144,0.0208800838547262,0.0222738989442279,-0.0227767580759605,0.064536925785413,0.348556608676512
Physical measures,X4270.Volume level set by participant (left),CASP9,Caspase-9,14207,-0.0225033296378124,0.0240111052593055,-0.0695650959460511,0.0245584366704263,0.34866903156782
Physical measures,X4270.Volume level set by participant (left),CREG1,Protein CREG1,16433,0.0316588515078515,0.0338213467243682,-0.0346309880719101,0.0979486910876131,0.349255431401205
Physical measures,X4270.Volume level set by participant (left),SLMAP,Sarcolemmal membrane-associated protein,14588,-0.0161796383690265,0.0172874544772028,-0.050063049144344,0.0177037724062909,0.349330962670977
Physical measures,X4270.Volume level set by participant (left),TIMP4,Metalloproteinase inhibitor 4,16671,0.0296134160878448,0.031683034651757,-0.032485331829599,0.0917121640052885,0.349968134916214
Physical measures,X4270.Volume level set by participant (left),RNASE6,Ribonuclease K6,14552,0.0464332976596365,0.0496954017578651,-0.0509696897857792,0.143836285105052,0.350134761656619
Physical measures,X4270.Volume level set by participant (left),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14652,-0.0398215005061305,0.0426411767818734,-0.123398206998602,0.0437552059863414,0.35038412761264
Physical measures,X4270.Volume level set by participant (left),S100A12,Protein S100-A12,16421,0.016400281472143,0.0175745204601191,-0.0180457786296905,0.0508463415739765,0.35073811679766
Physical measures,X4270.Volume level set by participant (left),DCTN1,Dynactin subunit 1,16810,-0.0187838991199855,0.0201420460175543,-0.0582623093143919,0.0206945110744209,0.351054634557684
Physical measures,X4270.Volume level set by participant (left),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14288,-0.026940251049447,0.0288949937045741,-0.0835744387104121,0.0296939366115182,0.351171382906561
Physical measures,X4270.Volume level set by participant (left),CD82,CD82 antigen,14404,-0.0322616849432997,0.0346694629375806,-0.100213832300958,0.0356904624143582,0.352101760427263
Physical measures,X4270.Volume level set by participant (left),ERBIN,Erbin,16576,-0.0119180197247644,0.012812426391675,-0.0370303754524475,0.0131943360029186,0.35228511426351
Physical measures,X4270.Volume level set by participant (left),C2orf69,UPF0565 protein C2orf69,14261,-0.0244875558427587,0.0263367656214069,-0.0761076164607163,0.0271325047751989,0.352497655296517
Physical measures,X4270.Volume level set by participant (left),CNTNAP2,Contactin-associated protein-like 2,16637,-0.0283492351290841,0.0305003888083586,-0.088129997193467,0.0314315269352988,0.352658406688416
Physical measures,X4270.Volume level set by participant (left),FABP2,"Fatty acid-binding protein, intestinal",16666,-0.0150164276075722,0.0161879417609094,-0.0467447934589547,0.0167119382438102,0.353612747211541
Physical measures,X4270.Volume level set by participant (left),IGSF8,Immunoglobulin superfamily member 8,16666,0.0388287100730724,0.041864572333337,-0.0432258517002681,0.120883271846413,0.353688875848128
Physical measures,X4270.Volume level set by participant (left),TIMP3,Metalloproteinase inhibitor 3,16733,-0.00906515385822906,0.00978983260801904,-0.0282532257699464,0.0101229180534883,0.35447161809174
Physical measures,X4270.Volume level set by participant (left),FGF3,Fibroblast growth factor 3,14207,0.0445320390310723,0.0481510504574487,-0.0498440198655272,0.138908097927672,0.355064634874366
Physical measures,X4270.Volume level set by participant (left),FXYD5,FXYD domain-containing ion transport regulator 5,16350,-0.0187071860416233,0.0202332927156536,-0.0583644397643044,0.0209500676810578,0.355200953428424
Physical measures,X4270.Volume level set by participant (left),SCRIB,Protein scribble homolog,14288,-0.0153491904025588,0.0166062206856213,-0.0478973829463766,0.017199002141259,0.355343870673338
Physical measures,X4270.Volume level set by participant (left),MEPE,Matrix extracellular phosphoglycoprotein,16630,-0.0440151080216718,0.0476233715274017,-0.137356916215379,0.0493267001720357,0.355378261326059
Physical measures,X4270.Volume level set by participant (left),ITGB7,Integrin beta-7,16810,0.0255803089632939,0.0276781717762287,-0.0286689077181143,0.0798295256447021,0.355392793104244
Physical measures,X4270.Volume level set by participant (left),HPCAL1,Hippocalcin-like protein 1,16843,-0.0165109152017038,0.0178806759742922,-0.0515570401113166,0.0185352097079089,0.355814975153863
Physical measures,X4270.Volume level set by participant (left),PTPRF,Receptor-type tyrosine-protein phosphatase F,16871,-0.0402727340342458,0.0436376810741355,-0.125802588939551,0.0452571208710598,0.356078286638809
Physical measures,X4270.Volume level set by participant (left),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16552,-0.0164881434621212,0.0178678953698378,-0.0515092183870033,0.0185329314627609,0.356135126584111
Physical measures,X4270.Volume level set by participant (left),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16675,0.0389839979255093,0.0422467398355516,-0.0438196121521719,0.121787608003191,0.356140765947048
Physical measures,X4270.Volume level set by participant (left),AGER,Advanced glycosylation end product-specific receptor,16615,-0.028757809464553,0.031253670685058,-0.0900150040072667,0.0324993850781607,0.357512024589428
Physical measures,X4270.Volume level set by participant (left),DCTD,Deoxycytidylate deaminase,14352,-0.0150299625599387,0.0163377494990517,-0.04705195157808,0.0169920264582026,0.357612772069585
Physical measures,X4270.Volume level set by participant (left),LAG3,Lymphocyte activation gene 3 protein,16576,-0.0290000587579089,0.0315647743958222,-0.0908670165737203,0.0328668990579025,0.358241020871118
Physical measures,X4270.Volume level set by participant (left),EPGN,Epigen,14572,0.0270498167656585,0.0294449207680238,-0.0306622279396682,0.0847618614709851,0.358289623343314
Physical measures,X4270.Volume level set by participant (left),LONP1,"Lon protease homolog, mitochondrial",14288,-0.0161722083886832,0.0176078708378662,-0.050683635230901,0.0183392184535346,0.358391136727132
Physical measures,X4270.Volume level set by participant (left),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16666,-0.0180115022419077,0.0196175475781876,-0.0564618954951554,0.0204388910113401,0.358562955797945
Physical measures,X4270.Volume level set by participant (left),MAPT,Microtubule-associated protein tau,16257,-0.022600795207497,0.0246308151416193,-0.0708771928850708,0.0256756024700767,0.358851316487733
Physical measures,X4270.Volume level set by participant (left),TDP1,Tyrosyl-DNA phosphodiesterase 1,14572,-0.0194682814683293,0.0212202706656506,-0.0610600119730045,0.0221234490363459,0.358928399127561
Physical measures,X4270.Volume level set by participant (left),EVI2B,Protein EVI2B,14144,-0.0363287326267181,0.0396938376900253,-0.114128654499168,0.0414711892457315,0.360089937209612
Physical measures,X4270.Volume level set by participant (left),PGLYRP1,Peptidoglycan recognition protein 1,16773,0.0267984840330115,0.0293075956272069,-0.0306444033963141,0.0842413714623372,0.360526695142664
Physical measures,X4270.Volume level set by participant (left),TSC1,Hamartin,14207,-0.0177880174165117,0.0194546380849173,-0.0559191080629496,0.0203430732299262,0.360557436401494
Physical measures,X4270.Volume level set by participant (left),MSRA,Mitochondrial peptide methionine sulfoxide reductase,16719,-0.0165526916544405,0.0181538308091299,-0.0521342000403352,0.0190288167314542,0.361886337236833
Physical measures,X4270.Volume level set by participant (left),VPS37A,Vacuolar protein sorting-associated protein 37A,16576,-0.0148554213435319,0.0162945626217617,-0.0467927640821847,0.0170819213951209,0.361950644894096
Physical measures,X4270.Volume level set by participant (left),MYL6B,Myosin light chain 6B,14261,-0.0148779036573255,0.0163234111142457,-0.046871789441247,0.0171159821265961,0.362075982620904
Physical measures,X4270.Volume level set by participant (left),DSG4,Desmoglein-4,16512,0.0235283110217492,0.0258258688109116,-0.0270903918476375,0.0741470138911359,0.362289416710565
Physical measures,X4270.Volume level set by participant (left),CNTN1,Contactin-1,16871,-0.0417662935669588,0.0458650216021257,-0.131661735907125,0.0481291487732076,0.362500750339404
Physical measures,X4270.Volume level set by participant (left),VEGFA,Vascular endothelial growth factor A,16799,-0.0200453906214305,0.022024087632567,-0.0632126023812619,0.0231218211384009,0.362752475886147
Physical measures,X4270.Volume level set by participant (left),RNASE4,Ribonuclease 4,14199,0.049772329573969,0.0547263097326292,-0.0574912375019843,0.157035896649922,0.363113756451059
Physical measures,X4270.Volume level set by participant (left),LAT2,Linker for activation of T-cells family member 2,16576,-0.00962348874711746,0.010581613037086,-0.0303634502998061,0.0111164728055711,0.363123842964342
Physical measures,X4270.Volume level set by participant (left),INHBC,Inhibin beta C chain,16671,0.0279869485058199,0.030778199137427,-0.0323383218035369,0.0883122188151768,0.36319925675819
Physical measures,X4270.Volume level set by participant (left),GSTM4,Glutathione S-transferase Mu 4,14175,-0.0195651425857474,0.021521899239756,-0.0617480650956691,0.0226177799241743,0.363323019702712
Physical measures,X4270.Volume level set by participant (left),SIRPB1,Signal-regulatory protein beta-1,16609,0.0251545205509244,0.0276794728380175,-0.02909724621159,0.0794062873134387,0.36348005255514
Physical measures,X4270.Volume level set by participant (left),SEMA7A,Semaphorin-7A,16805,-0.0414130347303089,0.0456298808885455,-0.130847601271858,0.0480215318112403,0.364110094496018
Physical measures,X4270.Volume level set by participant (left),MNDA,Myeloid cell nuclear differentiation antigen,16642,0.0117820657508157,0.0129919886201036,-0.0136822319445873,0.0372463634462188,0.364487834941386
Physical measures,X4270.Volume level set by participant (left),RCC1,Regulator of chromosome condensation,14572,-0.025362652815084,0.028013899948925,-0.0802698967149769,0.0295445910848089,0.365289905548081
Physical measures,X4270.Volume level set by participant (left),CD200R1,Cell surface glycoprotein CD200 receptor 1,16575,0.0329215126690819,0.0363903034515315,-0.0384034820959198,0.104246507434084,0.365649078555578
Physical measures,X4270.Volume level set by participant (left),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14352,-0.0154790710341985,0.0171127483527389,-0.0490200578055667,0.0180619157371696,0.365727257604916
Physical measures,X4270.Volume level set by participant (left),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14288,-0.015206391101078,0.0168232731751899,-0.0481800065244503,0.0177672243222942,0.366068904158914
Physical measures,X4270.Volume level set by participant (left),XRCC4,DNA repair protein XRCC4,16257,-0.0315308766804498,0.0348990264010061,-0.0999329684264218,0.0368712150655222,0.366279973535193
Physical measures,X4270.Volume level set by participant (left),DENND2B,DENN domain-containing protein 2B,14175,0.0276647808183609,0.0306472870164771,-0.0324039017339342,0.0877334633706561,0.366709590552709
Physical measures,X4270.Volume level set by participant (left),CIT,Citron Rho-interacting kinase,14261,0.0282784822037125,0.0313341527364847,-0.0331364571597976,0.0896934215672226,0.366816590737222
Physical measures,X4270.Volume level set by participant (left),RGMB,RGM domain family member B,16799,-0.0430021752611608,0.0476687887494056,-0.136433001209996,0.0504286506876741,0.367014902447282
Physical measures,X4270.Volume level set by participant (left),MYOM1,Myomesin-1,14168,-0.0289301826137516,0.0320802708011365,-0.0918075133839792,0.033947148156476,0.367175248448851
Physical measures,X4270.Volume level set by participant (left),CNTN5,Contactin-5,16692,-0.030873506645568,0.0342417956321568,-0.0979874260845954,0.0362404127934594,0.367265285185139
Physical measures,X4270.Volume level set by participant (left),PSG1,Pregnancy-specific beta-1-glycoprotein 1,16533,0.0100884025282208,0.0111950580838494,-0.011853911316124,0.0320307163725656,0.367522854262171
Physical measures,X4270.Volume level set by participant (left),CPLX2,Complexin-2,14144,-0.042621626542343,0.0473205192562157,-0.135369844284526,0.0501265911998396,0.367762811032031
Physical measures,X4270.Volume level set by participant (left),GUCA2A,Guanylin,16565,-0.0344589940846162,0.0382698258364271,-0.109467852724013,0.0405498645547809,0.367908807287451
Physical measures,X4270.Volume level set by participant (left),DNM1,Dynamin-1,14588,-0.0118293764410297,0.0131522898480845,-0.0376078645432754,0.0139491116612159,0.36844612412683
Physical measures,X4270.Volume level set by participant (left),MED21,Mediator of RNA polymerase II transcription subunit 21,14175,-0.0273872579254676,0.0304544051674392,-0.0870778920536484,0.0323033762027132,0.368514977247541
Physical measures,X4270.Volume level set by participant (left),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",14175,-0.0271588966881397,0.0302448721296505,-0.0864388460622547,0.0321210526859754,0.369218419981336
Physical measures,X4270.Volume level set by participant (left),EIF5,Eukaryotic translation initiation factor 5,14175,-0.0313715997995706,0.0349635150958245,-0.0999000893873867,0.0371568897882455,0.369591847710562
Physical measures,X4270.Volume level set by participant (left),MTPN,Myotrophin,16356,-0.0358537858162264,0.0399632617187231,-0.114181778784924,0.0424742071524709,0.369642146549476
Physical measures,X4270.Volume level set by participant (left),DLL1,Delta-like protein 1,16719,0.0385794279346661,0.0431521302070035,-0.0459987472710607,0.123157603140393,0.371317123505245
Physical measures,X4270.Volume level set by participant (left),CLEC4M,C-type lectin domain family 4 member M,14658,0.0270559244362322,0.0302816263909237,-0.0322960632899782,0.0864079121624427,0.371616686422171
Physical measures,X4270.Volume level set by participant (left),KRT14,"Keratin, type I cytoskeletal 14",15802,0.0403669430605061,0.0451800040484523,-0.0481858648744604,0.128919750995473,0.371619568733343
Physical measures,X4270.Volume level set by participant (left),LPL,Lipoprotein lipase,16666,-0.0238503113648488,0.0267075645687894,-0.076197137919676,0.0284965151899784,0.371860932658842
Physical measures,X4270.Volume level set by participant (left),TXNL1,Thioredoxin-like protein 1,14139,-0.0133952557454499,0.0150258564456555,-0.0428459343789347,0.0160554228880349,0.372686717842551
Physical measures,X4270.Volume level set by participant (left),SERPINA11,Serpin A11,16871,-0.0269526323369166,0.0302963569289533,-0.0863334919176651,0.0324282272438319,0.373675794803804
Physical measures,X4270.Volume level set by participant (left),IMPG1,Interphotoreceptor matrix proteoglycan 1,14168,0.0458334306095062,0.0515312591202985,-0.0551678372662788,0.146834698485291,0.373787326454809
Physical measures,X4270.Volume level set by participant (left),DDI2,Protein DDI1 homolog 2,14352,-0.0169124169746712,0.0190192415828919,-0.0541901304771394,0.020365296527797,0.373896190464459
Physical measures,X4270.Volume level set by participant (left),IL12RB2,Interleukin-12 receptor subunit beta-2,14207,-0.0315820148385408,0.0355219388943416,-0.10120501507145,0.0380409853943686,0.373972595223332
Physical measures,X4270.Volume level set by participant (left),BRAP,BRCA1-associated protein,14451,-0.0130749186780228,0.0147196731906981,-0.041925478131791,0.0157756407757453,0.374414917006688
Physical measures,X4270.Volume level set by participant (left),CA13,Carbonic anhydrase 13,16513,-0.0112220919216565,0.0126369786200233,-0.0359905700169023,0.0135463861735892,0.374534335709113
Physical measures,X4270.Volume level set by participant (left),PRRT3,Proline-rich transmembrane protein 3,14288,-0.0351110504137727,0.0395494175615139,-0.11262790883434,0.0424058080067945,0.374675853877822
Physical measures,X4270.Volume level set by participant (left),COL4A4,Collagen alpha-4(IV) chain,14388,-0.0254731223416582,0.0287115041995797,-0.0817476705728343,0.030801425889518,0.374980908620483
Physical measures,X4270.Volume level set by participant (left),NUDC,Nuclear migration protein nudC,16843,-0.0183024559784041,0.0206640942166639,-0.0588040806430654,0.0221991686862571,0.375784882369993
Physical measures,X4270.Volume level set by participant (left),ESYT2,Extended synaptotagmin-2,14628,-0.0155580667463006,0.0175940857893802,-0.0500424748934858,0.0189263414008845,0.376560596731612
Physical measures,X4270.Volume level set by participant (left),GIT1,ARF GTPase-activating protein GIT1,14207,-0.0144689754810938,0.0163980664250517,-0.0466091856741951,0.0176712347120075,0.377597844826155
Physical measures,X4270.Volume level set by participant (left),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,14144,-0.0509940856912781,0.0578231754001553,-0.164327509475582,0.0623393380930263,0.377847506923256
Physical measures,X4270.Volume level set by participant (left),AMFR,E3 ubiquitin-protein ligase AMFR,16257,-0.0172334937680651,0.0195521760125238,-0.0555557587526117,0.0210887712164816,0.378108706311869
Physical measures,X4270.Volume level set by participant (left),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14404,-0.0354712853897604,0.0403124117132839,-0.114483612347797,0.043541041568276,0.378922882301737
Physical measures,X4270.Volume level set by participant (left),BMP10,Bone morphogenetic protein 10,14352,-0.0459384308486034,0.0522828184948086,-0.148412755098428,0.0565358934012214,0.379604430554733
Physical measures,X4270.Volume level set by participant (left),POF1B,Protein POF1B,14207,0.028680921668471,0.0326532475312658,-0.03531944349281,0.092681286829752,0.379769650135851
Physical measures,X4270.Volume level set by participant (left),CLU,Clusterin,14697,-0.0398724018788854,0.0454852619851075,-0.129023515369696,0.0492787116119253,0.380718029817819
Physical measures,X4270.Volume level set by participant (left),MPHOSPH8,M-phase phosphoprotein 8,16356,-0.0151115409449566,0.0172471328837392,-0.0489159213970854,0.0186928395071722,0.380946705322437
Physical measures,X4270.Volume level set by participant (left),NFKB1,Nuclear factor NF-kappa-B p105 subunit,14175,-0.0187874586711744,0.0214471641449629,-0.0608239003953017,0.0232489830529529,0.381051412729909
Physical measures,X4270.Volume level set by participant (left),ISM2,Isthmin-2,14678,-0.0287683320322315,0.0328540664995078,-0.0931623023712668,0.0356256383068038,0.381240163857267
Physical measures,X4270.Volume level set by participant (left),LMOD1,Leiomodin-1,14629,-0.0358487835018835,0.0409833792068656,-0.11617620674734,0.0444786397435731,0.381743280738216
Physical measures,X4270.Volume level set by participant (left),SLAMF6,SLAM family member 6,16266,-0.0294766281345771,0.0337193077087887,-0.0955664712438029,0.0366132149746488,0.382035033249767
Physical measures,X4270.Volume level set by participant (left),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14629,-0.0217002483048169,0.024853882990867,-0.0704138589669163,0.0270133623572824,0.382615837264527
Physical measures,X4270.Volume level set by participant (left),C7orf50,Uncharacterized protein C7orf50,14628,-0.0623780272088675,0.0714576295045473,-0.20243498103778,0.0776789266200453,0.382711622116078
Physical measures,X4270.Volume level set by participant (left),TYRO3,Tyrosine-protein kinase receptor TYRO3,16666,-0.0390752379049166,0.0447798952516575,-0.126843832598165,0.0486933567883321,0.382890056024224
Physical measures,X4270.Volume level set by participant (left),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",14207,-0.0266798141959912,0.0306204159950315,-0.086695829546253,0.0333362011542706,0.383600730425112
Physical measures,X4270.Volume level set by participant (left),TXK,Tyrosine-protein kinase TXK,14404,-0.0168617515120925,0.0193873946851253,-0.0548610450949381,0.021137542070753,0.384463815972635
Physical measures,X4270.Volume level set by participant (left),COMP,Cartilage oligomeric matrix protein,16459,-0.0333961879165598,0.0384163564995656,-0.108692246655708,0.0418998708225887,0.384683665003102
Physical measures,X4270.Volume level set by participant (left),KCNIP4,Kv channel-interacting protein 4,16257,0.0218277353859481,0.0251360842048429,-0.0274389896555439,0.0710944604274402,0.385197809613665
Physical measures,X4270.Volume level set by participant (left),STK24,Serine/threonine-protein kinase 24,16257,-0.0183637035648938,0.021154002296141,-0.0598255480653302,0.0230981409355425,0.385354639568842
Physical measures,X4270.Volume level set by participant (left),NTproBNP,N-terminal prohormone of brain natriuretic peptide,16666,0.0106671407178092,0.0122889435299832,-0.0134191886009579,0.0347534700365764,0.38539179903329
Physical measures,X4270.Volume level set by participant (left),ITGA6,Integrin alpha-6,16637,-0.0202739857871745,0.0233814497797277,-0.0661016273554408,0.0255536557810917,0.385901363138828
Physical measures,X4270.Volume level set by participant (left),GIPC3,PDZ domain-containing protein GIPC3,14588,-0.0134783744802837,0.015552954985961,-0.0439621662527672,0.0170054172921998,0.386169009927314
Physical measures,X4270.Volume level set by participant (left),TCP11,T-complex protein 11 homolog,14404,-0.0223497024857772,0.025835661451352,-0.0729875989304271,0.0282881939588726,0.387013798397058
Physical measures,X4270.Volume level set by participant (left),DDA1,DET1- and DDB1-associated protein 1,14175,-0.0325885582996974,0.0377132968120398,-0.106506620051295,0.0413295034519006,0.387540337242631
Physical measures,X4270.Volume level set by participant (left),LYPD8,Ly6/PLAUR domain-containing protein 8,16266,-0.0210421293305692,0.0243540186086326,-0.0687760058034891,0.0266917471423507,0.387594841551792
Physical measures,X4270.Volume level set by participant (left),ULBP2,UL16-binding protein 2,16533,0.0293021037585277,0.0339728296454525,-0.0372846423465591,0.0958888498636145,0.388416242802461
Physical measures,X4270.Volume level set by participant (left),GFER,FAD-linked sulfhydryl oxidase ALR,16266,-0.0176214200589573,0.0204420143834846,-0.0576877682505872,0.0224449281326726,0.388689372688364
Physical measures,X4270.Volume level set by participant (left),TSPAN7,Tetraspanin-7,14168,-0.0137206157876506,0.0159200527644959,-0.0449239192060625,0.0174826876307613,0.388787494108118
Physical measures,X4270.Volume level set by participant (left),VWF,von Willebrand factor,16871,0.0146057346530014,0.0169562084542977,-0.0186284339174221,0.0478399032234249,0.389041177853885
Physical measures,X4270.Volume level set by participant (left),EPHA4,Ephrin type-A receptor 4,14352,-0.0451848235179573,0.0524908416196458,-0.148066873092463,0.0576972260565485,0.389355182192216
Physical measures,X4270.Volume level set by participant (left),ENO1,Alpha-enolase,16656,-0.0147280722360409,0.0171125893123806,-0.0482687472883069,0.0188126028162251,0.389439304499588
Physical measures,X4270.Volume level set by participant (left),MMP13,Collagenase 3,16257,-0.0346456116779625,0.0402564421713726,-0.113548238333853,0.0442570149779278,0.389458533731009
Physical measures,X4270.Volume level set by participant (left),SNRPB2,U2 small nuclear ribonucleoprotein B'',14628,-0.0309424396999228,0.0359674295771203,-0.101438601671079,0.0395537222712329,0.38964301756243
Physical measures,X4270.Volume level set by participant (left),GPD1,Glycerol-3-phosphate dehydrogenase,14572,-0.023712432736425,0.0275785297809687,-0.0777663511071238,0.0303414856342737,0.389905207604791
Physical measures,X4270.Volume level set by participant (left),MIA,Melanoma-derived growth regulatory protein,16719,0.0293754420272671,0.0343715625706907,-0.0379928206112866,0.0967437046658208,0.392760643483859
Physical measures,X4270.Volume level set by participant (left),NRXN3,Neurexin-3,14261,0.0349541047072775,0.040904855171202,-0.0452194114282785,0.115127620842833,0.39283011444535
Physical measures,X4270.Volume level set by participant (left),CCL25,C-C motif chemokine 25,16843,0.021584535564623,0.0252683213296135,-0.0279413742414195,0.0711104453706655,0.392998989288846
Physical measures,X4270.Volume level set by participant (left),C2,Complement C2,16685,0.0468472534137882,0.0549521443890356,-0.0608589495887216,0.154553456416298,0.3939433323014
Physical measures,X4270.Volume level set by participant (left),DIPK1C,Divergent protein kinase domain 1C,14261,-0.030195431907246,0.035428940070571,-0.0996361544455653,0.0392452906310732,0.394072173950627
Physical measures,X4270.Volume level set by participant (left),RPA2,Replication protein A 32 kDa subunit,14207,-0.0410694429864992,0.0483448437180572,-0.135825336673891,0.053686450700893,0.395611729696506
Physical measures,X4270.Volume level set by participant (left),CFI,Complement factor I,14697,-0.0612322772650046,0.0721884559258202,-0.202721650879612,0.080257096349603,0.396324777376508
Physical measures,X4270.Volume level set by participant (left),TBC1D17,TBC1 domain family member 17,16257,-0.0234394152610755,0.0276362432327663,-0.0776064519972974,0.0307276214751464,0.396372267168002
Physical measures,X4270.Volume level set by participant (left),SERPINA1,Alpha-1-antitrypsin,14363,-0.147619969560158,0.174070105049187,-0.488797375456564,0.193557436336248,0.396424859857092
Physical measures,X4270.Volume level set by participant (left),ACHE,Acetylcholinesterase,14352,-0.0389088469114213,0.0458985973845362,-0.128870097785112,0.0510524039622697,0.396611866005089
Physical measures,X4270.Volume level set by participant (left),MAPK9,Mitogen-activated protein kinase 9,16637,-0.0246531879473072,0.0291469330996831,-0.0817811768226861,0.0324748009280717,0.397662874329783
Physical measures,X4270.Volume level set by participant (left),PRSS22,Brain-specific serine protease 4,14207,-0.0358358491124299,0.0424816488338021,-0.119099880826682,0.0474281826018223,0.398929156750809
Physical measures,X4270.Volume level set by participant (left),USP28,Ubiquitin carboxyl-terminal hydrolase 28,14628,-0.0326567203759044,0.0387371764926821,-0.108581586301561,0.0432681455497524,0.399223755509365
Physical measures,X4270.Volume level set by participant (left),IL13,Interleukin-13,16350,0.0222615876790635,0.0264531466474071,-0.0295865797498545,0.0741097551079815,0.400053432707702
Physical measures,X4270.Volume level set by participant (left),SIGLEC9,Sialic acid-binding Ig-like lectin 9,16788,0.0348595447422526,0.041432944459086,-0.0463490263975559,0.116068115882061,0.400164736045884
Physical measures,X4270.Volume level set by participant (left),APCS,Serum amyloid P-component,14577,0.0355069128825602,0.0422410782650857,-0.0472856005170078,0.118299426282128,0.40059829993839
Physical measures,X4270.Volume level set by participant (left),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14572,-0.0116377242862823,0.0138460989688308,-0.0387760782651907,0.0155006296926261,0.400638746961069
Physical measures,X4270.Volume level set by participant (left),SNX9,Sorting nexin-9,16666,-0.0162656424769733,0.0193523319296984,-0.0541962130591821,0.0216649281052355,0.400639954848421
Physical measures,X4270.Volume level set by participant (left),ALPP,"Alkaline phosphatase, placental type",16576,0.0103552384892359,0.0123213838822176,-0.0137946739199106,0.0345051508983824,0.400680477345271
Physical measures,X4270.Volume level set by participant (left),SMTN,Smoothelin,14582,-0.0122417511386106,0.0145704833185881,-0.0407998984430432,0.016316396165822,0.400824244791541
Physical measures,X4270.Volume level set by participant (left),IGFBPL1,Insulin-like growth factor-binding protein-like 1,16666,-0.0320265394154223,0.0381489634365462,-0.106798507751053,0.0427454289202082,0.401193718039549
Physical measures,X4270.Volume level set by participant (left),MED18,Mediator of RNA polymerase II transcription subunit 18,16266,-0.0147952191071011,0.0176259149942217,-0.0493420124957757,0.0197515742815735,0.401256403603921
Physical measures,X4270.Volume level set by participant (left),ARL13B,ADP-ribosylation factor-like protein 13B,14175,-0.0181829860180204,0.0216620751797638,-0.0606406533703574,0.0242746813343167,0.401263197223763
Physical measures,X4270.Volume level set by participant (left),NCS1,Neuronal calcium sensor 1,16810,-0.037131332345865,0.0442372668988692,-0.123836375467649,0.0495737107759185,0.401274959964064
Physical measures,X4270.Volume level set by participant (left),ELAVL4,ELAV-like protein 4,14168,-0.0151032498043939,0.0179989844686671,-0.0503812593629814,0.0201747597541936,0.401417958015935
Physical measures,X4270.Volume level set by participant (left),CPPED1,Serine/threonine-protein phosphatase CPPED1,16799,-0.0161490496879178,0.019279131217589,-0.0539361468743921,0.0216380474985566,0.402242570189727
Physical measures,X4270.Volume level set by participant (left),DPP7,Dipeptidyl peptidase 2,16552,0.0178048450907553,0.0212760173329212,-0.0238961488817702,0.0595058390632809,0.402688718622931
Physical measures,X4270.Volume level set by participant (left),SPINK2,Serine protease inhibitor Kazal-type 2,14352,0.0329573000703347,0.0394218967253959,-0.0443096175114412,0.110224217652111,0.40316035520481
Physical measures,X4270.Volume level set by participant (left),OSMR,Oncostatin-M-specific receptor subunit beta,16762,0.0518572014676253,0.0620678443899917,-0.0697957735367584,0.173510176472009,0.403452542965626
Physical measures,X4270.Volume level set by participant (left),CCDC80,Coiled-coil domain-containing protein 80,16666,0.0300926238994976,0.0360533758393502,-0.0405719927456288,0.100757240544624,0.403916252561069
Physical measures,X4270.Volume level set by participant (left),DBN1,Drebrin,14207,-0.0237477119494842,0.0285075909673259,-0.0796225902454429,0.0321271663464745,0.404841168907596
Physical measures,X4270.Volume level set by participant (left),GRIK2,"Glutamate receptor ionotropic, kainate 2",14629,0.0298207634510836,0.0358395223434674,-0.0404247003421126,0.10006622724428,0.405386621098336
Physical measures,X4270.Volume level set by participant (left),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14572,0.0176943895155112,0.0212789956614314,-0.0240124419808944,0.0594012210119167,0.40568086391073
Physical measures,X4270.Volume level set by participant (left),TUBB3,Tubulin beta-3 chain,14168,-0.0441706211101149,0.0531966569360837,-0.148436068704839,0.0600948264846092,0.406367928499031
Physical measures,X4270.Volume level set by participant (left),GRAP2,GRB2-related adapter protein 2,16666,-0.008533785053196,0.0102804995010071,-0.0286835640751698,0.0116159939687778,0.406497315986178
Physical measures,X4270.Volume level set by participant (left),MXRA8,Matrix remodeling-associated protein 8,14352,-0.0407528719665829,0.0491291736905644,-0.137046052400089,0.0555403084669233,0.40683278893924
Physical measures,X4270.Volume level set by participant (left),RRP15,RRP15-like protein,14168,-0.0135042843011134,0.016285181950083,-0.0454232409232761,0.0184146723210492,0.406983990692863
Physical measures,X4270.Volume level set by participant (left),PSCA,Prostate stem cell antigen,14588,-0.00471138468907938,0.00568182725591534,-0.0158477661106734,0.00642499673251469,0.407003481117918
Physical measures,X4270.Volume level set by participant (left),GAS6,Growth arrest-specific protein 6,16747,0.0402925161114986,0.0486548719567895,-0.0550710329238089,0.135656065146806,0.407609194878325
Physical measures,X4270.Volume level set by participant (left),CST3,Cystatin-C,16693,0.0381036705868562,0.0460224218717016,-0.0521002762816789,0.128307617455391,0.407717969952669
Physical measures,X4270.Volume level set by participant (left),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14652,-0.0403498742676874,0.0487707758332699,-0.135940594900896,0.0552408463655216,0.408059487184963
Physical measures,X4270.Volume level set by participant (left),ESPL1,Separin,14144,-0.022070240500476,0.0267293313917062,-0.0744597300282201,0.030319249027268,0.408991810953669
Physical measures,X4270.Volume level set by participant (left),RETN,Resistin,16630,0.0238517562876139,0.0289976301121799,-0.0329835987322588,0.0806871113074865,0.410780541692848
Physical measures,X4270.Volume level set by participant (left),UNC5D,Netrin receptor UNC5D,14207,-0.0462807018710445,0.0562864744481224,-0.156602191789364,0.0640407880472754,0.410957053496433
Physical measures,X4270.Volume level set by participant (left),CTSO,Cathepsin O,16843,-0.0340458747842972,0.0414139799790439,-0.115217275543223,0.0471255259746289,0.411039304395713
Physical measures,X4270.Volume level set by participant (left),PKD1,Polycystin-1,14652,-0.0458940482272509,0.0558351361136794,-0.155330915010062,0.0635428185555607,0.411115094532162
Physical measures,X4270.Volume level set by participant (left),SERPINB1,Leukocyte elastase inhibitor,16595,-0.0122947278769695,0.0149593195364242,-0.0416149941683609,0.0170255384144219,0.411158449645432
Physical measures,X4270.Volume level set by participant (left),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16257,-0.0167571892862252,0.0204819558483418,-0.0569018227489752,0.0233874441765248,0.413286970844075
Physical measures,X4270.Volume level set by participant (left),STAT2,Signal transducer and activator of transcription 2,14207,-0.0160381524998627,0.0196044104743414,-0.0544627970295719,0.0223864920298464,0.413320108126126
Physical measures,X4270.Volume level set by participant (left),PRKG1,cGMP-dependent protein kinase 1,14352,-0.00977035311649219,0.0119445278424228,-0.0331816276876408,0.0136409214546564,0.413383722039824
Physical measures,X4270.Volume level set by participant (left),TGFBR1,TGF-beta receptor type-1,14207,0.0553749633063294,0.0678190444441108,-0.0775503638041277,0.188300290416787,0.414221915528917
Physical measures,X4270.Volume level set by participant (left),CCN5,CCN family member 5,16671,0.0267082920719057,0.0327118746823153,-0.0374069823054324,0.0908235664492438,0.414242568244628
Physical measures,X4270.Volume level set by participant (left),ARHGEF1,Rho guanine nucleotide exchange factor 1,14628,-0.013944434988002,0.0170848813042905,-0.0474308023444115,0.0195419323684074,0.41440726762219
Physical measures,X4270.Volume level set by participant (left),FURIN,Furin,16719,-0.0306180330139389,0.0375221969055654,-0.104161538948847,0.0429254729209693,0.414512987033848
Physical measures,X4270.Volume level set by participant (left),LRRC38,Leucine-rich repeat-containing protein 38,14261,0.0248943645384243,0.0305095034032975,-0.0349042621320388,0.0846929912088874,0.414539842414621
Physical measures,X4270.Volume level set by participant (left),PGF,Placenta growth factor,16843,0.0397592791748752,0.0487334874350744,-0.0557583561978706,0.135276914547621,0.414596736320186
Physical measures,X4270.Volume level set by participant (left),ZNRD2,Protein ZNRD2,14588,-0.0171205382722752,0.0209867287140253,-0.0582545265517648,0.0240134500072145,0.414639725384356
Physical measures,X4270.Volume level set by participant (left),ARG2,"Arginase-2, mitochondrial",14572,0.0279087441073376,0.034241245126035,-0.039204096339691,0.0950215845543663,0.415050051443904
Physical measures,X4270.Volume level set by participant (left),COPB2,Coatomer subunit beta',14175,-0.0280999272104384,0.0345134446314665,-0.0957462786881128,0.039546424267236,0.415559337288022
Physical measures,X4270.Volume level set by participant (left),BATF,Basic leucine zipper transcriptional factor ATF-like,14261,-0.0146635596510019,0.0180377447230257,-0.0500175393081323,0.0206904200061285,0.416267462499993
Physical measures,X4270.Volume level set by participant (left),NPPB,Natriuretic peptides B,16356,-0.00784079392107393,0.00966502249487613,-0.0267842380110311,0.0111026501688833,0.417231295530095
Physical measures,X4270.Volume level set by participant (left),IL7,Interleukin-7,16637,-0.015946040784472,0.0196659155688851,-0.0544912352994868,0.0225991537305427,0.417465380047766
Physical measures,X4270.Volume level set by participant (left),PTK7,Inactive tyrosine-protein kinase 7,16257,0.0276154475543028,0.0340811925873612,-0.0391836899169252,0.0944145850255308,0.417788799897277
Physical measures,X4270.Volume level set by participant (left),OSBPL2,Oxysterol-binding protein-related protein 2,14628,-0.0295441226614232,0.03647481249145,-0.101034755144665,0.0419465098218189,0.417960858893804
Physical measures,X4270.Volume level set by participant (left),DAG1,Dystroglycan,16733,-0.0215847694814452,0.0266509419379589,-0.0738206156798447,0.0306510767169542,0.418005479675587
Physical measures,X4270.Volume level set by participant (left),MTUS1,Microtubule-associated tumor suppressor 1,14404,-0.0216288505611978,0.0267226227661003,-0.0740051911827543,0.0307474900603587,0.418307962090276
Physical measures,X4270.Volume level set by participant (left),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16266,0.0130878252799834,0.0162213331436499,-0.0187059876815703,0.0448816382415371,0.419777411629001
Physical measures,X4270.Volume level set by participant (left),IL17RB,Interleukin-17 receptor B,16432,0.019554043079456,0.0242411539726695,-0.0279586187069762,0.0670667048658881,0.419881836474398
Physical measures,X4270.Volume level set by participant (left),CPXM1,Probable carboxypeptidase X1,16719,-0.014929308642014,0.018540506522369,-0.0512687014258574,0.0214100841418293,0.420700404021929
Physical measures,X4270.Volume level set by participant (left),SSH3,Protein phosphatase Slingshot homolog 3,14144,-0.041072191466888,0.0510569921126311,-0.141143896007645,0.0589995130738689,0.421157522095409
Physical measures,X4270.Volume level set by participant (left),FUT8,"Alpha-(1,6)-fucosyltransferase",16533,-0.0178240716198637,0.0221796727029456,-0.0612962301176371,0.0256480868779098,0.421626913370814
Physical measures,X4270.Volume level set by participant (left),BMP4,Bone morphogenetic protein 4,16500,-0.0190151288603443,0.0236715941709438,-0.0654114534353941,0.0273811957147055,0.421819354922713
Physical measures,X4270.Volume level set by participant (left),MAP2,Microtubule-associated protein 2,14628,-0.0244369490364804,0.0304382206612236,-0.0840958615324786,0.0352219634595179,0.422081646190901
Physical measures,X4270.Volume level set by participant (left),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16533,-0.0144372422298125,0.017988848260122,-0.0496953848196517,0.0208209003600267,0.422237038675907
Physical measures,X4270.Volume level set by participant (left),GDF2,Growth/differentiation factor 2,16666,-0.0281805670836856,0.0351204102441833,-0.0970165711622849,0.0406554369949137,0.42233389117984
Physical measures,X4270.Volume level set by participant (left),OBP2B,Odorant-binding protein 2b,16474,-0.0163500267456611,0.0203905959089614,-0.0563155947272254,0.0236155412359032,0.422656206102281
Physical measures,X4270.Volume level set by participant (left),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16810,0.0298902181043179,0.0373062775542748,-0.0432300859020606,0.103010522110696,0.423020558299025
Physical measures,X4270.Volume level set by participant (left),SPINT1,Kunitz-type protease inhibitor 1,16596,0.0396296999729203,0.0494990047864978,-0.0573883494086154,0.136647749354456,0.423365401945736
Physical measures,X4270.Volume level set by participant (left),AMN,Protein amnionless,16350,0.0216682997404641,0.0270676430559738,-0.0313842806492446,0.0747208801301728,0.423418868198738
Physical measures,X4270.Volume level set by participant (left),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16350,-0.00878549012714089,0.0109775813938815,-0.0303015496591487,0.0127305694048669,0.423541692069545
Physical measures,X4270.Volume level set by participant (left),ID4,DNA-binding protein inhibitor ID-4,14404,-0.0266563829180029,0.0333137873601794,-0.0919514061439546,0.0386386403079488,0.423630916724907
Physical measures,X4270.Volume level set by participant (left),OTOA,Otoancorin,14168,-0.0223753892538967,0.0280046384972432,-0.0772644807084934,0.0325137022007,0.424310383376831
Physical measures,X4270.Volume level set by participant (left),VPS53,Vacuolar protein sorting-associated protein 53 homolog,16576,-0.0130503761926274,0.0163459346270386,-0.0450884080616231,0.0189876556763683,0.424657590573844
Physical measures,X4270.Volume level set by participant (left),MTDH,Protein LYRIC,14207,-0.0133675253479036,0.0167694713271319,-0.0462356891490822,0.019500638453275,0.425386217254958
Physical measures,X4270.Volume level set by participant (left),PODXL,Podocalyxin,16576,-0.0661736057872217,0.0831013026720898,-0.229052159024518,0.0967049474500742,0.425868832292007
Physical measures,X4270.Volume level set by participant (left),MANF,Mesencephalic astrocyte-derived neurotrophic factor,16733,-0.00875240085748669,0.0109928721682491,-0.030298430307255,0.0127936285922816,0.425933657622978
Physical measures,X4270.Volume level set by participant (left),BID,BH3-interacting domain death agonist,16637,-0.0150245978056851,0.0188902123024211,-0.0520494139184304,0.0220002183070602,0.426413061263685
Physical measures,X4270.Volume level set by participant (left),TNC,Tenascin,16715,0.0209505277729429,0.0263503892106507,-0.0306962350799324,0.0725972906258182,0.426581351896864
Physical measures,X4270.Volume level set by participant (left),PLB1,"Phospholipase B1, membrane-associated",14628,0.0195058866615385,0.0245510048448948,-0.0286140828344553,0.0676258561575324,0.426914627484226
Physical measures,X4270.Volume level set by participant (left),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13792,-0.0245217000920235,0.0308684902487051,-0.0850239409794854,0.0359805407954384,0.426980598651397
Physical measures,X4270.Volume level set by participant (left),CCL18,C-C motif chemokine 18,16418,0.0143016937690285,0.0180102669002052,-0.0209984293553737,0.0496018168934307,0.427157083636778
Physical measures,X4270.Volume level set by participant (left),KLK4,Kallikrein-4,16810,-0.015800319782657,0.0199065267147125,-0.0548171121434936,0.0232164725781796,0.427366410889283
Physical measures,X4270.Volume level set by participant (left),C1GALT1C1,C1GALT1-specific chaperone 1,14175,0.0372390371160176,0.0469188145962599,-0.0547218394926518,0.129199913724687,0.427388689268132
Physical measures,X4270.Volume level set by participant (left),AMOT,Angiomotin,14352,-0.0291462474425914,0.0367998822870877,-0.101274016725283,0.0429815218401004,0.428362046377877
Physical measures,X4270.Volume level set by participant (left),PDLIM7,PDZ and LIM domain protein 7,16733,-0.00795282041460949,0.0100486592981069,-0.027648192638899,0.0117425518096801,0.428703759105304
Physical measures,X4270.Volume level set by participant (left),TMPRSS11B,Transmembrane protease serine 11B,14168,0.0156756316289895,0.0198137379829871,-0.0231592948176652,0.0545105580756443,0.428869935603836
Physical measures,X4270.Volume level set by participant (left),DHPS,Deoxyhypusine synthase,14572,-0.0288974510507509,0.0365299718421685,-0.100496195861401,0.0427012937598992,0.428921046333214
Physical measures,X4270.Volume level set by participant (left),DNAJA2,DnaJ homolog subfamily A member 2,16779,-0.0128449288515745,0.0162396347416469,-0.0446746129452023,0.0189847552420534,0.428977541734536
Physical measures,X4270.Volume level set by participant (left),CD55,Complement decay-accelerating factor,16114,0.0403602038568939,0.0510806149455114,-0.0597578014363085,0.140478209150096,0.42946489018161
Physical measures,X4270.Volume level set by participant (left),VEGFC,Vascular endothelial growth factor C,16719,-0.0180209240854367,0.0228226522754134,-0.062753322545247,0.0267114743743737,0.429768577072269
Physical measures,X4270.Volume level set by participant (left),MAVS,Mitochondrial antiviral-signaling protein,16266,-0.0109254536067888,0.013865779876246,-0.038102382164231,0.0162514749506534,0.430741144471472
Physical measures,X4270.Volume level set by participant (left),TNIP1,TNFAIP3-interacting protein 1,14628,-0.013695019358068,0.0173818806270783,-0.0477635053871414,0.0203734666710054,0.43077351509521
Physical measures,X4270.Volume level set by participant (left),SPAG1,Sperm-associated antigen 1,14629,0.0194643296463064,0.0247165135343916,-0.0289800368811011,0.067908696173714,0.431000220628389
Physical measures,X4270.Volume level set by participant (left),HMCN2,Hemicentin-2,14319,0.0204652764161518,0.0259949007465119,-0.0304847290470116,0.0714152818793151,0.43113077424984
Physical measures,X4270.Volume level set by participant (left),DLL4,Delta-like protein 4,14288,-0.0136648915379887,0.0173654428824858,-0.0477011595876608,0.0203713765116834,0.431352647652649
Physical measures,X4270.Volume level set by participant (left),TDRKH,Tudor and KH domain-containing protein,16257,-0.0114254599694224,0.0145350743852023,-0.0399142057644189,0.0170632858255741,0.431843023942762
Physical measures,X4270.Volume level set by participant (left),CILP,Cartilage intermediate layer protein 1,14678,-0.0212714876314643,0.0270949877198837,-0.0743776635624363,0.0318346882995078,0.432424659221469
Physical measures,X4270.Volume level set by participant (left),TJP3,Tight junction protein ZO-3,14168,-0.0281395236511623,0.0358646578526715,-0.0984342530423985,0.0421552057400739,0.432699414469002
Physical measures,X4270.Volume level set by participant (left),DRG2,Developmentally-regulated GTP-binding protein 2,16576,-0.0180034103724479,0.0230494057287828,-0.0631802456008622,0.0271734248559664,0.434767106711013
Physical measures,X4270.Volume level set by participant (left),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16772,-0.0282025525710171,0.0361139977032711,-0.0989859880694285,0.0425808829273942,0.434853912211461
Physical measures,X4270.Volume level set by participant (left),PBK,Lymphokine-activated killer T-cell-originated protein kinase,14144,-0.0377660194658258,0.0484262610509603,-0.132681491125708,0.0571494521940565,0.435482514725135
Physical measures,X4270.Volume level set by participant (left),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16637,-0.0254330649695303,0.0326247243251113,-0.0893775246467483,0.0385113947076878,0.435658574285176
Physical measures,X4270.Volume level set by participant (left),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14332,-0.0238464511612807,0.0305957714923393,-0.0838141632862657,0.0361212609637043,0.435754951862021
Physical measures,X4270.Volume level set by participant (left),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16257,0.0209147013920493,0.0268397339713464,-0.0316911771917895,0.0735205799758882,0.43584735625907
Physical measures,X4270.Volume level set by participant (left),BIN2,Bridging integrator 2,16671,-0.0109703357720963,0.0140887367114797,-0.0385842597265965,0.0166435881824038,0.436191085949397
Physical measures,X4270.Volume level set by participant (left),CSPG5,Chondroitin sulfate proteoglycan 5,14168,-0.0240858672444543,0.0309794178112241,-0.0848055261544535,0.0366337916655449,0.436888827037057
Physical measures,X4270.Volume level set by participant (left),SATB1,DNA-binding protein SATB1,14629,-0.0389502728510825,0.0501171895226247,-0.137179964315427,0.059279418613262,0.437062860722009
Physical measures,X4270.Volume level set by participant (left),SH3BP1,SH3 domain-binding protein 1,14588,-0.0236657003650982,0.0304681197593833,-0.0833832150934894,0.036051814363293,0.437326862873407
Physical measures,X4270.Volume level set by participant (left),SCAMP3,Secretory carrier-associated membrane protein 3,16576,-0.011829727641555,0.0152393743907579,-0.0416989014474406,0.0180394461643306,0.437606151535415
Physical measures,X4270.Volume level set by participant (left),UXS1,UDP-glucuronic acid decarboxylase 1,16266,0.0182084890521916,0.0234771720905685,-0.0278067682453226,0.0642237463497059,0.438006692198149
Physical measures,X4270.Volume level set by participant (left),HK2,Hexokinase-2,16356,0.0353027842387569,0.0455427397194913,-0.0539609856114462,0.12456655408896,0.438257972150493
Physical measures,X4270.Volume level set by participant (left),DOC2B,Double C2-like domain-containing protein beta,14261,-0.0319780558546961,0.0412717704371169,-0.112870725911445,0.048914614202053,0.438460857247931
Physical measures,X4270.Volume level set by participant (left),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14207,-0.032520639902197,0.0420043287540039,-0.114849124260045,0.0498078444556507,0.438812919409088
Physical measures,X4270.Volume level set by participant (left),GIPC2,PDZ domain-containing protein GIPC2,14628,-0.0357343163754536,0.0461866707096591,-0.126260190966385,0.0547915582154783,0.439124717265132
Physical measures,X4270.Volume level set by participant (left),ASAH2,Neutral ceramidase,16533,-0.0187364102457185,0.0242625596730139,-0.0662910272048259,0.0288182067133888,0.439986000599147
Physical measures,X4270.Volume level set by participant (left),RBPMS2,RNA-binding protein with multiple splicing 2,14288,-0.0111121397228169,0.0144112601576231,-0.0393582096317581,0.0171339301861242,0.440676177475973
Physical measures,X4270.Volume level set by participant (left),CDKL5,Cyclin-dependent kinase-like 5,14168,-0.0225854665427693,0.0293216165275197,-0.0800558349367079,0.0348849018511694,0.441154528630761
Physical measures,X4270.Volume level set by participant (left),LGALS3BP,Galectin-3-binding protein,14697,-0.0366042561325777,0.0475515392238322,-0.129805273011289,0.0565967607461335,0.44144238902101
Physical measures,X4270.Volume level set by participant (left),EDN1,Endothelin-1,14288,-0.038848318721828,0.0504869331663643,-0.137802707727902,0.0601060702842461,0.44162545747181
Physical measures,X4270.Volume level set by participant (left),TIE1,Tyrosine-protein kinase receptor Tie-1,16871,0.023168636574017,0.0301176991571254,-0.0358620537739488,0.0821993269219828,0.441743938406513
Physical measures,X4270.Volume level set by participant (left),SIGLEC10,Sialic acid-binding Ig-like lectin 10,16637,-0.029155837835599,0.0379413160292935,-0.103520817253014,0.0452091415818163,0.442233409240824
Physical measures,X4270.Volume level set by participant (left),CSF2,Granulocyte-macrophage colony-stimulating factor,14175,-0.0315113673520781,0.0410397558132504,-0.111949288746049,0.0489265540418926,0.442603721242931
Physical measures,X4270.Volume level set by participant (left),AMOTL2,Angiomotin-like protein 2,14491,-0.022776817490393,0.0297003767545178,-0.0809895559292479,0.0354359209484619,0.443161518722203
Physical measures,X4270.Volume level set by participant (left),CD3G,T-cell surface glycoprotein CD3 gamma chain,14207,-0.0130065967761095,0.0169809315651406,-0.0462892226437852,0.0202760290915662,0.443716963308503
Physical measures,X4270.Volume level set by participant (left),TSHB,Thyrotropin subunit beta,16666,-0.0125884472227397,0.0164406190672159,-0.0448120605944829,0.0196351661490035,0.443870561290677
Physical measures,X4270.Volume level set by participant (left),NOS2,"Nitric oxide synthase, inducible",14175,-0.0291777099020119,0.0381321654375167,-0.103916754159545,0.0455613343555208,0.444181188276444
Physical measures,X4270.Volume level set by participant (left),CD1C,T-cell surface glycoprotein CD1c,16719,-0.0399722057281824,0.0523145744954955,-0.142508771739353,0.0625643602829887,0.444833944384015
Physical measures,X4270.Volume level set by participant (left),DOK2,Docking protein 2,16666,-0.00809918384045735,0.0106023259424947,-0.0288797426877469,0.0126813750068322,0.444933893672084
Physical measures,X4270.Volume level set by participant (left),OPHN1,Oligophrenin-1,14628,-0.010835712304023,0.0142063142661159,-0.0386800882656102,0.0170086636575641,0.4456312809314
Physical measures,X4270.Volume level set by participant (left),CDH22,Cadherin-22,14404,-0.0407262995147361,0.0533956709311725,-0.145381814539834,0.0639292155103619,0.445638957580982
Physical measures,X4270.Volume level set by participant (left),FAM13A,Protein FAM13A,14588,-0.0166641013812453,0.0218506967556115,-0.0594914670222438,0.0261632642597532,0.445693579966072
Physical measures,X4270.Volume level set by participant (left),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16637,-0.0100477980499781,0.01318345295776,-0.0358873658471876,0.0157917697472314,0.445979969597604
Physical measures,X4270.Volume level set by participant (left),RNF31,E3 ubiquitin-protein ligase RNF31,14207,-0.0304041544682704,0.0399753163241916,-0.108755774463686,0.0479474655271452,0.446924666382621
Physical measures,X4270.Volume level set by participant (left),EFNA1,Ephrin-A1,16640,0.0354225354427946,0.0465741620417455,-0.0558628221590266,0.126707893044616,0.44692954221119
Physical measures,X4270.Volume level set by participant (left),IMMT,MICOS complex subunit MIC60,14572,-0.0253253926806583,0.0333322498245567,-0.0906566023367894,0.0400058169754729,0.447394532933618
Physical measures,X4270.Volume level set by participant (left),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14404,-0.0253889227685889,0.0334499358592772,-0.0909507970527721,0.0401729515155944,0.447857454611077
Physical measures,X4270.Volume level set by participant (left),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16871,0.0324298410580178,0.0427300544882005,-0.0513210657388551,0.116180747854891,0.447894954049148
Physical measures,X4270.Volume level set by participant (left),IL12RB1,Interleukin-12 receptor subunit beta-1,16350,-0.0263325113092601,0.0346962383335303,-0.0943371384429796,0.0416721158244593,0.44789684662045
Physical measures,X4270.Volume level set by participant (left),SEZ6,Seizure protein 6 homolog,14261,-0.0359400683077681,0.0474096281114857,-0.12886293940628,0.0569828027907439,0.448418443945368
Physical measures,X4270.Volume level set by participant (left),MENT,Protein MENT,14352,0.051040518177335,0.0673324232157682,-0.0809310313255707,0.183012067680241,0.448440849007031
Physical measures,X4270.Volume level set by participant (left),CD300C,CMRF35-like molecule 6,16799,0.0280980737185372,0.0370727145502764,-0.0445644468000045,0.100760594237079,0.448510779993593
Physical measures,X4270.Volume level set by participant (left),WASF1,Wiskott-Aldrich syndrome protein family member 1,16356,-0.0102340694248489,0.0135058521413655,-0.0367055396219252,0.0162374007722274,0.448611146560842
Physical measures,X4270.Volume level set by participant (left),SDC4,Syndecan-4,16666,-0.0204448829013528,0.0270159251822495,-0.0733960962585618,0.0325063304558563,0.449197463829348
Physical measures,X4270.Volume level set by participant (left),DLG4,Disks large homolog 4,14628,-0.0154735866767712,0.0204542072647955,-0.0555638329157704,0.024616659562228,0.449362288528623
Physical measures,X4270.Volume level set by participant (left),SDC1,Syndecan-1,16666,0.0242857613195652,0.0321241005831161,-0.0386774758233424,0.0872489984624729,0.449660987738809
Physical measures,X4270.Volume level set by participant (left),FDX2,"Ferredoxin-2, mitochondrial",14175,-0.0201935411083184,0.0267126071605345,-0.0725502511429661,0.0321631689263293,0.449688480487372
Physical measures,X4270.Volume level set by participant (left),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,14207,0.0343957758509808,0.0455645957684638,-0.0549108318552083,0.12370238355717,0.450333860236598
Physical measures,X4270.Volume level set by participant (left),LYPD3,Ly6/PLAUR domain-containing protein 3,16611,0.0279666842024008,0.0370719242262957,-0.0446942872811387,0.10062765568594,0.450625855933673
Physical measures,X4270.Volume level set by participant (left),CEP164,Centrosomal protein of 164 kDa,16350,-0.014977925889779,0.0199122373901631,-0.0540059111744986,0.0240500593949406,0.451943417151306
Physical measures,X4270.Volume level set by participant (left),VEGFD,Vascular endothelial growth factor D,16816,-0.0260859620443446,0.03471740189067,-0.0941320697500579,0.0419601456613687,0.452434510779637
Physical measures,X4270.Volume level set by participant (left),CTSB,Cathepsin B,16658,-0.0180712458106122,0.0240630669562584,-0.0652348570448787,0.0290923654236543,0.45266621318115
Physical measures,X4270.Volume level set by participant (left),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",14207,-0.0253327224522755,0.0337527070875025,-0.0914880283437804,0.0408225834392294,0.452942599254975
Physical measures,X4270.Volume level set by participant (left),SCGB1A1,Uteroglobin,16677,-0.0172510954837199,0.0229882617269207,-0.0623080884684845,0.0278058975010448,0.453005993485037
Physical measures,X4270.Volume level set by participant (left),PDCD1LG2,Programmed cell death 1 ligand 2,16576,0.030225225089082,0.0402978140375384,-0.0487584904244933,0.109208940602657,0.453237494593144
Physical measures,X4270.Volume level set by participant (left),TFPI2,Tissue factor pathway inhibitor 2,16654,-0.0238710702484811,0.0318645280786689,-0.0863255452826722,0.0385834047857099,0.45378195047505
Physical measures,X4270.Volume level set by participant (left),ENPEP,Glutamyl aminopeptidase,14175,-0.0268872761025491,0.035988579168088,-0.0974248912720015,0.0436503390669034,0.455012108487005
Physical measures,X4270.Volume level set by participant (left),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14572,-0.0145653876971116,0.0195432951911964,-0.0528702462718564,0.0237394708776333,0.456109535089086
Physical measures,X4270.Volume level set by participant (left),DNMBP,Dynamin-binding protein,16533,-0.015252224523705,0.020474195356751,-0.0553816474229369,0.0248771983755269,0.456313353291414
Physical measures,X4270.Volume level set by participant (left),SCN2B,Sodium channel subunit beta-2,14261,-0.0376942814792857,0.0507606362996423,-0.137185128626585,0.0617965656680133,0.457742899353111
Physical measures,X4270.Volume level set by participant (left),RUVBL1,RuvB-like 1,16266,-0.00948602548528923,0.0128035010861909,-0.0345808876142234,0.015608836643645,0.458768971657303
Physical measures,X4270.Volume level set by participant (left),AP1G2,AP-1 complex subunit gamma-like 2,14572,-0.01353012666195,0.0182717337445525,-0.049342724801273,0.0222824714773729,0.459011665897924
Physical measures,X4270.Volume level set by participant (left),CCDC134,Coiled-coil domain-containing protein 134,14572,-0.0225913468416037,0.0305262882017611,-0.0824228717170554,0.037240178033848,0.459274292903688
Physical measures,X4270.Volume level set by participant (left),IL13RA2,Interleukin-13 receptor subunit alpha-2,14168,-0.0388989739844767,0.0525816211093704,-0.141958951358843,0.0641610033898893,0.459444125993461
Physical measures,X4270.Volume level set by participant (left),PFDN2,Prefoldin subunit 2,16257,-0.0173936736714023,0.0235350365255394,-0.0635223452614595,0.0287349979186549,0.459884610751243
Physical measures,X4270.Volume level set by participant (left),CCDC28A,Coiled-coil domain-containing protein 28A,14261,-0.0378907260312579,0.0512789813722237,-0.138397529520816,0.0626160774583004,0.459971765558238
Physical measures,X4270.Volume level set by participant (left),NUB1,NEDD8 ultimate buster 1,16637,-0.0115692948447468,0.0156775131227385,-0.0422972205653142,0.0191586308758207,0.460552382780047
Physical measures,X4270.Volume level set by participant (left),CST1,Cystatin-SN,12706,-0.0117890852460941,0.0159762807317746,-0.0431025954803722,0.0195244249881841,0.460581725230538
Physical measures,X4270.Volume level set by participant (left),POMC,Pro-opiomelanocortin,14288,0.015521679153546,0.0210371401911801,-0.0257111156211669,0.056754473928259,0.460634340874708
Physical measures,X4270.Volume level set by participant (left),IGFBP6,Insulin-like growth factor-binding protein 6,16554,-0.0323796584142059,0.0438946218920014,-0.118413117322529,0.0536538004941167,0.460726682413235
Physical measures,X4270.Volume level set by participant (left),LPA,Apolipoprotein(a),14367,0.00618715788548512,0.00838882376558131,-0.0102549366950542,0.0226292524660245,0.460801391071412
Physical measures,X4270.Volume level set by participant (left),POSTN,Periostin,14678,-0.0284216245576131,0.0386052852438927,-0.104087983635643,0.0472447345204165,0.461614252758498
Physical measures,X4270.Volume level set by participant (left),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16671,0.025698650488989,0.0349158576467455,-0.0427364304986322,0.0941337314766102,0.46173096764029
Physical measures,X4270.Volume level set by participant (left),SLITRK6,SLIT and NTRK-like protein 6,16356,-0.0273656157425223,0.0371879166188464,-0.100253932315461,0.0455227008304166,0.461818030356187
Physical measures,X4270.Volume level set by participant (left),VSTM1,V-set and transmembrane domain-containing protein 1,16257,-0.0195323319958382,0.026548274604256,-0.0715669502201799,0.0325022862285035,0.461906343866826
Physical measures,X4270.Volume level set by participant (left),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16685,-0.0163685740808538,0.0222511749221781,-0.0599808769283229,0.0272437287666152,0.461967830580417
Physical measures,X4270.Volume level set by participant (left),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16710,-0.0128506254184807,0.0174863222133256,-0.0471238169565989,0.0214225661196375,0.462413256867064
Physical measures,X4270.Volume level set by participant (left),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16782,-0.0308825182115047,0.0420430971175973,-0.113286988561995,0.051521952138986,0.462627332078127
Physical measures,X4270.Volume level set by participant (left),SMNDC1,Survival of motor neuron-related-splicing factor 30,14588,-0.0187537207149662,0.0255416738416044,-0.0688154014445109,0.0313079600145785,0.462814243097543
Physical measures,X4270.Volume level set by participant (left),WARS,"Tryptophan--tRNA ligase, cytoplasmic",16671,-0.0248559646860039,0.0338719189271139,-0.0912449257831472,0.0415329964111394,0.463067463574261
Physical measures,X4270.Volume level set by participant (left),SPRR1B,Cornifin-B,14404,-0.0123814434016458,0.0168832851669833,-0.045472682328933,0.0207097955256414,0.46335382163048
Physical measures,X4270.Volume level set by participant (left),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,14175,-0.0229091233490941,0.0312569698964308,-0.0841727843460984,0.0383545376479103,0.463614187551316
Physical measures,X4270.Volume level set by participant (left),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14588,0.0272580436767042,0.0372106707873661,-0.0456748710665334,0.100190958419942,0.463855101572304
Physical measures,X4270.Volume level set by participant (left),GDNF,Glial cell line-derived neurotrophic factor,16257,-0.0250014064464831,0.0341377322364272,-0.0919113616298803,0.0419085487369142,0.463954129323916
Physical measures,X4270.Volume level set by participant (left),CDC42BPB,Serine/threonine-protein kinase MRCK beta,14588,-0.0103022116899679,0.0140769837008608,-0.037893099743655,0.0172886763637192,0.464273147403979
Physical measures,X4270.Volume level set by participant (left),SIRT1,NAD-dependent protein deacetylase sirtuin-1,14207,-0.0125122310919509,0.0170972110703402,-0.0460227647898177,0.0209983026059158,0.464285167184768
Physical measures,X4270.Volume level set by participant (left),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,14176,-0.0281059565563859,0.0384912695962221,-0.103548844964981,0.0473369318522095,0.465285874380626
Physical measures,X4270.Volume level set by participant (left),CD33,Myeloid cell surface antigen CD33,16719,0.011706445766411,0.0160428721816297,-0.0197375837095832,0.0431504752424051,0.465585265067626
Physical measures,X4270.Volume level set by participant (left),PAPPA,Pappalysin-1,16350,-0.019865672421797,0.0272536382091931,-0.0732828033118156,0.0335514584682216,0.46606216350698
Physical measures,X4270.Volume level set by participant (left),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14352,-0.0503373491797085,0.0691491628754694,-0.185869708415628,0.0851950100562115,0.466654171278166
Physical measures,X4270.Volume level set by participant (left),FRZB,Secreted frizzled-related protein 3,16473,-0.035953476074456,0.0494837909922043,-0.132941706419177,0.0610347542702645,0.46749927487396
Physical measures,X4270.Volume level set by participant (left),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16533,-0.00883840039860583,0.0121845039021514,-0.0327200280468226,0.0150432272496109,0.468228967088484
Physical measures,X4270.Volume level set by participant (left),SLC1A4,Neutral amino acid transporter A,14261,-0.0213080604306248,0.0293878596819311,-0.0789082654072098,0.0362921445459602,0.468425068635376
Physical measures,X4270.Volume level set by participant (left),CFC1,Cryptic protein,16266,-0.0198307617045594,0.0273807209588142,-0.0734969747838353,0.0338354513747165,0.468916539933951
Physical measures,X4270.Volume level set by participant (left),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16222,0.0205453381796453,0.0283948525606409,-0.0351085728392108,0.0761992491985014,0.469347244052548
Physical measures,X4270.Volume level set by participant (left),HJV,Hemojuvelin,14629,0.023459483201427,0.0324713203547607,-0.0401843046939039,0.087103271096758,0.470018481167342
Physical measures,X4270.Volume level set by participant (left),CWC15,Spliceosome-associated protein CWC15 homolog,14510,-0.0176530547354097,0.0244411560629596,-0.0655577206188105,0.0302516111479911,0.470141632256591
Physical measures,X4270.Volume level set by participant (left),XPNPEP2,Xaa-Pro aminopeptidase 2,16719,0.00926536080285194,0.0128352612369113,-0.0158917512214942,0.0344224728271981,0.470385913040051
Physical measures,X4270.Volume level set by participant (left),ESM1,Endothelial cell-specific molecule 1,16630,-0.0263320889027079,0.0364878576473406,-0.0978482898914955,0.0451841120860796,0.470509288729208
Physical measures,X4270.Volume level set by participant (left),CCN4,CCN family member 4,16810,-0.022648167552868,0.0314069201552089,-0.0842057310570774,0.0389093959513413,0.470845543676788
Physical measures,X4270.Volume level set by participant (left),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16350,-0.0170285458761467,0.0236357687278596,-0.0633546525827516,0.0292975608304582,0.471254214674031
Physical measures,X4270.Volume level set by participant (left),IGSF21,Immunoglobulin superfamily member 21,14288,0.0275750721206816,0.0383914751666779,-0.0476722192060072,0.10282236344737,0.472608567772031
Physical measures,X4270.Volume level set by participant (left),CTSZ,Cathepsin Z,16645,0.0289646799395198,0.0404604950164041,-0.0503378902926323,0.108267250171672,0.474078237038111
Physical measures,X4270.Volume level set by participant (left),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16637,-0.0114196112249386,0.0159579181352925,-0.0426971307701118,0.0198579083202347,0.474243588293888
Physical measures,X4270.Volume level set by participant (left),IGHMBP2,DNA-binding protein SMUBP-2,14175,-0.0186514451770713,0.0260747692706083,-0.0697579929474635,0.0324551025933209,0.474431628754068
Physical measures,X4270.Volume level set by participant (left),UPB1,Beta-ureidopropionase,14652,0.0116048365249349,0.0162307657962403,-0.0202074644356961,0.0434171374855658,0.474626578497997
Physical measures,X4270.Volume level set by participant (left),PSMA1,Proteasome subunit alpha type-1,16266,-0.0200886826599863,0.0281687224804246,-0.0752993787216184,0.0351220134016458,0.475759708485705
Physical measures,X4270.Volume level set by participant (left),CNDP1,Beta-Ala-His dipeptidase,16715,-0.0185760916120773,0.0260521533673341,-0.0696383122120521,0.0324861289878975,0.475834195802965
Physical measures,X4270.Volume level set by participant (left),CSH1,Chorionic somatomammotropin hormone 1,14672,-0.0312656027415829,0.0439081065021561,-0.117325491485809,0.0547942860026431,0.476433367193423
Physical measures,X4270.Volume level set by participant (left),AP2B1,AP-2 complex subunit beta,14261,-0.0214073323648764,0.0301065787701767,-0.0804162267544228,0.03760156202467,0.477063875856511
Physical measures,X4270.Volume level set by participant (left),SLAMF1,Signaling lymphocytic activation molecule,16350,0.0151018457954688,0.0212585425456353,-0.0265648975939763,0.056768589184914,0.477472764171237
Physical measures,X4270.Volume level set by participant (left),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14652,-0.0118928737099928,0.0167426212328425,-0.044708411326364,0.0209226639063785,0.477507596267475
Physical measures,X4270.Volume level set by participant (left),COMMD1,COMM domain-containing protein 1,14288,-0.0177219782222637,0.0249582226477672,-0.0666400946118875,0.03119613816736,0.477674987723855
Physical measures,X4270.Volume level set by participant (left),CGA,Glycoprotein hormones alpha chain,16671,0.0111070791709385,0.0156561377834201,-0.0195789508845649,0.041793109226442,0.478061849029277
Physical measures,X4270.Volume level set by participant (left),PPP3R1,Calcineurin subunit B type 1,16533,-0.0222306427134614,0.031382396899498,-0.0837401406364775,0.0392788552095548,0.478719694139505
Physical measures,X4270.Volume level set by participant (left),NOTCH2,Neurogenic locus notch homolog protein 2,14678,-0.0470667277733661,0.0664466315939492,-0.177302125697507,0.0831686701507744,0.478746144674918
Physical measures,X4270.Volume level set by participant (left),IQGAP2,Ras GTPase-activating-like protein IQGAP2,16576,-0.0162973814824559,0.0230880549898767,-0.0615499692626141,0.0289552062977024,0.480273094409416
Physical measures,X4270.Volume level set by participant (left),PCDH12,Protocadherin-12,14629,-0.0408321000584299,0.057923102978529,-0.154361381896347,0.072697181779487,0.480861091451198
Physical measures,X4270.Volume level set by participant (left),PMCH,Pro-MCH,14175,-0.0125834280825367,0.0178659080257138,-0.0476006078129358,0.0224337516478624,0.481241204307589
Physical measures,X4270.Volume level set by participant (left),CDH1,Cadherin-1,16130,0.022969065608256,0.0326379912878411,-0.0410013973159126,0.0869395285324247,0.481597133581758
Physical measures,X4270.Volume level set by participant (left),PRSS53,Serine protease 53,14628,-0.0270263097101617,0.0384064953668336,-0.102303040629155,0.0482504212088322,0.481636365647316
Physical measures,X4270.Volume level set by participant (left),PVR,Poliovirus receptor,16799,0.0239923772820678,0.034134227524595,-0.0429107086661384,0.0908954632302739,0.48213825113056
Physical measures,X4270.Volume level set by participant (left),PTGR1,Prostaglandin reductase 1,14652,-0.012702637367702,0.0181011633067874,-0.0481809174490053,0.0227756427136013,0.48284121308276
Physical measures,X4270.Volume level set by participant (left),TGFBR2,TGF-beta receptor type-2,16719,0.0279049576593283,0.0397694081383481,-0.050043082291834,0.105852997610491,0.482895436589164
Physical measures,X4270.Volume level set by participant (left),OSTN,Osteocrin,14261,-0.0253956852258033,0.0362687253226416,-0.0964823868581808,0.0456910164065741,0.483808273752554
Physical measures,X4270.Volume level set by participant (left),IKZF2,Zinc finger protein Helios,16266,-0.00989419726178692,0.0141379198841581,-0.0376045202347368,0.017816125711163,0.48404098695366
Physical measures,X4270.Volume level set by participant (left),EXOSC10,Exosome component 10,14175,-0.0172915536270732,0.0247410350950061,-0.065783982413285,0.0312008751591387,0.484624891415325
Physical measures,X4270.Volume level set by participant (left),WASF3,Wiskott-Aldrich syndrome protein family member 3,16257,-0.0105076737861656,0.0150358415574421,-0.0399779232387522,0.0189625756664209,0.484660943148243
Physical measures,X4270.Volume level set by participant (left),CST7,Cystatin-F,16668,0.00946958317862295,0.0135737132430597,-0.017134894777774,0.0360740611350199,0.485411277126096
Physical measures,X4270.Volume level set by participant (left),MMP3,Stromelysin-1,16671,-0.0180230719162718,0.0258757846956759,-0.0687396099197965,0.0326934660872528,0.486111255425051
Physical measures,X4270.Volume level set by participant (left),FZD10,Frizzled-10,14261,0.0174685759911484,0.0251265698169201,-0.031779500850015,0.0667166528323118,0.486926733431662
Physical measures,X4270.Volume level set by participant (left),CASP3,Caspase-3,16871,-0.0104619855224621,0.0150954655415499,-0.0400490979839,0.0191251269389757,0.488284683816551
Physical measures,X4270.Volume level set by participant (left),CENPJ,Centromere protein J,14404,0.0147128704065765,0.0212375900924725,-0.0269128061746695,0.0563385469878225,0.488461977228159
Physical measures,X4270.Volume level set by participant (left),SOD3,Extracellular superoxide dismutase,14672,-0.0165593404838272,0.0239238362684613,-0.0634500595700114,0.030331378602357,0.488842100688372
Physical measures,X4270.Volume level set by participant (left),SDK2,Protein sidekick-2,14352,-0.0268298355308785,0.0387868356209941,-0.102852033348027,0.0491923622862699,0.489121057932669
Physical measures,X4270.Volume level set by participant (left),PSMD5,26S proteasome non-ATPase regulatory subunit 5,14261,-0.0186406029890844,0.026955636087148,-0.0714736497198944,0.0341924437417256,0.489244458488827
Physical measures,X4270.Volume level set by participant (left),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14588,-0.010290815455313,0.0148828180818483,-0.0394611388957356,0.0188795079851096,0.489289971426282
Physical measures,X4270.Volume level set by participant (left),SDCCAG8,Serologically defined colon cancer antigen 8,14572,-0.00941916084989715,0.0136388474901137,-0.0361513019305201,0.0173129802307258,0.489819997242705
Physical measures,X4270.Volume level set by participant (left),TRIM40,E3 ubiquitin ligase TRIM40,14261,0.0142161122507468,0.0205952721162362,-0.0261506210970762,0.0545828455985698,0.49004134198044
Physical measures,X4270.Volume level set by participant (left),LEPR,Leptin receptor,16666,-0.0283744203909712,0.0411117383515898,-0.108953427560087,0.0522045867781449,0.49009183060593
Physical measures,X4270.Volume level set by participant (left),ADAMTSL5,ADAMTS-like protein 5,14652,-0.0255250631102643,0.0370540066397244,-0.0981509161241241,0.0471007899035956,0.490921612408679
Physical measures,X4270.Volume level set by participant (left),IL22RA1,Interleukin-22 receptor subunit alpha-1,16350,-0.0196646697720304,0.028558219415857,-0.0756387798271101,0.0363094402830493,0.491096265554576
Physical measures,X4270.Volume level set by participant (left),ANGPTL1,Angiopoietin-related protein 1,16379,-0.0305591021592696,0.0443846107263434,-0.117552939182903,0.0564347348643634,0.491143509912654
Physical measures,X4270.Volume level set by participant (left),IGLON5,IgLON family member 5,14144,-0.0118072983840241,0.0171659158633759,-0.0454524934762409,0.0218378967081928,0.491568695863018
Physical measures,X4270.Volume level set by participant (left),TADA3,Transcriptional adapter 3,14572,-0.0258501457440042,0.0377284936978275,-0.0997979933917462,0.0480977019037377,0.493252351171287
Physical measures,X4270.Volume level set by participant (left),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",14175,0.0122267258236998,0.0178473340355528,-0.0227540488859837,0.0472075005333832,0.493309102330508
Physical measures,X4270.Volume level set by participant (left),PFDN4,Prefoldin subunit 4,14144,-0.0193233961949419,0.0282409107735833,-0.0746755813111652,0.0360287889212815,0.493838531207544
Physical measures,X4270.Volume level set by participant (left),TBC1D23,TBC1 domain family member 23,16576,-0.00949302297661259,0.013884481119977,-0.0367066059717675,0.0177205600185424,0.494164945571312
Physical measures,X4270.Volume level set by participant (left),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16576,0.0190426173027572,0.0279224758842946,-0.0356854354304602,0.0737706700359746,0.495260067181705
Physical measures,X4270.Volume level set by participant (left),TXNDC5,Thioredoxin domain-containing protein 5,16799,-0.0128248662620523,0.0188081040654575,-0.049688750230349,0.0240390177062443,0.495324368764409
Physical measures,X4270.Volume level set by participant (left),VAMP8,Vesicle-associated membrane protein 8,14207,-0.0119907136351681,0.0176072825665505,-0.046500987465607,0.0225195601952708,0.49587706116978
Physical measures,X4270.Volume level set by participant (left),S100A13,Protein S100-A13,14207,-0.0289221646047954,0.0425213500675719,-0.112264010737236,0.0544196815276456,0.496401699558262
Physical measures,X4270.Volume level set by participant (left),ESAM,Endothelial cell-selective adhesion molecule,16871,-0.0270869785890322,0.0398447876673612,-0.10518276241706,0.0510088052389957,0.496632625000046
Physical measures,X4270.Volume level set by participant (left),RNASE1,Ribonuclease pancreatic,14672,0.0403393721116857,0.0594289734269795,-0.0761414158051941,0.156820160028566,0.497286136294631
Physical measures,X4270.Volume level set by participant (left),CD244,Natural killer cell receptor 2B4,16843,0.0313788906060986,0.0462512268792493,-0.0592735140772301,0.122031295289427,0.497499230922091
Physical measures,X4270.Volume level set by participant (left),SPINT2,Kunitz-type protease inhibitor 2,16733,-0.0205800777677819,0.0303384183441958,-0.0800433777224056,0.0388832221868418,0.497558949429463
Physical measures,X4270.Volume level set by participant (left),EFHD1,EF-hand domain-containing protein D1,14629,-0.0282858673922329,0.0417748027776124,-0.110164480836353,0.0535927460518873,0.498350973882436
Physical measures,X4270.Volume level set by participant (left),PER3,Period circadian protein homolog 3,14207,-0.00838604481042548,0.0123868207036243,-0.0326642133895291,0.0158921237686781,0.498408426662506
Physical measures,X4270.Volume level set by participant (left),CPE,Carboxypeptidase E,16717,-0.0220696543716967,0.0326150823147388,-0.0859952157085848,0.0418559069651913,0.498624597940793
Physical measures,X4270.Volume level set by participant (left),DENR,Density-regulated protein,14207,-0.0180996718726496,0.0267711894264451,-0.070571203148482,0.0343718594031828,0.498995984404306
Physical measures,X4270.Volume level set by participant (left),IFNL2,Interferon lambda-2,14168,-0.0161338210637459,0.0238642382455934,-0.0629077280251089,0.0306400858976171,0.499009232916757
Physical measures,X4270.Volume level set by participant (left),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16576,-0.0128069199250863,0.0189453036702691,-0.0499397151188138,0.0243258752686411,0.499053616528383
Physical measures,X4270.Volume level set by participant (left),RLN2,Prorelaxin H2,14330,-0.00852368460168487,0.012634408824117,-0.0332871258969541,0.0162397566935844,0.499915055916887
Physical measures,X4270.Volume level set by participant (left),RBPMS,RNA-binding protein with multiple splicing,14207,0.0147668234350417,0.021889086161705,-0.0281357854419002,0.0576694323119835,0.499927977574411
Physical measures,X4270.Volume level set by participant (left),PAM,Peptidyl-glycine alpha-amidating monooxygenase,16795,-0.0299441010663042,0.0444153552167545,-0.116998197291143,0.0571099951585347,0.50020392615693
Physical measures,X4270.Volume level set by participant (left),TMSB10,Thymosin beta-10,16671,-0.0115408033160877,0.0171254102344154,-0.045106607375542,0.0220250007433665,0.5003846400103
Physical measures,X4270.Volume level set by participant (left),GFRA1,GDNF family receptor alpha-1,16794,0.0306439487555548,0.0454806098589118,-0.0584980465679123,0.119785944079022,0.500460146480046
Physical measures,X4270.Volume level set by participant (left),CLIP2,CAP-Gly domain-containing linker protein 2,16637,-0.00778913477400029,0.0115603888157241,-0.0304474968528196,0.014869227304819,0.500461882100023
Physical measures,X4270.Volume level set by participant (left),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16533,-0.0167621104530194,0.0248814076244882,-0.0655296693970164,0.0320054484909775,0.500524110961634
Physical measures,X4270.Volume level set by participant (left),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14629,-0.0152329001716743,0.0226262287579702,-0.0595803085372958,0.0291145081939472,0.500804761120135
Physical measures,X4270.Volume level set by participant (left),ECHS1,"Enoyl-CoA hydratase, mitochondrial",14288,-0.0107402003459147,0.0159742286332986,-0.04204968846718,0.0205692877753505,0.50137467057611
Physical measures,X4270.Volume level set by participant (left),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16666,-0.0173033167378186,0.0257952887062678,-0.0678620826021035,0.0332554491264663,0.50236127687452
Physical measures,X4270.Volume level set by participant (left),PECR,Peroxisomal trans-2-enoyl-CoA reductase,14288,-0.0358964784389993,0.0536460239956273,-0.141042685470429,0.0692497285924303,0.503419640498809
Physical measures,X4270.Volume level set by participant (left),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16843,-0.0237405345128122,0.0355012699281766,-0.0933230235720383,0.0458419545464138,0.503681029452374
Physical measures,X4270.Volume level set by participant (left),IL2RB,Interleukin-2 receptor subunit beta,16350,0.0233631477209436,0.0349579498626193,-0.0451544340097902,0.0918807294516775,0.503937868721382
Physical measures,X4270.Volume level set by participant (left),SH3GLB2,Endophilin-B2,14628,-0.0149697511906025,0.0224373546734914,-0.0589469663506456,0.0290074639694406,0.504667789096862
Physical measures,X4270.Volume level set by participant (left),PRG3,Proteoglycan 3,14678,-0.0193554180546645,0.0290166617848983,-0.0762280751530652,0.0375172390437362,0.504753912083432
Physical measures,X4270.Volume level set by participant (left),FLT3,Receptor-type tyrosine-protein kinase FLT3,16266,-0.0290238848480906,0.0435541379811976,-0.114389995291238,0.0563422255950567,0.505173619392998
Physical measures,X4270.Volume level set by participant (left),ANGPT2,Angiopoietin-2,16810,0.0217804315306625,0.0326952759597001,-0.0423023093503498,0.0858631724116747,0.505315124306713
Physical measures,X4270.Volume level set by participant (left),ALDH1A1,Retinal dehydrogenase 1,16671,-0.0154784490967697,0.0232503348903925,-0.061049105481939,0.0300922072883996,0.505592814345803
Physical measures,X4270.Volume level set by participant (left),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14352,0.0242362052233076,0.0364209593309769,-0.047148875065407,0.0956212855120223,0.505775564883804
Physical measures,X4270.Volume level set by participant (left),CRYBB1,Beta-crystallin B1,14652,-0.0152946371609155,0.022988327935495,-0.0603517599144856,0.0297624855926547,0.505855134697763
Physical measures,X4270.Volume level set by participant (left),AKT3,RAC-gamma serine/threonine-protein kinase,16200,-0.0151007717833147,0.0227086733012564,-0.0596097714537774,0.0294082278871479,0.506073938312081
Physical measures,X4270.Volume level set by participant (left),PPP1R2,Protein phosphatase inhibitor 2,16666,-0.0108829845973433,0.016378718998756,-0.0429852738349051,0.0212193046402185,0.506405887721922
Physical measures,X4270.Volume level set by participant (left),SNU13,NHP2-like protein 1,14175,-0.0154700596284809,0.0232830547424175,-0.0611048469236191,0.0301647276666573,0.506423222020534
Physical measures,X4270.Volume level set by participant (left),F2R,Proteinase-activated receptor 1,16710,-0.0146651637094468,0.0220997609050712,-0.0579806950833863,0.0286503676644927,0.506962405123317
Physical measures,X4270.Volume level set by participant (left),ZBTB17,Zinc finger and BTB domain-containing protein 17,16356,0.0199519446258574,0.0300867166344834,-0.0390180199777301,0.0789219092294448,0.507245155096774
Physical measures,X4270.Volume level set by participant (left),ZNF830,Zinc finger protein 830,14572,-0.0121008516144612,0.0182519782418003,-0.0478747289683897,0.0236730257394673,0.507348420532784
Physical measures,X4270.Volume level set by participant (left),CD72,B-cell differentiation antigen CD72,14352,-0.0234268489334918,0.0354167645092582,-0.0928437073716378,0.0459900095046543,0.5083266164452
Physical measures,X4270.Volume level set by participant (left),VEGFB,Vascular endothelial growth factor B,14207,0.0335947243982276,0.0508081989260068,-0.0659893454967457,0.133178794293201,0.508490464277663
Physical measures,X4270.Volume level set by participant (left),PBLD,Phenazine biosynthesis-like domain-containing protein,16257,-0.0170674692984228,0.0258171738160561,-0.0676691299778927,0.0335341913810472,0.508564128566868
Physical measures,X4270.Volume level set by participant (left),AGXT,Serine--pyruvate aminotransferase,16666,0.0110501808910566,0.0167987643273484,-0.0218753971905462,0.0439757589726594,0.510677519451197
Physical measures,X4270.Volume level set by participant (left),LIF,Leukemia inhibitory factor,16257,0.0160073581036678,0.024388159506677,-0.0317934345294191,0.0638081507367547,0.511603251780977
Physical measures,X4270.Volume level set by participant (left),LAYN,Layilin,16498,-0.0248776130949189,0.0379641118752581,-0.0992872723704247,0.049532046180587,0.512288335176008
Physical measures,X4270.Volume level set by participant (left),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16637,-0.0214247068072158,0.0327310847209453,-0.0855776328602686,0.042728219245837,0.512755263161955
Physical measures,X4270.Volume level set by participant (left),INSL4,Early placenta insulin-like peptide,14572,-0.0180835631947484,0.0276853292930484,-0.0723468086091232,0.0361796822196264,0.513649167154042
Physical measures,X4270.Volume level set by participant (left),PI16,Peptidase inhibitor 16,14672,0.0385759119228559,0.0591727363292141,-0.0774026512824037,0.154554475128116,0.514462769748704
Physical measures,X4270.Volume level set by participant (left),BTN2A1,Butyrophilin subfamily 2 member A1,16733,0.0321623993693591,0.0493594915701889,-0.0645822041082112,0.128907002846929,0.514671413023442
Physical measures,X4270.Volume level set by participant (left),USO1,General vesicular transport factor p115,16576,-0.00961367981509365,0.0148040135629361,-0.0386295463984483,0.019402186768261,0.516090904982939
Physical measures,X4270.Volume level set by participant (left),VWA5A,von Willebrand factor A domain-containing protein 5A,14144,0.0122331953958959,0.0188531629226656,-0.0247190039325287,0.0491853947243206,0.516434889629948
Physical measures,X4270.Volume level set by participant (left),HYAL1,Hyaluronidase-1,16572,0.0359900761633678,0.0555587298459921,-0.0729050343347768,0.144885186661512,0.5171334167108
Physical measures,X4270.Volume level set by participant (left),OSCAR,Osteoclast-associated immunoglobulin-like receptor,16675,0.024310192036946,0.037544805406926,-0.0492776265606289,0.0978980106345209,0.517318514565281
Physical measures,X4270.Volume level set by participant (left),ATF2,Cyclic AMP-dependent transcription factor ATF-2,16257,-0.0124163402388073,0.0191857142820331,-0.0500203402315921,0.0251876597539775,0.517533719143406
Physical measures,X4270.Volume level set by participant (left),HTR1B,5-hydroxytryptamine receptor 1B,14168,-0.0225051394535245,0.034799575896759,-0.0907123082111722,0.0457020293041232,0.517831892261635
Physical measures,X4270.Volume level set by participant (left),SOST,Sclerostin,16639,-0.0212208434940701,0.032824584425863,-0.0855570289687616,0.0431153419806213,0.517969460698082
Physical measures,X4270.Volume level set by participant (left),IFNGR2,Interferon gamma receptor 2,16533,-0.0157452536283309,0.0243660176445081,-0.0635026482115666,0.0320121409549049,0.518160597941678
Physical measures,X4270.Volume level set by participant (left),FOXO1,Forkhead box protein O1,16637,-0.010031633349439,0.0155297568509182,-0.0404699567772387,0.0204066900783606,0.518312860751805
Physical measures,X4270.Volume level set by participant (left),AGR2,Anterior gradient protein 2 homolog,16127,0.0082855796101208,0.0128323410902243,-0.0168658089267188,0.0334369681469604,0.518496134090338
Physical measures,X4270.Volume level set by participant (left),HSBP1,Heat shock factor-binding protein 1,14288,0.0103075982805151,0.0159645167070825,-0.0209828544653665,0.0415980510263967,0.518512044303477
Physical measures,X4270.Volume level set by participant (left),IRAK4,Interleukin-1 receptor-associated kinase 4,16637,-0.00842161057183826,0.0130621896587967,-0.0340235023030798,0.0171802811594033,0.519109828078709
Physical measures,X4270.Volume level set by participant (left),VSIG10,V-set and immunoglobulin domain-containing protein 10,14572,-0.0268451922026985,0.0416450995858442,-0.108469587390953,0.0547792029855561,0.519184748884488
Physical measures,X4270.Volume level set by participant (left),IL32,Interleukin-32,16637,-0.0191629723191136,0.0297294688186469,-0.0774327312036615,0.0391067865654342,0.519209356951697
Physical measures,X4270.Volume level set by participant (left),FAM3D,Protein FAM3D,14588,0.0111173497896158,0.0172511119367291,-0.0226948296063732,0.0449295291856047,0.519298674045349
Physical measures,X4270.Volume level set by participant (left),SHPK,Sedoheptulokinase,14404,-0.0228284627690976,0.0355737623096151,-0.0925530368959432,0.046896111357748,0.521063982870676
Physical measures,X4270.Volume level set by participant (left),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16697,0.0162928340049282,0.0253900426835271,-0.0334716496547851,0.0660573176646414,0.521075691524663
Physical measures,X4270.Volume level set by participant (left),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14588,-0.0133584815649534,0.0208534036007427,-0.0542311526224092,0.0275141894925023,0.521799179707383
Physical measures,X4270.Volume level set by participant (left),SELP,P-selectin,16715,-0.0142287504078593,0.0222295597145045,-0.0577986874482881,0.0293411866325695,0.522127798962337
Physical measures,X4270.Volume level set by participant (left),RBP1,Retinol-binding protein 1,14261,-0.0133412163325431,0.0208431570816056,-0.0541938042124901,0.0275113715474039,0.522133120794037
Physical measures,X4270.Volume level set by participant (left),DPT,Dermatopontin,16871,0.030164254231182,0.0471582102767628,-0.0622658379112731,0.122594346373637,0.522415687678676
Physical measures,X4270.Volume level set by participant (left),HGFAC,Hepatocyte growth factor activator,14518,0.033618377253037,0.0526258829308552,-0.0695283532914391,0.136765107797513,0.522951229161941
Physical measures,X4270.Volume level set by participant (left),AKR7L,Aflatoxin B1 aldehyde reductase member 4,14207,0.0137447400334278,0.0215541778766171,-0.0285014486047417,0.0559909286715972,0.523690124959519
Physical measures,X4270.Volume level set by participant (left),MB,Myoglobin,16871,-0.0152169876675275,0.0238676299813415,-0.0619975424309568,0.0315635670959018,0.523770397763776
Physical measures,X4270.Volume level set by participant (left),FCRL5,Fc receptor-like protein 5,16671,0.0139759683384208,0.0219417184262807,-0.0290297997770894,0.056981736453931,0.524160503918779
Physical measures,X4270.Volume level set by participant (left),CDH3,Cadherin-3,16799,0.0222449789355335,0.0349956970084724,-0.0463465872010725,0.0908365450721394,0.525013908104138
Physical measures,X4270.Volume level set by participant (left),CTBS,Di-N-acetylchitobiase,14442,0.0335777903566301,0.0528918082649403,-0.0700901538426529,0.137245734555913,0.525543398419187
Physical measures,X4270.Volume level set by participant (left),PGM2,Phosphoglucomutase-2,14261,-0.0155869462674161,0.0245918754009838,-0.0637870220533444,0.0326131295185121,0.526205191105507
Physical measures,X4270.Volume level set by participant (left),IFNL1,Interferon lambda-1,16257,-0.0186839709715313,0.0294822582379401,-0.0764691971178939,0.0391012551748313,0.526261995048041
Physical measures,X4270.Volume level set by participant (left),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14629,-0.0104342949998139,0.0164776970906813,-0.0427305812975494,0.0218619912979215,0.526588499222374
Physical measures,X4270.Volume level set by participant (left),ARSA,Arylsulfatase A,16671,0.0177689039740686,0.0280887307589344,-0.0372850083134429,0.07282281626158,0.527004202425796
Physical measures,X4270.Volume level set by participant (left),ENAH,Protein enabled homolog,16350,0.0170317753851139,0.0269305916609292,-0.0357521842703073,0.069815735040535,0.527113301860759
Physical measures,X4270.Volume level set by participant (left),NUDT16,U8 snoRNA-decapping enzyme,14572,-0.010973668934502,0.0173527779300593,-0.0449851136774182,0.0230377758084141,0.527144044580918
Physical measures,X4270.Volume level set by participant (left),SERPINB8,Serpin B8,16843,0.0138033941346421,0.0218346844491372,-0.0289925873856668,0.0565993756549511,0.527279550181744
Physical measures,X4270.Volume level set by participant (left),GH1,Somatotropin,16639,0.00455186533341453,0.00720667949131308,-0.0095732264695591,0.0186769571363882,0.527645493678226
Physical measures,X4270.Volume level set by participant (left),SULT1A1,Sulfotransferase 1A1,16799,-0.00648824916582572,0.0102916332729603,-0.026659850380828,0.0136833520491765,0.528415847182778
Physical measures,X4270.Volume level set by participant (left),IFT20,Intraflagellar transport protein 20 homolog,14261,-0.0211767713167272,0.0336086515195171,-0.0870497282949808,0.0446961856615264,0.528640045921408
Physical measures,X4270.Volume level set by participant (left),TRIAP1,TP53-regulated inhibitor of apoptosis 1,16810,-0.0128472998381015,0.0204365800790307,-0.0529029967930017,0.0272083971167988,0.529591774624152
Physical measures,X4270.Volume level set by participant (left),IL21R,Interleukin-21 receptor,14207,0.0171587771011817,0.0272950064815747,-0.0363394356027047,0.0706569898050681,0.529593824387222
Physical measures,X4270.Volume level set by participant (left),ARHGAP45,Rho GTPase-activating protein 45,14352,-0.0117892222787822,0.0187616531197468,-0.048562062393486,0.0249836178359217,0.529772911793625
Physical measures,X4270.Volume level set by participant (left),CD274,Programmed cell death 1 ligand 1,16533,0.0237427792376606,0.0377980751211802,-0.0503414479998526,0.0978270064751739,0.52991578161062
Physical measures,X4270.Volume level set by participant (left),VMO1,Vitelline membrane outer layer protein 1 homolog,16576,0.0117040575712331,0.0186421304009288,-0.0248345180145874,0.0482426331570536,0.530125063932709
Physical measures,X4270.Volume level set by participant (left),IL18R1,Interleukin-18 receptor 1,16843,0.0240011382568363,0.0382628334101233,-0.0509940152270055,0.098996291740678,0.530490592412931
Physical measures,X4270.Volume level set by participant (left),LBP,Lipopolysaccharide-binding protein,16715,0.0135220577166454,0.0215569917380271,-0.0287296460898878,0.0557737615231785,0.530490734993283
Physical measures,X4270.Volume level set by participant (left),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16533,-0.0278710843161576,0.0444342899751095,-0.114962292667372,0.0592201240350571,0.530508823621613
Physical measures,X4270.Volume level set by participant (left),IL2,Interleukin-2,16350,0.0256762129852515,0.040982822854357,-0.0546501198092881,0.106002545779791,0.530988201653909
Physical measures,X4270.Volume level set by participant (left),FOXJ3,Forkhead box protein J3,14207,-0.0210216608827085,0.0335831385365561,-0.0868446124143585,0.0448012906489415,0.531352037348029
Physical measures,X4270.Volume level set by participant (left),AKT1S1,Proline-rich AKT1 substrate 1,16257,-0.0129349945114756,0.0206802248812608,-0.0534682352787468,0.0275982462557956,0.531667161641518
Physical measures,X4270.Volume level set by participant (left),LAMB1,Laminin subunit beta-1,14288,-0.0306987936666665,0.0491355067601818,-0.127004386916623,0.0656067995832899,0.532126626409299
Physical measures,X4270.Volume level set by participant (left),SPRY2,Protein sprouty homolog 2,16350,-0.00883952896089377,0.0142018353215687,-0.0366751261911685,0.0189960682693809,0.533673374817037
Physical measures,X4270.Volume level set by participant (left),HLA_E,,16637,0.0272019020562597,0.0437165264309042,-0.0584824897483125,0.112886293860832,0.533796654395589
Physical measures,X4270.Volume level set by participant (left),COX6B1,Cytochrome c oxidase subunit 6B1,14652,-0.0279623017883578,0.0449486080214871,-0.116061573510472,0.0601369699337569,0.533889130625038
Physical measures,X4270.Volume level set by participant (left),LDLRAP1,Low density lipoprotein receptor adapter protein 1,14629,-0.00958051366899979,0.0154190722832586,-0.0398018953441866,0.020640868006187,0.534384468749927
Physical measures,X4270.Volume level set by participant (left),IPCEF1,Interactor protein for cytohesin exchange factors 1,16500,-0.00923810950023076,0.0148894054975204,-0.0384213442753707,0.0199451252749092,0.534971119491276
Physical measures,X4270.Volume level set by participant (left),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16238,-0.0142842376502927,0.0230697013855196,-0.0595008523659112,0.0309323770653258,0.535808196223025
Physical measures,X4270.Volume level set by participant (left),NLGN2,Neuroligin-2,14168,0.0199522514763032,0.032281358309227,-0.0433192108097817,0.0832237137623881,0.536536849652334
Physical measures,X4270.Volume level set by participant (left),NFKB2,Nuclear factor NF-kappa-B p100 subunit,14404,0.0160848538283548,0.0260514532498051,-0.0349759945412633,0.0671457021979728,0.536963314518486
Physical measures,X4270.Volume level set by participant (left),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16350,0.0134903380870496,0.0218632385283305,-0.0293616094284782,0.0563422856025774,0.537221607932425
Physical measures,X4270.Volume level set by participant (left),TGM2,Protein-glutamine gamma-glutamyltransferase 2,16651,-0.0103077297384494,0.0167168078288051,-0.0430726730829074,0.0224572136060086,0.537501269843389
Physical measures,X4270.Volume level set by participant (left),CFH,Complement factor H,13756,0.0401614237092408,0.0652024978443664,-0.0876354720657173,0.167958319484199,0.537938279224214
Physical measures,X4270.Volume level set by participant (left),CCAR2,Cell cycle and apoptosis regulator protein 2,14628,-0.0163084707676662,0.0264899979850961,-0.0682288668184546,0.0356119252831223,0.538137537853923
Physical measures,X4270.Volume level set by participant (left),CBLN1,Cerebellin-1,14168,0.00972435675905874,0.0157970085860515,-0.0212377800696023,0.0406864935877197,0.538180224711144
Physical measures,X4270.Volume level set by participant (left),TCN1,Transcobalamin-1,14332,0.0276393563501755,0.0449463580156956,-0.0604555053605878,0.115734218060939,0.538603488868215
Physical measures,X4270.Volume level set by participant (left),DNAJA1,DnaJ homolog subfamily A member 1,14144,-0.0199539302254868,0.0324951803697513,-0.0836444837501993,0.0437366232992256,0.539186792213788
Physical measures,X4270.Volume level set by participant (left),ACP6,Lysophosphatidic acid phosphatase type 6,16794,-0.0114900922862149,0.0187242655416198,-0.0481896527477897,0.0252094681753599,0.539456835288839
Physical measures,X4270.Volume level set by participant (left),CRH,Corticoliberin,16215,-0.00912937285735813,0.0148790890843619,-0.0382923874627076,0.0200336417479913,0.539507676999184
Physical measures,X4270.Volume level set by participant (left),NFIC,Nuclear factor 1 C-type,14629,-0.0206106506890185,0.0336104432770348,-0.0864871195120068,0.0452658181339697,0.539739351550163
Physical measures,X4270.Volume level set by participant (left),HHEX,Hematopoietically-expressed homeobox protein HHEX,14628,-0.0119853769868697,0.0195466202262319,-0.0502967526302842,0.0263259986565448,0.539774299699123
Physical measures,X4270.Volume level set by participant (left),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16823,0.0280497199231353,0.0457578350605177,-0.0616356367954795,0.11773507664175,0.539882221200203
Physical measures,X4270.Volume level set by participant (left),LPCAT2,Lysophosphatidylcholine acyltransferase 2,16576,0.0193022407098498,0.0314981199805486,-0.0424340744520255,0.0810385558717251,0.540012959072619
Physical measures,X4270.Volume level set by participant (left),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14678,-0.0348043265914174,0.0568299927080069,-0.146191112299111,0.0765824591162761,0.54026356290034
Physical measures,X4270.Volume level set by participant (left),ECE1,Endothelin-converting enzyme 1,16257,-0.0220458055949122,0.0360006416508936,-0.0926070632306637,0.0485154520408392,0.540299856980839
Physical measures,X4270.Volume level set by participant (left),PALM3,Paralemmin-3,14175,-0.0117161056595825,0.0191699664787167,-0.0492892399578672,0.0258570286387021,0.541096949066353
Physical measures,X4270.Volume level set by participant (left),GRP,Gastrin-releasing peptide,14288,-0.0171561221644,0.028086589949297,-0.0722058384650222,0.0378935941362222,0.541322084183352
Physical measures,X4270.Volume level set by participant (left),FGFR4,Fibroblast growth factor receptor 4,14352,-0.0173319157039304,0.0283744911051753,-0.0729459182700739,0.0382820868622131,0.541323558020823
Physical measures,X4270.Volume level set by participant (left),TPSD1,Tryptase delta,14629,-0.0242673919446766,0.0397318204324222,-0.102141759992224,0.053606976102871,0.541354891383659
Physical measures,X4270.Volume level set by participant (left),TEF,Thyrotroph embryonic factor,14175,0.0214134469723028,0.0350639155307271,-0.0473118274679224,0.0901387214125279,0.541409637859431
Physical measures,X4270.Volume level set by participant (left),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14288,-0.0122304777115358,0.0200593158610702,-0.0515467367992334,0.0270857813761619,0.542059929231889
Physical measures,X4270.Volume level set by participant (left),IL20RB,Interleukin-20 receptor subunit beta,14207,-0.0216757430030889,0.035696975817324,-0.091641815605044,0.0482903295988662,0.543717883554018
Physical measures,X4270.Volume level set by participant (left),MFAP5,Microfibrillar-associated protein 5,16871,-0.0186110015550121,0.0306555316910806,-0.0786958436695301,0.0414738405595058,0.543792116692487
Physical measures,X4270.Volume level set by participant (left),SLC27A4,Long-chain fatty acid transport protein 4,16257,-0.00981490962302986,0.0162249540695641,-0.0416158195993754,0.0219860003533157,0.545236083962827
Physical measures,X4270.Volume level set by participant (left),KIFBP,KIF-binding protein,16576,-0.0096673987914422,0.0160029884622089,-0.0410332561773717,0.0216984585944873,0.545785707119488
Physical measures,X4270.Volume level set by participant (left),GPR37,Prosaposin receptor GPR37,16356,0.0117459799323607,0.0195131815573119,-0.0264998559199707,0.049991815784692,0.5472150805172
Physical measures,X4270.Volume level set by participant (left),UPK3BL1,Uroplakin-3b-like protein 1,14360,-0.0157141041847849,0.0261377403950553,-0.0669440753590933,0.0355158669895235,0.547713873653168
Physical measures,X4270.Volume level set by participant (left),TJAP1,Tight junction-associated protein 1,16719,-0.00947918588634859,0.0157826298081208,-0.0404131403102653,0.0214547685375682,0.548108744567466
Physical measures,X4270.Volume level set by participant (left),ATXN2,Ataxin-2,14168,-0.00825358158318938,0.013742018351736,-0.0351879375525919,0.0186807743862132,0.548109979296841
Physical measures,X4270.Volume level set by participant (left),DCTN6,Dynactin subunit 6,16257,-0.0108518755649876,0.0180826898195438,-0.0462939476112935,0.0245901964813182,0.548431256805433
Physical measures,X4270.Volume level set by participant (left),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16799,0.0159307487375129,0.0265490970946589,-0.0361054815680187,0.0679669790430444,0.548481943618798
Physical measures,X4270.Volume level set by participant (left),CACYBP,Calcyclin-binding protein,14314,-0.00908772122676319,0.0151475113700952,-0.0387768435121497,0.0206014010586233,0.548550308396784
Physical measures,X4270.Volume level set by participant (left),RPGR,X-linked retinitis pigmentosa GTPase regulator,14261,-0.0221553087087851,0.0369306194583692,-0.0945393228471886,0.0502287054296185,0.548571054209895
Physical measures,X4270.Volume level set by participant (left),H2AP,Huntingtin-interacting protein M,14144,-0.0183078003189168,0.0305319218288175,-0.0781503671033991,0.0415347664655656,0.548763687722011
Physical measures,X4270.Volume level set by participant (left),ATP6V1G2,V-type proton ATPase subunit G 2,14175,-0.00926844100345888,0.0154618981868026,-0.039573761449592,0.0210368794426742,0.548890794004339
Physical measures,X4270.Volume level set by participant (left),ANXA5,Annexin A5,16224,0.0251055649460061,0.0418927367139406,-0.0570041990133175,0.10721532890533,0.548993195667884
Physical measures,X4270.Volume level set by participant (left),AXIN1,Axin-1,16637,-0.00839404788757572,0.0140158499899573,-0.0358651138678921,0.0190770180927406,0.549249859541543
Physical measures,X4270.Volume level set by participant (left),CTLA4,Cytotoxic T-lymphocyte protein 4,14678,-0.0304699447356837,0.0508855012684303,-0.130205527221807,0.0692656377504395,0.549319359474541
Physical measures,X4270.Volume level set by participant (left),CEP112,Centrosomal protein of 112 kDa,14175,0.0202237239909689,0.0337790675594359,-0.0459832484255255,0.0864306964074633,0.549378660793123
Physical measures,X4270.Volume level set by participant (left),CXCL13,C-X-C motif chemokine 13,16799,0.012260029479437,0.020488815827661,-0.0278980495427786,0.0524181085016525,0.549596701621476
Physical measures,X4270.Volume level set by participant (left),ALCAM,CD166 antigen,16871,0.0386888285625097,0.0646907230858654,-0.0881049886857864,0.165482645810806,0.549809020915542
Physical measures,X4270.Volume level set by participant (left),TLR4,Toll-like receptor 4,14207,-0.0315461990154307,0.0527555558613393,-0.134947088503656,0.0718546904727942,0.549870008839458
Physical measures,X4270.Volume level set by participant (left),F11R,Junctional adhesion molecule A,16671,0.0134263465495848,0.0224593983811141,-0.0305940742773988,0.0574467673765684,0.549978007283245
Physical measures,X4270.Volume level set by participant (left),ZP3,Zona pellucida sperm-binding protein 3,14288,0.00343083108758209,0.00574487142662921,-0.00782911690861116,0.0146907790837753,0.550384045947587
Physical measures,X4270.Volume level set by participant (left),PALM2,Paralemmin-2,14628,0.023677572555459,0.039684728054078,-0.0541044944305338,0.101459639541452,0.550755717593586
Physical measures,X4270.Volume level set by participant (left),ADGRG1,Adhesion G-protein coupled receptor G1,16576,0.0111413232178987,0.0186738071373352,-0.0254593387712784,0.0477419852070758,0.550763678401332
Physical measures,X4270.Volume level set by participant (left),FAM171A2,Protein FAM171A2,14629,-0.00551440983172103,0.0092432359659231,-0.0236311523249303,0.0126023326614882,0.550791281390146
Physical measures,X4270.Volume level set by participant (left),GNAS,Neuroendocrine secretory protein 55,14629,0.00943690989068368,0.0158258912076507,-0.0215818368763117,0.040455656657679,0.550986981864608
Physical measures,X4270.Volume level set by participant (left),CSRP3,Cysteine and glycine-rich protein 3,14175,0.00915730963204786,0.0153674085885753,-0.0209628112015597,0.0392774304656554,0.55125717355182
Physical measures,X4270.Volume level set by participant (left),WASHC3,WASH complex subunit 3,14628,-0.0112004182720211,0.0188194548330382,-0.0480865497447759,0.0256857132007337,0.551751725375586
Physical measures,X4270.Volume level set by participant (left),CHIT1,Chitotriosidase-1,16723,-0.00479752037894633,0.0080666562977872,-0.0206081667226093,0.0110131259647166,0.5520288804221
Physical measures,X4270.Volume level set by participant (left),BGN,Biglycan,16243,-0.00662017827307745,0.0111337768710213,-0.0284423809402792,0.0152020243941243,0.552117096301997
Physical measures,X4270.Volume level set by participant (left),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16719,-0.0164725585264271,0.0277324043840519,-0.0708280711191689,0.0378829540663147,0.55253196755133
Physical measures,X4270.Volume level set by participant (left),CD74,HLA class II histocompatibility antigen gamma chain,16799,0.0217196194541905,0.0366329731338036,-0.0500810078880645,0.0935202467964456,0.553257351902057
Physical measures,X4270.Volume level set by participant (left),GRSF1,G-rich sequence factor 1,14061,-0.011105338619312,0.0187364368170381,-0.0478287547807067,0.0256180775420826,0.553382463595949
Physical measures,X4270.Volume level set by participant (left),PDRG1,p53 and DNA damage-regulated protein 1,14261,-0.0172652567968445,0.0291579603369741,-0.0744148590573137,0.0398843454636248,0.553773999958674
Physical measures,X4270.Volume level set by participant (left),SULT2A1,Bile salt sulfotransferase,16637,-0.0133954133503383,0.0226251550572411,-0.0577407172625308,0.0309498905618541,0.553819528829138
Physical measures,X4270.Volume level set by participant (left),MRPL24,"39S ribosomal protein L24, mitochondrial",14175,-0.0228075266358453,0.0385361596356046,-0.0983383995216303,0.0527233462499398,0.553962216475006
Physical measures,X4270.Volume level set by participant (left),DGCR6,Protein DGCR6,14168,-0.0211609354016546,0.0357998956642984,-0.0913287309036795,0.0490068601003702,0.554470027106627
Physical measures,X4270.Volume level set by participant (left),IGSF9,Protein turtle homolog A,14652,-0.010477815778891,0.0177288641113946,-0.0452263894372243,0.0242707578794424,0.554527390412064
Physical measures,X4270.Volume level set by participant (left),KLK11,Kallikrein-11,16556,0.0243010317021975,0.0412239909040358,-0.0564979904697128,0.105100053874108,0.555542276106789
Physical measures,X4270.Volume level set by participant (left),EGLN1,Egl nine homolog 1,16637,0.0138618081894486,0.0235366062640819,-0.032269940088152,0.0599935564670492,0.555904987634344
Physical measures,X4270.Volume level set by participant (left),NOP56,Nucleolar protein 56,14175,-0.00784844990397116,0.0133347125485169,-0.0339844864990643,0.018287586691122,0.556157233558327
Physical measures,X4270.Volume level set by participant (left),SLC44A4,Choline transporter-like protein 4,14261,-0.0126393454720829,0.0214902994996511,-0.0547603324913992,0.0294816415472333,0.55644637905543
Physical measures,X4270.Volume level set by participant (left),TREML2,Trem-like transcript 2 protein,16671,0.022216774791702,0.0378104406468242,-0.0518916888760734,0.0963252384594774,0.556820143855489
Physical measures,X4270.Volume level set by participant (left),SCGB3A1,Secretoglobin family 3A member 1,14352,0.034120014503935,0.0580687914506299,-0.0796948167392996,0.14793484574717,0.556824025189839
Physical measures,X4270.Volume level set by participant (left),NRTN,Neurturin,16350,-0.0148385315193006,0.0253602728539045,-0.0645446663129534,0.0348676032743521,0.558482308352976
Physical measures,X4270.Volume level set by participant (left),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14404,0.0119355201998796,0.0204559927310253,-0.02815822555293,0.0520292659526893,0.559584049433402
Physical measures,X4270.Volume level set by participant (left),FBP1,"Fructose-1,6-bisphosphatase 1",16666,0.00988209916837269,0.0169752252415959,-0.0233893423051553,0.0431535406419006,0.560474650643545
Physical measures,X4270.Volume level set by participant (left),TET2,Methylcytosine dioxygenase TET2,14355,0.00859638952465762,0.0147840008447689,-0.0203802521310894,0.0375730311804047,0.560935763940586
Physical measures,X4270.Volume level set by participant (left),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,14168,-0.0141673677148696,0.0243941060307562,-0.0619798155351517,0.0336450801054125,0.561404649141397
Physical measures,X4270.Volume level set by participant (left),SH2B3,SH2B adapter protein 3,16266,-0.00809755473197847,0.0139816597287857,-0.0355016078003985,0.0193064983364416,0.562492301763023
Physical measures,X4270.Volume level set by participant (left),CDHR1,Cadherin-related family member 1,16257,0.0171532770134436,0.029621196107171,-0.0409042673566114,0.0752108213834987,0.56253787839235
Physical measures,X4270.Volume level set by participant (left),NACC1,Nucleus accumbens-associated protein 1,14572,-0.0153040717929729,0.0264646215895657,-0.0671747301085217,0.0365665865225759,0.563081225505016
Physical measures,X4270.Volume level set by participant (left),CA1,Carbonic anhydrase 1,16306,-0.0122570390635357,0.0211996821861938,-0.0538084161484755,0.0292943380214041,0.563156744511851
Physical measures,X4270.Volume level set by participant (left),HEBP1,Heme-binding protein 1,16356,-0.013726630636205,0.0237527638788268,-0.0602820478387055,0.0328287865662954,0.563342203218307
Physical measures,X4270.Volume level set by participant (left),CLINT1,Clathrin interactor 1,14144,-0.0178662264512416,0.0310836244724588,-0.0787901304172609,0.0430576775147777,0.565449665812954
Physical measures,X4270.Volume level set by participant (left),SEL1L,Protein sel-1 homolog 1,14288,-0.027502679695319,0.0478615248862742,-0.121311268472416,0.0663059090817784,0.565550451449878
Physical measures,X4270.Volume level set by participant (left),PSMG3,Proteasome assembly chaperone 3,16637,-0.0141790962590939,0.0246818009678603,-0.0625554261561,0.0341972336379122,0.565653677354601
Physical measures,X4270.Volume level set by participant (left),ERI1,3'-5' exoribonuclease 1,14404,-0.0256693772615377,0.0447176469428884,-0.113315965269599,0.0619772107465235,0.565954864494326
Physical measures,X4270.Volume level set by participant (left),NIT2,Omega-amidase NIT2,14605,-0.011903775256685,0.0207502966629363,-0.0525743567160402,0.0287668062026703,0.566201523697972
Physical measures,X4270.Volume level set by participant (left),CNST,Consortin,16666,-0.00718791399951962,0.0125480720312532,-0.0317821351807759,0.0174063071817367,0.566767437659282
Physical measures,X4270.Volume level set by participant (left),CA2,Carbonic anhydrase 2,16601,-0.0102859860708723,0.0179997401054654,-0.0455654766775845,0.0249935045358399,0.567701086295972
Physical measures,X4270.Volume level set by participant (left),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,14207,-0.0149961722404826,0.0262542288788556,-0.0664544608430397,0.0364621163620744,0.56787940518222
Physical measures,X4270.Volume level set by participant (left),KRT17,"Keratin, type I cytoskeletal 17",14175,0.0216831140802563,0.0381092821831408,-0.0530110789986996,0.0963773071592122,0.569384174785677
Physical measures,X4270.Volume level set by participant (left),FSHB,Follitropin subunit beta,14288,-0.0130314587679927,0.0229288391031125,-0.0579719834100933,0.0319090658741078,0.569810627206275
Physical measures,X4270.Volume level set by participant (left),RTKN2,Rhotekin-2,14175,0.016596435900334,0.0292359972462228,-0.0407061187022627,0.0738989905029308,0.570267199707668
Physical measures,X4270.Volume level set by participant (left),RCOR1,REST corepressor 1,16356,0.0153425369259301,0.027040871400047,-0.0376575710181621,0.0683426448700222,0.570461637003715
Physical measures,X4270.Volume level set by participant (left),CCL26,C-C motif chemokine 26,16637,-0.00766449080089441,0.0135105974500917,-0.0341452618030741,0.0188162802012852,0.570521615506385
Physical measures,X4270.Volume level set by participant (left),SKIV2L,Helicase SKI2W,14175,-0.0210632194982339,0.0371656212490506,-0.093907837146373,0.0517813981499052,0.570900275816038
Physical measures,X4270.Volume level set by participant (left),CHEK2,Serine/threonine-protein kinase Chk2,16356,0.0213008657260234,0.037648026101088,-0.052489265432109,0.0950909968841559,0.571544512857513
Physical measures,X4270.Volume level set by participant (left),ARHGEF10,Rho guanine nucleotide exchange factor 10,14629,-0.00911066978335088,0.0161073857343373,-0.040681145822652,0.0224598062559502,0.571660380715579
Physical measures,X4270.Volume level set by participant (left),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16712,-0.0140205148412552,0.0248080064275431,-0.0626442074392397,0.0346031777567293,0.571971933977439
Physical measures,X4270.Volume level set by participant (left),NEDD9,Enhancer of filamentation 1,14207,0.0242353836647279,0.0428989519119,-0.0598465620825961,0.108317329412052,0.572122717015079
Physical measures,X4270.Volume level set by participant (left),ARNT,Aryl hydrocarbon receptor nuclear translocator,16350,-0.0192484756407941,0.0341384502545093,-0.0861598381396323,0.0476628868580441,0.572873721662471
Physical measures,X4270.Volume level set by participant (left),CCL11,Eotaxin,16843,0.018719439647771,0.0332584306955679,-0.046467084515542,0.0839059638110841,0.573545922749385
Physical measures,X4270.Volume level set by participant (left),DSG2,Desmoglein-2,16671,-0.0263257231637764,0.0467743234307391,-0.118003397088025,0.0653519507604721,0.57356214689831
Physical measures,X4270.Volume level set by participant (left),NPTX1,Neuronal pentraxin-1,16671,0.0176174046602245,0.0313426720226354,-0.0438142325041408,0.0790490418245898,0.574062219420404
Physical measures,X4270.Volume level set by participant (left),AMIGO1,Amphoterin-induced protein 1,14261,-0.0166642556396372,0.0296727311289876,-0.074822808652453,0.0414942973731785,0.574396271515222
Physical measures,X4270.Volume level set by participant (left),GP1BA,Platelet glycoprotein Ib alpha chain,16546,0.0215629036456569,0.0384182227555625,-0.0537368129552456,0.0968626202465595,0.574622735072022
Physical measures,X4270.Volume level set by participant (left),MFAP4,Microfibril-associated glycoprotein 4,14352,-0.0260966753422612,0.0465081721527555,-0.117252692761662,0.0650593420771396,0.574724362256143
Physical measures,X4270.Volume level set by participant (left),KIT,Mast/stem cell growth factor receptor Kit,16685,0.0239961345248865,0.0427933731631387,-0.0598788768748654,0.107871145924638,0.574979488590648
Physical measures,X4270.Volume level set by participant (left),TMOD4,Tropomodulin-4,14144,0.0210255881351095,0.0375212248990535,-0.0525160126670354,0.0945671889372543,0.575239259545074
Physical measures,X4270.Volume level set by participant (left),CHRDL1,Chordin-like protein 1,16710,0.0226970533030457,0.0405050066105682,-0.056692759653668,0.102086866259759,0.575247022445228
Physical measures,X4270.Volume level set by participant (left),MVK,Mevalonate kinase,16350,-0.00936415735742594,0.0167295194192089,-0.0421540154190754,0.0234257007042235,0.575665442519156
Physical measures,X4270.Volume level set by participant (left),ICAM1,Intercellular adhesion molecule 1,16535,0.0250780672189942,0.0448349273462408,-0.0627983903796378,0.112954524817626,0.57593577892617
Physical measures,X4270.Volume level set by participant (left),RLN1,Prorelaxin H1,14629,-0.011714168206603,0.0209756191338044,-0.0528263817088595,0.0293980452956536,0.576534834655934
Physical measures,X4270.Volume level set by participant (left),ZHX2,Zinc fingers and homeoboxes protein 2,14628,-0.0262329507609129,0.0472519374316168,-0.118846748126882,0.066380846605056,0.57878554467678
Physical measures,X4270.Volume level set by participant (left),HMMR,Hyaluronan mediated motility receptor,14100,-0.0172299894834663,0.0310586090931009,-0.0781048633059441,0.0436448843390115,0.579069501523073
Physical measures,X4270.Volume level set by participant (left),CYTL1,Cytokine-like protein 1,14678,0.0336661780389039,0.0606998177105617,-0.085305464673797,0.152637820751605,0.579153541322109
Physical measures,X4270.Volume level set by participant (left),CDA,Cytidine deaminase,14619,-0.0172983991361029,0.031256143327572,-0.078560440058144,0.0439636417859383,0.579970646768947
Physical measures,X4270.Volume level set by participant (left),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14207,-0.0181586440940624,0.0328213132211175,-0.0824884180074527,0.0461711298193279,0.580095681414062
Physical measures,X4270.Volume level set by participant (left),NCR1,Natural cytotoxicity triggering receptor 1,16608,-0.0190439960873859,0.0344805739727708,-0.0866259210740167,0.0485379288992449,0.580742818944873
Physical measures,X4270.Volume level set by participant (left),CYB5A,Cytochrome b5,14144,0.0115475361973992,0.0209080499833874,-0.0294322417700402,0.0525273141648385,0.580750906534052
Physical measures,X4270.Volume level set by participant (left),NADK,NAD kinase,16666,0.0126883048377907,0.0229891996288645,-0.0323705264347838,0.0577471361103651,0.581007420529675
Physical measures,X4270.Volume level set by participant (left),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14629,-0.00837369688060098,0.015173482800022,-0.038113723168644,0.0213663294074421,0.58105006617662
Physical measures,X4270.Volume level set by participant (left),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16710,-0.00826967250616649,0.0149874589511583,-0.0376450920504367,0.0211057470381038,0.581111396812277
Physical measures,X4270.Volume level set by participant (left),KRT18,"Keratin, type I cytoskeletal 18",16576,0.00882424188873175,0.0160316287623105,-0.0225977504853968,0.0402462342628603,0.582033934632572
Physical measures,X4270.Volume level set by participant (left),IDUA,Alpha-L-iduronidase,16810,0.0148299052775469,0.0270015206270804,-0.0380930751515306,0.0677528857066244,0.582858476840578
Physical measures,X4270.Volume level set by participant (left),VSNL1,Visinin-like protein 1,14628,0.0213813793482262,0.0389670922109546,-0.0549941213852448,0.0977568800816971,0.583217337381479
Physical measures,X4270.Volume level set by participant (left),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16637,0.00458738097054734,0.00836050696265891,-0.0117992126762641,0.0209739746173588,0.583221113999477
Physical measures,X4270.Volume level set by participant (left),RBP7,Retinoid-binding protein 7,14588,-0.0126857296114896,0.023201599135313,-0.0581608639167031,0.0327894046937239,0.584551310589097
Physical measures,X4270.Volume level set by participant (left),PLXNB2,Plexin-B2,16779,-0.0287008722993508,0.0526152469024301,-0.131826756228114,0.0744250116294122,0.585426673280609
Physical measures,X4270.Volume level set by participant (left),FABP3,"Fatty acid-binding protein, heart",14652,-0.015673321121515,0.0288238378018461,-0.0721680432131334,0.0408214009701034,0.586613223588976
Physical measures,X4270.Volume level set by participant (left),COMT,Catechol O-methyltransferase,16216,-0.00875628142867767,0.016113120393617,-0.040337997400167,0.0228254345428116,0.586844310905947
Physical measures,X4270.Volume level set by participant (left),THAP12,52 kDa repressor of the inhibitor of the protein kinase,14117,-0.00924332210033979,0.0170095609654334,-0.0425820615925892,0.0240954173919096,0.586849796455472
Physical measures,X4270.Volume level set by participant (left),GBP4,Guanylate-binding protein 4,16257,-0.0142932039596336,0.0263307319658696,-0.0659014386127379,0.0373150306934708,0.587251880271243
Physical measures,X4270.Volume level set by participant (left),CNTF,Ciliary neurotrophic factor,14168,0.0236876439992005,0.0436454415260127,-0.0618574213917844,0.109232709390185,0.587324996197695
Physical measures,X4270.Volume level set by participant (left),PMS1,PMS1 protein homolog 1,14261,-0.0160413975338714,0.0295919071570506,-0.0740415355616905,0.0419587404939478,0.587766835846952
Physical measures,X4270.Volume level set by participant (left),GIPR,Gastric inhibitory polypeptide receptor,14207,0.0171313557592711,0.03161782007554,-0.0448395715887872,0.0791022831073295,0.587946912406517
Physical measures,X4270.Volume level set by participant (left),ACE,Angiotensin-converting enzyme,14672,-0.0295600974555671,0.0545614897278263,-0.136500617322107,0.0773804224109725,0.587981166794863
Physical measures,X4270.Volume level set by participant (left),LMOD2,Leiomodin-2,14168,-0.0129464023432731,0.0239558744545962,-0.0598999162742817,0.0340071115877354,0.588911068892308
Physical measures,X4270.Volume level set by participant (left),CD63,CD63 antigen,16500,-0.0136436749189271,0.0252685256905065,-0.0631699852723199,0.0358826354344656,0.589240597590384
Physical measures,X4270.Volume level set by participant (left),CEP85,Centrosomal protein of 85 kDa,16266,0.0105726642509935,0.0196057963313965,-0.0278546965585437,0.0490000250605307,0.589713357314504
Physical measures,X4270.Volume level set by participant (left),HCG22,Protein PBMUCL2,14175,-0.0148024425017755,0.0274878439199438,-0.0686786165848655,0.0390737315813144,0.590234381410832
Physical measures,X4270.Volume level set by participant (left),FN1,Fibronectin,14697,-0.0291080859693539,0.054114923541957,-0.13517333611159,0.0769571641728818,0.590658470830302
Physical measures,X4270.Volume level set by participant (left),ADGRV1,Adhesion G-protein coupled receptor V1,14168,-0.0119166052646278,0.0221615656286945,-0.0553532738968691,0.0315200633676135,0.590782308787953
Physical measures,X4270.Volume level set by participant (left),CRTAP,Cartilage-associated protein,14261,-0.0157548599749533,0.0293013609894206,-0.0731855275142176,0.0416758075643111,0.590803933690834
Physical measures,X4270.Volume level set by participant (left),CLEC2L,C-type lectin domain family 2 member L,14261,-0.0152538054335134,0.0284216495752024,-0.0709602386009101,0.0404526277338833,0.591485520512737
Physical measures,X4270.Volume level set by participant (left),UROS,Uroporphyrinogen-III synthase,14261,-0.0118208060683803,0.0220571000452522,-0.0550527221570746,0.031411110020314,0.59202330575289
Physical measures,X4270.Volume level set by participant (left),ISM1,Isthmin-1,16637,0.016987060774909,0.0316990765600913,-0.0451431292828699,0.0791172508326879,0.592045178445366
Physical measures,X4270.Volume level set by participant (left),CLEC4C,C-type lectin domain family 4 member C,16637,-0.0144044672970379,0.0268873216687323,-0.0671036177677532,0.0382946831736774,0.592149187524448
Physical measures,X4270.Volume level set by participant (left),SPARC,SPARC,16719,-0.00954330100976285,0.0178204235784765,-0.0444713312235768,0.0253847292040511,0.592293281167022
Physical measures,X4270.Volume level set by participant (left),MARCO,Macrophage receptor MARCO,16666,0.025894009077985,0.0484206326508253,-0.0690104309176326,0.120798449073603,0.592814518411051
Physical measures,X4270.Volume level set by participant (left),BRDT,Bromodomain testis-specific protein,14175,0.0221498413417384,0.0414561922998705,-0.0591042955660079,0.103403978249485,0.593145755597361
Physical measures,X4270.Volume level set by participant (left),CHP1,Calcineurin B homologous protein 1,14168,0.0108425470137166,0.0203314079776227,-0.0290070126224239,0.0506921066498571,0.593840868242024
Physical measures,X4270.Volume level set by participant (left),CDH17,Cadherin-17,16666,0.0100654723543913,0.0189098193115885,-0.0269977734963222,0.0471287182051048,0.594533555420676
Physical measures,X4270.Volume level set by participant (left),TGFBR3,Transforming growth factor beta receptor type 3,16871,-0.0198673863399078,0.0373397888058037,-0.093053372399283,0.0533185997194674,0.594684436757975
Physical measures,X4270.Volume level set by participant (left),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14352,-0.0115535697689514,0.0217432441555101,-0.0541703283137512,0.0310631887758484,0.59517503279218
Physical measures,X4270.Volume level set by participant (left),KEL,Kell blood group glycoprotein,16257,0.0196886726744741,0.0371186991292735,-0.0530639776189019,0.0924413229678501,0.595824797487842
Physical measures,X4270.Volume level set by participant (left),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14352,-0.0132815977624367,0.0250463599774142,-0.0623724633181684,0.0358092677932951,0.595925637643129
Physical measures,X4270.Volume level set by participant (left),DAPK2,Death-associated protein kinase 2,14207,-0.0144347229153335,0.0272758560177227,-0.0678954007100699,0.0390259548794029,0.596666351007489
Physical measures,X4270.Volume level set by participant (left),KDM3A,Lysine-specific demethylase 3A,14207,-0.00857960187854735,0.0162137763281599,-0.0403586034817408,0.0231993997246461,0.596706162022737
Physical measures,X4270.Volume level set by participant (left),AMBN,Ameloblastin,16350,-0.023923868078046,0.0452597763906978,-0.112633029803814,0.0647852936477217,0.597097037053964
Physical measures,X4270.Volume level set by participant (left),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16671,0.0251341575603448,0.0475593461529913,-0.0680821608995181,0.118350476020208,0.597173350146292
Physical measures,X4270.Volume level set by participant (left),AXL,Tyrosine-protein kinase receptor UFO,16715,-0.0242275207608612,0.0459154687850064,-0.114221839579474,0.0657667980577515,0.597745912154362
Physical measures,X4270.Volume level set by participant (left),PDCD6,Programmed cell death protein 6,16666,-0.00941950762520214,0.0178799575147831,-0.0444642243541771,0.0256252091037728,0.598326061803876
Physical measures,X4270.Volume level set by participant (left),IL16,Pro-interleukin-16,16843,0.0164387414923924,0.0312238081001052,-0.0447599223838139,0.0776374053685987,0.598560994431187
Physical measures,X4270.Volume level set by participant (left),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14572,-0.00888962571921667,0.0168871076063121,-0.0419883566275883,0.024209105189155,0.598607959658843
Physical measures,X4270.Volume level set by participant (left),RNASEH2A,Ribonuclease H2 subunit A,14629,-0.0151896207862456,0.0288603578677738,-0.0717559222070822,0.041376680634591,0.598677795428526
Physical measures,X4270.Volume level set by participant (left),NBN,Nibrin,16350,-0.0130426489010537,0.0247878182785831,-0.0616267727270766,0.0355414749249693,0.598776047576624
Physical measures,X4270.Volume level set by participant (left),CA8,Carbonic anhydrase-related protein,14207,-0.0316836449646244,0.0603979363427924,-0.150063600196498,0.0866963102672487,0.599882287951089
Physical measures,X4270.Volume level set by participant (left),FRMD4B,FERM domain-containing protein 4B,14175,-0.0103278765048728,0.0197171951719215,-0.048973579041839,0.0283178260320934,0.600425511018099
Physical measures,X4270.Volume level set by participant (left),RAC3,Ras-related C3 botulinum toxin substrate 3,14261,-0.0114223902044789,0.0218280417723163,-0.054205352078219,0.0313605716692611,0.600780783157938
Physical measures,X4270.Volume level set by participant (left),TAFA5,Chemokine-like protein TAFA-5,16576,0.0187948573930011,0.0359450491542162,-0.0516574389492626,0.0892471537352648,0.601066499883887
Physical measures,X4270.Volume level set by participant (left),APOH,Beta-2-glycoprotein 1,16671,-0.0195278277382824,0.037365105277985,-0.092763434083133,0.0537077786065682,0.601244248270806
Physical measures,X4270.Volume level set by participant (left),HMOX2,Heme oxygenase 2,16257,0.0148678975921925,0.0284717257312341,-0.0409366848410264,0.0706724800254114,0.601539127573957
Physical measures,X4270.Volume level set by participant (left),NAMPT,Nicotinamide phosphoribosyltransferase,16266,0.0128172009173367,0.0245470496507609,-0.0352950163981547,0.0609294182328281,0.601574178081554
Physical measures,X4270.Volume level set by participant (left),LYPLA2,Acyl-protein thioesterase 2,14168,0.00708809533714269,0.0135815314536156,-0.0195317063119438,0.0337078969862292,0.60175355747143
Physical measures,X4270.Volume level set by participant (left),SLC16A1,Monocarboxylate transporter 1,16257,0.0116198967196813,0.0222984989809193,-0.0320851612829204,0.0553249547222831,0.602299564750179
Physical measures,X4270.Volume level set by participant (left),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16576,0.0167486056366104,0.0321568765321096,-0.0462788723663245,0.0797760836395452,0.60248480857201
Physical measures,X4270.Volume level set by participant (left),SPRING1,SREBP regulating gene protein,14144,0.0126226633473331,0.0243025285258116,-0.0350102925632577,0.0602556192579239,0.60349197574885
Physical measures,X4270.Volume level set by participant (left),KLRB1,Killer cell lectin-like receptor subfamily B member 1,16843,-0.0174397111203134,0.0336193417946886,-0.0833336210379031,0.0484541987972764,0.603948600252763
Physical measures,X4270.Volume level set by participant (left),ECSCR,Endothelial cell-specific chemotaxis regulator,14168,0.0149147940612787,0.0288503343763321,-0.0416318613163322,0.0714614494388895,0.60518429261827
Physical measures,X4270.Volume level set by participant (left),MRPL28,"39S ribosomal protein L28, mitochondrial",14629,0.0206463892986894,0.03998111887567,-0.0577166036976238,0.0990093822950026,0.605580443861641
Physical measures,X4270.Volume level set by participant (left),EEF1D,Elongation factor 1-delta,14652,-0.00839022060584459,0.0162673692467952,-0.0402742643295632,0.023493823117874,0.606022867660771
Physical measures,X4270.Volume level set by participant (left),DTX2,Probable E3 ubiquitin-protein ligase DTX2,14261,0.0119767165965513,0.0232484673889415,-0.033590279485774,0.0575437126788766,0.606448126340148
Physical measures,X4270.Volume level set by participant (left),MUCL3,Mucin-like protein 3,14144,0.0175495787375202,0.0341292240641274,-0.0493437004281696,0.0844428579032099,0.607113416360163
Physical measures,X4270.Volume level set by participant (left),MFGE8,Lactadherin,16671,-0.0150759038377365,0.029348124954181,-0.0725982287479313,0.0424464210724583,0.607473998210594
Physical measures,X4270.Volume level set by participant (left),CDHR5,Cadherin-related family member 5,16666,-0.0166780039753811,0.0325530767343274,-0.0804820343746628,0.0471260264239006,0.608425016506278
Physical measures,X4270.Volume level set by participant (left),BTN1A1,Butyrophilin subfamily 1 member A1,14562,0.0190217691153306,0.0371764054849284,-0.0538439856351291,0.0918875238657903,0.608895068129695
Physical measures,X4270.Volume level set by participant (left),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",14207,-0.0273460676535271,0.0535748350634748,-0.132352744377938,0.0776606090708835,0.609759953887351
Physical measures,X4270.Volume level set by participant (left),ZBP1,Z-DNA-binding protein 1,14207,-0.0184473402079239,0.0361543089926648,-0.0893097858335469,0.0524151054176992,0.609891935119067
Physical measures,X4270.Volume level set by participant (left),PXDNL,Peroxidasin-like protein,14572,-0.0127090866497462,0.0249666699723059,-0.0616437597954658,0.0362255864959734,0.610730416192858
Physical measures,X4270.Volume level set by participant (left),ARHGAP1,Rho GTPase-activating protein 1,16266,-0.0146721301337253,0.0288333632062551,-0.0711855220179854,0.0418412617505348,0.61085763477488
Physical measures,X4270.Volume level set by participant (left),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,14168,-0.0132016243965188,0.0260275874844328,-0.0642156958660071,0.0378124470729696,0.61201075366873
Physical measures,X4270.Volume level set by participant (left),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16719,0.0182891753188464,0.0361407194178144,-0.05254663474007,0.0891249853777627,0.612825038244305
Physical measures,X4270.Volume level set by participant (left),GASK1A,Golgi-associated kinase 1A,14175,0.0177964729381346,0.0351809171873851,-0.0511581247491402,0.0867510706254094,0.612965720162644
Physical measures,X4270.Volume level set by participant (left),SAMD9L,Sterile alpha motif domain-containing protein 9-like,16637,-0.00904911381944492,0.0179391905762253,-0.0442099273488465,0.0261116997099566,0.613964051573967
Physical measures,X4270.Volume level set by participant (left),PLA2G1B,Phospholipase A2,16842,0.0148485287174408,0.0294661594532022,-0.0429051438108356,0.0726022012457172,0.614325585308958
Physical measures,X4270.Volume level set by participant (left),SFTPA2,Pulmonary surfactant-associated protein A2,16266,-0.0129347028769861,0.0256959290222583,-0.0632987237606123,0.0374293180066402,0.61470706890508
Physical measures,X4270.Volume level set by participant (left),HSD17B3,Testosterone 17-beta-dehydrogenase 3,14175,-0.0152949619918394,0.0303851791352831,-0.0748499130969943,0.0442599891133155,0.614712583707117
Physical measures,X4270.Volume level set by participant (left),CLASP1,CLIP-associating protein 1,14144,0.0101636833325496,0.0202067539127012,-0.0294415543363448,0.0497689210014439,0.614983034877061
Physical measures,X4270.Volume level set by participant (left),DEFB4A_DEFB4B,Beta-defensin 4A,16406,0.00442338322559929,0.00879723492812118,-0.0128191972335182,0.0216659636847168,0.615100979541135
Physical measures,X4270.Volume level set by participant (left),ASPN,Asporin,14652,-0.0270602582932068,0.0538258182729137,-0.132558862108118,0.078438345521704,0.615156392882485
Physical measures,X4270.Volume level set by participant (left),TIMP1,Metalloproteinase inhibitor 1,16436,0.0230807144563243,0.0459496116247098,-0.0669805243281069,0.113141953240755,0.615459808676553
Physical measures,X4270.Volume level set by participant (left),PRKCQ,Protein kinase C theta type,16350,-0.0141634611107826,0.0282247871447245,-0.0694840439144428,0.0411571216928775,0.615808423955059
Physical measures,X4270.Volume level set by participant (left),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14288,-0.0206607375141673,0.0412094253466175,-0.101431211193538,0.0601097361652031,0.616125860093386
Physical measures,X4270.Volume level set by participant (left),TGFBI,Transforming growth factor-beta-induced protein ig-h3,16505,-0.0238300757134953,0.0476382972488988,-0.117201138321337,0.0695409868943464,0.616920252153531
Physical measures,X4270.Volume level set by participant (left),SUSD5,Sushi domain-containing protein 5,14249,-0.0217271658122712,0.0434389740237876,-0.106867554898895,0.0634132232743525,0.616958345825856
Physical measures,X4270.Volume level set by participant (left),XG,Glycoprotein Xg,16764,0.0198515952228083,0.03975046169302,-0.0580593096955108,0.0977625001411274,0.617500376257792
Physical measures,X4270.Volume level set by participant (left),DCLRE1C,Protein artemis,14144,-0.0236495105641353,0.0474514887051783,-0.116654428426285,0.0693554072980141,0.618214520532428
Physical measures,X4270.Volume level set by participant (left),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",14168,-0.0139814490752426,0.0280548424075544,-0.0689689401940493,0.0410060420435641,0.618237120342101
Physical measures,X4270.Volume level set by participant (left),CHRM1,Muscarinic acetylcholine receptor M1,14261,-0.02002363435828,0.0402762812369624,-0.0989651455827263,0.0589178768661664,0.619086028994426
Physical measures,X4270.Volume level set by participant (left),STX3,Syntaxin-3,14628,-0.0189809094829136,0.0381831329000406,-0.0938198499669931,0.0558580310011658,0.61912464558953
Physical measures,X4270.Volume level set by participant (left),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16356,0.0126307471459346,0.0254491401968886,-0.0372495676399671,0.0625110619318363,0.619680049728847
Physical measures,X4270.Volume level set by participant (left),SRP14,Signal recognition particle 14 kDa protein,16576,-0.0108627551620039,0.021913019883027,-0.0538122741327368,0.032086763808729,0.620097492252827
Physical measures,X4270.Volume level set by participant (left),ATP5F1D,"ATP synthase subunit delta, mitochondrial",14175,0.013780470942307,0.0279092788324254,-0.0409217155692467,0.0684826574538607,0.621483713876226
Physical measures,X4270.Volume level set by participant (left),NOTCH1,Neurogenic locus notch homolog protein 1,16871,-0.0388689811474554,0.0789638554184691,-0.193638137767655,0.115900175472744,0.622557776135726
Physical measures,X4270.Volume level set by participant (left),S100G,Protein S100-G,14629,-0.0152963034867749,0.0311406606504007,-0.0763319983615603,0.0457393913880105,0.623292127055193
Physical measures,X4270.Volume level set by participant (left),DYNLT3,Dynein light chain Tctex-type 3,14572,0.0160262362084256,0.0326659869399166,-0.0479990981938109,0.080051570610662,0.623710220331588
Physical measures,X4270.Volume level set by participant (left),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16356,0.0075930252948826,0.0154781381292358,-0.0227441254384195,0.0379301760281847,0.623741078463616
Physical measures,X4270.Volume level set by participant (left),CASP2,Caspase-2,16637,-0.00927102087218625,0.0189351775183587,-0.0463839688081692,0.0278419270637967,0.624410058738246
Physical measures,X4270.Volume level set by participant (left),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,14175,-0.0142834624415443,0.0291847664226019,-0.0714856046298441,0.0429186797467555,0.624555501218003
Physical measures,X4270.Volume level set by participant (left),VNN2,Vascular non-inflammatory molecule 2,16576,-0.0133999898290027,0.0273858067248089,-0.0670761710096283,0.0402761913516228,0.624632840052912
Physical measures,X4270.Volume level set by participant (left),CD302,CD302 antigen,16576,-0.0207146450245768,0.042631796703423,-0.104272966563286,0.0628436765141323,0.627046909301737
Physical measures,X4270.Volume level set by participant (left),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14697,-0.0359254892125647,0.0741087763061247,-0.181178690772569,0.10932771234744,0.62784886634585
Physical measures,X4270.Volume level set by participant (left),CCT5,T-complex protein 1 subunit epsilon,16266,-0.0126214672135656,0.0260493512604304,-0.0636781956840091,0.0384352612568779,0.628022436719101
Physical measures,X4270.Volume level set by participant (left),CNGB3,Cyclic nucleotide-gated cation channel beta-3,14168,0.0133101832042623,0.0274927426398409,-0.0405755923698259,0.0671959587783504,0.628297962197297
Physical measures,X4270.Volume level set by participant (left),NLGN1,Neuroligin-1,14261,-0.0108444249035324,0.0224134392095881,-0.0547747657543251,0.0330859159472603,0.628509824356802
Physical measures,X4270.Volume level set by participant (left),SERPINA7,Thyroxine-binding globulin,14697,0.0379650425895643,0.0785153245831737,-0.115924993593456,0.191855078772585,0.628721905039119
Physical measures,X4270.Volume level set by participant (left),EDDM3B,Epididymal secretory protein E3-beta,14572,0.0137982774597411,0.0285842615764587,-0.0422268752301178,0.0698234301496001,0.629299765562131
Physical measures,X4270.Volume level set by participant (left),BLVRB,Flavin reductase,16671,-0.00878255501898687,0.0181967246875662,-0.0444481354066166,0.0268830253686429,0.629354288928586
Physical measures,X4270.Volume level set by participant (left),AKR1C4,Aldo-keto reductase family 1 member C4,16356,-0.0115966225540675,0.0240429288232994,-0.0587207630477344,0.0355275179395994,0.629578097931473
Physical measures,X4270.Volume level set by participant (left),CD46,Membrane cofactor protein,16499,0.0217201822874209,0.0450457405956514,-0.0665694692800559,0.110009833854898,0.629684058931703
Physical measures,X4270.Volume level set by participant (left),CDC27,Cell division cycle protein 27 homolog,16266,-0.00992162320277737,0.0205848228315689,-0.0502678759526524,0.0304246295470976,0.629821458989224
Physical measures,X4270.Volume level set by participant (left),DCUN1D2,DCN1-like protein 2,14144,0.00886273258022418,0.0184477075177311,-0.0272947741545289,0.0450202393149772,0.630932941810278
Physical measures,X4270.Volume level set by participant (left),FCER2,Low affinity immunoglobulin epsilon Fc receptor,16671,-0.0122200157684413,0.0254541095121861,-0.0621100704123261,0.0376700388754436,0.631176622085543
Physical measures,X4270.Volume level set by participant (left),CCL22,C-C motif chemokine 22,16454,0.0118596702963921,0.0247246566245918,-0.0366006566878077,0.060319997280592,0.631468610550943
Physical measures,X4270.Volume level set by participant (left),IL15RA,Interleukin-15 receptor subunit alpha,16350,-0.0174651101610724,0.0364299799706292,-0.0888678709035057,0.0539376505813609,0.631649232025582
Physical measures,X4270.Volume level set by participant (left),OLFM4,Olfactomedin-4,13702,0.00594404405587502,0.0124052664514999,-0.0183702781890648,0.0302583663008149,0.631836100722985
Physical measures,X4270.Volume level set by participant (left),DUSP29,Dual specificity phosphatase 29,14261,-0.0109964016741464,0.022984704155302,-0.0560464218185383,0.0340536184702454,0.632356801856146
Physical measures,X4270.Volume level set by participant (left),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16675,0.0226205064986858,0.0473075940581715,-0.0701023778553304,0.115343390852702,0.632543998958774
Physical measures,X4270.Volume level set by participant (left),MOG,Myelin-oligodendrocyte glycoprotein,16810,-0.0185231232584775,0.0387823787100481,-0.0945365855301719,0.0574903390132168,0.632929047326468
Physical measures,X4270.Volume level set by participant (left),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14319,-0.0155042747622208,0.0324631807845916,-0.0791321091000203,0.0481235595755787,0.63294530790749
Physical measures,X4270.Volume level set by participant (left),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,14008,-0.0276046565364057,0.0580260102664887,-0.141335636658724,0.0861263235859122,0.634274876741935
Physical measures,X4270.Volume level set by participant (left),IFNW1,Interferon omega-1,14175,-0.0206923849936755,0.0436026787918981,-0.106153635425796,0.0647688654384448,0.635103073775154
Physical measures,X4270.Volume level set by participant (left),KLRK1,NKG2-D type II integral membrane protein,14628,-0.0149299923554535,0.0314711108085355,-0.0766133695401831,0.0467533848292761,0.635219576487116
Physical measures,X4270.Volume level set by participant (left),TOP2B,DNA topoisomerase 2-beta,14207,-0.00943731566977112,0.0198951969975406,-0.0484319017849507,0.0295572704454085,0.63525660268094
Physical measures,X4270.Volume level set by participant (left),CRHR1,Corticotropin-releasing factor receptor 1,16356,0.00975537568201291,0.0205797003449769,-0.0305808369941417,0.0500915883581675,0.635485530159181
Physical measures,X4270.Volume level set by participant (left),GAD2,Glutamate decarboxylase 2,14207,-0.0159034235186642,0.0335879738617328,-0.0817358522876606,0.0499290052503321,0.635874022905222
Physical measures,X4270.Volume level set by participant (left),FGF5,Fibroblast growth factor 5,16350,-0.0181530382635648,0.0383870551145866,-0.0933916662881545,0.057085589761025,0.636294563302946
Physical measures,X4270.Volume level set by participant (left),IL17F,Interleukin-17F,16350,-0.00786179433882904,0.0166558540173695,-0.0405072682128732,0.0247836795352151,0.636923184629121
Physical measures,X4270.Volume level set by participant (left),GPRC5C,G-protein coupled receptor family C group 5 member C,14572,-0.0125801877953097,0.0266921159984113,-0.064896735152196,0.0397363595615765,0.637428402868216
Physical measures,X4270.Volume level set by participant (left),C8B,Complement component C8 beta chain,14697,-0.0223068009860882,0.0473636342207057,-0.115139524058672,0.070525922086495,0.637669907798307
Physical measures,X4270.Volume level set by participant (left),ADGRE1,Adhesion G protein-coupled receptor E1,14588,-0.0127333541124228,0.0270840767375135,-0.0658181445179492,0.0403514362931037,0.638260813479132
Physical measures,X4270.Volume level set by participant (left),EIF5A,Eukaryotic translation initiation factor 5A-1,16350,0.0195642960889989,0.0416565882057966,-0.0620826167943625,0.10121120897236,0.638606572306764
Physical measures,X4270.Volume level set by participant (left),CLEC7A,C-type lectin domain family 7 member A,16843,-0.00969260064167551,0.0206451976491477,-0.0501571880340049,0.0307719867506539,0.638729433118707
Physical measures,X4270.Volume level set by participant (left),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14504,-0.00653012353243536,0.0139148911541351,-0.0338033101945402,0.0207430631296694,0.638869205691882
Physical measures,X4270.Volume level set by participant (left),PDGFC,Platelet-derived growth factor C,16266,-0.0210351275065856,0.0448389728912342,-0.108919514373405,0.0668492593602335,0.638985877587353
Physical measures,X4270.Volume level set by participant (left),CTSL,Cathepsin L1,16666,0.0243579405198662,0.0519948464463046,-0.0775519585148907,0.126267839554623,0.639455824355614
Physical measures,X4270.Volume level set by participant (left),TOP1,DNA topoisomerase 1,14588,0.00606979530455455,0.0129673343075145,-0.0193461799381738,0.0314857705472829,0.63973187525281
Physical measures,X4270.Volume level set by participant (left),TAX1BP1,Tax1-binding protein 1,14628,-0.0105327748365461,0.0225904528934305,-0.0548100625076698,0.0337445128345777,0.641044269300773
Physical measures,X4270.Volume level set by participant (left),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16257,0.0200011951241277,0.0429195336986926,-0.0641210909253098,0.104123481173565,0.64121020283732
Physical measures,X4270.Volume level set by participant (left),BRD3,Bromodomain-containing protein 3,14175,0.0147315228749904,0.0316184764414491,-0.0472406909502497,0.0767037367002306,0.641283501643335
Physical measures,X4270.Volume level set by participant (left),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14288,-0.0148179654717524,0.0318497053212586,-0.0772433879014192,0.0476074569579144,0.641762006756115
Physical measures,X4270.Volume level set by participant (left),RNF5,E3 ubiquitin-protein ligase RNF5,14288,-0.0101847974100983,0.0218983896668026,-0.0531056411570313,0.0327360463368348,0.641871638929739
Physical measures,X4270.Volume level set by participant (left),MAGED1,Melanoma-associated antigen D1,16266,-0.0124204647062913,0.0269102871269946,-0.0651646274752007,0.0403236980626182,0.644409658119889
Physical measures,X4270.Volume level set by participant (left),APOL1,Apolipoprotein L1,14672,0.0106566871547838,0.0231361312973922,-0.0346901301881049,0.0560035044976725,0.645086705831811
Physical measures,X4270.Volume level set by participant (left),WFDC1,WAP four-disulfide core domain protein 1,14255,-0.0124895991074894,0.0271267529768718,-0.0656580349421582,0.0406788367271794,0.645224471885466
Physical measures,X4270.Volume level set by participant (left),ASAH1,Acid ceramidase,14549,-0.0146459952630942,0.0318315768254752,-0.0770358858410256,0.0477438953148372,0.645444861954906
Physical measures,X4270.Volume level set by participant (left),JAM2,Junctional adhesion molecule B,16799,0.0226612934365407,0.0493073109763045,-0.0739810360770161,0.119303622950097,0.645814360300336
Physical measures,X4270.Volume level set by participant (left),ALDH2,"Aldehyde dehydrogenase, mitochondrial",14572,-0.0125003032762222,0.0272088890082711,-0.0658297257324335,0.0408291191799891,0.645939569150143
Physical measures,X4270.Volume level set by participant (left),PYY,Peptide YY,14175,-0.00732482847991211,0.0159442010788467,-0.0385754625944517,0.0239258056346275,0.64595118710404
Physical measures,X4270.Volume level set by participant (left),RAB27B,Ras-related protein Rab-27B,14652,-0.00851656634713471,0.0185479736066158,-0.0448705946161017,0.0278374619218323,0.646123042053212
Physical measures,X4270.Volume level set by participant (left),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16698,-0.0237874206712376,0.0518144572566973,-0.125343756894364,0.0777689155518891,0.646176607478859
Physical measures,X4270.Volume level set by participant (left),PDCD1,Programmed cell death protein 1,16779,0.0139617196850581,0.0304506723427447,-0.0457215981067215,0.0736450374768377,0.64659716852556
Physical measures,X4270.Volume level set by participant (left),TPP1,Tripeptidyl-peptidase 1,16514,0.0126925374937624,0.0278050246098054,-0.0418053107414561,0.0671903857289809,0.648048277201541
Physical measures,X4270.Volume level set by participant (left),GIGYF2,GRB10-interacting GYF protein 2,14629,-0.00842490516497357,0.0184822860120932,-0.0446501857486763,0.0278003754187291,0.648514150041227
Physical measures,X4270.Volume level set by participant (left),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16715,0.0135008630827103,0.029628990642131,-0.0445719585758664,0.071573684741287,0.648637570226896
Physical measures,X4270.Volume level set by participant (left),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14678,0.00468621378124679,0.0102870898631415,-0.0154764823505106,0.0248489099130042,0.648725245995095
Physical measures,X4270.Volume level set by participant (left),EDA2R,Tumor necrosis factor receptor superfamily member 27,16810,0.0150490892650364,0.033097861458594,-0.0498227191938077,0.0799208977238806,0.649342009160546
Physical measures,X4270.Volume level set by participant (left),KYNU,Kynureninase,16843,-0.0125725471829257,0.027773256850748,-0.0670081306103919,0.0418630362445404,0.650781148928056
Physical measures,X4270.Volume level set by participant (left),IGLC2,Immunoglobulin lambda constant 2,14664,-0.0261504727010096,0.0577852599666258,-0.139409582235596,0.087108636833577,0.650882586819116
Physical measures,X4270.Volume level set by participant (left),CXCL12,Stromal cell-derived factor 1,16350,-0.0144636874243099,0.032047379569088,-0.0772765513797224,0.0483491765311025,0.651763483567146
Physical measures,X4270.Volume level set by participant (left),SPINT3,Kunitz-type protease inhibitor 3,14588,0.00449994882416801,0.00998048695204263,-0.0150618056018355,0.0240617032501716,0.652086585118676
Physical measures,X4270.Volume level set by participant (left),TRIM5,Tripartite motif-containing protein 5,16637,-0.00691341968676922,0.0153385634060469,-0.0369770039626212,0.0231501645890828,0.652196193531301
Physical measures,X4270.Volume level set by participant (left),CCL13,C-C motif chemokine 13,16816,0.00817888641735639,0.0181487027769651,-0.0273925710254952,0.043750343860208,0.652240748687213
Physical measures,X4270.Volume level set by participant (left),IL18RAP,Interleukin-18 receptor accessory protein,16420,0.0033535183514755,0.0074458452263419,-0.0112403382921546,0.0179473749951056,0.652436744318611
Physical measures,X4270.Volume level set by participant (left),FCRL6,Fc receptor-like protein 6,16637,-0.00833140079723292,0.0185017774934226,-0.0445948846843411,0.0279320830898753,0.652498048951337
Physical measures,X4270.Volume level set by participant (left),DUSP13,Dual specificity protein phosphatase 13 isoform A,14572,-0.0158203682040443,0.0352526968176628,-0.0849156539666635,0.0532749175585748,0.653603946916245
Physical measures,X4270.Volume level set by participant (left),ERC2,ERC protein 2,14261,0.00912024729442751,0.0203293695465648,-0.0307253170168395,0.0489658116056946,0.653709592595249
Physical measures,X4270.Volume level set by participant (left),CA5A,"Carbonic anhydrase 5A, mitochondrial",16356,0.00642253364989837,0.0143386621990873,-0.0216812442603126,0.0345263115601094,0.65421888194465
Physical measures,X4270.Volume level set by participant (left),RNASET2,Ribonuclease T2,16781,-0.0211243730009338,0.0471677182851141,-0.113573100839757,0.0713243548378898,0.654262493596331
Physical measures,X4270.Volume level set by participant (left),HTRA2,"Serine protease HTRA2, mitochondrial",16719,-0.00925601917289152,0.0207775149746893,-0.0499799485232825,0.0314679101774994,0.655976882524143
Physical measures,X4270.Volume level set by participant (left),ZNF174,Zinc finger protein 174,14207,0.0182032309071688,0.0408658024421764,-0.061893741879497,0.0983002036938346,0.656009174208649
Physical measures,X4270.Volume level set by participant (left),PTGDS,Prostaglandin-H2 D-isomerase,16485,0.0191678370553946,0.0430888124175842,-0.0652862352830703,0.10362190939386,0.656437713785334
Physical measures,X4270.Volume level set by participant (left),SOX9,Transcription factor SOX-9,14261,-0.0247203566305536,0.0555780200306768,-0.13365327589068,0.0842125626295729,0.656480762405076
Physical measures,X4270.Volume level set by participant (left),SCN3B,Sodium channel subunit beta-3,14168,0.0147631132918823,0.0332105491318492,-0.0503295630065421,0.0798557895903066,0.656665635382858
Physical measures,X4270.Volume level set by participant (left),LRRC25,Leucine-rich repeat-containing protein 25,16576,-0.0144359859155702,0.032505893967017,-0.0781475380909236,0.0492755662597832,0.656973456368345
Physical measures,X4270.Volume level set by participant (left),SIAE,Sialate O-acetylesterase,16695,-0.0121729518945487,0.0274166345864543,-0.0659095556839991,0.0415636518949017,0.657049237228167
Physical measures,X4270.Volume level set by participant (left),STX1B,Syntaxin-1B,14261,0.0155552920028876,0.0350663743764815,-0.0531748017750161,0.0842853857807913,0.657341671152132
Physical measures,X4270.Volume level set by participant (left),CCL15,C-C motif chemokine 15,16871,-0.0125172668394009,0.0282323566634449,-0.0678526858997529,0.0428181522209512,0.657506720574218
Physical measures,X4270.Volume level set by participant (left),PAK4,Serine/threonine-protein kinase PAK 4,16257,0.00952636078027423,0.0215097056010945,-0.0326326621978709,0.0516853837584194,0.657853645756549
Physical measures,X4270.Volume level set by participant (left),GPR101,Probable G-protein coupled receptor 101,14168,-0.0107872065283813,0.0243753096710231,-0.0585628134835866,0.0369884004268239,0.658100596226894
Physical measures,X4270.Volume level set by participant (left),ITGAV,Integrin alpha-V,16810,-0.0338308839237342,0.0765207221913356,-0.183811499418752,0.116149731571284,0.658412394687082
Physical measures,X4270.Volume level set by participant (left),ADRA2A,Alpha-2A adrenergic receptor,14175,0.00905084881890596,0.0204873784916107,-0.031104413024651,0.0492061106624629,0.658657464712954
Physical measures,X4270.Volume level set by participant (left),GHR,Growth hormone receptor,14352,0.0226831451051583,0.0515133829178034,-0.0782830854137363,0.123649375624053,0.659701139241813
Physical measures,X4270.Volume level set by participant (left),SKAP1,Src kinase-associated phosphoprotein 1,16498,0.00795255790807403,0.0180768276303543,-0.0274780242474204,0.0433831400635685,0.659992809376005
Physical measures,X4270.Volume level set by participant (left),CSTB,Cystatin-B,16431,-0.0127793744413618,0.0290668232407833,-0.0697503479932971,0.0441915991105734,0.660192780901024
Physical measures,X4270.Volume level set by participant (left),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16757,-0.00570505493239176,0.0129762276401984,-0.0311384611071807,0.0197283512423971,0.66019314551995
Physical measures,X4270.Volume level set by participant (left),KIF1C,Kinesin-like protein KIF1C,14175,0.0187970550777374,0.042784315633232,-0.0650602035633973,0.102654313718872,0.660418617496638
Physical measures,X4270.Volume level set by participant (left),KCNC4,Potassium voltage-gated channel subfamily C member 4,14168,-0.0118973353397993,0.0270817647477032,-0.0649775942452975,0.0411829235656989,0.660442426244304
Physical measures,X4270.Volume level set by participant (left),CTSH,Pro-cathepsin H,16293,-0.0078130341594725,0.0177950816125212,-0.0426913941200141,0.0270653258010691,0.660626918248516
Physical measures,X4270.Volume level set by participant (left),CPTP,Ceramide-1-phosphate transfer protein,14175,-0.0161368381210581,0.0367929358104085,-0.0882509923094587,0.0559773160673425,0.660968795083218
Physical measures,X4270.Volume level set by participant (left),VAMP5,Vesicle-associated membrane protein 5,16356,-0.0103692699776317,0.0237232968116687,-0.0568669317285024,0.0361283917732389,0.662050199732784
Physical measures,X4270.Volume level set by participant (left),CLEC11A,C-type lectin domain family 11 member A,16636,-0.0114433671026964,0.0262151175201304,-0.062824997442152,0.0399382632367593,0.662466711893814
Physical measures,X4270.Volume level set by participant (left),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14261,-0.0128779041308274,0.029522279633535,-0.070741572212556,0.0449857639509012,0.662691216886532
Physical measures,X4270.Volume level set by participant (left),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14404,0.00880376143710863,0.0202070693744642,-0.0308020945368413,0.0484096174110585,0.663077413630595
Physical measures,X4270.Volume level set by participant (left),SCARA5,Scavenger receptor class A member 5,16799,0.0184635218437438,0.0424458481696831,-0.064730340568835,0.101657384256323,0.663575239369351
Physical measures,X4270.Volume level set by participant (left),CCL5,C-C motif chemokine 5,16715,-0.00532495551218037,0.0122818042491247,-0.0293972918404647,0.018747380816104,0.664610248796016
Physical measures,X4270.Volume level set by participant (left),AKR1B10,Aldo-keto reductase family 1 member B10,14261,0.0106303054503171,0.0245310269248883,-0.037450507322464,0.0587111182230983,0.664773449186974
Physical measures,X4270.Volume level set by participant (left),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,14117,-0.0120971275248989,0.0279852093377378,-0.066948137826865,0.0427538827770673,0.665552809529428
Physical measures,X4270.Volume level set by participant (left),SOD1,Superoxide dismutase [Cu-Zn],16346,-0.0117372363415561,0.027163723812395,-0.0649781350138503,0.041503662330738,0.665680024469048
Physical measures,X4270.Volume level set by participant (left),ODAM,Odontogenic ameloblast-associated protein,16231,-0.0104610973654865,0.0242755173146792,-0.0580411113022578,0.0371189165712848,0.666523539397971
Physical measures,X4270.Volume level set by participant (left),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16266,-0.00448122763966024,0.0104474918008266,-0.0249583115692804,0.0159958562899599,0.667980899682647
Physical measures,X4270.Volume level set by participant (left),IL17RA,Interleukin-17 receptor A,16671,0.0121793902118403,0.0284226551999836,-0.0435290139801275,0.0678877944038081,0.668285441781852
Physical measures,X4270.Volume level set by participant (left),CD109,CD109 antigen,16671,-0.0161799996115748,0.0378960833330119,-0.0904563229442782,0.0580963237211286,0.669416136884085
Physical measures,X4270.Volume level set by participant (left),FGR,Tyrosine-protein kinase Fgr,16257,0.00959676412430783,0.0225272448245888,-0.0345566357318861,0.0537501639805018,0.670108386630303
Physical measures,X4270.Volume level set by participant (left),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14697,-0.0234473542634834,0.0550673967867478,-0.131379451965509,0.0844847434385423,0.670264372101801
Physical measures,X4270.Volume level set by participant (left),IL1R1,Interleukin-1 receptor type 1,16640,0.0236679683069765,0.0556484597840093,-0.0854030128696816,0.132738949483635,0.670614613924967
Physical measures,X4270.Volume level set by participant (left),FUOM,Fucose mutarotase,14352,0.0100875284354138,0.023725095564244,-0.0364136588705044,0.056588715741332,0.670709008932471
Physical measures,X4270.Volume level set by participant (left),CYTH3,Cytohesin-3,14144,0.00861236460022284,0.0203178966620409,-0.0312107128573774,0.048435442057823,0.671659261753113
Physical measures,X4270.Volume level set by participant (left),KRT8,"Keratin, type II cytoskeletal 8",14168,-0.00917964951916506,0.021797013779384,-0.0519017965267577,0.0335424974884276,0.673657403405951
Physical measures,X4270.Volume level set by participant (left),EREG,Proepiregulin,16498,-0.0068099676798582,0.0161872036055999,-0.038536886746834,0.0249169513871176,0.673979144696631
Physical measures,X4270.Volume level set by participant (left),STX4,Syntaxin-4,16576,-0.0077816299166715,0.0185300270406938,-0.0441004829164313,0.0285372230830883,0.674529594845001
Physical measures,X4270.Volume level set by participant (left),CREBZF,CREB/ATF bZIP transcription factor,14144,-0.0240755393737911,0.0576033593486382,-0.136978123697122,0.0888270449495397,0.675987293763376
Physical measures,X4270.Volume level set by participant (left),UNC79,Protein unc-79 homolog,14144,-0.0112906687822881,0.0270392391525696,-0.0642875775213245,0.0417062399567483,0.676270755725085
Physical measures,X4270.Volume level set by participant (left),CCNE1,G1/S-specific cyclin-E1,14207,-0.00659176190119988,0.0158136071185518,-0.0375864318535615,0.0244029080511617,0.67680091943107
Physical measures,X4270.Volume level set by participant (left),TSPAN15,Tetraspanin-15,14175,0.0125536579520315,0.0301690774624283,-0.0465777338743281,0.071685049778391,0.677335744098624
Physical measures,X4270.Volume level set by participant (left),TINAGL1,Tubulointerstitial nephritis antigen-like,16613,-0.0236815440922393,0.0569532698459331,-0.135309952990268,0.0879468648057896,0.677556923191935
Physical measures,X4270.Volume level set by participant (left),ANG,Angiogenin,16578,-0.0155835092316387,0.0374831784161021,-0.0890505389271987,0.0578835204639214,0.677600722165027
Physical measures,X4270.Volume level set by participant (left),PDIA3,Protein disulfide-isomerase A3,14352,0.0246883310086352,0.05939297996722,-0.0917219097271159,0.141098571744386,0.677652161025731
Physical measures,X4270.Volume level set by participant (left),TSLP,Thymic stromal lymphopoietin,16356,0.00866573786647444,0.0209172887000318,-0.0323321479855879,0.0496636237185368,0.678670174022662
Physical measures,X4270.Volume level set by participant (left),CALCB,Calcitonin gene-related peptide 2,14628,0.0160504828968702,0.0387435689679218,-0.0598869122802566,0.0919878780739969,0.67867897468004
Physical measures,X4270.Volume level set by participant (left),CTNNA1,Catenin alpha-1,14168,-0.0172758333210732,0.0417814535414199,-0.0991674822622562,0.0646158156201097,0.679260573583809
Physical measures,X4270.Volume level set by participant (left),ZPR1,Zinc finger protein ZPR1,14168,0.00657114981626545,0.0159193481343463,-0.0246307725270533,0.0377730721595842,0.679775841115604
Physical measures,X4270.Volume level set by participant (left),CHGB,Secretogranin-1,16735,-0.0128461179411341,0.031132497249718,-0.0738658125505815,0.0481735766683132,0.679884995812289
Physical measures,X4270.Volume level set by participant (left),GH2,Growth hormone variant,16266,-0.00327138145347544,0.00792859342253171,-0.0188114245616376,0.0122686616546867,0.679901096169458
Physical measures,X4270.Volume level set by participant (left),CPQ,Carboxypeptidase Q,14649,0.0158468104238055,0.0384718283330406,-0.0595579731089541,0.0912515939565651,0.680413718346675
Physical measures,X4270.Volume level set by participant (left),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16576,-0.0123397566256711,0.0300127291413242,-0.0711647057426665,0.0464851924913244,0.680967306577902
Physical measures,X4270.Volume level set by participant (left),MYH4,Myosin-4,14175,-0.0130768844346695,0.031869483402414,-0.0755410719034008,0.0493873030340619,0.681572874664888
Physical measures,X4270.Volume level set by participant (left),M6PR,Cation-dependent mannose-6-phosphate receptor,14288,-0.0152489038265798,0.0372579844378349,-0.0882745533247361,0.0577767456715766,0.682341200727038
Physical measures,X4270.Volume level set by participant (left),RFC4,Replication factor C subunit 4,14572,-0.0284532630916852,0.0695873836711664,-0.164844535087171,0.107938008903801,0.68262980213236
Physical measures,X4270.Volume level set by participant (left),IGFBP1,Insulin-like growth factor-binding protein 1,16866,0.00416257481060927,0.0101808937277991,-0.015791976895877,0.0241171265170956,0.682646548986985
Physical measures,X4270.Volume level set by participant (left),BRK1,Protein BRICK1,16257,-0.0119110505476619,0.0291587722606461,-0.0690622441785282,0.0452401430832045,0.682919767738135
Physical measures,X4270.Volume level set by participant (left),ANXA1,Annexin A1,14256,0.0135463347397697,0.0331628560729966,-0.0514528631633035,0.078545532642843,0.682928088898883
Physical measures,X4270.Volume level set by participant (left),NECTIN2,Nectin-2,16639,0.0176820639424635,0.0433637564502594,-0.0673108987000449,0.102675026584972,0.683454141990514
Physical measures,X4270.Volume level set by participant (left),CRTAM,Cytotoxic and regulatory T-cell molecule,16533,0.0103062890787623,0.025295239751552,-0.0392723808342796,0.0598849589918041,0.683690233007915
Physical measures,X4270.Volume level set by participant (left),AKR1B1,Aldo-keto reductase family 1 member B1,16266,-0.00729546509123139,0.0179068497823599,-0.0423928906646569,0.0278019604821941,0.683710797981152
Physical measures,X4270.Volume level set by participant (left),AGT,Angiotensinogen,14672,-0.0225272392403576,0.0553489686392163,-0.131011217773222,0.0859567392925064,0.684011158884105
Physical measures,X4270.Volume level set by participant (left),SUSD1,Sushi domain-containing protein 1,16356,-0.0109443393007843,0.0269819895873571,-0.0638290388920043,0.0419403602904356,0.685029738457802
Physical measures,X4270.Volume level set by participant (left),FOLR3,Folate receptor gamma,16677,0.00269794302042202,0.00665355089726034,-0.0103430167382082,0.0157389027790523,0.685123163587137
Physical measures,X4270.Volume level set by participant (left),DEFB116,Beta-defensin 116,14168,-0.00798454379994675,0.0198165262924674,-0.0468249353331829,0.0308558477332894,0.687010602042303
Physical measures,X4270.Volume level set by participant (left),PRG2,Bone marrow proteoglycan,14678,-0.0113411221487617,0.0282155288888892,-0.0666435587709845,0.0439613144734612,0.687729544422781
Physical measures,X4270.Volume level set by participant (left),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16222,-0.0110603876374646,0.0275196300876386,-0.0649988626092362,0.042878087334307,0.687756282535544
Physical measures,X4270.Volume level set by participant (left),SNAP23,Synaptosomal-associated protein 23,16666,-0.00617818733343116,0.0154198898543549,-0.0364011714479669,0.0240447967811045,0.688673014323713
Physical measures,X4270.Volume level set by participant (left),SLAMF7,SLAM family member 7,16637,0.00870721409218291,0.0217441457128277,-0.0339113115049594,0.0513257396893252,0.688838007992832
Physical measures,X4270.Volume level set by participant (left),ASGR2,Asialoglycoprotein receptor 2,14672,0.0224898287117729,0.0563136404535757,-0.0878849065772355,0.132864564000781,0.689628376017437
Physical measures,X4270.Volume level set by participant (left),YAP1,Transcriptional coactivator YAP1,14628,-0.0217109313496046,0.0543792168734336,-0.128294196421534,0.0848723337223252,0.689714447002185
Physical measures,X4270.Volume level set by participant (left),NENF,Neudesin,14572,-0.00516117695685261,0.0129424097832909,-0.0305283001321029,0.0202059462183976,0.6900610065383
Physical measures,X4270.Volume level set by participant (left),PDIA5,Protein disulfide-isomerase A5,14144,-0.00968028974974467,0.0242818905216364,-0.057272795172152,0.0379122156726626,0.690147607188086
Physical measures,X4270.Volume level set by participant (left),SERPINE1,Plasminogen activator inhibitor 1,16871,-0.00738388363178335,0.0185236901358969,-0.0436903162981413,0.0289225490345746,0.6901794551834
Physical measures,X4270.Volume level set by participant (left),C9,Complement component C9,14672,0.011052352750878,0.0277327378042451,-0.0433038133454424,0.0654085188471983,0.69024469723664
Physical measures,X4270.Volume level set by participant (left),TF,Serotransferrin,14697,-0.0264067136992427,0.0663221313910672,-0.156398091225734,0.103584663827249,0.690519218666284
Physical measures,X4270.Volume level set by participant (left),PSAPL1,Proactivator polypeptide-like 1,14588,0.0115646951157163,0.0290636357566271,-0.0454000309672728,0.0685294211987054,0.69070276844964
Physical measures,X4270.Volume level set by participant (left),NCLN,Nicalin,16350,-0.00956124491614335,0.0240921567691999,-0.0567818721837752,0.0376593823514885,0.691474921020158
Physical measures,X4270.Volume level set by participant (left),CD22,B-cell receptor CD22,16843,-0.0121114313422397,0.0306550998477262,-0.072195427043783,0.0479725643593035,0.692783693035481
Physical measures,X4270.Volume level set by participant (left),MILR1,Allergin-1,16350,-0.00995417685094786,0.0254057168966414,-0.059749381968365,0.0398410282664693,0.695204796168217
Physical measures,X4270.Volume level set by participant (left),IL18BP,Interleukin-18-binding protein,16715,0.0162896969644704,0.0415927383542553,-0.06523207020987,0.0978114641388109,0.695323595510928
Physical measures,X4270.Volume level set by participant (left),KHK,Ketohexokinase,14288,-0.00938918810505491,0.0240122591673814,-0.0564532160731225,0.0376748398630126,0.69579092092665
Physical measures,X4270.Volume level set by participant (left),PGA4,Pepsin A-4,14672,-0.0081701505057836,0.0209122795747744,-0.0491582184723414,0.0328179174607742,0.696034474208264
Physical measures,X4270.Volume level set by participant (left),BSG,Basigin,16811,0.0249437851314202,0.0638513556240025,-0.100204871891625,0.150092442154465,0.696057987176434
Physical measures,X4270.Volume level set by participant (left),SKAP2,Src kinase-associated phosphoprotein 2,16733,-0.00476564269677327,0.012216636535332,-0.0287102503060241,0.0191789649124775,0.696471641504296
Physical measures,X4270.Volume level set by participant (left),HGF,Hepatocyte growth factor,16843,0.01408302095052,0.0362027907128127,-0.056874448846593,0.085040490747633,0.697278302983814
Physical measures,X4270.Volume level set by participant (left),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,14175,-0.0110053131558044,0.0282998466323445,-0.0664730125551996,0.0444623862435908,0.697368967360829
Physical measures,X4270.Volume level set by participant (left),IZUMO1,Izumo sperm-egg fusion protein 1,14144,0.012640626436265,0.0325090584248548,-0.0510771280764504,0.0763583809489805,0.697404825801405
Physical measures,X4270.Volume level set by participant (left),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14352,-0.011751045634565,0.0302452358053933,-0.0710317078131358,0.0475296165440058,0.697632950414349
Physical measures,X4270.Volume level set by participant (left),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,14168,0.00788179816227015,0.0202933020930811,-0.0318930739401688,0.0476566702647091,0.697730275906743
Physical measures,X4270.Volume level set by participant (left),HSPB6,Heat shock protein beta-6,16810,-0.0128241505324445,0.0330216383121576,-0.0775465616242734,0.0518982605593845,0.697757542600616
Physical measures,X4270.Volume level set by participant (left),APOA2,Apolipoprotein A-II,14672,0.0117840106662107,0.0303690287114281,-0.0477392856081883,0.0713073069406098,0.69800150456582
Physical measures,X4270.Volume level set by participant (left),PTP4A3,Protein tyrosine phosphatase type IVA 3,14207,-0.0113429687392538,0.0292763739502312,-0.068724661681707,0.0460387242031994,0.698433009557939
Physical measures,X4270.Volume level set by participant (left),INSL5,Insulin-like peptide INSL5,14588,0.00596986655183268,0.0154127538955252,-0.0242391310833967,0.036178864187062,0.698515434615239
Physical measures,X4270.Volume level set by participant (left),STC1,Stanniocalcin-1,16799,0.0112440411620987,0.0291022631244332,-0.0457963945617903,0.0682844768859877,0.69923265823773
Physical measures,X4270.Volume level set by participant (left),MN1,Transcriptional activator MN1,14261,-0.0100016091769863,0.0259178673714013,-0.0608006292249329,0.0407974108709603,0.699579232639823
Physical measures,X4270.Volume level set by participant (left),SERPINA6,Corticosteroid-binding globulin,14697,0.032909724492865,0.0853153601646585,-0.134308381429866,0.200127830415596,0.6996932843888
Physical measures,X4270.Volume level set by participant (left),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16257,-0.00911938397936842,0.0236488317879048,-0.0554710942836617,0.0372323263249249,0.699785629562377
Physical measures,X4270.Volume level set by participant (left),TGFB2,Transforming growth factor beta-2 proprotein,14572,-0.0105878202491456,0.0276034490706917,-0.0646905804277013,0.0435149399294101,0.701303713298771
Physical measures,X4270.Volume level set by participant (left),CD177,CD177 antigen,16648,0.00380970034311601,0.0099445415413889,-0.0156816010780062,0.0233010017642383,0.70165450630518
Physical measures,X4270.Volume level set by participant (left),CORO1A,Coronin-1A,16331,0.005353793276828,0.0139864944738323,-0.0220597358918833,0.0327673224455393,0.701885603199013
Physical measures,X4270.Volume level set by participant (left),FGF2,Fibroblast growth factor 2,16637,-0.00717811457659486,0.0187755475056415,-0.0439781876876523,0.0296219585344626,0.702234943649972
Physical measures,X4270.Volume level set by participant (left),GKN1,Gastrokine-1,15992,-0.017717539147596,0.0463659734099781,-0.108594847031153,0.073159768735961,0.70237466697613
Physical measures,X4270.Volume level set by participant (left),CHM,Rab proteins geranylgeranyltransferase component A 1,14261,-0.00939514282778671,0.0246436719837528,-0.0576967399159423,0.0389064542603688,0.703031178247397
Physical measures,X4270.Volume level set by participant (left),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16576,-0.01248904855693,0.0327638247477403,-0.0767061450625009,0.051728047948641,0.703071548010431
Physical measures,X4270.Volume level set by participant (left),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14261,0.0106671988686507,0.0280311054102424,-0.0442737677354243,0.0656081654727257,0.703543877179466
Physical measures,X4270.Volume level set by participant (left),SCGB3A2,Secretoglobin family 3A member 2,16710,0.00596107170694012,0.0156687528612813,-0.0247496839011712,0.0366718273150514,0.703621234583812
Physical measures,X4270.Volume level set by participant (left),PRUNE2,Protein prune homolog 2,14404,-0.0202688086687069,0.0533130489085426,-0.12476238452945,0.0842247671920366,0.703813884030641
Physical measures,X4270.Volume level set by participant (left),SEMA3G,Semaphorin-3G,14352,0.0127317891938375,0.0334920328673936,-0.052912595226254,0.0783761736139289,0.70384429406359
Physical measures,X4270.Volume level set by participant (left),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16637,0.00567323066341882,0.0149353261771169,-0.0236000086437303,0.0349464699705679,0.704059281248685
Physical measures,X4270.Volume level set by participant (left),CNPY2,Protein canopy homolog 2,16356,0.00814263686248328,0.0214865378552402,-0.0339709773337875,0.050256251058754,0.704719088461874
Physical measures,X4270.Volume level set by participant (left),WAS,Wiskott-Aldrich syndrome protein,16350,0.0070753384255763,0.0187108641834537,-0.0295979553739929,0.0437486322251455,0.705331023014609
Physical measures,X4270.Volume level set by participant (left),DDX39A,ATP-dependent RNA helicase DDX39A,14207,0.0242333007879204,0.0641439738693275,-0.101488887995962,0.149955489571802,0.705588212644066
Physical measures,X4270.Volume level set by participant (left),DNLZ,DNL-type zinc finger protein,14168,0.00635527506877725,0.0168254587175426,-0.0266226240176062,0.0393331741551607,0.705645916243094
Physical measures,X4270.Volume level set by participant (left),NME3,Nucleoside diphosphate kinase 3,16675,-0.0203026086785215,0.0538318402617419,-0.125813015591536,0.0852077982344925,0.706067904359109
Physical measures,X4270.Volume level set by participant (left),NXPE4,NXPE family member 4,14175,0.0160987828162875,0.0427934712263289,-0.0677764207873171,0.099973986419892,0.706775955294247
Physical measures,X4270.Volume level set by participant (left),SEMA3F,Semaphorin-3F,16666,-0.0183509902720495,0.0488100671248717,-0.114018721836798,0.077316741292699,0.706945979578014
Physical measures,X4270.Volume level set by participant (left),ARHGEF12,Rho guanine nucleotide exchange factor 12,16637,-0.0049267818215677,0.013125581631964,-0.0306529218202172,0.0207993581770818,0.707399606961514
Physical measures,X4270.Volume level set by participant (left),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,14175,-0.00882523879506553,0.0235357063018652,-0.0549552231467213,0.0373047455565902,0.707686656648438
Physical measures,X4270.Volume level set by participant (left),KLK7,Kallikrein-7,13992,0.0145130298775757,0.0388065616944561,-0.0615478310435582,0.0905738907987096,0.708421956735688
Physical measures,X4270.Volume level set by participant (left),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16637,0.00783133515929567,0.0209424644538321,-0.0332158951702152,0.0488785654888065,0.70844981821722
Physical measures,X4270.Volume level set by participant (left),CLEC4G,C-type lectin domain family 4 member G,16637,0.0141602094750569,0.0378749855570664,-0.0600747622167933,0.0883951811669071,0.708507993983525
Physical measures,X4270.Volume level set by participant (left),PODXL2,Podocalyxin-like protein 2,16719,0.0167988943174047,0.0449541367332342,-0.0713112136797342,0.104909002314544,0.708639991209976
Physical measures,X4270.Volume level set by participant (left),CD300A,CMRF35-like molecule 8,14352,0.0187647152683666,0.050287086506986,-0.079797974285326,0.117327404822059,0.709041008352417
Physical measures,X4270.Volume level set by participant (left),ENO3,Beta-enolase,14288,-0.00920252194897164,0.0247982585668701,-0.057807108740037,0.0394020648420937,0.710571917527127
Physical measures,X4270.Volume level set by participant (left),SMAD5,Mothers against decapentaplegic homolog 5,16576,-0.0230108542107322,0.0620145169585197,-0.144559307449431,0.0985375990279664,0.710600621807415
Physical measures,X4270.Volume level set by participant (left),DMD,Dystrophin,14288,-0.00998750589234892,0.0269212702947982,-0.0627531956701533,0.0427781838854555,0.710650934210539
Physical measures,X4270.Volume level set by participant (left),NDRG1,Protein NDRG1,16257,-0.00706123970585465,0.019034178035738,-0.0443682286559011,0.0302457492441918,0.710659601756817
Physical measures,X4270.Volume level set by participant (left),PCSK9,Proprotein convertase subtilisin/kexin type 9,16871,0.0114496251992391,0.0309442993905021,-0.0492012016061449,0.0721004520046232,0.711381494994798
Physical measures,X4270.Volume level set by participant (left),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,14175,0.0163992865987489,0.0443214264576211,-0.0704707092581885,0.103269282455686,0.71138199292066
Physical measures,X4270.Volume level set by participant (left),SCARB2,Lysosome membrane protein 2,16182,-0.0160798830720718,0.0434590678935163,-0.101259656143364,0.0690998899992201,0.711386858455397
Physical measures,X4270.Volume level set by participant (left),COL6A3,Collagen alpha-3(VI) chain,16871,0.0136164906662629,0.0368258225632738,-0.0585621215577537,0.0857951028902794,0.711570529870225
Physical measures,X4270.Volume level set by participant (left),BACH1,Transcription regulator protein BACH1,16637,0.00669540988891783,0.0181447759065699,-0.0288683508879592,0.0422591706657949,0.712132935498258
Physical measures,X4270.Volume level set by participant (left),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16810,-0.0148709264401203,0.0403643940738028,-0.0939851388247737,0.0642432859445332,0.712567014098514
Physical measures,X4270.Volume level set by participant (left),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",14175,0.0129467880300395,0.0352016382540645,-0.0560484229479268,0.0819419990080059,0.713035800680683
Physical measures,X4270.Volume level set by participant (left),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14629,-0.00797726916884893,0.0217339478661594,-0.0505758069865214,0.0346212686488235,0.713593091352238
Physical measures,X4270.Volume level set by participant (left),GBP2,Guanylate-binding protein 2,16350,0.0079185428823797,0.0215804368325861,-0.034379113309489,0.0502161990742484,0.713674839247749
Physical measures,X4270.Volume level set by participant (left),TOP1MT,"DNA topoisomerase I, mitochondrial",14144,0.011175699289927,0.0304678952254671,-0.0485413753519885,0.0708927739318426,0.713771857158119
Physical measures,X4270.Volume level set by participant (left),VASH1,Tubulinyl-Tyr carboxypeptidase 1,16637,-0.00581767397375801,0.0158727956301724,-0.0369283534088958,0.0252930054613798,0.71398284199805
Physical measures,X4270.Volume level set by participant (left),AOC1,Amiloride-sensitive amine oxidase [copper-containing],16350,-0.00846305378500801,0.0231226473808896,-0.0537834426515517,0.0368573350815356,0.714364496220302
Physical measures,X4270.Volume level set by participant (left),CAPS,Calcyphosin,14628,-0.00572090408770663,0.0156516632831924,-0.0363981641227638,0.0249563559473506,0.714732952339395
Physical measures,X4270.Volume level set by participant (left),PFDN6,Prefoldin subunit 6,14261,0.00834529891318004,0.0228352444545504,-0.0364117802177388,0.0531023780440989,0.714775759132748
Physical measures,X4270.Volume level set by participant (left),VIT,Vitrin,14652,0.0141434777290196,0.0387876841470246,-0.0618803831991486,0.0901673386571879,0.715386641182279
Physical measures,X4270.Volume level set by participant (left),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16266,-0.00731531526408605,0.0200684420969918,-0.0466494617741899,0.0320188312460178,0.715475722224242
Physical measures,X4270.Volume level set by participant (left),KLK1,Kallikrein-1,16524,-0.00365440730721462,0.0100292359041636,-0.0233117096793753,0.016002895064946,0.715582335527031
Physical measures,X4270.Volume level set by participant (left),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14572,-0.0053265789096,0.0146657576681862,-0.034071463939245,0.023418306120045,0.716461998461233
Physical measures,X4270.Volume level set by participant (left),SHMT1,"Serine hydroxymethyltransferase, cytosolic",16710,-0.00548914024509255,0.0151671348162983,-0.0352167244850373,0.0242384439948522,0.71742374544417
Physical measures,X4270.Volume level set by participant (left),RAB6B,Ras-related protein Rab-6B,16257,-0.0099824844605454,0.0276394084746182,-0.0641557250707971,0.0441907561497063,0.717978165980405
Physical measures,X4270.Volume level set by participant (left),SERPINA3,Alpha-1-antichymotrypsin,14631,-0.0355413952021253,0.0986139957141566,-0.228824826801872,0.157742036397622,0.718546326877646
Physical measures,X4270.Volume level set by participant (left),CR2,Complement receptor type 2,16715,-0.00975045442878534,0.027060776518275,-0.0627895764046044,0.0432886675470337,0.718614738675095
Physical measures,X4270.Volume level set by participant (left),MOCS2,Molybdopterin synthase catalytic subunit,14352,-0.00803654095391049,0.0223159121231441,-0.051775728715273,0.035702646807452,0.718758189484078
Physical measures,X4270.Volume level set by participant (left),DAAM1,Disheveled-associated activator of morphogenesis 1,14352,-0.00655067707670303,0.0181913645506451,-0.0422057515959673,0.0291043974425613,0.718779026670045
Physical measures,X4270.Volume level set by participant (left),ABL1,Tyrosine-protein kinase ABL1,16576,-0.00666210430739444,0.0185423347962804,-0.0430050805081041,0.0296808718933152,0.719381572351661
Physical measures,X4270.Volume level set by participant (left),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,16092,-0.00539007415726068,0.0150581065772929,-0.0349039630487548,0.0241238147342335,0.720384193772097
Physical measures,X4270.Volume level set by participant (left),CD6,T-cell differentiation antigen CD6,16811,0.00867568951237406,0.0242630672371723,-0.0388799222724837,0.0562313012972318,0.720671335963357
Physical measures,X4270.Volume level set by participant (left),PLTP,Phospholipid transfer protein,16804,-0.01270295968236,0.0355262617953939,-0.0823344328013321,0.056928513436612,0.720673119594281
Physical measures,X4270.Volume level set by participant (left),RNF149,E3 ubiquitin-protein ligase RNF149,14288,-0.0176735780433699,0.0494429451746389,-0.114581750585662,0.0792345944989222,0.720757250287462
Physical measures,X4270.Volume level set by participant (left),WIF1,Wnt inhibitory factor 1,16810,0.0130963672366762,0.0366448185932294,-0.0587274772060534,0.0849202116794059,0.720806895761716
Physical measures,X4270.Volume level set by participant (left),PTPRS,Receptor-type tyrosine-protein phosphatase S,16871,0.0182049181337373,0.0509665360089498,-0.0816894924438043,0.118099328711279,0.720951383384346
Physical measures,X4270.Volume level set by participant (left),CD99,CD99 antigen,16671,0.0233212984402584,0.06549303605452,-0.105045052226601,0.151687649107118,0.721779011605196
Physical measures,X4270.Volume level set by participant (left),CD80,T-lymphocyte activation antigen CD80,14652,-0.0155675052538169,0.0438299342938527,-0.101474176469768,0.0703391659621344,0.722460050040799
Physical measures,X4270.Volume level set by participant (left),DDX4,Probable ATP-dependent RNA helicase DDX4,14207,0.00994504040102026,0.0280575503684834,-0.0450477583212071,0.0649378391232476,0.723005823088551
Physical measures,X4270.Volume level set by participant (left),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,14168,-0.0108076927418589,0.030539580850222,-0.0706652712082939,0.0490498857245762,0.723425600693872
Physical measures,X4270.Volume level set by participant (left),STX5,Syntaxin-5,14207,-0.0126994411552858,0.0359300804863983,-0.0831223989086263,0.0577235165980548,0.723757312975885
Physical measures,X4270.Volume level set by participant (left),FOS,Proto-oncogene c-Fos,14117,0.0151708062679441,0.0429604585319835,-0.0690316924547436,0.0993733049906319,0.723993129088583
Physical measures,X4270.Volume level set by participant (left),F12,Coagulation factor XII,14697,0.0121051770624437,0.0343453994839691,-0.0552118059261357,0.0794221600510231,0.724502791012278
Physical measures,X4270.Volume level set by participant (left),CRYM,Ketimine reductase mu-crystallin,14168,-0.00690340862896563,0.0195981228456501,-0.0453157294064399,0.0315089121485086,0.724657181153961
Physical measures,X4270.Volume level set by participant (left),TCTN3,Tectonic-3,14652,0.0174363052806075,0.0495140528173682,-0.0796112382414342,0.114483848802649,0.724731879078508
Physical measures,X4270.Volume level set by participant (left),MZT1,Mitotic-spindle organizing protein 1,16266,-0.00816942982290155,0.0232175745433805,-0.0536758759279274,0.0373370162821243,0.724944783558461
Physical measures,X4270.Volume level set by participant (left),CALCA,Calcitonin,16498,-0.00736472718830843,0.020938571092503,-0.0484043265296143,0.0336748721529975,0.725045128225973
Physical measures,X4270.Volume level set by participant (left),MLN,Promotilin,16637,-0.0050134794474535,0.0142955767494273,-0.033032809876331,0.023005850981424,0.725816784899423
Physical measures,X4270.Volume level set by participant (left),SHISA5,Protein shisa-5,14678,0.0200787873221142,0.0573360560846375,-0.0922998826037753,0.132457457248004,0.726197557671331
Physical measures,X4270.Volume level set by participant (left),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16799,-0.00782096117607883,0.0223494809488397,-0.0516259438358047,0.0359840214836471,0.726388661939529
Physical measures,X4270.Volume level set by participant (left),HMBS,Porphobilinogen deaminase,16810,-0.0103777481235426,0.0297480533988929,-0.0686839327853727,0.0479284365382876,0.727202771972418
Physical measures,X4270.Volume level set by participant (left),CPB1,Carboxypeptidase B,16871,0.00737146363535629,0.0211444710465778,-0.0340716996159362,0.0488146268866488,0.727376190750117
Physical measures,X4270.Volume level set by participant (left),KLRF1,Killer cell lectin-like receptor subfamily F member 1,14207,-0.0114141557331979,0.032834166494706,-0.0757691220628215,0.0529408105964258,0.728122898957104
Physical measures,X4270.Volume level set by participant (left),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16489,-0.0173572142226986,0.0499598864417575,-0.115278591648543,0.080564163203146,0.728277986578536
Physical measures,X4270.Volume level set by participant (left),DBH,Dopamine beta-hydroxylase,14639,0.00454514387958002,0.0130844097825144,-0.0211002992941482,0.0301905870533082,0.728317652972279
Physical measures,X4270.Volume level set by participant (left),STK4,Serine/threonine-protein kinase 4,16666,-0.00519950449072509,0.0149711272089309,-0.0345429138202297,0.0241439048387796,0.728368734578337
Physical measures,X4270.Volume level set by participant (left),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",14144,0.0089715443399911,0.0258800519921497,-0.0417533575646222,0.0596964462446044,0.728852928503268
Physical measures,X4270.Volume level set by participant (left),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",14168,-0.0162798641414169,0.0469643801203234,-0.108330049177251,0.0757703208944169,0.728864843026806
Physical measures,X4270.Volume level set by participant (left),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,14175,0.0251162956760594,0.0724600723954897,-0.116905446219101,0.167138037571219,0.728880047562115
Physical measures,X4270.Volume level set by participant (left),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16547,0.00750516452709406,0.021734318097061,-0.0350940989431455,0.0501044279973336,0.729862709484627
Physical measures,X4270.Volume level set by participant (left),HEXIM1,Protein HEXIM1,16637,-0.00563620837597176,0.0163361894852472,-0.0376551397670563,0.0263827230151128,0.730088474143261
Physical measures,X4270.Volume level set by participant (left),LMNB1,Lamin-B1,14558,-0.00879891466731671,0.0255258674959497,-0.0588296149593781,0.0412317856247447,0.730320539917501
Physical measures,X4270.Volume level set by participant (left),PNLIP,Pancreatic triacylglycerol lipase,14672,-0.007930874809503,0.0230414101890644,-0.0530920387800692,0.0372302891610632,0.730700121724668
Physical measures,X4270.Volume level set by participant (left),CXADR,Coxsackievirus and adenovirus receptor,16637,0.00843014016136294,0.0247253632124615,-0.0400315717350616,0.0568918520577875,0.733144693170533
Physical measures,X4270.Volume level set by participant (left),AIF1L,Allograft inflammatory factor 1-like,14288,-0.00894968102465747,0.026251910946307,-0.0604034264794192,0.0425040644301042,0.733172280936413
Physical measures,X4270.Volume level set by participant (left),LTBR,Tumor necrosis factor receptor superfamily member 3,16544,0.0153731401846334,0.0452166250279474,-0.0732514448701436,0.10399772523941,0.733869381295458
Physical measures,X4270.Volume level set by participant (left),CLEC1A,C-type lectin domain family 1 member A,16356,-0.0132293561729045,0.03904930916225,-0.0897660021309145,0.0633072897851056,0.734775361599191
Physical measures,X4270.Volume level set by participant (left),MYO9B,Unconventional myosin-IXb,16350,0.00616458683550554,0.0182558685781326,-0.0296169155776343,0.0419460892486454,0.735610952673024
Physical measures,X4270.Volume level set by participant (left),MMP1,Interstitial collagenase,16019,0.00479366966700918,0.0141985691351354,-0.0230355258378562,0.0326228651718746,0.735656717091845
Physical measures,X4270.Volume level set by participant (left),GLO1,Lactoylglutathione lyase,16356,-0.00771802132645905,0.0228723782210459,-0.052547882639709,0.0371118399867909,0.735790689757331
Physical measures,X4270.Volume level set by participant (left),FOLR1,Folate receptor alpha,16653,0.0150577219486431,0.0446765689900071,-0.0725083532717708,0.102623797169057,0.736092160416209
Physical measures,X4270.Volume level set by participant (left),CTSV,Cathepsin L2,16796,-0.0102336904549698,0.0303705204251813,-0.0697599104883251,0.0492925295783855,0.736150278142952
Physical measures,X4270.Volume level set by participant (left),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,14144,0.00619069516739854,0.0184347596868225,-0.0299414338187735,0.0423228241535706,0.737014287459107
Physical measures,X4270.Volume level set by participant (left),FRMD7,FERM domain-containing protein 7,14261,0.0150292127956502,0.0447937880251447,-0.0727666117336335,0.102825037324934,0.737237784257617
Physical measures,X4270.Volume level set by participant (left),EZR,Ezrin,16799,-0.0172634322458009,0.0514648545376704,-0.118134547139635,0.083607682648033,0.737296490927018
Physical measures,X4270.Volume level set by participant (left),PTX3,Pentraxin-related protein PTX3,16637,-0.00863083651622791,0.0257357883789602,-0.0590729817389899,0.041811308706534,0.73735535212441
Physical measures,X4270.Volume level set by participant (left),CD70,CD70 antigen,16637,0.00984814941325009,0.0295370969999495,-0.0480445607066509,0.0677408595331511,0.738824271428853
Physical measures,X4270.Volume level set by participant (left),PTPRC,Receptor-type tyrosine-protein phosphatase C,14678,-0.0215811618241987,0.0649056808620081,-0.148796296313735,0.105633972665337,0.739516226664727
Physical measures,X4270.Volume level set by participant (left),PYDC1,Pyrin domain-containing protein 1,14288,-0.0118741806934763,0.0357769005284095,-0.081996905729159,0.0582485443422064,0.739973287217618
Physical measures,X4270.Volume level set by participant (left),SCGB2A2,Mammaglobin-A,14175,-0.0160502430285172,0.0484579620193433,-0.11102784858643,0.0789273625293956,0.740483265390519
Physical measures,X4270.Volume level set by participant (left),EPHX2,Bifunctional epoxide hydrolase 2,16356,-0.00677416947141925,0.0204789063671283,-0.0469128259509907,0.0333644870081522,0.740809125887474
Physical measures,X4270.Volume level set by participant (left),ARG1,Arginase-1,16645,0.00823774685127618,0.0249613054602841,-0.0406864118508807,0.0571619055534331,0.741388498320419
Physical measures,X4270.Volume level set by participant (left),SERPINA5,Plasma serine protease inhibitor,14490,-0.0145633451251002,0.0443022733590671,-0.101395800908872,0.0722691106586714,0.742366941989431
Physical measures,X4270.Volume level set by participant (left),CLEC4A,C-type lectin domain family 4 member A,16637,-0.0119268923150612,0.0363048681330804,-0.0830844338558988,0.0592306492257763,0.742522308986246
Physical measures,X4270.Volume level set by participant (left),BTN3A2,Butyrophilin subfamily 3 member A2,16637,0.0111496465130285,0.0340062493924625,-0.055502602296198,0.0778018953222551,0.743013697868445
Physical measures,X4270.Volume level set by participant (left),ACY1,Aminoacylase-1,16666,0.0068271101905951,0.0208574739799079,-0.0340535388100243,0.0477077591912145,0.743428466448361
Physical measures,X4270.Volume level set by participant (left),TCL1B,T-cell leukemia/lymphoma protein 1B,16356,0.00522376055184307,0.0159842429812906,-0.0261053556914864,0.0365528767951726,0.74381814287166
Physical measures,X4270.Volume level set by participant (left),SYTL4,Synaptotagmin-like protein 4,14652,-0.00634330487383656,0.0194948719461589,-0.044553253888308,0.0318666441406348,0.744895679303003
Physical measures,X4270.Volume level set by participant (left),CD2AP,CD2-associated protein,16666,-0.00668527108847945,0.0205608951105372,-0.0469846255051324,0.0336140833281735,0.745075460518654
Physical measures,X4270.Volume level set by participant (left),CD4,T-cell surface glycoprotein CD4,16616,-0.0137625323151042,0.0423437893242992,-0.0967563593907307,0.0692312947605223,0.745170854923059
Physical measures,X4270.Volume level set by participant (left),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14261,-0.00985780930233866,0.0303321253022217,-0.0693087748946931,0.0495931562900158,0.745189123891082
Physical measures,X4270.Volume level set by participant (left),MFAP3,Microfibril-associated glycoprotein 3,16356,0.00866460060012313,0.026663659807696,-0.043596172622961,0.0609253738232072,0.745216138719828
Physical measures,X4270.Volume level set by participant (left),DLK1,Protein delta homolog 1,16871,-0.00737130779595155,0.0226849777856989,-0.0518338642559213,0.0370912486640183,0.74522881031081
Physical measures,X4270.Volume level set by participant (left),CD40,Tumor necrosis factor receptor superfamily member 5,16645,-0.00824432789369761,0.0253848195953647,-0.0579985743006125,0.0415099185132172,0.745356254301581
Physical measures,X4270.Volume level set by participant (left),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14261,0.0152762678428011,0.0470445508783415,-0.0769310518787482,0.10748358756435,0.745398387993682
Physical measures,X4270.Volume level set by participant (left),B4GALT1,"Beta-1,4-galactosyltransferase 1",16733,-0.0147140254008923,0.0455143508229982,-0.103922153013969,0.074494102212184,0.746484812871498
Physical measures,X4270.Volume level set by participant (left),ADH1B,All-trans-retinol dehydrogenase,14352,0.00653898606341611,0.0202370933603483,-0.0331257169228665,0.0462036890496988,0.746609958218062
Physical measures,X4270.Volume level set by participant (left),TDO2,"Tryptophan 2,3-dioxygenase",14261,-0.0124849510359469,0.0386510213147921,-0.0882409528129395,0.0632710507410457,0.746686833023264
Physical measures,X4270.Volume level set by participant (left),IFNGR1,Interferon gamma receptor 1,16733,0.019453676739084,0.0605349820445738,-0.0991948880682806,0.138102241546449,0.747939670992474
Physical measures,X4270.Volume level set by participant (left),PGLYRP4,Peptidoglycan recognition protein 4,14175,-0.00742172637587161,0.0232871348738696,-0.0530645107286561,0.0382210579769128,0.749954922275877
Physical measures,X4270.Volume level set by participant (left),JCHAIN,Immunoglobulin J chain,16350,-0.0066003085858226,0.0207371183634889,-0.0472450605782608,0.0340444434066156,0.750273018603032
Physical measures,X4270.Volume level set by participant (left),LMNB2,Lamin-B2,14628,0.016547913160831,0.0519951696600595,-0.0853626193728855,0.118458445694548,0.750293286406073
Physical measures,X4270.Volume level set by participant (left),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14628,0.0075722986463226,0.0238261695827738,-0.0391269937359141,0.0542715910285593,0.750630305188464
Physical measures,X4270.Volume level set by participant (left),IDI2,Isopentenyl-diphosphate delta-isomerase 2,16257,0.00862019194179459,0.027140790286846,-0.0445757570204235,0.0618161409040127,0.750784716285007
Physical measures,X4270.Volume level set by participant (left),LELP1,Late cornified envelope-like proline-rich protein 1,14168,0.00655653433448735,0.0207572947355895,-0.034127763347268,0.0472408320162427,0.752108487698832
Physical measures,X4270.Volume level set by participant (left),NTF3,Neurotrophin-3,16637,-0.0112294193786343,0.0356331096312377,-0.0810703142558602,0.0586114754985916,0.752659289722939
Physical measures,X4270.Volume level set by participant (left),CPA1,Carboxypeptidase A1,16871,0.00650417131512326,0.0206723685937003,-0.0340136711285293,0.0470220137587759,0.753045612123755
Physical measures,X4270.Volume level set by participant (left),ANK2,Ankyrin-2,14175,0.00666533489478985,0.0212238206373203,-0.034933353554358,0.0482640233439377,0.753487904785053
Physical measures,X4270.Volume level set by participant (left),INHBB,Inhibin beta B chain,14352,0.00908679402618559,0.0292083938450824,-0.0481616579101759,0.0663352459625471,0.755727492882876
Physical measures,X4270.Volume level set by participant (left),LDLR,Low-density lipoprotein receptor,16722,0.00757520407942423,0.0243929146907353,-0.040234908714417,0.0553853168732654,0.756147102994059
Physical measures,X4270.Volume level set by participant (left),ITM2A,Integral membrane protein 2A,16637,-0.00635858083016565,0.0204872566775095,-0.0465136039180843,0.033796442257753,0.756285316258596
Physical measures,X4270.Volume level set by participant (left),CEP290,Centrosomal protein of 290 kDa,14404,0.00863295608554841,0.0279526164960085,-0.0461541722466283,0.0634200844177251,0.757445806649008
Physical measures,X4270.Volume level set by participant (left),ZP4,Zona pellucida sperm-binding protein 4,14144,-0.014238960115992,0.046239216078269,-0.104867823629399,0.0763899033974152,0.758131607850571
Physical measures,X4270.Volume level set by participant (left),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16675,-0.0114862409170598,0.0373624792180568,-0.0847167001844512,0.0617442183503315,0.758522100173383
Physical measures,X4270.Volume level set by participant (left),CTRL,Chymotrypsin-like protease CTRL-1,14628,0.00662488603625239,0.0215506462651799,-0.0356143806435001,0.0488641527160049,0.758535632971216
Physical measures,X4270.Volume level set by participant (left),SEMA4D,Semaphorin-4D,16799,-0.0129199227286803,0.0420360590387712,-0.0953105984446719,0.0694707529873112,0.758578261031353
Physical measures,X4270.Volume level set by participant (left),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14207,0.0103520728262967,0.0337731781246249,-0.0558433562979681,0.0765475019505615,0.759215093949174
Physical measures,X4270.Volume level set by participant (left),CPVL,Probable serine carboxypeptidase CPVL,16807,-0.0095334703680353,0.031124463851292,-0.0705374195165677,0.0514704787804971,0.759378885302341
Physical measures,X4270.Volume level set by participant (left),CPA2,Carboxypeptidase A2,16735,0.00582734560071307,0.0190442546917863,-0.0314993935951881,0.0431540847966143,0.75961630538446
Physical measures,X4270.Volume level set by participant (left),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14261,-0.00853210295648611,0.0279024955690605,-0.0632209942718448,0.0461567883588725,0.759774501080879
Physical measures,X4270.Volume level set by participant (left),JUN,Transcription factor AP-1,16350,-0.00757688834594579,0.0247892844132955,-0.0561638857960049,0.0410101091041133,0.75987370366393
Physical measures,X4270.Volume level set by participant (left),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16799,-0.0073572757510468,0.0240912353230892,-0.0545760969843016,0.039861545482208,0.760071236840589
Physical measures,X4270.Volume level set by participant (left),SNAP29,Synaptosomal-associated protein 29,16719,-0.00439132841167627,0.0143951305407849,-0.0326057842716147,0.0238231274482621,0.760326907852402
Physical measures,X4270.Volume level set by participant (left),POLR2A,DNA-directed RNA polymerase II subunit RPB1,14207,-0.0155618970199249,0.0510594674907645,-0.115638453301823,0.0845146592619736,0.760538296341986
Physical measures,X4270.Volume level set by participant (left),SCIN,Adseverin,14168,-0.00614295692167284,0.0201722847312827,-0.045680634994987,0.0333947211516413,0.760732732738465
Physical measures,X4270.Volume level set by participant (left),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14404,0.0062636319717665,0.0206079955020725,-0.0341280392122956,0.0466553031558286,0.761176600230098
Physical measures,X4270.Volume level set by participant (left),HIP1R,Huntingtin-interacting protein 1-related protein,14591,0.0108295223520328,0.0357110457370354,-0.0591641272925566,0.0808231719966221,0.761700523445962
Physical measures,X4270.Volume level set by participant (left),CLSTN1,Calsyntenin-1,16257,-0.00759398839468498,0.02511130933123,-0.0568121546838957,0.0416241778945258,0.762341057869857
Physical measures,X4270.Volume level set by participant (left),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16454,-0.00830810439902532,0.0277467983097335,-0.062691829086103,0.0460756202880523,0.764619044195052
Physical measures,X4270.Volume level set by participant (left),PKLR,Pyruvate kinase PKLR,16689,-0.0055751109740308,0.0186430295687766,-0.0421154489288329,0.0309652269807713,0.764909184387828
Physical measures,X4270.Volume level set by participant (left),ICAM5,Intercellular adhesion molecule 5,16666,0.00831284912842093,0.0278092229175399,-0.0461932277899573,0.0628189260467992,0.765001628886392
Physical measures,X4270.Volume level set by participant (left),CA11,Carbonic anhydrase-related protein 11,16266,0.0120496808208312,0.0403562655800114,-0.0670485997159913,0.0911479613576536,0.765262321362541
Physical measures,X4270.Volume level set by participant (left),ARHGAP5,Rho GTPase-activating protein 5,14144,0.00582903562357646,0.0195389212176572,-0.0324672499630316,0.0441253212101845,0.765456116666266
Physical measures,X4270.Volume level set by participant (left),CRNN,Cornulin,16172,0.00575112643356577,0.0193208443232396,-0.0321177284399839,0.0436199813071154,0.765963188085839
Physical measures,X4270.Volume level set by participant (left),KRT5,"Keratin, type II cytoskeletal 5",16257,-0.00764200690949171,0.0256768371489958,-0.0579686077215234,0.04268459390254,0.765995034169492
Physical measures,X4270.Volume level set by participant (left),CD276,CD276 antigen,16630,-0.0104123313692638,0.034997378122968,-0.0790071924902812,0.0581825297517535,0.766075193061729
Physical measures,X4270.Volume level set by participant (left),PTPRB,Receptor-type tyrosine-protein phosphatase beta,14652,-0.0148329268959218,0.0498906768623762,-0.112618653546179,0.0829527997543355,0.766235142239452
Physical measures,X4270.Volume level set by participant (left),FCN2,Ficolin-2,16524,-0.00907710505788367,0.0306021106513832,-0.0690572419345948,0.0509030318188275,0.766762692251675
Physical measures,X4270.Volume level set by participant (left),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14678,-0.00706384022452799,0.0238384071080511,-0.0537871181563081,0.0396594377072521,0.766988519660459
Physical measures,X4270.Volume level set by participant (left),BCL2,Apoptosis regulator Bcl-2,14588,-0.0083306067650046,0.0281526028155272,-0.063509708283438,0.0468484947534288,0.767303842851409
Physical measures,X4270.Volume level set by participant (left),ERBB2,Receptor tyrosine-protein kinase erbB-2,16719,-0.0150892201904967,0.0510186469990908,-0.115085768308715,0.0849073279277214,0.767417870235008
Physical measures,X4270.Volume level set by participant (left),PRSS27,Serine protease 27,16600,-0.00928890489873237,0.0314636596572431,-0.0709576778269288,0.0523798680294641,0.767824585249287
Physical measures,X4270.Volume level set by participant (left),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14404,0.00626681208837278,0.0212639210220765,-0.0354104731148971,0.0479440972916426,0.768215295154311
Physical measures,X4270.Volume level set by participant (left),IL5,Interleukin-5,16350,-0.00268786013903825,0.00915917199184768,-0.0206398372430597,0.0152641169649832,0.769173503248081
Physical measures,X4270.Volume level set by participant (left),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16576,0.00404387342039145,0.0137952106033068,-0.0229947393620899,0.0310824862028727,0.769421842722295
Physical measures,X4270.Volume level set by participant (left),REST,RE1-silencing transcription factor,14144,0.0128240112099898,0.0437847849339341,-0.072994167260521,0.0986421896805006,0.76961253244463
Physical measures,X4270.Volume level set by participant (left),CD160,CD160 antigen,16843,-0.00786853728211856,0.026890374050853,-0.0605736704217905,0.0448365958575534,0.769819757243428
Physical measures,X4270.Volume level set by participant (left),IL20,Interleukin-20,16350,0.00745867158968439,0.0255990089049966,-0.042715385864109,0.0576327290434778,0.770775391078337
Physical measures,X4270.Volume level set by participant (left),STX6,Syntaxin-6,16266,0.00530173933773672,0.0182517492210342,-0.0304716891354903,0.0410751678109637,0.771453962168914
Physical measures,X4270.Volume level set by participant (left),CTRB1,Chymotrypsinogen B,16671,0.00660298010017371,0.0227806923980509,-0.038047177000006,0.0512531372003534,0.771934723545996
Physical measures,X4270.Volume level set by participant (left),F7,Coagulation factor VII,16697,-0.0120846581036829,0.04171133775689,-0.0938388801071872,0.0696695638998215,0.772033150769068
Physical measures,X4270.Volume level set by participant (left),SPP1,Osteopontin,16839,0.00762000625971484,0.0263265699647447,-0.0439800708711847,0.0592200833906144,0.772246981301054
Physical measures,X4270.Volume level set by participant (left),FABP5,Fatty acid-binding protein 5,16733,-0.00548997743506508,0.018998369572697,-0.0427267817975512,0.0317468269274211,0.772607170193111
Physical measures,X4270.Volume level set by participant (left),ELOB,Elongin-B,14175,0.010942736233256,0.0379068727689464,-0.0633547343938789,0.0852402068603908,0.772834932880086
Physical measures,X4270.Volume level set by participant (left),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16356,0.00646426170765442,0.0224392366230039,-0.0375166420734333,0.0504451654887421,0.773290301074448
Physical measures,X4270.Volume level set by participant (left),ERMAP,Erythroid membrane-associated protein,14207,-0.00958869523802612,0.0334449820547508,-0.0751408600653378,0.0559634695892855,0.774345791055216
Physical measures,X4270.Volume level set by participant (left),LRP11,Low-density lipoprotein receptor-related protein 11,16666,0.0101416508702276,0.0353909122306665,-0.0592245371018786,0.0795078388423339,0.774452139403651
Physical measures,X4270.Volume level set by participant (left),SCN2A,Sodium channel protein type 2 subunit alpha,14168,-0.00902207210138585,0.0315096150365618,-0.0707809175730469,0.0527367733702752,0.774631420869797
Physical measures,X4270.Volume level set by participant (left),THBS2,Thrombospondin-2,16671,0.00960077570870213,0.0335899612768063,-0.0562355483938382,0.0754370998112425,0.775017423773548
Physical measures,X4270.Volume level set by participant (left),NAAA,N-acylethanolamine-hydrolyzing acid amidase,16445,0.00609121443199101,0.0214066699343439,-0.035865858639323,0.048048287503305,0.775994423819184
Physical measures,X4270.Volume level set by participant (left),CBX2,Chromobox protein homolog 2,14175,0.0109664613480834,0.0385716118642193,-0.0646338979057865,0.0865668206019532,0.776173675924534
Physical measures,X4270.Volume level set by participant (left),DPEP1,Dipeptidase 1,16498,-0.00748198875226002,0.0263317423848925,-0.0590922038266493,0.0441282263221292,0.776304118081087
Physical measures,X4270.Volume level set by participant (left),TNPO1,Transportin-1,14404,-0.0115610722141977,0.040807193115048,-0.0915431707196919,0.0684210262912964,0.776943545331939
Physical measures,X4270.Volume level set by participant (left),FEN1,Flap endonuclease 1,16266,0.00584708256611345,0.0206408753719571,-0.0346090331629224,0.0463031982951493,0.776968215370199
Physical measures,X4270.Volume level set by participant (left),CCL19,C-C motif chemokine 19,16799,0.00287028284317433,0.01015062192142,-0.0170249361228088,0.0227655018091574,0.777357283415936
Physical measures,X4270.Volume level set by participant (left),CDH5,Cadherin-5,16871,-0.0116373323131819,0.0412145743083462,-0.0924178979575404,0.0691432333311767,0.777671227124937
Physical measures,X4270.Volume level set by participant (left),CPA4,Carboxypeptidase A4,14070,0.00975501968275302,0.0346125617352732,-0.0580856013183824,0.0775956406838885,0.778074440379695
Physical measures,X4270.Volume level set by participant (left),NPHS2,Podocin,14207,-0.00408469897309831,0.014540732184903,-0.0325845340555082,0.0244151361093115,0.77878026114407
Physical measures,X4270.Volume level set by participant (left),AIDA,"Axin interactor, dorsalization-associated protein",14261,0.00481803669178091,0.0171911498230946,-0.0288766169614845,0.0385126903450463,0.779280096838656
Physical measures,X4270.Volume level set by participant (left),EGFLAM,Pikachurin,14588,0.0134914140018327,0.048210543758579,-0.081001251764982,0.107984079768648,0.779601441963461
Physical measures,X4270.Volume level set by participant (left),SH2D1A,SH2 domain-containing protein 1A,16637,0.00630494947577344,0.0225520484390038,-0.0378970654646741,0.050506964416221,0.77980841141062
Physical measures,X4270.Volume level set by participant (left),OMP,Olfactory marker protein,14168,-0.00868485034841317,0.0311363062971677,-0.0697120106908618,0.0523423099940354,0.780302610459239
Physical measures,X4270.Volume level set by participant (left),CCL24,C-C motif chemokine 24,16710,0.00425400769353667,0.0152777224834303,-0.0256903283739868,0.0341983437610602,0.780674115225375
Physical measures,X4270.Volume level set by participant (left),RBP2,Retinol-binding protein 2,16576,-0.00461361513430643,0.0165842527429453,-0.0371187505104792,0.0278915202418663,0.78086804660407
Physical measures,X4270.Volume level set by participant (left),LRP2,Low-density lipoprotein receptor-related protein 2,14261,0.0112200213610195,0.0404266352093714,-0.0680161836493484,0.0904562263713874,0.78136927656188
Physical measures,X4270.Volume level set by participant (left),MLLT1,Protein ENL,14144,0.00596327581312303,0.0215413968594856,-0.0362578620314687,0.0481844136577148,0.781915731062788
Physical measures,X4270.Volume level set by participant (left),GLA,Alpha-galactosidase A,14314,-0.0110838685446006,0.0402186506432679,-0.0899124238054058,0.0677446867162045,0.782866771323627
Physical measures,X4270.Volume level set by participant (left),STX8,Syntaxin-8,16637,-0.00689927578570158,0.0251352721608375,-0.0561644092209431,0.0423658576495399,0.783714710997124
Physical measures,X4270.Volume level set by participant (left),LAMA1,Laminin subunit alpha-1,14175,0.00761269389412413,0.027811517467093,-0.0468978803413781,0.0621232681296263,0.78430033626142
Physical measures,X4270.Volume level set by participant (left),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14629,0.00950537709188652,0.0347894059626866,-0.0586818585949792,0.0776926127787523,0.784683204851762
Physical measures,X4270.Volume level set by participant (left),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16583,0.00185933563920785,0.00681223220586682,-0.0114926394842911,0.0152113107627068,0.784902177993167
Physical measures,X4270.Volume level set by participant (left),CEP20,Centrosomal protein 20,16266,0.00490219260732947,0.0179624531723061,-0.0303042156103905,0.0401086008250495,0.784923320631778
Physical measures,X4270.Volume level set by participant (left),ANPEP,Aminopeptidase N,16676,-0.0123157103451442,0.045140576528793,-0.100791240341579,0.0761598196512902,0.784987162477435
Physical measures,X4270.Volume level set by participant (left),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14352,0.0140932470029818,0.0517602265698209,-0.0873567970738671,0.115543291079831,0.785411062994514
Physical measures,X4270.Volume level set by participant (left),ANXA11,Annexin A11,16612,-0.00555661037778872,0.0204648421446905,-0.0456677009813821,0.0345544802258047,0.78599463072607
Physical measures,X4270.Volume level set by participant (left),SLC28A1,Sodium/nucleoside cotransporter 1,14144,0.00697362124545242,0.025706975546785,-0.0434120508262462,0.0573592933171511,0.786184649675993
Physical measures,X4270.Volume level set by participant (left),IL10RA,Interleukin-10 receptor subunit alpha,16350,0.00599609618336662,0.0221548771565745,-0.0374274630435195,0.0494196554102527,0.786667867938498
Physical measures,X4270.Volume level set by participant (left),CD83,CD83 antigen,16637,-0.0102750738892185,0.0381116793476854,-0.0849739654106818,0.0644238176322448,0.787468013560418
Physical measures,X4270.Volume level set by participant (left),BAMBI,BMP and activin membrane-bound inhibitor homolog,16266,-0.0116378478416047,0.043226221828339,-0.0963612426251491,0.0730855469419398,0.787755185915879
Physical measures,X4270.Volume level set by participant (left),SCN3A,Sodium channel protein type 3 subunit alpha,14261,-0.011195580128356,0.0416358735538606,-0.0928018922939229,0.0704107320372109,0.788016192147338
Physical measures,X4270.Volume level set by participant (left),TMPRSS15,Enteropeptidase,16576,-0.00381522375352806,0.0141905679735835,-0.0316287369817516,0.0239982894746955,0.78804360781031
Physical measures,X4270.Volume level set by participant (left),NECTIN1,Nectin-1,14207,-0.0126027791640453,0.0470404331938082,-0.104802028223909,0.0795964698958188,0.788769598618902
Physical measures,X4270.Volume level set by participant (left),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",14168,-0.00713062184537447,0.0266332404059806,-0.0593317730410964,0.0450705293503475,0.788908040635301
Physical measures,X4270.Volume level set by participant (left),MMP8,Neutrophil collagenase,16785,0.00455553050571303,0.0170745792100176,-0.0289106447459215,0.0380217057573475,0.789624957247211
Physical measures,X4270.Volume level set by participant (left),DCDC2C,Doublecortin domain-containing protein 2C,14144,-0.00622815446841468,0.0233963741472202,-0.0520850477969663,0.039628738860137,0.79008776217217
Physical measures,X4270.Volume level set by participant (left),YES1,Tyrosine-protein kinase Yes,16576,-0.00310010123876032,0.0116545692555501,-0.0259430569796385,0.0197428545021178,0.790243457947658
Physical measures,X4270.Volume level set by participant (left),SCARF2,Scavenger receptor class F member 2,16799,-0.0114104432160951,0.0429911730564489,-0.095673142406735,0.0728522559745447,0.790694098882055
Physical measures,X4270.Volume level set by participant (left),ALMS1,Alstrom syndrome protein 1,14404,0.00846209119199492,0.0319382779402094,-0.0541369335708155,0.0710611159548053,0.791050703335017
Physical measures,X4270.Volume level set by participant (left),TNFSF8,Tumor necrosis factor ligand superfamily member 8,14678,-0.0108680743378168,0.0411221843978269,-0.0914675557575575,0.0697314070819239,0.791562199531191
Physical measures,X4270.Volume level set by participant (left),AMY2A,Pancreatic alpha-amylase,16025,-0.00736375224409757,0.0278635154867197,-0.0619762425980683,0.0472487381098731,0.791568059929819
Physical measures,X4270.Volume level set by participant (left),TSPAN1,Tetraspanin-1,16356,0.00586282968693412,0.0221915095030283,-0.0376325289390014,0.0493581883128696,0.791634945917671
Physical measures,X4270.Volume level set by participant (left),BCR,Breakpoint cluster region protein,16637,0.00387319641347894,0.01466249932578,-0.0248653022650499,0.0326116950920078,0.791662503688947
Physical measures,X4270.Volume level set by participant (left),MYH7B,Myosin-7B,14144,-0.00917492588687115,0.0348823487029817,-0.0775443293447153,0.059194477570973,0.792535231644707
Physical measures,X4270.Volume level set by participant (left),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16799,0.0071999245830242,0.0274424557783225,-0.0465872887424879,0.0609871379085363,0.79304370461776
Physical measures,X4270.Volume level set by participant (left),GGH,Gamma-glutamyl hydrolase,16377,0.00993612021510701,0.0380124859233554,-0.0645683521946695,0.0844405926248836,0.793794317509735
Physical measures,X4270.Volume level set by participant (left),FCRL2,Fc receptor-like protein 2,16753,-0.00660320069443349,0.0253235769847111,-0.0562374115844673,0.0430310101956004,0.794286137859647
Physical measures,X4270.Volume level set by participant (left),THOP1,Thimet oligopeptidase,16584,-0.0102683635713082,0.0397222950426664,-0.0881240618549343,0.0675873347123179,0.796021340369593
Physical measures,X4270.Volume level set by participant (left),CLEC6A,C-type lectin domain family 6 member A,16266,-0.00711530842697833,0.0277623977954725,-0.0615296081061045,0.0472989912521478,0.797727840713625
Physical measures,X4270.Volume level set by participant (left),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,16057,0.00884623849602909,0.0347074429095059,-0.0591803496066024,0.0768728265986606,0.798818930342689
Physical measures,X4270.Volume level set by participant (left),CLMP,CXADR-like membrane protein,16810,0.0156125566335837,0.0613862268382923,-0.104704447969469,0.135929561236637,0.799241252858553
Physical measures,X4270.Volume level set by participant (left),FGA,Fibrinogen alpha chain,14361,0.012482808381779,0.049134802720646,-0.0838214049506871,0.108787021714245,0.799458814903352
Physical measures,X4270.Volume level set by participant (left),FTCD,Formimidoyltransferase-cyclodeaminase,14584,0.00445668638641824,0.0176963154184827,-0.0302280918338079,0.0391414646066444,0.801166267888944
Physical measures,X4270.Volume level set by participant (left),RAB10,Ras-related protein Rab-10,14652,-0.00687110805526726,0.0272862271316735,-0.0603521132333473,0.0466098971228128,0.801186840059724
Physical measures,X4270.Volume level set by participant (left),RNASE10,Inactive ribonuclease-like protein 10,14288,0.00794381281544949,0.0315465203003159,-0.0538873669731697,0.0697749926040687,0.801189506533395
Physical measures,X4270.Volume level set by participant (left),TPSAB1,Tryptase alpha/beta-1,16809,-0.0060140603823773,0.0239403925796584,-0.0529372298385078,0.0409091090737532,0.80165500944835
Physical measures,X4270.Volume level set by participant (left),FZD8,Frizzled-8,14168,-0.00858216941075957,0.0342303180387994,-0.0756735927668064,0.0585092539452872,0.802035500005938
Physical measures,X4270.Volume level set by participant (left),PPIE,Peptidyl-prolyl cis-trans isomerase E,14404,0.00594161677265005,0.0237003991483646,-0.0405111655581447,0.0523943991034448,0.802052031780975
Physical measures,X4270.Volume level set by participant (left),CXCL1,Growth-regulated alpha protein,16609,-0.00340122668414286,0.0136097585307648,-0.0300763534044419,0.0232739000361562,0.802659365729275
Physical measures,X4270.Volume level set by participant (left),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16308,-0.00422326522488872,0.016941448527977,-0.0374285043397237,0.0289819738899463,0.803142735278806
Physical measures,X4270.Volume level set by participant (left),LAMP2,Lysosome-associated membrane glycoprotein 2,16143,0.0167520171625445,0.0673355686461208,-0.115225697383852,0.148729731708941,0.803530978375846
Physical measures,X4270.Volume level set by participant (left),BAG3,BAG family molecular chaperone regulator 3,16500,-0.0078367650046518,0.0315053756876811,-0.0695873013525067,0.0539137713432031,0.803562110749511
Physical measures,X4270.Volume level set by participant (left),TP53,Cellular tumor antigen p53,16266,0.00741532129143471,0.0299564609720847,-0.0512993422138512,0.0661299847967206,0.804496076995909
Physical measures,X4270.Volume level set by participant (left),GIP,Gastric inhibitory polypeptide,14288,0.00739663889187519,0.0299841316911219,-0.0513722592227238,0.0661655370064741,0.805155477444725
Physical measures,X4270.Volume level set by participant (left),SNAP25,Synaptosomal-associated protein 25,14168,-0.00788975324363057,0.0319850220153787,-0.0705803963937729,0.0548008899065118,0.805167013529273
Physical measures,X4270.Volume level set by participant (left),REG1A,Lithostathine-1-alpha,16528,-0.00653388513117279,0.0265205879496257,-0.0585142375124392,0.0454464672500936,0.805398659910872
Physical measures,X4270.Volume level set by participant (left),SDHB,Succinate dehydrogenase,14588,-0.00551428362364324,0.0224411708172776,-0.0494989784255073,0.0384704111782209,0.805901099960096
Physical measures,X4270.Volume level set by participant (left),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14261,-0.00875809379198627,0.0357226591909263,-0.0787745058062018,0.0612583182222293,0.80632899844943
Physical measures,X4270.Volume level set by participant (left),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14652,-0.00405926106135425,0.0166035809964826,-0.0366022798144601,0.0284837576917516,0.80686169725435
Physical measures,X4270.Volume level set by participant (left),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,14175,0.00699231058962643,0.0287569147905059,-0.0493712423997651,0.063355863579018,0.807890923069447
Physical measures,X4270.Volume level set by participant (left),UBQLN3,Ubiquilin-3,14175,-0.00730094506254517,0.0301231468067763,-0.0663423128038267,0.0517404226787364,0.808497040836167
Physical measures,X4270.Volume level set by participant (left),IRAK1,Interleukin-1 receptor-associated kinase 1,16350,-0.00451730820797416,0.0187414704547525,-0.0412505902992891,0.0322159738833407,0.809532757466643
Physical measures,X4270.Volume level set by participant (left),FNDC1,Fibronectin type III domain-containing protein 1,14628,0.00755107118030024,0.0315865964385102,-0.0543586578391797,0.0694608001997802,0.811062915725583
Physical measures,X4270.Volume level set by participant (left),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14572,0.00561809340566266,0.0235011969672807,-0.0404442526502076,0.0516804394615329,0.811065813635658
Physical measures,X4270.Volume level set by participant (left),VWA1,von Willebrand factor A domain-containing protein 1,16794,0.00720032808444753,0.0301366895228267,-0.0518675833802928,0.0662682395491879,0.811168728274857
Physical measures,X4270.Volume level set by participant (left),C1S,Complement C1s subcomponent,14697,0.0162709535763451,0.0683248810307004,-0.117645813243828,0.150187720396518,0.811775081384378
Physical measures,X4270.Volume level set by participant (left),NUCB2,Nucleobindin-2,16784,-0.00810115177712497,0.0340203223110187,-0.0747809835067217,0.0585786799524718,0.811785629546268
Physical measures,X4270.Volume level set by participant (left),ENDOU,Poly(U)-specific endoribonuclease,13528,-0.00695181959867967,0.0292129869063308,-0.0642092739350881,0.0503056347377287,0.81190783545802
Physical measures,X4270.Volume level set by participant (left),EHD3,EH domain-containing protein 3,14288,0.0031996122661999,0.0134611128447528,-0.0231841689095155,0.0295833934419153,0.812122627202627
Physical measures,X4270.Volume level set by participant (left),HLA_DRA,,16585,0.0083807392846733,0.0353739490307775,-0.0609522008156505,0.0777136793849971,0.812723026942151
Physical measures,X4270.Volume level set by participant (left),CDH2,Cadherin-2,16666,-0.00812688883354706,0.0345357790840513,-0.0758170158382877,0.0595632381711935,0.813964856146188
Physical measures,X4270.Volume level set by participant (left),DDR1,Epithelial discoidin domain-containing receptor 1,16799,0.0127073845945641,0.0542275054927038,-0.0935785261711354,0.118993295360264,0.814728031138729
Physical measures,X4270.Volume level set by participant (left),KLRD1,Natural killer cells antigen CD94,16843,-0.0063130111810816,0.0270290971360313,-0.059290041567703,0.0466640192055398,0.815326689401797
Physical measures,X4270.Volume level set by participant (left),CPB2,Carboxypeptidase B2,14672,0.0150785015922673,0.06458133108005,-0.111500907324631,0.141657910509165,0.81539132905256
Physical measures,X4270.Volume level set by participant (left),FH,"Fumarate hydratase, mitochondrial",14168,-0.00427805790554462,0.0183680812875616,-0.0402794972291654,0.0317233814180762,0.81583685601724
Physical measures,X4270.Volume level set by participant (left),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14588,0.00654193856623534,0.0281743509203855,-0.0486797892377203,0.061763666370191,0.816389955547275
Physical measures,X4270.Volume level set by participant (left),ERBB3,Receptor tyrosine-protein kinase erbB-3,16589,0.0150509346994968,0.0649752398658087,-0.112300535437488,0.142402404836482,0.816819658368251
Physical measures,X4270.Volume level set by participant (left),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16266,-0.00370065081910408,0.0159771358452868,-0.0350158370758662,0.027614535437658,0.816834794797662
Physical measures,X4270.Volume level set by participant (left),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14288,-0.00477336286724976,0.020648274954542,-0.045243981778152,0.0356972560436525,0.817182244067642
Physical measures,X4270.Volume level set by participant (left),CD69,Early activation antigen CD69,16585,0.003428373781097,0.014984229081189,-0.0259407152180335,0.0327974627802275,0.819028115739027
Physical measures,X4270.Volume level set by participant (left),THBD,Thrombomodulin,16666,-0.0103003653787594,0.0450681776947359,-0.0986339936604416,0.0780332629029229,0.819220921622467
Physical measures,X4270.Volume level set by participant (left),CADPS,Calcium-dependent secretion activator 1,14261,0.00820603671311959,0.0359163489037204,-0.0621900071381723,0.0786020805644115,0.819279210826094
Physical measures,X4270.Volume level set by participant (left),CA9,Carbonic anhydrase 9,16810,-0.00626942542340128,0.0275836176576394,-0.0603333160323744,0.0477944651855719,0.820202566638479
Physical measures,X4270.Volume level set by participant (left),ICAM3,Intercellular adhesion molecule 3,16871,0.0109778006614736,0.0483788758675963,-0.0838447960390151,0.105800397361962,0.820494068046496
Physical measures,X4270.Volume level set by participant (left),TEX101,Testis-expressed protein 101,14261,-0.00678922387140633,0.0299272136831714,-0.0654465626904223,0.0518681149476096,0.820537520391186
Physical measures,X4270.Volume level set by participant (left),SAG,S-arrestin,14168,0.00635536152319878,0.0280934431682864,-0.0487077870866426,0.0614185101330402,0.82103184451394
Physical measures,X4270.Volume level set by participant (left),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,14144,-0.00511084166129278,0.0226689749175601,-0.0495420324997106,0.0393203491771251,0.821628318397162
Physical measures,X4270.Volume level set by participant (left),DUOX2,Dual oxidase 2,16356,-0.00389077956238727,0.0173891268461158,-0.0379734681807743,0.0301919090559997,0.822956316362786
Physical measures,X4270.Volume level set by participant (left),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",14175,-0.00510753228081607,0.0229740957641513,-0.0501367599785526,0.0399216954169205,0.824070317999598
Physical measures,X4270.Volume level set by participant (left),SLAMF8,SLAM family member 8,16266,0.00551367041028007,0.024802290816474,-0.0430988195900089,0.054126160410569,0.824079343422222
Physical measures,X4270.Volume level set by participant (left),CKAP4,Cytoskeleton-associated protein 4,16747,0.0104449435556327,0.0470336408860202,-0.081740992580967,0.102630879692232,0.82425907441957
Physical measures,X4270.Volume level set by participant (left),GAGE2A,G antigen 2A,14144,-0.00527103063327812,0.0238215554086246,-0.0519612792341824,0.0414192179676262,0.824884259418658
Physical measures,X4270.Volume level set by participant (left),CLEC1B,C-type lectin domain family 1 member B,16799,-0.0029075957815755,0.0131954977391615,-0.0287707713503319,0.0229555797871809,0.825603159992967
Physical measures,X4270.Volume level set by participant (left),SMOC2,SPARC-related modular calcium-binding protein 2,16733,-0.00722904624930134,0.032933813803256,-0.0717793213036831,0.0573212288050804,0.826261507058609
Physical measures,X4270.Volume level set by participant (left),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14572,0.00678742852945673,0.0309270838071781,-0.0538296557326124,0.0674045127915259,0.826290513730322
Physical measures,X4270.Volume level set by participant (left),NBL1,Neuroblastoma suppressor of tumorigenicity 1,16719,-0.0105420333195416,0.0481475755346234,-0.104911281367403,0.0838272147283202,0.826689703984267
Physical measures,X4270.Volume level set by participant (left),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,14175,-0.00692942744458994,0.0319676507023893,-0.069586022821273,0.0557271679320932,0.828395596534347
Physical measures,X4270.Volume level set by participant (left),PROC,Vitamin K-dependent protein C,16685,0.0105546554963344,0.0487005536471197,-0.0848984296520203,0.106007740644689,0.828424868025264
Physical measures,X4270.Volume level set by participant (left),LYPD1,Ly6/PLAUR domain-containing protein 1,16257,-0.00451018594350397,0.0208309320472109,-0.0453388127560373,0.0363184408690294,0.8285899257706
Physical measures,X4270.Volume level set by participant (left),PARD3,Partitioning defective 3 homolog,14404,0.00431459339353571,0.0199533776557073,-0.0347940268116506,0.043423213598722,0.828808623762828
Physical measures,X4270.Volume level set by participant (left),EGFL7,Epidermal growth factor-like protein 7,16266,-0.00702468678690878,0.032494876059117,-0.0707146438627781,0.0566652702889605,0.828851488022547
Physical measures,X4270.Volume level set by participant (left),FCN1,Ficolin-1,14639,0.00557773888753305,0.0260259343581933,-0.0454330924545258,0.0565885702295919,0.830304686631483
Physical measures,X4270.Volume level set by participant (left),TBR1,T-box brain protein 1,14261,0.00669427117784714,0.031248421246227,-0.0545526344647579,0.0679411768204521,0.830372718058047
Physical measures,X4270.Volume level set by participant (left),CR1,Complement receptor type 1,14606,-0.00903194531145285,0.0421947578471044,-0.0917336706917775,0.0736697800688718,0.830508148872004
Physical measures,X4270.Volume level set by participant (left),PADI2,Protein-arginine deiminase type-2,16350,-0.00478796354662739,0.0224645141007298,-0.0488184111840577,0.0392424840908029,0.831224696127602
Physical measures,X4270.Volume level set by participant (left),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",14144,0.00583602972029181,0.0273889389979541,-0.0478462907156983,0.0595183501562819,0.831267792569399
Physical measures,X4270.Volume level set by participant (left),IGF2R,Cation-independent mannose-6-phosphate receptor,16671,-0.0115390594422961,0.0541978520608961,-0.117766849481652,0.0946887305970604,0.831402722000147
Physical measures,X4270.Volume level set by participant (left),PADI4,Protein-arginine deiminase type-4,16231,-0.00381970673129394,0.0181269531513912,-0.0393485349080208,0.0317091214454329,0.833108623482504
Physical measures,X4270.Volume level set by participant (left),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16350,0.00634464090493116,0.0301433353569638,-0.0527362963947179,0.0654255782045803,0.833293829597861
Physical measures,X4270.Volume level set by participant (left),CEP152,Centrosomal protein of 152 kDa,14144,-0.00758555519265329,0.0361219866243327,-0.0783846489763454,0.0632135385910388,0.833672040990244
Physical measures,X4270.Volume level set by participant (left),CD34,Hematopoietic progenitor cell antigen CD34,16738,0.0109872423701704,0.0526343112235938,-0.0921760076280735,0.114150492368414,0.834648471180206
Physical measures,X4270.Volume level set by participant (left),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16350,0.00622037710270038,0.0298821965762967,-0.0523487281868412,0.0647894823922419,0.835104046963692
Physical measures,X4270.Volume level set by participant (left),DGKZ,Diacylglycerol kinase zeta,16350,-0.00752205069474294,0.0362007408788476,-0.0784755028172842,0.0634314014277983,0.835397715713351
Physical measures,X4270.Volume level set by participant (left),WNT9A,Protein Wnt-9a,16350,0.0094074367483236,0.0453607809090858,-0.0794996938334845,0.0983145673301317,0.835706768615055
Physical measures,X4270.Volume level set by participant (left),TCN2,Transcobalamin-2,16839,-0.00872826507417943,0.042262017525051,-0.0915618194232794,0.0741052892749205,0.836381454666526
Physical measures,X4270.Volume level set by participant (left),CD7,T-cell antigen CD7,14184,-0.00718365938579349,0.0347998766906019,-0.0753914176993731,0.0610240989277862,0.836459781968324
Physical measures,X4270.Volume level set by participant (left),TAGLN3,Transgelin-3,14144,-0.00511837941182116,0.0248075044109554,-0.0537410880572937,0.0435043292336514,0.836540935805373
Physical measures,X4270.Volume level set by participant (left),DPP10,Inactive dipeptidyl peptidase 10,16637,-0.00744808823391064,0.0362043924953319,-0.0784086975247611,0.0635125210569398,0.837009552230093
Physical measures,X4270.Volume level set by participant (left),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,14168,-0.00559670489099842,0.0273165912259013,-0.059137223693765,0.0479438139117682,0.837666491921562
Physical measures,X4270.Volume level set by participant (left),CLEC10A,C-type lectin domain family 10 member A,16533,0.0071724654902586,0.035078257277366,-0.0615809187733789,0.0759258497538961,0.837988435905838
Physical measures,X4270.Volume level set by participant (left),DLGAP5,Disks large-associated protein 5,14629,-0.00584039170550898,0.0287193567342859,-0.0621303309047094,0.0504495474936914,0.838855859020364
Physical measures,X4270.Volume level set by participant (left),SEPTIN7,Septin-7,14404,-0.00559750388178787,0.0277926184091148,-0.060071035963653,0.0488760282000772,0.840386678219973
Physical measures,X4270.Volume level set by participant (left),PPP1R9B,Neurabin-2,16843,-0.00267273527184704,0.0132899934359362,-0.0287211224062819,0.0233756518625879,0.840615894396656
Physical measures,X4270.Volume level set by participant (left),SIGLEC15,Sialic acid-binding Ig-like lectin 15,16257,-0.00330987775885699,0.0164671351670493,-0.0355854626862736,0.0289657071685596,0.840701870437974
Physical measures,X4270.Volume level set by participant (left),CRELD2,Protein disulfide isomerase CRELD2,16710,0.00489526634195582,0.0243670759392665,-0.0428642024990066,0.0526547351829183,0.840781757282134
Physical measures,X4270.Volume level set by participant (left),TREH,Trehalase,14678,-0.00389766405015115,0.0194270791973273,-0.0419747392769127,0.0341794111766104,0.840990313022504
Physical measures,X4270.Volume level set by participant (left),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16637,0.00566244571189552,0.028313530614753,-0.0498320742930204,0.0611569657168115,0.841490221108035
Physical measures,X4270.Volume level set by participant (left),F9,Coagulation factor IX,16685,-0.0138117043317223,0.069202432549795,-0.14944847212932,0.121825063465876,0.841808308605261
Physical measures,X4270.Volume level set by participant (left),CTF1,Cardiotrophin-1,16356,0.00307326479574087,0.0155209053518602,-0.027347709693905,0.0334942392853868,0.843041198889727
Physical measures,X4270.Volume level set by participant (left),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14588,0.00858724208053054,0.0434768407391058,-0.0766273657681168,0.0938018499291778,0.843428849313949
Physical measures,X4270.Volume level set by participant (left),MTR,Methionine synthase,14175,-0.00446968869619007,0.0227116420396747,-0.0489845070939525,0.0400451297015724,0.843985582345253
Physical measures,X4270.Volume level set by participant (left),RALY,RNA-binding protein Raly,14572,-0.00599601155541658,0.0304777873875534,-0.0657324748350213,0.0537404517241882,0.844038589106986
Physical measures,X4270.Volume level set by participant (left),TFRC,Transferrin receptor protein 1,16731,-0.00629916259157223,0.0321936933403443,-0.0693988015386471,0.0568004763555026,0.844875158470117
Physical measures,X4270.Volume level set by participant (left),ARTN,Artemin,16350,-0.00549032093531491,0.0283029471440831,-0.0609640973377178,0.049983455467088,0.846190766139922
Physical measures,X4270.Volume level set by participant (left),IL1B,Interleukin-1 beta,16270,-0.00416699654226942,0.0215152345238089,-0.0463368562089349,0.0380028631243961,0.846431569476104
Physical measures,X4270.Volume level set by participant (left),SCPEP1,Retinoid-inducible serine carboxypeptidase,14237,-0.00580255882537757,0.0300145599469297,-0.0646310963213598,0.0530259786706046,0.846707365503958
Physical measures,X4270.Volume level set by participant (left),RSPO1,R-spondin-1,16533,0.00688610754467388,0.0363248895120059,-0.0643106758988577,0.0780828909882055,0.84964846493749
Physical measures,X4270.Volume level set by participant (left),TPRKB,EKC/KEOPS complex subunit TPRKB,14144,0.0043097814986401,0.0227523763777209,-0.0402848762016929,0.0489044391989731,0.849765463613706
Physical measures,X4270.Volume level set by participant (left),DNAJC21,DnaJ homolog subfamily C member 21,14628,-0.00684687065782504,0.0363714337454802,-0.0781348807989662,0.0644411394833161,0.850684408239846
Physical measures,X4270.Volume level set by participant (left),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14628,-0.00682930416766645,0.0364941542601617,-0.0783578465175834,0.0646992381822505,0.851558016561786
Physical measures,X4270.Volume level set by participant (left),DEFB118,Beta-defensin 118,14168,-0.00496564339237161,0.0266457466048169,-0.0571913067378127,0.0472600199530695,0.852166834805471
Physical measures,X4270.Volume level set by participant (left),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,14175,-0.00493123440636589,0.0264907875609654,-0.0568531780258581,0.0469907092131263,0.85233056035563
Physical measures,X4270.Volume level set by participant (left),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16766,-0.00429330864658692,0.0230968323719484,-0.0495631000956058,0.0409764828024319,0.852538759647814
Physical measures,X4270.Volume level set by participant (left),GC,Vitamin D-binding protein,14697,-0.0105504267500337,0.0569598754870594,-0.12219178270467,0.101090929204603,0.853054654487807
Physical measures,X4270.Volume level set by participant (left),GBA,Lysosomal acid glucosylceramidase,14261,0.00519846499746831,0.0281608194784987,-0.0499967411803892,0.0603936711753258,0.85354603450301
Physical measures,X4270.Volume level set by participant (left),GP6,Platelet glycoprotein VI,16633,-0.00271237454995315,0.0147237439610437,-0.0315709127135988,0.0261461636136925,0.853844906470051
Physical measures,X4270.Volume level set by participant (left),BSND,Barttin,14144,0.00820920013098088,0.0446331083988093,-0.0792716923306853,0.0956900925926471,0.854073953539781
Physical measures,X4270.Volume level set by participant (left),IL1RL2,Interleukin-1 receptor-like 2,16350,-0.00601788232029508,0.0328586264541389,-0.0704207901704073,0.0583850255298171,0.85468677963006
Physical measures,X4270.Volume level set by participant (left),SOD2,"Superoxide dismutase [Mn], mitochondrial",16671,0.00623497383263249,0.0341942312082059,-0.060785719335451,0.073255667000716,0.855318181164813
Physical measures,X4270.Volume level set by participant (left),LGALS1,Galectin-1,16666,0.0067259859924212,0.0369095498690294,-0.0656167317508764,0.0790687037357188,0.855405326840009
Physical measures,X4270.Volume level set by participant (left),ANXA3,Annexin A3,16785,-0.0034713659666414,0.0191047383461876,-0.0409166531251692,0.0339739211918864,0.855818924102833
Physical measures,X4270.Volume level set by participant (left),GRPEL1,"GrpE protein homolog 1, mitochondrial",16576,-0.0038611262371538,0.0214083788510034,-0.0458215487851205,0.0380992963108129,0.856875424220645
Physical measures,X4270.Volume level set by participant (left),CSF3R,Granulocyte colony-stimulating factor receptor,14207,-0.00845517150914208,0.0470186761048616,-0.100611776674671,0.0837014336563867,0.857291888275632
Physical measures,X4270.Volume level set by participant (left),PON1,Serum paraoxonase/arylesterase 1,14672,-0.00991020090606738,0.0551299255552929,-0.117964854994441,0.0981444531823066,0.857342824896128
Physical measures,X4270.Volume level set by participant (left),TMED10,Transmembrane emp24 domain-containing protein 10,14175,0.0055136518553986,0.0307420826372175,-0.0547408301135476,0.0657681338243448,0.857663940063128
Physical measures,X4270.Volume level set by participant (left),ITGBL1,Integrin beta-like protein 1,14678,-0.00705463211120896,0.0397397699998904,-0.0849445813109942,0.0708353170885762,0.85910185322492
Physical measures,X4270.Volume level set by participant (left),SORCS2,VPS10 domain-containing receptor SorCS2,16266,-0.00640665737575755,0.0360924097859996,-0.0771477805563167,0.0643344658048016,0.85911233656109
Physical measures,X4270.Volume level set by participant (left),MAEA,E3 ubiquitin-protein transferase MAEA,16266,0.00581682761538035,0.032778292561726,-0.0584286258056025,0.0700622810363632,0.859149489928029
Physical measures,X4270.Volume level set by participant (left),CTAG1A_CTAG1B,Cancer/testis antigen 1,14374,0.00521383635869346,0.0297174189453074,-0.053032304774109,0.063459977491496,0.860730771647967
Physical measures,X4270.Volume level set by participant (left),DCC,Netrin receptor DCC,14261,0.0118635390305347,0.067631652060408,-0.120694499007865,0.144421577068934,0.860756829278022
Physical measures,X4270.Volume level set by participant (left),TPPP2,Tubulin polymerization-promoting protein family member 2,14404,-0.00325704541360509,0.0186436480309476,-0.0397985955542624,0.0332845047270522,0.861317821711426
Physical measures,X4270.Volume level set by participant (left),CGN,Cingulin,14261,-0.00670329284274256,0.0384361909939365,-0.082038227190858,0.0686316415053729,0.861553160801855
Physical measures,X4270.Volume level set by participant (left),SERPINF1,Pigment epithelium-derived factor,14427,0.00990262602930982,0.0569739693750521,-0.101766353945792,0.121571606004412,0.862017496830239
Physical measures,X4270.Volume level set by participant (left),ANGPTL2,Angiopoietin-related protein 2,16665,0.00546892184143976,0.0318099582546919,-0.0568785963377563,0.0678164400206358,0.86349871106641
Physical measures,X4270.Volume level set by participant (left),BTC,Probetacellulin,16266,-0.00303001824699173,0.0176302565511303,-0.0375853210872072,0.0315252845932237,0.863546061736423
Physical measures,X4270.Volume level set by participant (left),LRG1,Leucine-rich alpha-2-glycoprotein,14697,-0.00961443693940106,0.055993513843014,-0.119361724071709,0.100132850192906,0.863670829591674
Physical measures,X4270.Volume level set by participant (left),GPKOW,G-patch domain and KOW motifs-containing protein,16257,0.00793819597647279,0.0464833480111613,-0.0831691661254033,0.0990455580783489,0.864402777320618
Physical measures,X4270.Volume level set by participant (left),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16543,-0.00210400017364138,0.0124325865909063,-0.0264718698918178,0.022263869544535,0.865615682585038
Physical measures,X4270.Volume level set by participant (left),SMPD3,Sphingomyelin phosphodiesterase 3,14207,-0.00428257361412112,0.025397621928809,-0.0540619125945867,0.0454967653663445,0.866097127395458
Physical measures,X4270.Volume level set by participant (left),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16671,0.00562120402481477,0.0335046477723902,-0.06004790560907,0.0712903136586995,0.866763226244462
Physical measures,X4270.Volume level set by participant (left),MORF4L1,Mortality factor 4-like protein 1,14404,0.00602436388321115,0.0359474034491954,-0.0644325468772118,0.0764812746436341,0.866909539412777
Physical measures,X4270.Volume level set by participant (left),CBS,Cystathionine beta-synthase,14288,0.00498587579773719,0.0298203601531992,-0.0534620301025333,0.0634337816980077,0.867217386315674
Physical measures,X4270.Volume level set by participant (left),NPY,Pro-neuropeptide Y,16810,-0.003162749789136,0.0189958713692104,-0.0403946576727885,0.0340691580945165,0.867768088915022
Physical measures,X4270.Volume level set by participant (left),MORF4L2,Mortality factor 4-like protein 2,14144,-0.0065238724833122,0.0392218057843829,-0.0833986118207027,0.0703508668540783,0.867897441184292
Physical measures,X4270.Volume level set by participant (left),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16715,-0.00493767607810097,0.029764032789601,-0.063275180345719,0.0533998281895171,0.868242334909987
Physical measures,X4270.Volume level set by participant (left),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16576,0.00446543319147215,0.0270931017044036,-0.0486370461491589,0.0575679125321032,0.86908917925822
Physical measures,X4270.Volume level set by participant (left),RNF4,E3 ubiquitin-protein ligase RNF4,14404,0.00366821558554426,0.0222649903828863,-0.0399711655649128,0.0473075967360014,0.869141009637947
Physical measures,X4270.Volume level set by participant (left),SPRR3,Small proline-rich protein 3,14628,-0.00350583684882166,0.0213956592379934,-0.0454413289552888,0.0384296552576454,0.869845679046825
Physical measures,X4270.Volume level set by participant (left),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16481,-0.00511275290472215,0.031378424645326,-0.0666144652095611,0.0563889594001168,0.870568870557624
Physical measures,X4270.Volume level set by participant (left),CASC3,Protein CASC3,14261,0.00579155101064861,0.0357126957294869,-0.0642053326191457,0.0757884346404429,0.871173773532059
Physical measures,X4270.Volume level set by participant (left),CASP1,Caspase-1,16257,0.00294477955348393,0.0181616617309591,-0.032652077439196,0.0385416365461639,0.871195555592527
Physical measures,X4270.Volume level set by participant (left),ZCCHC8,Zinc finger CCHC domain-containing protein 8,14175,0.00391624684588346,0.0241583829098537,-0.0434341836574298,0.0512666773491967,0.871223781159661
Physical measures,X4270.Volume level set by participant (left),LGMN,Legumain,16733,0.005679789634478,0.0352921778582255,-0.0634928789676439,0.0748524582365999,0.872145580966665
Physical measures,X4270.Volume level set by participant (left),GPHA2,Glycoprotein hormone alpha-2,14588,-0.00500419266506384,0.0312631114611654,-0.0662798911289479,0.0562715057988202,0.872830509799087
Physical measures,X4270.Volume level set by participant (left),CRX,Cone-rod homeobox protein,16356,0.00191771478955419,0.0119816014785773,-0.0215662241084574,0.0254016536875658,0.872839756025405
Physical measures,X4270.Volume level set by participant (left),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16637,-0.002178415721301,0.0136342604782611,-0.0289015662586927,0.0245447348160907,0.873060158457989
Physical measures,X4270.Volume level set by participant (left),TP73,Tumor protein p73,14261,-0.00692517870937777,0.0434583163352978,-0.0921034787265614,0.0782531213078058,0.873393648676665
Physical measures,X4270.Volume level set by participant (left),ADGRB3,Adhesion G protein-coupled receptor B3,16500,0.00606631320050604,0.0382389636605034,-0.0688820555740807,0.0810146819750928,0.873952725001216
Physical measures,X4270.Volume level set by participant (left),LETM1,Mitochondrial proton/calcium exchanger protein,14629,-0.00445926957298544,0.0282532812438243,-0.0598357008108811,0.0509171616649102,0.874591427736316
Physical measures,X4270.Volume level set by participant (left),EPB41L5,Band 4.1-like protein 5,14261,-0.00366829761355232,0.0232901883830811,-0.0493170668443912,0.0419804716172866,0.874849895556404
Physical measures,X4270.Volume level set by participant (left),SAT1,Diamine acetyltransferase 1,14175,-0.00482457863067913,0.0308605856187781,-0.0653113264434842,0.055662169182126,0.875771479993884
Physical measures,X4270.Volume level set by participant (left),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16350,-0.00477615433696478,0.0308310514971465,-0.0652050152713719,0.0556527065974424,0.87689121415289
Physical measures,X4270.Volume level set by participant (left),EDNRB,Endothelin receptor type B,14207,-0.00519168291854722,0.033581204995739,-0.0710108447101956,0.0606274788731012,0.877138196661425
Physical measures,X4270.Volume level set by participant (left),LRP1,Prolow-density lipoprotein receptor-related protein 1,16576,0.00734585867122337,0.0481444345072765,-0.0870172329630385,0.101708950305485,0.878731670614542
Physical measures,X4270.Volume level set by participant (left),CEND1,Cell cycle exit and neuronal differentiation protein 1,14168,0.00390800393270279,0.0256715850392865,-0.0464083027442987,0.0542243106097043,0.879007133709282
Physical measures,X4270.Volume level set by participant (left),COLEC12,Collectin-12,16630,0.00760261517796897,0.0499731650022073,-0.0903447882263573,0.105550018582295,0.879083132014277
Physical measures,X4270.Volume level set by participant (left),SORD,Sorbitol dehydrogenase,16744,-0.00293931436418366,0.0193719236799006,-0.0409082847767889,0.0350296560484216,0.879401220155568
Physical measures,X4270.Volume level set by participant (left),GID8,Glucose-induced degradation protein 8 homolog,14629,0.00650366908589631,0.0433830223540483,-0.0785270547280383,0.0915343928998309,0.88083550503878
Physical measures,X4270.Volume level set by participant (left),GFAP,Glial fibrillary acidic protein,16235,0.00422591857938569,0.0282355328825137,-0.0511157258703412,0.0595675630291125,0.881029455385189
Physical measures,X4270.Volume level set by participant (left),TPR,Nucleoprotein TPR,14175,-0.00476900521278363,0.0318856537799864,-0.067264886621557,0.0577268761959898,0.881109275703671
Physical measures,X4270.Volume level set by participant (left),CLIC5,Chloride intracellular channel protein 5,14261,0.00682650409405866,0.0456914625461455,-0.0827287624963865,0.0963817706845038,0.881236680272581
Physical measures,X4270.Volume level set by participant (left),FUCA1,Tissue alpha-L-fucosidase,16772,-0.00229598743510904,0.0153925764258816,-0.0324654372298369,0.0278734623596188,0.88142760185776
Physical measures,X4270.Volume level set by participant (left),PLXNA4,Plexin-A4,16637,-0.00237095327049946,0.0159323693875081,-0.0335983972700153,0.0288564907290164,0.881702523107783
Physical measures,X4270.Volume level set by participant (left),ITGA2,Integrin alpha-2,14352,-0.00642282914040896,0.043190085929819,-0.0910753975628543,0.0782297392820364,0.881783987089505
Physical measures,X4270.Volume level set by participant (left),TPPP3,Tubulin polymerization-promoting protein family member 3,16257,-0.00487145502048135,0.0327741609666887,-0.0691088105151912,0.0593659004742285,0.881841871479325
Physical measures,X4270.Volume level set by participant (left),GPC1,Glypican-1,16810,-0.00637340207365096,0.0429163910922329,-0.0904895286144273,0.0777427244671254,0.881944121847396
Physical measures,X4270.Volume level set by participant (left),KLK15,Kallikrein-15,14534,-0.00418307850056692,0.0281751357120612,-0.0594063444962068,0.051040187495073,0.88197627203861
Physical measures,X4270.Volume level set by participant (left),F10,Coagulation factor X,14672,-0.00808036057264965,0.054461383672659,-0.114824672571061,0.098663951425762,0.882053901484741
Physical measures,X4270.Volume level set by participant (left),AHNAK2,Protein AHNAK2,14288,-0.00753956912992259,0.0508265346068513,-0.107159576959351,0.0920804386995059,0.88207715065906
Physical measures,X4270.Volume level set by participant (left),NPL,N-acetylneuraminate lyase,14652,0.00487227656970376,0.0329875612915622,-0.0597833435617582,0.0695278967011658,0.882581236963103
Physical measures,X4270.Volume level set by participant (left),CFB,Complement factor B,14429,-0.00649097903091447,0.0444365314427278,-0.0935865806586609,0.080604622596832,0.88386577564417
Physical measures,X4270.Volume level set by participant (left),MNAT1,CDK-activating kinase assembly factor MAT1,14404,0.00476342321232403,0.0328024540418755,-0.059529386709752,0.0690562331344001,0.884542800033199
Physical measures,X4270.Volume level set by participant (left),CD93,Complement component C1q receptor,16020,-0.00604573494253553,0.0417303334467614,-0.0878371884981878,0.0757457186131167,0.884810389147189
Physical measures,X4270.Volume level set by participant (left),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14352,-0.00342745455207353,0.0236708289334548,-0.0498222792616449,0.0429673701574979,0.884873535601042
Physical measures,X4270.Volume level set by participant (left),SCRG1,Scrapie-responsive protein 1,14652,0.00779734682666925,0.0540444693229885,-0.0981298130463882,0.113724506699727,0.885284121761112
Physical measures,X4270.Volume level set by participant (left),IL11,Interleukin-11,16350,0.00293169645360406,0.020372350675887,-0.0369981108711345,0.0428615037783426,0.885576746070961
Physical measures,X4270.Volume level set by participant (left),IL24,Interleukin-24,16350,0.00386388910367197,0.0270699578056294,-0.0491932281953617,0.0569210064027057,0.886499522457595
Physical measures,X4270.Volume level set by participant (left),IFNLR1,Interferon lambda receptor 1,16637,-0.00488758717585912,0.0343399364239669,-0.0721938625668343,0.062418688215116,0.886821443859962
Physical measures,X4270.Volume level set by participant (left),CTRC,Chymotrypsin-C,16650,-0.00282618092057286,0.0199445170442835,-0.0419174343273686,0.0362650724862229,0.887316993783138
Physical measures,X4270.Volume level set by participant (left),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16719,-0.00191358025254286,0.0135165070996271,-0.0284059341678119,0.0245787736627262,0.887418547014103
Physical measures,X4270.Volume level set by participant (left),SMC3,Structural maintenance of chromosomes protein 3,14144,0.00386434027797796,0.0273460009431167,-0.0497338215705308,0.0574625021264867,0.887624843946404
Physical measures,X4270.Volume level set by participant (left),FYB1,FYN-binding protein 1,16633,0.00197362372070817,0.0139794326989478,-0.0254260643692296,0.0293733118106459,0.887729038102482
Physical measures,X4270.Volume level set by participant (left),SIGLEC7,Sialic acid-binding Ig-like lectin 7,16666,0.006341192667734,0.0449683593617305,-0.0817967916812577,0.0944791770167257,0.887860159118535
Physical measures,X4270.Volume level set by participant (left),CEBPA,CCAAT/enhancer-binding protein alpha,14207,0.00550589908067304,0.0390859938036176,-0.0711026487744175,0.0821144469357636,0.887977569869084
Physical measures,X4270.Volume level set by participant (left),S100A11,Protein S100-A11,16540,0.00359009568159059,0.0257020291511986,-0.0467858814547587,0.0539660728179399,0.888913417240148
Physical measures,X4270.Volume level set by participant (left),ACRV1,Acrosomal protein SP-10,14207,0.00276968790655774,0.0198329400299251,-0.0361028745520954,0.0416422503652109,0.888937804918006
Physical measures,X4270.Volume level set by participant (left),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16719,0.00503152784705047,0.0361126397371398,-0.0657492460377436,0.0758123017318446,0.889192076347884
Physical measures,X4270.Volume level set by participant (left),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16266,-0.00234663322534484,0.0168824379879078,-0.0354362116816441,0.0307429452309544,0.889453072441041
Physical measures,X4270.Volume level set by participant (left),SRPK2,SRSF protein kinase 2,16637,-0.00210743814996687,0.0151772136818691,-0.0318547769664302,0.0276399006664965,0.889566093629574
Physical measures,X4270.Volume level set by participant (left),CLEC5A,C-type lectin domain family 5 member A,16600,0.00593406184243994,0.0429519151670584,-0.0782516918849946,0.0901198155698745,0.890118860180631
Physical measures,X4270.Volume level set by participant (left),ANGPTL7,Angiopoietin-related protein 7,16810,-0.00479895306610064,0.0347825134109227,-0.072972679351509,0.0633747732193078,0.89026556130486
Physical measures,X4270.Volume level set by participant (left),ADA,Adenosine deaminase,16843,-0.00482427804645215,0.035534100017291,-0.0744711140803425,0.0648225579874382,0.892008886045311
Physical measures,X4270.Volume level set by participant (left),BANK1,B-cell scaffold protein with ankyrin repeats,16637,-0.00176862871640325,0.0130460508714212,-0.0273388884243888,0.0238016309915822,0.892164343433117
Physical measures,X4270.Volume level set by participant (left),CALY,Neuron-specific vesicular protein calcyon,14175,-0.00546527998491946,0.0407002940199139,-0.0852378562639506,0.0743072962941117,0.893182211759139
Physical measures,X4270.Volume level set by participant (left),SUSD4,Sushi domain-containing protein 4,14572,0.0046012781281805,0.0345150663538655,-0.0630482519253959,0.0722508081817569,0.89394835231636
Physical measures,X4270.Volume level set by participant (left),KLK6,Kallikrein-6,16691,-0.00559777222906942,0.0420443589999632,-0.0880047158689973,0.0768091714108584,0.894084526193005
Physical measures,X4270.Volume level set by participant (left),CLEC3B,Tetranectin,14341,-0.00906614264561659,0.0683830668616369,-0.143096953694425,0.124964668403192,0.894528388376807
Physical measures,X4270.Volume level set by participant (left),CELA3A,Chymotrypsin-like elastase family member 3A,16843,0.0028919909098391,0.0218255285209357,-0.0398860449911949,0.0456700268108732,0.894586479968416
Physical measures,X4270.Volume level set by participant (left),ESR1,Estrogen receptor,14207,-0.0034037913649743,0.0257932113237084,-0.0539584855594427,0.0471509028294941,0.895014146035214
Physical measures,X4270.Volume level set by participant (left),SMARCA2,Probable global transcription activator SNF2L2,16257,-0.00239897086869942,0.0183030766737998,-0.0382730011493469,0.0334750594119481,0.895722135207598
Physical measures,X4270.Volume level set by participant (left),TBC1D5,TBC1 domain family member 5,16637,0.00205675216649592,0.0157422780742229,-0.0287981128589811,0.0329116171919729,0.896052585900258
Physical measures,X4270.Volume level set by participant (left),CPXM2,Inactive carboxypeptidase-like protein X2,14652,-0.00761779148267097,0.058884648211723,-0.123031701977648,0.107796119012306,0.897068213900562
Physical measures,X4270.Volume level set by participant (left),KCNH2,Potassium voltage-gated channel subfamily H member 2,14261,0.00245778854345754,0.0192208110697844,-0.0352150011533199,0.040130578240235,0.898252693006921
Physical measures,X4270.Volume level set by participant (left),OLR1,Oxidized low-density lipoprotein receptor 1,16511,-0.00266666289514143,0.0209191525706166,-0.04366820193355,0.0383348761432671,0.898566242814012
Physical measures,X4270.Volume level set by participant (left),MATN2,Matrilin-2,16675,0.0053889956822583,0.0423459129929946,-0.0776089937840112,0.0883869851485278,0.89873513016507
Physical measures,X4270.Volume level set by participant (left),GLB1,Beta-galactosidase,16533,0.00392100407065849,0.0309457622791386,-0.0567326899964531,0.0645746981377701,0.89917488691732
Physical measures,X4270.Volume level set by participant (left),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16843,-0.00170341884188251,0.0134615822727772,-0.0280881200965258,0.0246812824127608,0.899306575040793
Physical measures,X4270.Volume level set by participant (left),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14404,0.00369147040282877,0.0292446260366688,-0.0536279966290421,0.0610109374346996,0.899553759865529
Physical measures,X4270.Volume level set by participant (left),CD58,Lymphocyte function-associated antigen 3,16609,-0.00907446886269186,0.0720352115441041,-0.150263483489136,0.132114545763752,0.899755074483002
Physical measures,X4270.Volume level set by participant (left),THY1,Thy-1 membrane glycoprotein,16799,-0.00560755327823664,0.0445979477545439,-0.0930195308771428,0.0818044243206695,0.899942663756134
Physical measures,X4270.Volume level set by participant (left),SERPING1,Plasma protease C1 inhibitor,14672,0.00951598274060954,0.0777512675638617,-0.142876501684559,0.161908467165778,0.902591784025507
Physical measures,X4270.Volume level set by participant (left),SCARF1,Scavenger receptor class F member 1,16871,-0.00355773080239089,0.0294581736814864,-0.0612957512181043,0.0541802896133225,0.903872846322949
Physical measures,X4270.Volume level set by participant (left),RAB44,Ras-related protein Rab-44,14572,-0.00416150071906037,0.0344887633383127,-0.0717594768621533,0.0634364754240326,0.903960020923955
Physical measures,X4270.Volume level set by participant (left),ARMCX2,Armadillo repeat-containing X-linked protein 2,14168,-0.00295457428890258,0.0245922273640379,-0.0511553399224169,0.0452461913446117,0.904371887495786
Physical measures,X4270.Volume level set by participant (left),CEMIP2,Cell surface hyaluronidase,14207,-0.00554267406604416,0.0461973940357472,-0.0960895663761086,0.0850042182440203,0.90450222047992
Physical measures,X4270.Volume level set by participant (left),SAA4,Serum amyloid A-4 protein,14697,-0.00540028239747726,0.0453123643694325,-0.094212516561565,0.0834119517666105,0.905135172221601
Physical measures,X4270.Volume level set by participant (left),AMY2B,Alpha-amylase 2B,15538,-0.00333955192591703,0.0280876846470125,-0.0583914138340616,0.0517123099822275,0.90535820153009
Physical measures,X4270.Volume level set by participant (left),GIMAP8,GTPase IMAP family member 8,14144,0.00357171931652849,0.0301942434007607,-0.0556089977489625,0.0627524363820195,0.905838453360188
Physical measures,X4270.Volume level set by participant (left),SPESP1,Sperm equatorial segment protein 1,14652,-0.00575556049826672,0.0486615790065758,-0.101132255351155,0.0896211343546219,0.905849561136684
Physical measures,X4270.Volume level set by participant (left),TNN,Tenascin-N,14678,0.00390143185527191,0.0332167796393504,-0.0612034562378548,0.0690063199483987,0.906502184288214
Physical measures,X4270.Volume level set by participant (left),CLSTN2,Calsyntenin-2,16843,0.00370201917535381,0.0316017401511171,-0.0582373915208357,0.0656414298715433,0.906745712885239
Physical measures,X4270.Volume level set by participant (left),CBLIF,Cobalamin binding intrinsic factor,16639,-0.00201735851174251,0.0172616705511243,-0.035850232791946,0.031815515768461,0.906965077077894
Physical measures,X4270.Volume level set by participant (left),IL1RL1,Interleukin-1 receptor-like 1,16805,0.00315501795988599,0.0270564172548236,-0.0498755598595682,0.0561855957793402,0.90717141154549
Physical measures,X4270.Volume level set by participant (left),LTB,Lymphotoxin-beta,14572,-0.00480619938009541,0.0415964447715326,-0.0863352311322994,0.0767228323721086,0.908015926516129
Physical measures,X4270.Volume level set by participant (left),IL12A_IL12B,Interleukin-12,16576,-0.00191113127399859,0.0166337939003953,-0.0345133673187734,0.0306911047707762,0.90853014524354
Physical measures,X4270.Volume level set by participant (left),LY75,Lymphocyte antigen 75,16637,-0.00372110111695461,0.0324583411841958,-0.0673394498379784,0.0598972476040692,0.908729980595429
Physical measures,X4270.Volume level set by participant (left),FGL1,Fibrinogen-like protein 1,14672,-0.00261385910099217,0.0229067932854847,-0.0475111739405422,0.0422834557385579,0.909153372295947
Physical measures,X4270.Volume level set by participant (left),CXCL9,C-X-C motif chemokine 9,16733,-0.00219642498370989,0.0192516897899727,-0.0399297369720564,0.0355368870046367,0.909167832035163
Physical measures,X4270.Volume level set by participant (left),LTA,Lymphotoxin-alpha,16637,-0.00354530858170206,0.0317197055900262,-0.0657159315381534,0.0586253143747493,0.911007197507622
Physical measures,X4270.Volume level set by participant (left),PLA2G2A,"Phospholipase A2, membrane associated",16611,-0.00250104836524284,0.0224929158289123,-0.0465871633899109,0.0415850666594252,0.911464873681494
Physical measures,X4270.Volume level set by participant (left),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14288,-0.00447223409068256,0.0404493162343349,-0.083752893909979,0.0748084257286139,0.911963731550211
Physical measures,X4270.Volume level set by participant (left),DSC2,Desmocollin-2,16497,0.00417277986599937,0.0379465197840201,-0.0702023989106801,0.0785479586426789,0.912438663348775
Physical measures,X4270.Volume level set by participant (left),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16576,0.00440624880273316,0.0401259718812499,-0.0742406560845166,0.0830531536899829,0.912561077946586
Physical measures,X4270.Volume level set by participant (left),GAL,Galanin peptides,16733,-0.00213947752736528,0.0195292262395625,-0.0404167609569078,0.0361378059021773,0.912765518383486
Physical measures,X4270.Volume level set by participant (left),OPTC,Opticin,16576,0.00313597699652558,0.0286594266906033,-0.0530364993170568,0.059308453310108,0.912868966799354
Physical measures,X4270.Volume level set by participant (left),RASA1,Ras GTPase-activating protein 1,16257,0.00434895546175709,0.0399540913908741,-0.0739610636643562,0.0826589745878704,0.913323750635669
Physical measures,X4270.Volume level set by participant (left),HBZ,Hemoglobin subunit zeta,14652,0.00141938942441142,0.0130736987542016,-0.0242050601338237,0.0270438389826465,0.913546382738924
Physical measures,X4270.Volume level set by participant (left),CHRDL2,Chordin-like protein 2,16666,0.00250970044667607,0.0231851959038674,-0.0429332835249041,0.0479526844182562,0.913802007042911
Physical measures,X4270.Volume level set by participant (left),DCXR,L-xylulose reductase,16719,0.00263913449541513,0.0244315403630555,-0.0452466846161736,0.0505249536070039,0.913979842218056
Physical measures,X4270.Volume level set by participant (left),FGF23,Fibroblast growth factor 23,16804,0.0023575618037941,0.021962988044505,-0.0406898947634358,0.045405018371024,0.914518560626429
Physical measures,X4270.Volume level set by participant (left),NPTX2,Neuronal pentraxin-2,14678,0.00464765978904111,0.0434120088350167,-0.0804398775275916,0.0897351971056738,0.914743390945868
Physical measures,X4270.Volume level set by participant (left),CD8A,T-cell surface glycoprotein CD8 alpha chain,16799,0.00269039684848525,0.0251639271563447,-0.0466309003779503,0.0520116940749208,0.914857830561889
Physical measures,X4270.Volume level set by participant (left),CASP10,Caspase-10,16257,0.00200078656704416,0.0187969643462857,-0.0348412635516759,0.0388428366857642,0.915232982165552
Physical measures,X4270.Volume level set by participant (left),PITHD1,PITH domain-containing protein 1,14117,0.00195085202162112,0.0188838240817099,-0.0350614431785304,0.0389631472217726,0.917719914889116
Physical measures,X4270.Volume level set by participant (left),HDGF,Hepatoma-derived growth factor,16774,0.00141408236037047,0.0139339816897982,-0.0258965217516339,0.0287246864723749,0.919167121274669
Physical measures,X4270.Volume level set by participant (left),DDX58,Antiviral innate immune response receptor RIG-I,16266,-0.00234902331055717,0.0233639918851986,-0.0481424474055464,0.043444400784432,0.919916611602943
Physical measures,X4270.Volume level set by participant (left),SIL1,Nucleotide exchange factor SIL1,14288,0.00431992277901789,0.0436704352922808,-0.0812741303938525,0.0899139759518883,0.921202390825878
Physical measures,X4270.Volume level set by participant (left),C1R,Complement C1r subcomponent,14697,0.00728529145549067,0.0737553811834441,-0.13727525566406,0.151845838575041,0.921317151030852
Physical measures,X4270.Volume level set by participant (left),RAB39B,Ras-related protein Rab-39B,14175,-0.00156772636788979,0.0161173556411901,-0.0331577434246225,0.0300222906888429,0.922513790722458
Physical measures,X4270.Volume level set by participant (left),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,14175,0.00215329328901238,0.0223159175474666,-0.0415859051040222,0.045892491682047,0.923131699397537
Physical measures,X4270.Volume level set by participant (left),VSTM2B,V-set and transmembrane domain-containing protein 2B,14404,0.00327859654173466,0.0339890622710179,-0.0633399655094605,0.0698971585929298,0.923156313745025
Physical measures,X4270.Volume level set by participant (left),PGR,Progesterone receptor,14207,0.00136927582360561,0.0144064963997263,-0.026867457119858,0.0296060087670692,0.924279853981676
Physical measures,X4270.Volume level set by participant (left),PLG,Plasminogen,14271,0.00644597443367826,0.0678300382723824,-0.126500900580191,0.139392849447548,0.924291328163679
Physical measures,X4270.Volume level set by participant (left),IL3,Interleukin-3,14144,0.00237652755700518,0.0251727436495573,-0.0469620499961271,0.0517151051101375,0.92478579497622
Physical measures,X4270.Volume level set by participant (left),MRPL46,"39S ribosomal protein L46, mitochondrial",16257,0.00436200058689982,0.0465925842571928,-0.0869594645571981,0.0956834657309978,0.925412128023061
Physical measures,X4270.Volume level set by participant (left),CES2,Cocaine esterase,16576,-0.00211779197561583,0.0228180204338008,-0.0468411120258654,0.0426055280746337,0.92605383620564
Physical measures,X4270.Volume level set by participant (left),VWC2,Brorin,16465,-0.00300328593925737,0.0325993290726855,-0.0668979709217209,0.0608913990432061,0.926598074734073
Physical measures,X4270.Volume level set by participant (left),TPSG1,Tryptase gamma,14207,-0.00498928019026917,0.0545178633242779,-0.111844292305854,0.101865731925316,0.927083544041767
Physical measures,X4270.Volume level set by participant (left),BTD,Biotinidase,14697,0.0063119672498148,0.0698171169430516,-0.130529581958566,0.143153516458196,0.927964900706597
Physical measures,X4270.Volume level set by participant (left),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16785,0.00406134876212944,0.045223428347147,-0.0845765707982787,0.0926992683225376,0.928442214545739
Physical measures,X4270.Volume level set by participant (left),PRAME,Melanoma antigen preferentially expressed in tumors,14144,-0.00531319042243078,0.0594533293450284,-0.121841715938686,0.111215335093825,0.92879118486282
Physical measures,X4270.Volume level set by participant (left),MAGEA3,Melanoma-associated antigen 3,14404,-0.00157526324602049,0.017680873271719,-0.0362297748585897,0.0330792483665487,0.929008287523357
Physical measures,X4270.Volume level set by participant (left),MSLNL,Mesothelin-like protein,14261,0.00357664225561203,0.040348302247634,-0.0755060301497507,0.0826593146609747,0.929365940158289
Physical measures,X4270.Volume level set by participant (left),CCL4,C-C motif chemokine 4,16668,0.00169398250319259,0.0191555448110563,-0.0358508853264777,0.0392388503328629,0.929533588651752
Physical measures,X4270.Volume level set by participant (left),TMPRSS5,Transmembrane protease serine 5,16443,0.00298015190866839,0.0338838630943769,-0.0634322197563104,0.0693925235736472,0.929915936790206
Physical measures,X4270.Volume level set by participant (left),MAN2B2,Epididymis-specific alpha-mannosidase,14652,0.00216316707674317,0.0246637869592647,-0.0461778553634157,0.050504189516902,0.93011139025448
Physical measures,X4270.Volume level set by participant (left),PLA2G10,Group 10 secretory phospholipase A2,16533,-0.00183291135460335,0.021443424455171,-0.0438620232867385,0.0401962005775318,0.931883521355669
Physical measures,X4270.Volume level set by participant (left),APOE,Apolipoprotein E,14697,0.00173209238811285,0.0203170163876418,-0.0380892597316651,0.0415534445078908,0.932061192037945
Physical measures,X4270.Volume level set by participant (left),IL9,Interleukin-9,14404,-0.00221334768136252,0.026010093936109,-0.0531931317961361,0.0487664364334111,0.93218647665089
Physical measures,X4270.Volume level set by participant (left),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14652,0.00162844576664688,0.0191747444187003,-0.0359540532940058,0.0392109448272995,0.932320909533697
Physical measures,X4270.Volume level set by participant (left),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16533,0.00195900746732507,0.0231802680811099,-0.0434743179716503,0.0473923329063004,0.93265050151549
Physical measures,X4270.Volume level set by participant (left),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14572,-0.00325903479473694,0.0387182415267525,-0.0791467881871718,0.0726287185976979,0.932919955198134
Physical measures,X4270.Volume level set by participant (left),CCL2,C-C motif chemokine 2,16500,-0.00208419123810996,0.025086667663771,-0.0512540598591011,0.0470856773828812,0.933789226182116
Physical measures,X4270.Volume level set by participant (left),CREB3,Cyclic AMP-responsive element-binding protein 3,14144,0.0022178480571039,0.027348841486559,-0.0513858812565517,0.0558215773707595,0.9353677323422
Physical measures,X4270.Volume level set by participant (left),FOSB,Protein fosB,16257,0.00262748276693191,0.0328957387331362,-0.0618481651500151,0.0671031306838789,0.936339213742022
Physical measures,X4270.Volume level set by participant (left),IL12B,Interleukin-12 subunit beta,16843,0.00184489887212769,0.0232281480506148,-0.0436822713070773,0.0473720690513326,0.936695418829568
Physical measures,X4270.Volume level set by participant (left),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",14175,0.00194326967735862,0.0244685695909436,-0.0460151267208908,0.0499016660756081,0.936700467645374
Physical measures,X4270.Volume level set by participant (left),CDH6,Cadherin-6,16666,-0.00262367490804135,0.0332672639328851,-0.067827512216496,0.0625801624004134,0.937139703671134
Physical measures,X4270.Volume level set by participant (left),FAS,Tumor necrosis factor receptor superfamily member 6,16805,0.00306063523238643,0.0389311465390357,-0.0732444119841235,0.0793656824488964,0.937338502968422
Physical measures,X4270.Volume level set by participant (left),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14629,0.00162331149220632,0.0206719699039237,-0.0388937495194842,0.0421403725038969,0.937409786092258
Physical measures,X4270.Volume level set by participant (left),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16576,-0.00352588980134585,0.0449114426853937,-0.0915523174647174,0.0845005378620257,0.937425229601624
Physical measures,X4270.Volume level set by participant (left),LRRC59,Leucine-rich repeat-containing protein 59,14652,0.00238100367863616,0.0303654162415428,-0.0571352121547876,0.06189721951206,0.937501644951579
Physical measures,X4270.Volume level set by participant (left),ART5,Ecto-ADP-ribosyltransferase 5,14168,0.00188868202399057,0.0242084892328522,-0.0455599568723998,0.0493373209203809,0.937815359842802
Physical measures,X4270.Volume level set by participant (left),HDAC8,Histone deacetylase 8,14207,-0.00187940423391514,0.0241004268169947,-0.0491162407952248,0.0453574323273945,0.937843314045219
Physical measures,X4270.Volume level set by participant (left),SCGN,Secretagogin,16350,0.00228289912837672,0.0292778400523279,-0.0551016673741859,0.0596674656309394,0.937849993684503
Physical measures,X4270.Volume level set by participant (left),ICA1,Islet cell autoantigen 1,16350,-0.00129042209824794,0.0165708527088327,-0.03376929340756,0.0311884492110641,0.937930026867406
Physical measures,X4270.Volume level set by participant (left),C3,Complement C3,13885,0.00222951448084566,0.0289615943674086,-0.0545352104792752,0.0589942394409665,0.938639166554846
Physical measures,X4270.Volume level set by participant (left),RELB,Transcription factor RelB,14207,-0.00227527713670293,0.0298985815222248,-0.0608764969202635,0.0563259426468576,0.939340743806066
Physical measures,X4270.Volume level set by participant (left),ADAMTSL2,ADAMTS-like protein 2,14678,-0.00337722105726432,0.0451825674835868,-0.0919350533250944,0.0851806112105657,0.940417741363283
Physical measures,X4270.Volume level set by participant (left),BHLHE40,Class E basic helix-loop-helix protein 40,14168,0.00158330241716408,0.0213031607477917,-0.0401708926485077,0.0433374974828358,0.940754889914652
Physical measures,X4270.Volume level set by participant (left),IL31RA,Interleukin-31 receptor subunit alpha,14169,0.00285246569177995,0.0385005586923685,-0.0726086293452622,0.0783135607288221,0.940940660547783
Physical measures,X4270.Volume level set by participant (left),LGALS8,Galectin-8,16799,-0.00153705677470282,0.0208524439041292,-0.0424078468267961,0.0393337332773905,0.941241137279919
Physical measures,X4270.Volume level set by participant (left),VCAN,Versican core protein,16799,-0.00306336465778235,0.0416341756900832,-0.0846663490103455,0.0785396196947808,0.941346953146856
Physical measures,X4270.Volume level set by participant (left),GGT5,Glutathione hydrolase 5 proenzyme,16533,0.00406192974349514,0.0553211631822582,-0.104367550093731,0.112491409580721,0.941469196838391
Physical measures,X4270.Volume level set by participant (left),VASN,Vasorin,16335,0.00344169839122422,0.0470390499073382,-0.0887548394271587,0.0956382362096071,0.941674254433383
Physical measures,X4270.Volume level set by participant (left),METAP1,Methionine aminopeptidase 1,16257,-0.00316535344113925,0.0435595369849806,-0.0885420459317012,0.0822113390494227,0.942071774589599
Physical measures,X4270.Volume level set by participant (left),FOLR2,Folate receptor beta,16799,0.00307932879240523,0.0428104092978969,-0.0808290734314726,0.0869877310162831,0.94265891767101
Physical measures,X4270.Volume level set by participant (left),ATP6V1F,V-type proton ATPase subunit F,16222,-0.00139239665452208,0.0195046226242657,-0.0396214569980828,0.0368366636890386,0.943089814100685
Physical measures,X4270.Volume level set by participant (left),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16266,0.00154127819966408,0.0216302533226,-0.0408540183126319,0.0439365747119601,0.94319515239749
Physical measures,X4270.Volume level set by participant (left),PNLIPRP1,Inactive pancreatic lipase-related protein 1,14628,0.00129661244759491,0.0184664651544068,-0.0348976592550425,0.0374908841502323,0.944023944828206
Physical measures,X4270.Volume level set by participant (left),FUS,RNA-binding protein FUS,16260,-0.00230333614529714,0.0336685018019996,-0.0682935996772163,0.063686927386622,0.945458355633554
Physical measures,X4270.Volume level set by participant (left),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,14168,-0.00159392009919625,0.0235431395304232,-0.0477384735788257,0.0445506333804332,0.946023730284134
Physical measures,X4270.Volume level set by participant (left),SFRP4,Secreted frizzled-related protein 4,14352,-0.00237517658906858,0.0356679003234594,-0.0722842612230491,0.0675339080449119,0.946907894865463
Physical measures,X4270.Volume level set by participant (left),PRL,Prolactin,16799,0.00108057399760489,0.0163697843093639,-0.0310042032487483,0.0331653512439581,0.94737042969195
Physical measures,X4270.Volume level set by participant (left),HEPACAM2,HEPACAM family member 2,14628,-0.00228628439247033,0.0346687177759584,-0.0702369712333487,0.0656644024484081,0.947421234573711
Physical measures,X4270.Volume level set by participant (left),PTPRM,Receptor-type tyrosine-protein phosphatase mu,16610,-0.00334696008385317,0.051291465797164,-0.103878233046295,0.0971843128785883,0.947972758316227
Physical measures,X4270.Volume level set by participant (left),THRAP3,Thyroid hormone receptor-associated protein 3,14175,-0.000831062826962219,0.0132676014261462,-0.0268355616222087,0.0251734359682843,0.950055244753901
Physical measures,X4270.Volume level set by participant (left),ARHGEF5,Rho guanine nucleotide exchange factor 5,14168,0.00129979890158943,0.0208497956986169,-0.0395658006676996,0.0421653984708785,0.950292090836798
Physical measures,X4270.Volume level set by participant (left),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14404,-0.0013243854275726,0.021402402819192,-0.0432730949531889,0.0406243240980438,0.950659077826436
Physical measures,X4270.Volume level set by participant (left),SGSH,N-sulphoglucosamine sulphohydrolase,14419,0.00164689181349884,0.026629273936338,-0.0505464851017236,0.0538402687287212,0.950686994835008
Physical measures,X4270.Volume level set by participant (left),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16266,0.00181483214425879,0.0294864685844226,-0.0559786462812095,0.059608310569727,0.950923573003236
Physical measures,X4270.Volume level set by participant (left),MUC16,Mucin-16,16576,-0.000415349808411759,0.0067716883850214,-0.0136878590430537,0.0128571594262302,0.951092181257998
Physical measures,X4270.Volume level set by participant (left),SPINK4,Serine protease inhibitor Kazal-type 4,16637,-0.00120206331107925,0.0198820177378613,-0.0401708180772874,0.0377666914551289,0.951790139319936
Physical measures,X4270.Volume level set by participant (left),FARSA,Phenylalanine--tRNA ligase alpha subunit,14261,-0.00128960681369987,0.0216896717887391,-0.0438013635196285,0.0412221498922288,0.95258880115444
Physical measures,X4270.Volume level set by participant (left),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16266,0.00169904952683905,0.0287988430890628,-0.054746682927724,0.0581447819814021,0.952955107461346
Physical measures,X4270.Volume level set by participant (left),FBN2,Fibrillin-2,14261,-0.00147247170309826,0.0250522534907561,-0.0505748885449803,0.0476299451387838,0.953131334764334
Physical measures,X4270.Volume level set by participant (left),TDGF1,Teratocarcinoma-derived growth factor 1,16257,-0.000528891626499281,0.00900362313990173,-0.0181759929807067,0.0171182097277081,0.953158258242222
Physical measures,X4270.Volume level set by participant (left),LIFR,Leukemia inhibitory factor receptor,16637,-0.00306100420228717,0.0521834932970352,-0.105340651064476,0.0992186426599018,0.953224838721445
Physical measures,X4270.Volume level set by participant (left),PPY,Pancreatic prohormone,16613,0.000739561148048405,0.0126994183369805,-0.0241512987924334,0.0256304210885302,0.953561483266881
Physical measures,X4270.Volume level set by participant (left),GAD1,Glutamate decarboxylase 1,14144,-0.00337819143720526,0.0580284075133774,-0.117113870163425,0.110357487289014,0.953577266892042
Physical measures,X4270.Volume level set by participant (left),CXCL6,C-X-C motif chemokine 6,16843,0.000978025240681856,0.0168549508792458,-0.0320576784826399,0.0340137289640036,0.953728614024231
Physical measures,X4270.Volume level set by participant (left),EPHA10,Ephrin type-A receptor 10,16257,-0.00112146851892247,0.0197889008219606,-0.0399077141299652,0.0376647770921203,0.95480750090693
Physical measures,X4270.Volume level set by participant (left),KLB,Beta-klotho,16257,-0.000988908241394279,0.0175045798061029,-0.0352978846613559,0.0333200681785674,0.954948764964654
Physical measures,X4270.Volume level set by participant (left),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,14144,0.00147479911058533,0.0266783176248101,-0.0508147034340425,0.0537643016552131,0.955915528855459
Physical measures,X4270.Volume level set by participant (left),SFRP1,Secreted frizzled-related protein 1,16468,-0.00161980039008504,0.0294362077376631,-0.0593147675559047,0.0560751667757346,0.956117237744354
Physical measures,X4270.Volume level set by participant (left),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,14175,0.00136798777678673,0.0255965945113377,-0.0488013374654352,0.0515373130190086,0.957378797190562
Physical measures,X4270.Volume level set by participant (left),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16266,-0.00191165541627432,0.0357858234724433,-0.0720518694222632,0.0682285585897145,0.957398445138322
Physical measures,X4270.Volume level set by participant (left),PAMR1,Inactive serine protease PAMR1,16671,0.00241738097941485,0.0460386192024645,-0.0878183126574156,0.0926530746162453,0.95812480761012
Physical measures,X4270.Volume level set by participant (left),RNASE3,Eosinophil cationic protein,16576,0.00057266674503602,0.010953186573066,-0.0208955789381733,0.0220409124282454,0.958303735539102
Physical measures,X4270.Volume level set by participant (left),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16356,0.000706250988241427,0.0136791679427619,-0.0261049181795718,0.0275174201560547,0.958824405181389
Physical measures,X4270.Volume level set by participant (left),CES3,Carboxylesterase 3,16576,-0.000789596606719395,0.0153780808040558,-0.0309306349826688,0.02935144176923,0.959050761054507
Physical measures,X4270.Volume level set by participant (left),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,14175,0.00103825033656999,0.0206284924798469,-0.03939359492393,0.0414700955970699,0.959859420199011
Physical measures,X4270.Volume level set by participant (left),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14588,0.000427404273709673,0.00858772655833655,-0.01640453978063,0.0172593483280493,0.960306993892242
Physical measures,X4270.Volume level set by participant (left),RNF168,E3 ubiquitin-protein ligase RNF168,14207,0.0017788941216233,0.0358708658564366,-0.0685280029569925,0.0720857912002391,0.960448527697899
Physical measures,X4270.Volume level set by participant (left),TK1,"Thymidine kinase, cytosolic",14404,0.00164521249039992,0.0334487389628799,-0.0639143158768446,0.0672047408576444,0.960771683824983
Physical measures,X4270.Volume level set by participant (left),IKBKG,NF-kappa-B essential modulator,16637,0.000737255774283963,0.0150225920253775,-0.0287070245954558,0.0301815361440238,0.960858945406741
Physical measures,X4270.Volume level set by participant (left),IL5RA,Interleukin-5 receptor subunit alpha,16637,-0.0011122259010104,0.0226893208051137,-0.0455832946790333,0.0433588428770125,0.960904108172314
Physical measures,X4270.Volume level set by participant (left),IL31,Interleukin-31,14207,-0.00130175161456071,0.0267033609349571,-0.0536403390470767,0.0510368358179553,0.961120326177196
Physical measures,X4270.Volume level set by participant (left),CGREF1,Cell growth regulator with EF hand domain protein 1,16666,-0.00143668161508019,0.0297708062187221,-0.0597874618037755,0.0569140985736151,0.96151115068104
Physical measures,X4270.Volume level set by participant (left),GPNMB,Transmembrane glycoprotein NMB,16172,0.00213588563541032,0.0455125063495868,-0.0870686268097797,0.0913403980806004,0.962569883200095
Physical measures,X4270.Volume level set by participant (left),FGFBP1,Fibroblast growth factor-binding protein 1,16719,-0.00177786850101903,0.0384413864387834,-0.0771229859210345,0.0735672489189965,0.963112489687951
Physical measures,X4270.Volume level set by participant (left),PSIP1,PC4 and SFRS1-interacting protein,16637,0.000945127530504623,0.0204657889445873,-0.0391678188008866,0.0410580738618958,0.963166660473379
Physical measures,X4270.Volume level set by participant (left),CNTN3,Contactin-3,16671,-0.00175765994459113,0.0387910425475464,-0.077788103337782,0.0742727834485997,0.963859983195861
Physical measures,X4270.Volume level set by participant (left),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16871,-0.00208242658368276,0.0464249650670431,-0.0930753581150872,0.0889105049477217,0.964222819850124
Physical measures,X4270.Volume level set by participant (left),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,14168,-0.00211155444506509,0.0471502324488678,-0.094526010044846,0.0903029011547158,0.964280474897929
Physical measures,X4270.Volume level set by participant (left),GGA1,ADP-ribosylation factor-binding protein GGA1,16257,0.00082325415140249,0.0187573217345204,-0.0359410964482575,0.0375876047510625,0.964992825776518
Physical measures,X4270.Volume level set by participant (left),NPR1,Atrial natriuretic peptide receptor 1,14175,-0.00155319366209456,0.0358809118692413,-0.0718797809258074,0.0687733936016183,0.965472994990847
Physical measures,X4270.Volume level set by participant (left),MPRIP,Myosin phosphatase Rho-interacting protein,14544,0.00143863535354904,0.0334036892581979,-0.0640325955925189,0.066909866299617,0.965647794201205
Physical measures,X4270.Volume level set by participant (left),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16266,-0.000535558831735395,0.0127399417745811,-0.0255058447099144,0.0244347270464436,0.966469099507167
Physical measures,X4270.Volume level set by participant (left),MERTK,Tyrosine-protein kinase Mer,16843,0.00205828947629511,0.0489854594922869,-0.0939532111285873,0.0980697900811775,0.966484547345378
Physical measures,X4270.Volume level set by participant (left),DCUN1D1,DCN1-like protein 1,14168,0.000811021599635461,0.0194720906506273,-0.0373542760755941,0.038976319274865,0.966777931719188
Physical measures,X4270.Volume level set by participant (left),FOLH1,Glutamate carboxypeptidase 2,14207,0.000571920159557261,0.0137379410372226,-0.0263544442733991,0.0274982845925136,0.966793681756124
Physical measures,X4270.Volume level set by participant (left),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14352,0.00163745375202804,0.0396006928298801,-0.075979904194537,0.0792548116985931,0.967018151254343
Physical measures,X4270.Volume level set by participant (left),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16533,0.00130034095826082,0.0321988647250235,-0.0618094339027852,0.0644101158193068,0.967786929289024
Physical measures,X4270.Volume level set by participant (left),CD207,C-type lectin domain family 4 member K,16293,0.00131915645819401,0.0335137591073234,-0.0643678113921598,0.0670061243085478,0.968602547300965
Physical measures,X4270.Volume level set by participant (left),PECAM1,Platelet endothelial cell adhesion molecule,16671,0.00155692891133995,0.0410785522960469,-0.0789570335889121,0.082070891411592,0.969766862322632
Physical measures,X4270.Volume level set by participant (left),HRAS,GTPase Hras,14355,-0.000568329109981856,0.0151667317764137,-0.0302951233917528,0.0291584651717891,0.970109116620475
Physical measures,X4270.Volume level set by participant (left),GJA8,Gap junction alpha-8 protein,14144,0.000929659594509738,0.0250750676053584,-0.0482174729119927,0.0500767921010121,0.970425682757448
Physical measures,X4270.Volume level set by participant (left),ITGA5,Integrin alpha-5,16671,-0.0018517239416836,0.050972803026551,-0.101758417873724,0.0980549699903564,0.971021510307768
Physical measures,X4270.Volume level set by participant (left),REG1B,Lithostathine-1-beta,16871,0.00081237478693352,0.0225063505052034,-0.0433000722032651,0.0449248217771322,0.971206750879547
Physical measures,X4270.Volume level set by participant (left),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16350,0.000630459069910242,0.0184045599966762,-0.0354424785235751,0.0367033966633956,0.972673756341332
Physical measures,X4270.Volume level set by participant (left),RANGAP1,Ran GTPase-activating protein 1,16266,0.00089451927195455,0.0264449125567967,-0.050937509339367,0.0527265478832761,0.973016509463992
Physical measures,X4270.Volume level set by participant (left),GBP1,Guanylate-binding protein 1,14589,0.000710378344675743,0.0231199361853371,-0.0446046965785851,0.0460254532679365,0.975488642811833
Physical measures,X4270.Volume level set by participant (left),CHCHD6,MICOS complex subunit MIC25,14572,0.00147637193394893,0.0499555132360332,-0.0964364340086761,0.0993891778765739,0.976423369552147
Physical measures,X4270.Volume level set by participant (left),GNLY,Granulysin,16671,-0.000688955545135074,0.0238083355515119,-0.0473532932260984,0.0459753821358282,0.976914722725017
Physical measures,X4270.Volume level set by participant (left),FGF19,Fibroblast growth factor 19,16733,-0.000483127206906394,0.0168213827213717,-0.033453037340795,0.0324867829269822,0.977087437582358
Physical measures,X4270.Volume level set by participant (left),DSCAM,Down syndrome cell adhesion molecule,14629,0.00118346861651268,0.0414206787015985,-0.0800010616386204,0.0823679988716458,0.977206391984434
Physical measures,X4270.Volume level set by participant (left),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14652,-0.00101425454205973,0.0366292905935669,-0.0728076641054509,0.0707791550213315,0.977910005981488
Physical measures,X4270.Volume level set by participant (left),TNF,Tumor necrosis factor,16330,-0.000888810148407675,0.0330618858663248,-0.0656901064464042,0.0639124861495888,0.978553201264922
Physical measures,X4270.Volume level set by participant (left),EPHB6,Ephrin type-B receptor 6,16498,-0.00109011181163127,0.040975905682021,-0.0814028869483925,0.07922266332513,0.978776122631832
Physical measures,X4270.Volume level set by participant (left),GLP1R,Glucagon-like peptide 1 receptor,14168,0.00102093428808403,0.0396665548076917,-0.0767255131349918,0.0787673817111598,0.97946674755635
Physical measures,X4270.Volume level set by participant (left),CXCL11,C-X-C motif chemokine 11,16799,0.000411211433908523,0.0160814126829916,-0.031108357424755,0.031930780292572,0.979600137117598
Physical measures,X4270.Volume level set by participant (left),SHBG,Sex hormone-binding globulin,14672,0.0007053423378312,0.028178991921995,-0.054525481829279,0.0559361665049414,0.980030747817016
Physical measures,X4270.Volume level set by participant (left),IFNG,Interferon gamma,16350,-0.00028267671668023,0.0113207584854706,-0.0224713633482026,0.0219060099148421,0.980079382508833
Physical measures,X4270.Volume level set by participant (left),EVI5,Ecotropic viral integration site 5 protein homolog,14207,-0.000425488280130609,0.0172584505623992,-0.0342520513824329,0.0334010748221717,0.980331365365009
Physical measures,X4270.Volume level set by participant (left),STX16,Syntaxin-16,16266,-0.000500825721471032,0.0215338255940188,-0.0427071238857478,0.0417054724428058,0.981445055496599
Physical measures,X4270.Volume level set by participant (left),REG3G,Regenerating islet-derived protein 3-gamma,14572,0.000853270890123898,0.0371511282339398,-0.0719629404483981,0.0736694822286458,0.981676461683944
Physical measures,X4270.Volume level set by participant (left),TRAF3,"TNF receptor-associated factor 3, Isoform 2",14207,-0.000936331705731069,0.0408029808145714,-0.0809101741022911,0.0790375106908289,0.981692369817124
Physical measures,X4270.Volume level set by participant (left),CD3E,T-cell surface glycoprotein CD3 epsilon chain,14404,-0.000908714761914776,0.040718544586287,-0.0807170621510373,0.0788996326272077,0.982195417255997
Physical measures,X4270.Volume level set by participant (left),ING1,Inhibitor of growth protein 1,16222,0.000639052857889594,0.0289963100934827,-0.0561937149253364,0.0574718206411156,0.982417029457128
Physical measures,X4270.Volume level set by participant (left),COL9A2,Collagen alpha-2(IX) chain,14404,0.000687898669281991,0.0315964026514436,-0.0612410505275474,0.0626168478661114,0.982630591294971
Physical measures,X4270.Volume level set by participant (left),GLRX,Glutaredoxin-1,16579,0.000459127554490695,0.0220507636686527,-0.0427603692360685,0.0436786243450499,0.98338838535031
Physical measures,X4270.Volume level set by participant (left),SHC1,SHC-transforming protein 1,14144,0.000268703751790851,0.0131919555561874,-0.0255875291383364,0.0261249366419181,0.983749493751145
Physical measures,X4270.Volume level set by participant (left),FGF20,Fibroblast growth factor 20,14207,-0.000680369474332984,0.0336645956411818,-0.0666629769310494,0.0653022379823834,0.983875945338798
Physical measures,X4270.Volume level set by participant (left),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14261,-0.000621743415888899,0.0312451368868926,-0.0618622117141984,0.0606187248824206,0.984124312554911
Physical measures,X4270.Volume level set by participant (left),SERPINA12,Serpin A12,16143,0.000216624775488649,0.0110448213358553,-0.0214312250427878,0.0218644745937651,0.984352141355523
Physical measures,X4270.Volume level set by participant (left),CLPS,Colipase,16633,-0.000352402353529921,0.0181548673851207,-0.0359359424283665,0.0352311377213066,0.984513546491554
Physical measures,X4270.Volume level set by participant (left),TSPAN8,Tetraspanin-8,14588,0.00027604178567108,0.0146165044373245,-0.028372306911485,0.0289243904828272,0.984932607627554
Physical measures,X4270.Volume level set by participant (left),GBP6,Guanylate-binding protein 6,14175,-0.000583591465069064,0.0324342162037844,-0.0641546552244866,0.0629874722943485,0.98564462697381
Physical measures,X4270.Volume level set by participant (left),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16356,-0.000653090826619832,0.0368517684828826,-0.0728825570530698,0.0715763753998301,0.985860764380591
Physical measures,X4270.Volume level set by participant (left),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14261,0.000328068507559014,0.0191678983504133,-0.037241012259251,0.037897149274369,0.986344698938519
Physical measures,X4270.Volume level set by participant (left),PPM1A,Protein phosphatase 1A,16266,0.000653062935204211,0.0394722384109512,-0.0767125243502602,0.0780186502206686,0.986799911407235
Physical measures,X4270.Volume level set by participant (left),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16266,-0.000238787068368253,0.0149347300084797,-0.0295108578849884,0.0290332837482519,0.987243594888112
Physical measures,X4270.Volume level set by participant (left),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14207,0.000666135209926243,0.0417231058708881,-0.0811111522970145,0.082443422716867,0.987262044755327
Physical measures,X4270.Volume level set by participant (left),STC2,Stanniocalcin-2,16647,0.000659542119649283,0.0471694398947684,-0.0917925600740968,0.0931116443133954,0.988844187737242
Physical measures,X4270.Volume level set by participant (left),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16257,-0.000356540866480532,0.0261866070149343,-0.0516822906157517,0.0509692088827906,0.989136993437047
Physical measures,X4270.Volume level set by participant (left),NRP2,Neuropilin-2,16671,0.000445115946912591,0.0437672637986661,-0.085338721098473,0.0862289529922982,0.991885723316974
Physical measures,X4270.Volume level set by participant (left),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14652,0.000527596228998456,0.0537879375358506,-0.104896761341269,0.105951953799266,0.992173952688243
Physical measures,X4270.Volume level set by participant (left),MDK,Midkine,16673,0.000240569106277367,0.0249489682980168,-0.0486594087578357,0.0491405469703904,0.99230667505463
Physical measures,X4270.Volume level set by participant (left),TTR,Transthyretin,14543,-0.00054375307117507,0.058975180502456,-0.116135106855989,0.115047600713639,0.992643709391004
Physical measures,X4270.Volume level set by participant (left),CRISP2,Cysteine-rich secretory protein 2,16810,-0.000177093149092342,0.021919654476815,-0.0431396159236497,0.042785429625465,0.993553901643116
Physical measures,X4270.Volume level set by participant (left),RARRES1,Retinoic acid receptor responder protein 1,16266,0.000285981768788877,0.0379004946727494,-0.0739989877898,0.0745709513273778,0.99397963630979
Physical measures,X4270.Volume level set by participant (left),RPS10,40S ribosomal protein S10,14175,0.000240905281221164,0.0355448010074525,-0.0694269046933858,0.0699087152558281,0.994592465469892
Physical measures,X4270.Volume level set by participant (left),DEFB103A_DEFB103B,Beta-defensin 103,14108,0.000246118606561226,0.0367923469980093,-0.071866881509537,0.0723591187226595,0.994662768111032
Physical measures,X4270.Volume level set by participant (left),MUC2,Mucin-2,14678,9.86019303910867e-05,0.0158646580794312,-0.0309961279052941,0.0311933317660763,0.995041109018584
Physical measures,X4270.Volume level set by participant (left),HIF1A,Hypoxia-inducible factor 1-alpha,14207,-0.000130919179875106,0.0224852698180432,-0.0442020480232398,0.0439402096634896,0.995354471500141
Physical measures,X4270.Volume level set by participant (left),DAND5,DAN domain family member 5,14207,0.000139458551415317,0.026600796015752,-0.0519981016394586,0.0522770187422892,0.99581706672021
Physical measures,X4270.Volume level set by participant (left),CRYBB2,Beta-crystallin B2,14628,-0.000102857305027523,0.0207571257003318,-0.0407868236776778,0.0405811090676228,0.996046344915645
Physical measures,X4270.Volume level set by participant (left),EPHA2,Ephrin type-A receptor 2,16111,0.000209422303020506,0.0427452899586633,-0.0835713460159596,0.0839901906220006,0.996090994859439
Physical measures,X4270.Volume level set by participant (left),MEP1A,Meprin A subunit alpha,14588,9.39643660621186e-05,0.0202673739562204,-0.0396300885881299,0.0398180173202541,0.996300894127372
Physical measures,X4270.Volume level set by participant (left),CCL17,C-C motif chemokine 17,16610,-6.47336657992083e-05,0.0139709007593212,-0.0274476991540687,0.0273182318224703,0.996303099535845
Physical measures,X4270.Volume level set by participant (left),DNER,Delta and Notch-like epidermal growth factor-related receptor,16619,0.000227691337430758,0.0493826663580866,-0.096562334724419,0.0970177173992805,0.996321218824808
Physical measures,X4270.Volume level set by participant (left),TACSTD2,Tumor-associated calcium signal transducer 2,14826,-8.62446190946242e-05,0.0463063088344558,-0.0908466099346281,0.0906741206964388,0.998513981133358
Physical measures,X4270.Volume level set by participant (left),ELOA,Elongin-A,16576,3.98064384820443e-05,0.0248799320952703,-0.0487248604682478,0.0488044733452119,0.998723451112944
Physical measures,X4270.Volume level set by participant (left),CDC123,Cell division cycle protein 123 homolog,14144,3.12848090341124e-05,0.0233337305734829,-0.0457028271149923,0.0457653967330606,0.998930251773268
Physical measures,X4270.Volume level set by participant (left),PROK1,Prokineticin-1,16637,-1.74987021466487e-05,0.0202425667568097,-0.0396929295454937,0.0396579321412004,0.999310278548663
Physical measures,X4270.Volume level set by participant (left),ZBTB16,Zinc finger and BTB domain-containing protein 16,16266,-3.56306944675578e-06,0.0176962823622327,-0.0346882764994229,0.0346811503605294,0.999839351888511
